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The gastrointestinal (GI) microbiota is increasingly recognized for its ability to influence 
brain function and behavior. In children with Autism Spectrum Disorder (ASD), a microbial 
dysbiosis has been described and some bacterial taxa were found to predict certain symptoms of 
ASD. Additionally, picky eating behavior and food aversions are common in children with ASD, 
resulting in limited diet variety and decreased nutrient intake (e.g., fiber). Diet is one of the 
major determinants of the GI microbiota; however, previous studies have not systematically 
investigated the role of diet in shaping the GI microbiota in children with ASD. Likewise, overall 
microbial stability is recognized as more beneficial due to its ability to protect against pathogen 
invasion and maintain overall function. In children with ASD little is known about the stability 
of the microbiota. Therefore, the goal this dissertation research was to assess the impact of diet 
on the GI microbiota in children with ASD and microbial stability over a 6-month period with 
the following aims :1) to investigate differences in microbiota composition and volatile fatty acid 
(VFA) concentration between children with ASD and unaffected controls and investigate the 
relationship to ASD symptoms; 2) to determine the effect of long-term dietary patterns and short-
term nutrient intake on the fecal microbial composition and VFA concentration in children with 
ASD and uncover relationships between diet, fecal microbiota, VFAs and ASD symptoms; and 
3) to analyze the microbiota composition and VFA concentrations in children with ASD and 
unaffected controls over a 6-month period and identify dietary factors that correlate with a more 
stable microbial profile.  
Children with ASD (ASD; n=26) and age- and sex-matched unaffected controls (CONT; 
n=32) were recruited in the Midwest area. Fecal samples, a 3-day food diary, a food frequency 




nutrition supplement use were collected at baseline, 6-weeks post-baseline and 6-months post 
baseline. ASD symptoms were assessed using the Pervasive Developmental Disorder Behavior 
Inventory – Screening Version (PDDBI-SV). Bacterial DNA was analyzed using 16S rRNA 
sequencing and quantitative Polymerase Chain Reaction. VFA concentrations were analyzed by 
gas chromatography. Dietary patterns were derived from the Youth and Adolescence Food 
Frequency Questionnaire (YAQ) using Principal Component Analysis and exploratory Factor 
Analysis. Nutrient intake was assessed by the Nutrition Data System for Research. All data were 
analyzed using SAS 9.4.  
Differences in microbiota composition between ASD and CONT were observed. Overall, 
β-diversity assessed by permutational multivariate analysis (PERMANOVA) differed (p=0.02) 
based on unweighted but not weighted d UniFrac. α-diversity measured as observed Operational 
Taxonomic Units (OTUs) tended to be higher (p=0.08) in ASD. Microbial abundances on the 
phyla, family, order and genera level were observed. Namely, ASD had higher levels of 
Firmicutes, Clostridiales, Clostridiaceae, Peptostreptococcaceae, Coriobacteriaceae, Clostridium, 
SMB53, Blautia, and Roseburia, but lower levels of Bacteroidetes, Streptophyta, Rikenellaceae, 
Butyricimonas, Butyrivibrio, Faecalibacterium, Dialister, and Bilophila compared to CONT. 
Furthermore, higher concentrations of acetate, propionate and butyrate were detected in ASD. 
Lastly, Peptostreptococcaceae and Faecalibacterium predicted social deficit (SOCDEF) scores in 
children with ASD as measured by the PDDBI-SV. 
Investigating dietary intake revealed that children with ASD consumed lower amounts of 
insoluble fiber, pectin, vitamin C and dairy, but consumed more snacks and sweets than 
unaffected children. To analyze the impact of nutrition on the GI microbiota, four analyses were 




with the abundance of bacterial taxa. Second, children with ASD characterized as picky eaters or 
having a repetitive eating pattern harbored a unique microbial composition. Third, two dietary 
patterns (DP) were empirically derived for children with ASD using the YAQ. DP-1, 
characterized by intakes of vegetables, starchy vegetables, legumes, nuts and seeds, fruit, grains, 
juice and dairy, was associated with lower abundance of Enterobacteriaceae, Lactococcus, 
Roseburia, Leuconostoc, and Ruminococcus. DP-2, characterized by intakes of fried foods, Kid’s 
meals, condiments, protein foods, snacks and starchy foods, was associated with higher 
abundance of Barnesiellaceae, Alistipes, and lower abundance of Streptophyta as well as higher 
concentrations of propionate, butyrate, isobutyrate, valerate, and isovalerate. Diet-induced 
microbial comppsition was related to some GI symptoms, but was not related to SOCDEF 
scores. Lastly, moderation analysis did not reveal a significant interaction between microbial 
taxa and dietary components in prediction SOCDEF scores.  
To investigate the temporal microbial stability, two additional samples collected over a 6-
month period were analyzed for microbiota composition and VFA concentration. We found that 
overall the microbiota composition and metabolites concentration varied in children with ASD 
and variability in community membership negatively correlated with median SOCDEF scores. 
Furthermore, different bacteria taxa contributed to a stable microbiota profile in each group. 
Clostridiales, Ruminococcaceae, Lactococcus, Turicibacter, Dorea, and Phascolarctobacterium 
contributed to a more stable microbiota community in children with ASD whereas 
Barnesiellaceae, Adlercreutia, Faecalibacterium, Sutterella and Bilophila contributed more in to 
a stable microbiota in CONT children. Lastly, GI microbiota variability was related to habitual 




Overall, the results presented herein contribute to the growing literature on a microbial 
dysbiosis and the impact of specific microbial taxa on symptoms in children with ASD. 
Importantly, this research offers new insight into the effect of diet on the microbiota 
composition, microbial metabolism and the temporal variability in children with ASD. Future 
studies are warranted to analyze whether dietary intake could potentially be a modifiable 
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Autism spectrum disorder (ASD) is typified by deficits in social communications skills 
and the presence of repetitive or restrictive behaviors (APA, 2013). In 2014, 1-in-59 children in 
the United States were diagnosed with ASD and there is a continuing upward trend in the 
number of children being diagnosed with ASD (CDC, 2014). Whether this increase is due to 
enhanced clinical testing and diagnostic methods, broader diagnostic criteria or increased 
environmental risk factors is unknown. Identifying causes underlying the development of ASD is 
challenging due to difficulties in stratifying the ASD population due to the phenotypic 
heterogeneity of the disease and occurring comorbidities (e.g. anxiety, hyperactivity); however, 
genetic as well as environmental factors are suggested to play a role (Hallmayer et al., 2011). 
Because genetic factors might account for only 10-20% of the observed ASD cases and 
concordance rate of monozygotic twins is less than 100% (77% for male and 50% for female 
pairs), importance of environmental elements, including the gastrointestinal (GI) microbiota and 
nutrition, in contributing to ASD symptom development has be suggested (Hallmayer et al., 
2011).  
Increasing evidence is presented for the ability of the GI microbiota to influence 
cognitive function and behavior via the “microbiome-gut-brain axis” (Cryan & Dinan, 2012; 
Bienenstock et al., 2015). Differences in fecal microbiota composition at the phyla and genus 
level between children with ASD and unaffected controls have been documented (Finegold et al., 
2010; De Angelis et al., 2013; Kang et al., 2013). Furthermore, specific bacterial taxa have been 
shown to be associated with the severity of some symptoms of ASD. For example, a lower ratio 




positively associated with severity of ASD symptoms (Tomova et al., 2015). Besides differences 
in the fecal microbiota, deviations in microbial products between children with ASD and 
unaffected controls have also been observed, suggesting that some microbial products could be a 
way of communication between the GI microbiota and symptoms of ASD (Wang et al., 2012). 
Lastly, intervention studies showing that some probiotics can alleviate some symptoms of ASD 
provide additional evidence for a microbiota-brain connection in ASD (West et al., 2013).  
Emerging research also supports a potential role of nutrition in cognitive function. For 
example, in healthy children an interrelationship between dietary intake, neurodevelopment, and 
cognitive function has been reported (Khan et al., 2015a), suggesting an important role of diet 
quality on brain function. Achieving adequate nutritional intake in children with ASD is a 
challenge due to GI symptoms or problematic eating behaviors (Liu X et al., 2016). Food 
selectivity and aversions with lower intakes of fruits and vegetables are commonly reported 
(Cermak et al., 2010) which can lead to malnutrition and nutrient deficiencies (Ledford & Gast, 
2006).  
The GI microbiota is influences by a variety of environmental factors, including diet. It 
has been estimated that more than 50% of microbial changes can be attributed to diet (Zhang et 
al., 2010). Thereby, long-term dietary patterns as well as short-term nutrient intake can 
determine the composition and function of the GI microbiota (Berding et al., 2018, David et al., 
2014). Diet-induced changes in microbiota composition can lead to increased risk of developing 
certain diseases (e.g., inflammatory bowel diseases), whereas a healthier long-term dietary 
pattern may be more beneficial in promoting a microbial profile that could potentially protect 
against diseases (Albenberg & Wu, 2014). The GI microbiota undergoes changes during early 




that the microbiota composition can undergo temporal variations over weeks or even the course 
of the day (Kazcmarek et al., 2017; Caporaso et al., 2011; Flores et al., 2014). Thereby, a stable 
microbiota with high levels of commensal bacteria could be indicative of health due to the ability 
to protect against pathogen invasion and maintain functions (Galloway- Peña et al., 2017; Ley et 
al., 2008). Greater microbial instability was previously found in patients with intestinal diseases 
such as Inflammatory Bowel Syndrome of Chron’s disease (Mättö 2005; Maukonen et al., 2006; 
Scanlan et al., 2006).  
Although the impact of diet on the microbiota composition is well described and the 
nutritional intake of children with ASD is often limited, most of the research published to date 
analyzing the GI microbiota in children with ASD lacks in providing substantial information on 
dietary intake in the study population. Additionally, previous research lacks in informing about 
the temporal dynamics of the microbiota composition in the ASD population and the potential 
impact of dietary factors on the variability. Thus, this dissertation research presents a new 
approach at investigating the microbiota-ASD connection by systematically analyzing the 
microbiota composition in the context of dietary intake, by examining the potential moderating 
effect of diet on the microbiota-ASD interaction and by determining the impact of diet on long-
term variability in children with ASD.  
 
1.1 Objective 
The long-term goal of this research is to develop evidence-based recommendations to 
alleviate symptoms of ASD symptoms through manipulation of the gut microbiota. Thus, the 
overall objective of this dissertation research was to 1) systematically describe the influence of 




relationship between diet and longitudinal microbial dynamics in children with ASD and the 
association with ASD symptoms. The central hypothesis is that diet-induced microbial profiles 
will be associated with ASD symptom severity and long-term dietary patterns will determine 
microbial stability in children with ASD. The rationale is to gain a better understanding of the 
interplay between diet, microbiota and severity of ASD symptoms in order to determine whether 
manipulation of the GI microbiota could be used as an effective intervention option for 
management of symptoms of ASD.  
 
1.2 Specific Aims 
 
Specific Aim 1: Analyze the fecal microbial composition and VFAs concentration in 
children with ASD and unaffected controls and determine association with symptom 
severity. 
The overall objective of this aim is to characterize the microbial profile and bacterial 
metabolic activity of children with ASD. Our working hypothesis is that microbial 
composition between children with ASD and unaffected controls will differ in overall 
diversity and composition (e.g. Bacteroidetes-to-Firmicutes ratio) and specific bacterial 
taxa will predict severity of symptoms of ASD. We further hypothesize that VFA 
(volatile fatty acid) concentrations will be greater in children with ASD and will be 
associated with higher propionate concentrations relative to acetate and butyrate.  
 





The overall objective of Aim 2 is to characterize dietary patterns or specific nutrients that 
drive a microbial profile associated with symptom severity in children with ASD. The 
working hypotheses are that 1) dietary patterns (i.e. fruit and vegetables vs. processed 
foods) and nutrient intake (e.g. dietary fiber) will determine the GI microbiota 
compostion in children with ASD and that 2) a microbial profile and VFA concentrations 
induced by specific dietary patterns and nutrient intake will predict symptoms of ASD. 
 
Specific Aim 3: Determine long-term variability of microbiota composition in children with 
ASD and association with dietary patterns. 
The overall objective is to investigate potential changes in the GI microbiota composition 
in children with ASD. The working hypotheses are that 1) the microbiota composition of 
children with ASD will be more variable compared to unaffected controls and will be 
associated with more severe ASD symptoms and that 2) dietary pattern characterized by 
higher intakes of fruit and vegetables will be associated with a more stable microbial 
profile compared to a dietary pattern high in processed foods. 
 
This dissertation research provides new evidence for a microbial dysbiosis in children 
with ASD and fills the gap in the existing literature on the impact of diet on the microbiota 
composition in children with ASD. Understanding the impact of diet on the GI microbiota in 
children with ASD can provide a significant step towards developing targeted dietary or 
prebiotic intervention strategies to alleviate some symptoms of ASD. Within this dissertation, 
Chapter 2 provides a literature review in the microbiota, nutrition and microbiota-gut-brain axis 




includes how long-term dietary patterns influence the microbiota composition and longitudinal 
variability in healthy children. Chapter 4 describes the differences in microbiota composition and 
VFA concentrations between children with ASD and unaffected controls and the impact of 
specific bacterial taxa on ASD symptoms (Aim 1) Chapter 5 systematically examines the 
relationship of diet and the microbiota composition in children with ASD and the association 
with ASD symptom severity (Aim 2). Chapter 6 analyzed the longitudinal variability of the 
microbiota in children with ASD and unaffected control and determines the impact of dietary 









Autism spectrum disorder (ASD) is typified by deficits in social communications skills 
and the presence of repetitive or restrictive behaviors (APA, 2013). The term “spectrum” refers 
to the wide variety in symptoms and intensity of symptoms and includes Autistic Disorder, 
Pervasive Developmental Disorder Not Otherwise Specified and Asperger Syndrome (APA, 
2013). In 2014, 1-in-59 children in the United States were diagnosed with ASD and there is a 
continuing upward trend in the number of children being diagnosed with ASD (CDC, 2014) 
(Figure 1.1). Between 2000 and 2010, ASD diagnoses have double from 6.7 to 14.7 per 1000 
children aged 8 and under (Baio, 2012). Whether this increase is due to enhanced clinical test 
and diagnostic methods, broader diagnostic criteria or increased environmental risk factors is 
unknown. Identifying causes for the development of ASD is challenging due to difficulties in 
stratifying the ASD population because of the phenotypic heterogeneity of the disease and 
occurring comorbidities (e.g. anxiety, hyperactivity); however, genetic as well as environmental 
factors are suggested to play a role (Hallmayer et al., 2011). Because genetic factors might 
account for only 10-20% of the observed ASD cases and concordance rate of monozygotic twins 
is less than 100% (77% for male and 50% for female pairs), importance of environmental 
elements, including the GI microbiota and nutrition, in contributing to ASD symptom 
development has be suggested (Hallmayer et al., 2011). Additionally, only half of the recent 
increase in incidence of ASD could be explained by known factors (e.g. genetics, awareness, 
                                                 
1 A portion of this literature review was previously published in Nutrition Reviews, entitled “Microbiome and 





improved clinical testing). Approximately 46% are left unexplained which could be accounted 
for by unknown environmental factors (Nardone et al., 2014).  
Food selectivity, food neophobia, and “picky eating” are prevalent among children with 
ASD and can contribute to the development of nutrient deficiencies (Marí-Bauset et al., 2013). 
Indeed, vitamin, mineral and fatty acid deficiencies have been observed in children with ASD, 
including deficiencies in vitamin D and calcium (Ranjan & Nasser, 2015). Because parents are 
concerned about the nutritional status of their children and side effects of traditional medication, 
Complementary and Alternative Medicine are commonly used by parents of children with ASD 
(Levy & Hyman 2015).  
The microbiome-gut-brain axis has been described as a way of communication between 
the gut microbiota and the brain (Bienenstock et al., 2015). Functional and inflammatory 
gastrointestinal (GI) diseases show a high co-morbidity (94%) with psychiatric diseases, such as 
depression or anxiety (Whitehead et al., 2002). On the other hand, compositional differences in 
the GI microbiota of patients with neurodevelopmental disorders, including ASD, have been 
reported (Finegold et al., 2010; Parracho et al., 2005) Alleviation of ASD symptoms after 
probiotic treatment highlights the potential of the GI microbiota to influence the symptoms 
associated with ASD (Critchfield et al., 2011). Likewise, studies have begun to investigate the 
potential of dietary interventions in managing diseases with an underlying gut-brain connection.  
Although dietary problems are well documented in children with ASD, studies 
investigating the GI microbiota composition thus far have not paid much attention to dietary 
impact on the GI microbiota in children with ASD. To further understand the potential of 
manipulating the GI microbiota and alleviating some symptoms of ASD, it is important to 




The goal of this review is to summarize the current evidence base regarding the GI environment 
and the nutritional status of children with ASD. Potential underlying mechanisms of the 
microbiome-gut-brain-axis in ASD and interplay between nutrition, microbiota and ASD 
symptoms will also be reviewed. 
 
2.2 Diagnostic Criteria and Treatment Recommendations 
Diagnostic Criteria 
A number of tools are available for ASD screening and diagnosis. These instruments 
differ in specificity of the appropriate age range, length of administration and method of 
administration. For example, different screening tools are available for parents, 
teachers/caregivers and clinicians. Examples for screening scales include Autism Behavior 
Checklist (ABC) or Autism Spectrum Quotient (ASQ). Most commonly used diagnostic scales 
include Autism Diagnostic Interview – Revised (ADI-R) and Autism Diagnostic Observation 
Schedule (ADOS). Although the tools available for ASD diagnosis show a high level of 
specificity and sensitivity, the phenotypic heterogenic nature of ASD makes a clinical 
multidisciplinary team assessment, i.e. including both qualitative and quantitative data from 
multiple sources, important for a more comprehensive and accurate diagnosis (Le Couteur et al., 
2008). Correctness of diagnosis with multidisciplinary team approach for ASD is approximated 
at 80.8% (Falkmer et al., 2013). 
Diagnostic tools used in the clinical setting are guided by the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) which is published by the American Psychiatric Association 
(APA). According to the DSM 5th edition, to be diagnosed with ASD, the child has to show 




“a) deficits in social communication and social interaction (social-emotional reciprocity, 
nonverbal communicative behaviors used for social interaction, developing, maintaining 
and understanding relationships) 
b) restricted, repetitive patterns of behavior, interests or activities manifested by at least 2 
of the following: stereotyped or repetitive motor movements, use of objects or speech; 
insistence on sameness, inflexible adherence to routines or ritualized patterns of verbal or 
nonverbal behavior; highly restricted, fixated interests that are abnormal in intensity or 
focus; hyper- or hypoactivity to sensory input or unusual interest in sensory aspects of the 
environment, 
c) symptoms must be present in early development period; 
d) symptoms cause clinically significant impairment in social, occupational or other 
important areas of current functioning, 
e) disturbances are not better explained by intellectual disability and global 
developmental delay” 
In order to provide a more reliable diagnosis of ASD and assist in targeted intervention 
strategies, an increasing number of investigators are exploring the use of biomarkers for ASD 
diagnosis. These markers include biochemical (e.g. serotonin levels), immunological (e.g. 
inflammatory cytokines), hormonal (e.g. oxytocin) or functional markers (e.g. brain 
connectivity) (Fakhoury, 2015). However, translating the discovery of biomarkers into the 
clinical application is challenging and none of the biomarkers proposed for ASD has yet been 







Early diagnosis and intervention has been proven to be important in providing better 
short- and long-term outcomes for the family and the affected child. For example, secondary 
symptoms, such as disruptive behavior, and other comorbidities (e.g. anxiety) were shown to be 
decreased in children receiving early intervention (Koegel et al., 2014). The health care cost for a 
child with ASD is 6-times higher compared to that of an unaffected child (Shimabukuro et al., 
2008). Once a child has been diagnosed with ASD, treatment and interventions usually last for 
the entire duration of their lives. Over the life of an affected child, the health care cost, e.g. costs 
for educational services, parental productivity loss and medical costs, can go up to $1.4 million 
per family (Buescher et al., 2014). Due to the heterogeneity of symptoms, treatment among 
individuals varies significantly and no single medicine or therapy is effective in treating all 
symptoms. A multimodal approach is most likely to promote optimal treatment. 
The pharmacological treatments available for ASD do not specifically target the “core” 
symptoms of ASD (impaired social interaction, communication and imaginative play and 
restrictive, repetitive activities and interests), but rather are targeting problematic “associated” 
behaviors (hyperactivity/inattention, aggression, motor stereotypes) (West et al., 2009). 
Examples for medications used in the ASD population include antipsychotic agents (e.g. 
risperidone, methylphenidate (MPH) and atomoxetine) antidepressants (e.g. selective serotonin 
reuptake inhibitors (SSRIs)) and anticonvulsants (Hirota et al., 2014). Some pharmacological 
treatment is used in conjunction with behavioral and educational therapy to increase the 
effectiveness.  
Risperidone and aripiprazole are the only drugs approved by the FDA and are usually the first-




atypical neuroleptics mostly target dopaminergic or serotoninergic systems and are used for 
irritable, aggressive or self-injurious behavior, in children and adolescents with autism. Recent 
reviews of randomized controlled trials using risperidone found that most studies reported an 
improvement in associated behaviors of autism (Canitano & Scandurra, 2011; West et al., 2009). 
Studies investigating the effect of MPH and atomoxetine, mostly treating hyperactivity and 
attention disorder, reported differing levels of improvements (Canitano & Scandurra, 2011). 
Moderate responses have been observed with SSRIs, which commonly treat deficits in 
socialization and communication as well as aggression and repetitive behaviors; however, its use 
is not generally recommended (Canitano & Scandurra, 2011; West et al., 2009). Evidence 
presented for the use of anticonvulsants is limited and thus far does not appear to provide a large 
size effect on behavioral symptoms (Hirota et al., 2014). 
Although there is limited knowledge on the effect of pharmacological treatment, almost half of 
patients are taking some form of medication with other studies reporting even higher percentages 
(Aman et al., 2003; Coury et al., 2012). When stratified by age, one study found that the 
percentage of children taking medication with age and reaches about 75% at age 12 years (Coury 
et al., 2012).  
In general, pharmacological treatment for the pediatric ASD population is not well 
studied. Studies published to date have shown more success in treating associated behaviors 
compared to core symptoms. Developing targeted treatment options is made more difficult by the 
missing knowledge of the exact neuropathology of ASD. Likewise, the effects of medicine on 
the developing brain are unknown and potential neurobiological abnormalities need to be 




interventions have failed and when physical risks due to associated behaviors outweigh potential 
side effects from medication (McKinney& Renk, 2011). 
Behavioral and Educational Intervention: Early intensive multidisciplinary behavioral 
intervention is recommended before considering pharmacotherapy for improvement of behavior. 
The literature has shown that most families adopt multiple treatment approaches in order to 
alleviate symptoms (Bowker et al., 2011). Parents mostly learn about treatment options from the 
internet, professionals or occupational therapists (Green, 2007). 
Behavioral interventions are usually started right after diagnosis and are the most 
common treatment approaches for ASD. A large amount of interventions available for ASD are 
based on methods derived from the applied behavior analysis (ABA) which is the most validated 
approach for education and treatment of ASD (Manning-Courtney et al., 2003). Examples of 
behavioral interventions include developmental interventions to improve cognitive performance, 
language skills and adaptive behavior, social skill intervention or play-/interaction-based 
intervention.  
Educational interventions traditionally focus on areas of academic progression and also 
address core areas of social, cognitive and behavioral deficits via the classroom or specialized 
institutions. One of the most widely known approaches to educational intervention in children 
with Autism is the TEACCH (Treatment and Education of Autistic and related Communication 
Handicapped Children) Method (Gerlach, 2003). The evidence presented to date has shown 
improvement in functioning of a subgroup of ASD children using of educational and behavioral 
intervention. Education is lifelong process, should begin as early as possible. Goals for 
educational intervention include enhancing social skills, improving language skills, fine and 




Other forms of nonpharmacological therapy included speech and language therapy to 
develop language function and a functional communication system as well as occupational 
therapy to regulate sensory systems and promote fine motor skills (Manning-Courtney et al., 
2003) 
Complementary and Alternative Medicine: National Center for Complementary and 
Integrative Health (NCCIH) defines two domains of CAM: natural products and mind and body 
practices (NCCIH, 2014). Natural products include herbs, vitamins and mineral or probiotics. 
Mind and body practices include yoga, meditation or massage therapy. Interestingly, parents 
learned about CAM through family or community, nonmedical professionals or internet and 
rarely asked physician for information (Wong & Smith, 2006). Additionally, parents with higher 
degree and higher socioeconomic status are more likely to use CAM (Wong & Smith, 2006; 
Akins et al., 2014). 
Although only a very little amount of high quality research is published to support use of CAM 
in management of ASD, reported percentages of parents of children with ASD using CAM 
ranges from 28% to 95% (Akins et al., 2014; Hanson et al., 2007; Wong & Smith, 2006). 
Thereby, approximately 50% use biologically based therapy, 30% mind body therapy and 25% 
manipulation of body based therapy (Hanson et al., 2007). The most commonly used CAM 
therapies in ASD include vitamin C, omega 3 fatty acids, melatonin, acupuncture or secretin 
(Levy & Hyman, 2015). Diet has been suggested as a therapeutic measure for ASD symptoms 
and one-third of children have been treated with some dietary intervention at time of ASD 
diagnosis (Levy et al., 2003). A number of nutrition intervention strategies and CAM have been 




Surveys have shown that most parents chose CAM for their child because of safety and 
absence of side effects (Hanson et al., 2007) and to treat core symptoms as well as comorbid 
disorders (e.g. attention, hyperactivity, GI symptoms, sleep) (Wong & Smith, 2006). A variety of 
treatment options are available for children diagnosed with ASD. Scientific evidence to support 
treatment of ASD is scarce and parents often choose treatment options due to anecdotal reports 
of other parents. Due to the heterogeneity of the symptoms, treatment plans require 
individualization and often involve and multidimensional approach. Because the underlying 
causes of ASD are not well understood, treatments often lack in specificity and focus on treating 
behavioral symptoms rather than the core of the disease. New data on mechanisms involved in 
ASD etiology will support the development of new targeted treatment options.  
 
2.3 Genetic and Environmental Risk Factors 
Evidence for the genetic contribution to ASD is based on family and twin studies (Tick et 
al., 2015), overlap with other genetic disorder (Rutter et al., 1994) and molecular data. Specific 
genetic etiology can be identified in approximately 25% of individuals diagnosed with ASD 
which includes single gene disorders (Fragile X syndrome), genetic syndromes, chromosomal 
anomalies, de novo and inherited copy number variation and single nucleotide variation 
(Betancur, 2011; Iossifov et al., 2012). De novo mutations can lead to loss of function, single-
nucleotide variants or insertion/deletion variants and contribute to ASD symptoms. Common 
alleles that contribute to the development of ASD are difficult to identify due to the 
heterogeneity of the disorder and no strong contribution has been identified yet (State, 2010). 
Instead studies have discovered rare variants, especially copy number variants (CNVs) and 




chromosomal regions by whole genome sequencing studies. Gene mutations in the γ-amino 
butyric acid (GABA) receptor subunits genes and genes have been proposed to be involved in 
the serotoninergic system (Klauck, 2006). To date, up to 100 genes have been discussed to be 
involved in ASD; however, their association is often indirect and no single gene has been 
specifically identified for ASD.  Other genetic variations associated with ASD include variations 
in genes encoding chromatin remodeling, transcription and splicing and synaptic function (De 
Rubeis et al., 2014), presynaptic vesicle cycling and transport, cytoskeleton dynamics, cell 
adhesion, translational regulation, protein turnover and degradation. Because of the vast variety 
in genetic abnormalities, an overview of genetic abnormalities in ASD are available from 
different sources including Autism Chromosome Rearrangement Database 
(http://projects.tcag.ca/autism), SFARI gene (https://://gene.sfari.org/autdb/Welcome/do) and 
Autism Genetic Database (http://wren.bcf.ku.edu/).   
Environmental Risk Factors: Because of the variance in ASD risk as well as the 
difference in symptom severity among monozygotic twins, environmental risk factors have been 
estimated to account to up to 55% of ASD diagnoses (Hallmeyer er al., 2011). These risk factors 
could influence neurodevelopment at different stages pre- or postnatally, which are critical 
periods in neurodevelopment. Especially the perinatal period has been heavily investigated as 
prenatal insults can lead to long-lasting disturbances in the developing fetus. In ASD, a 
combination of environmental factors is likely to be involved in the development of symptoms 
(Gardener et al., 2009). Thereby, critical periods have been identified in which an environment 
exposure is most likely to demonstrate an association with ASD development (Lyall et al., 2014). 
Prenatal and perinatal environmental exposures indicated to increase the risk of ASD 




(Herbert, 2010). Proposed dietary risk factors include maternal folate and iron status or 
polyunsaturated fatty acid (PUFA) intake (Schmidt et al., 2014; Lyall et al.; 2013, DeVilbiss et 
al., 2015). Supplemental folic acid and adequate PUFA intake are associated with decreased risk 
of ASD (Schmidt et al., 2012; Suren et al., 2013; Lyall et al., 2013). Likewise, maternal dietary 
intervention in a rodent model could ameliorate some behavioral deficits observed in the 
offspring caused by a prenatal insult (Kang, Kurti, et al. 2014). 
Maternal obesity during pregnancy could increase the risk of the newborn for developing 
key features of ASD, including decreased social interaction (Li, Ou, et al., 2016; Krakowiak et 
al., 2012). Inconsistent evidence is presented in the literature regarding smoking and alcohol 
exposure and the risk of ASD. Whereas some studies report no association between smoking or 
alcohol and risk for ASD (Lee et al., 2012), others document a positive correlation (Ronald et al., 
2010). Air pollution and endocrine disrupting chemicals (e.g. phthalates) show elevated risk for 
developing ASD (Lyall et al., 2014). Prenatal exposure to sodium valproate poses a significant 
increase in the risk of ASD diagnosis (Christensen et al., 2013). A meta-analysis including 
prenatal risk factors besides maternal nutrition status found an increased risk of developing ASD 
symptoms with gestational diabetes, maternal bleeding during pregnancy, psychiatric medication 
during pregnancy, advanced maternal and paternal age and birth order. When controlling for 
covariate, the effect was also significant with intra-taurine infections and nausea/vomiting 
(Gardener et al., 2009). Antibiotic use, hospitalization, duration of breastfeeding and route of 
birth are associated with increased incidence of ASD (Niehus & Lord, 2006; Curran et al., 2015; 
Schultz et al., 2006). 
Additional evidence for maternal infection during pregnancy as a risk factor for 




response to viral infection can alter brain development and lead to deficits in social interaction 
(Shi et al., 2003). Additionally, ASD-like behavior is observed in a model of maternal immune 
activation in mice (Malkova et al., 2012). It has also been hypothesized that ASD might be 
caused by an autoimmune reaction in the brain triggered by a previous maternal viral infection 
(Singh, 2009).  
Immune system disturbances are widely reported in children with ASD. Thus, a few 
studies investigated postnatal infection as a risk factor for ASD. In a Danish cohort study 
investigating the association between hospitalization during childhood and diagnosis with ASD 
children hospitalized for an infection were more likely to be diagnosed with an ASD compared 
to children who were never hospitalized and a stronger associated was observed with increased 
number of admissions, but the authors did not find a causal relationship (Atladóttir et al., 2010). 
On the other hand, an earlier study did not find an association between the rate of infection and 
later ASD diagnosis in the first 2 years of life, but a modest increase in the first 30 days 
compared to controls (Rosen et al., 2007). Mechanisms underlying the development of ASD 
through environmental exposures are believed to involve gene-environment interactions and 
epigenetic changes.  
Gene-environment interaction and epigenetic modification: The heterogeneity of ASD 
phenotypes might not only be explained by the variety in genetics and differences in 
environmental exposures, but also by the combination of these factors. Specifically, during the 
prenatal period, exposure to environmental factors could trigger the development of ASD 
symptoms in genetically susceptible individuals. Especially de novo changes in DNA described 
above might be indicative of gene-environment interaction. Offspring in a rodent model with a 




maternal infection compared to a conventional strain (Schwartzer et al., 2013). To date, most of 
the human research on epigenetic modification in ASD focuses on DNA methylation as well as 
the dietary factors and the enzymes involved in this process.  
Interaction between genetics and the environment in ASD was first suggested to prenatal 
complications. In an epidemiological study, children with ASD had more prenatal complications 
compared to their unaffected siblings (Glasson et al., 2004). Altered levels of DNA methylation 
was found in brain tissues of individuals with ASD in genes that are important during brain 
development (Nardone et al., 2014). It has been hypothesized that an early prenatal 
immunological insult contributes to DNA methylation and subsequently development of ASD 
symptoms (Nardone et al., 2014). Additionally, interactive effects were found between copy 
number variations and maternal infection in individuals presenting with severe social 
communication impairments and repetitive/restricted behaviors, suggesting an interaction 
between genetic susceptibility and environmental insult in ASD development (Mazina et al., 
2014). The maternal nutritional status, especially levels of folate and methionine, is suggested as 
the one of the most significant factor causing DNA hypomethylation in the offspring with ASD. 
Not only the nutritional status of the mother during pregnancy, but also the concentration of 
methyl cycle substrates and co-factors in the children might play an important role in epigenetic 
modifications and subsequent behavioral changes. For example, decreased blood concentrations 
of vitamin B12, folate and methionine have been reported in children with ASD (Schaevitz et al., 
2012). Additionally, gestational diabetes and smoking during pregnancy, two factors known to 
be associated with ASD, have been found to cause dysregulation in DNA methylation (Finer et 




Although increased awareness, improved detection and broadening of the ASD 
diagnostic criteria contribute to the rise in ASD diagnoses observed in the past decade, other 
factors are believed to account for up to half of new cases (Hertz-Picciotto & Delwiche, 2009; 
King & Bearman, 2009). Identifying these factors is difficult but would allow for more 
meaningful family counseling, medical monitoring and treatment (Battaglia & Carey, 2006).  
 
2.4 Intestinal Environment in ASD 
Development of the GI Microbiota from in utero to Adulthood: The word microbiota is 
defined as a collection of microbes, including bacteria, viruses and fungi. The human GI tract is 
predominantly inhabited by bacterial species and contains approximately ~3 million bacterial 
genes or approximately 100-times as many genes as the human genome (Human Microbiome 
Project Consortium, 2012). 
Intestinal colonization is a successive process throughout the course of life and is influenced 
by genetic factors, mode of delivery (vaginal birth vs. Cesarean section), early feeding practices 
(breast feeding vs. formula feeding), gestational age and birth environment (Penders et al., 2006). 
Some bacteria that become part of the adult microbiota already colonize the gut during the first 
months of life (Jost et al., 2015). The GI microbiota is very diverse between newborns but 
converges to a more generalized profile with age (Bergström et al., 2014). Bacterial species vary 
significantly among the infant population and can appear and disappear transiently. Low species 
diversity and high instability are characteristic within the first year of life and large 
compositional shift in abundances of major bacterial taxa appear over time (Palmer et al., 2007). 
Early colonizers are usually facultative anaerobes (e.g. Enterobacteria or Lactobacillus), 




The notion that the infant gut is sterile at birth has recently been challenged by studies 
revealing that the infant is exposed to microbiota in utero. Detection of a microbiome in the 
meconium of newborn infants suggests intrauterine colonization on the neonatal gut (Rautava et 
al., 2012). Previously the presence of bacteria in the placenta and amniotic fluid has long been 
associated with preterm birth, but recent reports suggest that in utero bacteria colonization in 
nonpathological situations might also influence prenatal programming (Collado et al., 2016; 
Rautava et al., 2012; Jiménez et al., 2008). A unique low-abundance, low richness and low 
diversity microbiome is present in the placenta and amniotic fluid, with Proteobacteria as the 
major phylum and other commensal microbiota from Firmicutes, Tenericutes, Bacteroidetes and 
Fusobacteria phyla (Aagaard et al., 2014; Collado et al., 2016). On the genus level 
Propionibacterium, Streptococcus and Bifidobacterium were found in placenta samples (Collado 
et al., 2016; Satokari et al., 2009). On the species level, Lactobacillus rhmnosus was identified in 
placenta samples (Satokari et al., 2009). Likewise, Enterococcus faecium, Propionibacterium 
acnes, Staphylococcus epidermidis and Streptococcus sanguinis were identified in umbilical cord 
blood of healthy neonates born by C-section (Jiménez et al., 2005). The exact mechanism by 
which microbiome colonize the placenta and amniotic fluid is unknown, but it is hypothesized 
that microbes could translocate from the oral cavity, vagina or maternal GI tract to the placenta 
and amniotic fluid (Aagaard et al., 2014). In an animal study, a genetically labeled Enterococcus 
faecium strain fed to pregnant mice was found in meconium of offspring, suggesting that 
microbes in fetal intestine could come from microbes present in maternal gut (Jimenez et al, 
2008).  
Meconium: Studies have now reported the presence of a unique meconium microbiome 




detected in meconium samples and dominant groups in fecal, skin and vaginal environment of 
pregnant women and the detection of bacterial phyla in meconium which are also present in the 
amniotic fluid and placenta support the notion that microbiota in meconium is not assimilated 
during contact with maternal habitats during birth but during intrauterine life (Gosalbes et al., 
2013; Ardissone et al., 2014). The most predominantly phyla identified in meconium samples are 
Firmicutes and Proteobacteria. On the genus level, bacterial populations present in meconium 
include Enterococcus, Escherichia, Leuconostoc, Lactococcus, Streptococcus, Lactobacillus and 
Staphylococcus. Some species identified include Enterococcus fecalis, Staphylococcus 
epidermis, Escherichia coli and S. aureus (Ardissone et al., 2014; Gosalbes et al., 2013; Moles et 
al., 2013). 
Route of birth: Upon birth neonates are exposed to the microbiota of their mother as well 
as the hospital environment. Naturally born infants are exposed to the mother’s vaginal bacteria 
whereas babies born by cesarean section (C-section) are first introduced to bacteria via the 
mother’s skin, the hospital environment or the health care workers (Dominguez-Bello et al., 
2010). Overall, infants born via C-section seem to have a less diverse microbiome compared to 
vaginally delivered babies (Biasucci et al., 2008; Jakobsson et al., 2014). The dominant phyla in 
infants born via C-section Propionibacterium, Corynebacterium and Streptococcus, whereas 
vaginal delivered infants have higher proportion of Bacteroidetes during first 12 months 
(Jakobsson et al., 2014; Penders et al., 2006). On the genus level, infants born via C-section have 
lower abundance of Bifidobacterium and delayed colonization with Lactobacillus, 
Bifidobacterium and Bacteroides, but higher levels of Staphylococcus and Enterococcus 
(Biasucci et al., 2008; Jakobson et al., 2014). Naturally born infants, on the other hand, have an 




Dominguez-Bello et al., 2010; Bäckhed et al., 2015). Lower levels of Bacteroides fragilis but 
higher abundance of C. difficile, E. coli, Enterobacter hormaechei, E. canderogenus, 
Haemophilus parainfluenzae, H. aegyptius, H. influence, H. haemolyticus, Staphylococcus 
saprophyticus, S. lugdunensis, S. aureus, Streptococcus australis, Veilonella dispar, and V. 
paravula were reported in C-section delivered infants whereas B. longum and B. catenulatum 
predominantly colonized the GI tract of vaginally born infants (Bäckhed et al., 2015). 
Whether the differences in microbiome composition between vaginally and C-section 
delivered infants persists into later life is currently unknown. Significant differences from 4 
months to up to 2 years have been reported, whereas others have not found any differences after 
6 months of age (Huurre et al., 2008; Bäckhed et al., 2015). Although a gradual decrease in 
difference between route of birth was observed, the microbiome of C-section delivered babies 
remained more heterogeneous, suggesting that the mode of birth is important in shaping early 
microbiome (Bäckhed et al., 2015). This observation is especially important giving data that 
describes the long lasting effect of early microbiome composition on other aspects of health (e.g. 
immune system, cognition).  
Breast-feeding vs. formula feeding: After birth the GI microbiota is mostly shaped by the 
infant’s early nutrition. Human milk is the gold standard for infant nutrition and the American 
Academy of Pediatrics recommends exclusive breast feeding for the first 6 months of life and in 
combination with other foods until 12 months of age. (AAP). Human milk harbors a unique 
microbiome including commensal, mutualistic and probiotic bacteria of which some can be 
found as first colonizers of the neonatal gut (Collado et al., 2009, Solís et al., 2010). Bacteria 
detected in human milk include Staphylococcus, Streptococcus, Propionibacterium and 




phylum and Clostridia class (Jost et al., 2015). Additionally, human milk oligosaccharides 
(HMO) are resistant to digestion and can be fermented in the GI tract, thereby promoting the 
growth of beneficial bacteria (Jost et al., 2015; Rautava et al., 2012). Additionally, HMOs found 
in the mother’s breast milk could predict several fecal bacterial genera (Wang et al., 2015). Even 
though the impact of feeding mode on microbiome composition is often contradictory, it is now 
generally accepted that the microbiota of breast-fed infants is dominated by Bacteroidetes and 
higher abundance of Bifidobacteria and Lactobacilli and lower abundance of Streptococcus and 
Enterococcus (Harmsen et al., 2000a; Solís et al., 2010; Wang et al., 2015). The GI microbiota of 
formula-infants, on the other hand, is more diverse and less stable, resembles an adult profile and 
is more prone to changes over time (Harmsen et al., 2000a). The microbiome in formula fed 
infants in generally dominated by Firmicutes and higher numbers of Bacteroides and members of 
Clostridia class (Harmsen et al., 2000a; Penders et al., 2006; Jost et al., 2015). 
Introduction of Solid Foods: With the cessation of breastfeeding and the introduction of 
solid food, significant changes occur in the microbiome and a shift to an adult-like composition 
with higher alpha diversity and enriched in Bacteroides, Bilophila, Roseburia, Clostridum and 
Anaerostipes is observed (Bäckhed et al., 2015; Palmer et al., 2007; Koenig et al., 2011). During 
the shift to a more adult-like microbiome, a decrease in Bifidobacterium and Lactobacillus as 
well as an increase in SCFA-producing bacteria and SCFA concentrations are observed (Koenig 
et al., 2011; Bergström et al., 2014; Yatsunenko et al., 2012). 
As the infant gets older the microbiome becomes more similar to that of the mother in 
composition as well as functionality, mainly to adapt to changes of energy sources (Bäckhed et 
al., 2015). Thereby, the initial microbial exposure is important in shaping the successional 




Although previous studies have suggested that the GI microbiota becomes relatively 
stable and resembles that of an adult after the first 3 years of life, (Palmer et al., 2007, Bergström 
et al., 2014 Yatsunenko et al., 2012), other studies suggest that the GI microbiota might have a 
prolonged development into pre-adolescence and profound differences in microbial composition 
and functional potential exist between children and adults (Hollister et al., 2015). Most notably, 
lower abundances of Bacteroidetes but greater abundances of Firmicutes and Actinobacteria 
were identified in children’s microbiome compared to adults (Hollister et al., 2015; Agans et al., 
2011, Ringel-Kulka et al., 2013). Additionally, differences in abundances of Bacilli, Clostridium 
cluster IV and Bifidobacterium were observed (Agans et al., 2011; Ringel-Kulka et al., 2013). 
Besides compositional changes, functional changes occur as the as the GI microbiota matures to 
a more adult-like composition (Yatsunenko et al., 2012). For example, whereas the earlier 
microbiome is specialized for lactate utilization and developmental functions (e.g. folate 
metabolism), bacterial species at later time points are more specialized for plant polysaccharide 
utilization, vitamin biosynthesis or xenobiotic degradation (Koenig et al., 2011). 
Other influences that could change the microbiota composition in its development are the 
mother’s diet, antibiotic use and gestational age. Antibiotic use was linked to a decrease in 
Bifidobacteria, Lactobacilli and Bacteroides (Penders et al., 2006). Infants born preterm or late 
preterm presented higher counts of C. difficile and lower levels of coliform organisms as well as 
Lactobacilli (Penders et al., 2006, Hall et al., 1990). Additionally, differences in diversity 
between different geographical regions as well as temporal variability at the genus level are 
common during the microbiome development (Lin et al., 2013, De Filippo et al., 2010; 
Yatsunenko et al., 2012). Childhood may provide opportunities for microbiome interventions to 




Differences in Microbial cComposition between Children with ASD and Unaffected Controls  
Microbial dysbiosis has gained increasing attention in recent years as a potential 
environmental factor contributing to ASD symptomology via the microbiota-gut-brain axis 
(Bienenstock et al., 2015). In 1997, Bolte first hypothesized that C. tetani might be involved in 
ASD symptomology (Bolte, 1998). Since then, a number of human studies have evaluated the 
intestinal microbiota in children with ASD showing differences on the bacterial phyla and genus 
levels. Additionally, germ-free mice exhibit significant social impairments, suggesting that the 
GI microbiota could contribute to some symptoms of ASD (Desbonnet et al., 2014). Several 
studies have shown changes in the relative abundances of Bacteroidetes, Firmicutes, 
Actinobacteria, Proteobacteria and Verrucomicrobia (Finegold et al., 2010; Kang et al., 2013; De 
Angelis et al., 2013). Specifically, higher abundance of Bacteroidetes and Proteobacteria, but 
lower abundance of Firmicutes and Actinobacteria was observed in a subset of children with 
ASD. Additional studies have revealed bacterial differences at the genus level, including 
significant reductions in the relative abundances of Prevotella, Coprococcuss, Enterococcus, 
Lactobacillus, Streptococcus, Lactococcus, Staphylococcus, Ruminococcus and Bifidobacteria in 
children with ASD compared to non-affected controls (Kang et al., 2013; De Angelis et al., 
2013; Wang et al., 2011). Conversely, Clostridia, Sutterella and Desulfovibrio bacteria were 
found to be increased in children with ASD (Finegold et al., 2010, Kang et al., 2013, Parracho et 
al., 2005). Significant but not consistent evidence is presented in the literature regarding 
microbial dysbiosis in ASD. For example, studies using sibling as the control group found no 
differences in the microbiota composition (Gondalia et al., 2012; Son et al., 2015). Other studies 
which included siblings as a control group demonstrated intermediate levels of some bacterial 




differences could be attributed to environmental factors since siblings live in the same household 
as children with ASD and are exposed to the same environmental factors. Larger studies are 
needed to further define a potentially distinct ASD microbiome.  
Besides differences in bacterial composition of the intestine in children with ASD, 
increasing research is investigating the composition of yeast and fungi in stool samples of 
children with ASD and is suspected to be involved in the gut-to-brain communication. Thus far, 
studies observed differences in the β-diversity of the GI mycobiota between children with ASD 
and controls (Strati et al., 2017). Additionally, an overall higher yeast concentration with a 
higher presence of Candida spp. was described in children with ASD compared to unaffected 
controls (Iovene et al., 2017; Kantarcioglu et al., 2016). Furthermore, some yeast, such as 
Candida krusei or Candida glabrate, that were isolated from stool samples of children with ASD 
stool was not found in stool specimen of control children (Kantarcioglu et al., 2016). Fungal 
dysbiosis has been associated with inflammation in GI disorders such as Chron’s disease, but no 
studies have shown a correlation between GI or ASD symptoms and yeast population to date; 
however, it is hypothesized that higher levels of Candida can cause decreased absorption of 
carbohydrates and minerals and higher absorption of toxins which could contribute to some 
symptoms of ASD (Burrus, 2012).  
In order to develop potential strategies to ameliorate some symptoms of ASD through 
manipulation of the GI microbiota, a few researchers are investigating associations between 
specific bacteria and ASD symptom severity. Reduced bacterial richness was significantly 
associated with ASD symptoms (Kang et al., 2013). Higher abundance of Clostridia and 
Desulfovibrio and lower Bacteroidetes/Firmicutes ratio was associated with ASD severity in two 




symptoms and microbiota is difficult due to often occurring co-morbid GI symptoms, making it 
difficult to decipher whether ASD symptoms and microbial dysbiosis are related to each other or 
to GI symptoms. For example, a decrease of beneficial bacteria was found in children with ASD 
and co-morbid GI symptoms (De Angelis et al., 2013, Wang et al., 2011). However, one study 
described the presence of ASD symptoms rather than the severity of GI symptoms was a stronger 
predictor for microbial changes (Kang et al., 2013). Additional evidence for specific microbiota 
influencing ASD symptom severity comes from probiotic supplementation studies which are 
described in more detail below.  
Because human studies to date only allow to make conclusions about associations 
between the microbiota and ASD behaviors, animal models are invaluable to further investigate 
the role of the GI microbiota in ASD symptomology. Several mouse models using genetic 
mutations or prenatal exposure to environmental risk factors have been developed to investigate 
underlying causes for the development of ASD. Interestingly, the GI microbiota composition and 
microbial metabolites in these models is often different from commensal mice (De Theije et al., 
2014). A mouse model that mimics prenatal insult as environmental risk factor, a dysbiotic 
microbiota similar to that observed in human studies of ASD with IBD was observed (Lim et al., 
2017). In the same study, correlation between serum levels of serotonin and Sporanaerobacter 
was detected which let the authors to hypothesize that environmental factors might be 
responsible for microbial dysbiosis in ASD which in turn causes other abnormalities often found 
in this population such as hyperserotenemia (Lim et al., 2017). Sex-specific alterations in 
microbiota were observed in mouse model of ASD with Bacteroides, Parabacteroides, 
Sutterella, Dehalobacterium and Oscillospira as main drivers of the microbiota profile that was 




2017). These finding are especially intriguing due to the higher occurrence of ASD in boys 
compared to girls. Lastly, GI barrier defects and alterations in microbiota composition were 
observed in maternal immune activation (MIA) mouse model of ASD which could be corrected 
with oral administration of Bacteroides fragilis, suggesting that the GI microbiota could 
contribute to the development of symtpoms associated with ASD (Hsiao et al., 2013). 
 
Bacterial Metabolites in Children with ASD 
Besides differences in the microbial composition, significant deviations are also seen in 
the bacterial metabolites present in the feces and urine of children with ASD.  
Volatile Fatty Acids: VFA (acetate, propionate, butyrate, isobutyrate, isovalerate, 
valerate) are the end-products of microbial fermentation in the colon and have been implicated to 
have various health benefits to the host (e.g. weight control, lipid profiles, colon health) (Byrne 
et al., 2015). VFA can be rapidly absorbed in the large intestine and be detected in the blood 
(Tsukahara et al., 2014). Especially during early brain development, propionate in particular 
serves as a major energy source for brain metabolism (Zhao et al., 2017). However, 
accumulation of VFA, specifically propionate, has also been shown to have broad effects on the 
nervous system physiology, causing developmental delay or seizures (Feliz et al., 2003). In 
children with ASD, elevated concentrations in stool, urine and serum have been reported and 
VFA-producing bacteria, e.g. Clostridia, Desulfovibrio and Bacteroides were shown to be 
increased in the feces (De Angelis et al., 2013; Wang et al., 2012; Adams et al., 2011a; Zhao et 
al., 2017). In animal studies, propionate could cause neurobiological changes similar to those 
observed in individuals with ASD and intraventricular administration of propionate could 




(Thomas et al., 2012; MacFabe et al., 2011; Foley et al., 2015). The exact effect of VFA on the 
brain are unknown, but translocation of VFAs through the blood brain barrier (BBB) facilitated 
by monocarboxylic acid transporters or passive diffusion could cause potential effects on the 
brain and contribute to development of ASD symptoms (Conn et al., 1983). Likewise, VFAs 
could also interact with membrane receptors (i.e., G-coupled receptors) and trigger the activation 
of gene expression (Nankova et al., 2014). In addition to propionate, butyrate has been of interest 
in eliciting ASD-behaviors due to its similar structure to valproic acid which is used in a mouse 
model of ASD to induce autism-like behaviors (Nankova et al.,  2014).  
Serotonin: Although most serotonin, or 5-hydroxytryptamine (5-HT), is produced in the 
GI tract, 5-HT modulates neurodevelopment and might be important in social function and 
repetitive behavior (Muller et al., 2016). Elevated levels of whole blood and platelet 5-HT are 
consistently observed in a subset of children with ASD, making it a potential candidate as a 
biomarker for ASD (Gabriele et al., 2014). An adult study of acute tryptophan depletion, the 
precursor of central serotonin synthesis, using Magnetic Resonance Imaging showed that adults 
with autism had abnormal brain activation of brain regions for inhibitory control after tryptophan 
depletion. These brain areas might partially be related to some restrictive and repetitive 
symptoms observed in individuals with ASD (Daly et al., 2014).  
Genetic, GI or immune changes have been proposed as potential contributing factors to 
the hyperserotonemia observed in children with ASD (Schain & Freedman, 1961; Anderson et 
al., 1987; Hanley et al., 1977); however, not all cases can be explained by genetic variations. 
Some bacterial strains that are known to influence 5-HT metabolism (e.g. Clostridial species, 
Lactobacillus) were increased in the stool of affected children. In patients with ASD, altered 




dysfunction of the serotonergic system have been reported to contribute to symptomology 
(Muller et al., 2016; Gabriele et al., 2014; Schain & Freedman, 1961; Anderson et al, 1987; 
Melke et a., 2008). Evidence for aberrations in the central serotonin system in ASD come from 
neuroimaging of post-mortem studies showing decreased serotonin receptor binding. These 
results suggest that peripheral alterations in the serotonin system can affect the central serotonin 
signaling system (Muller et al., 2016). Interestingly, studies observed high blood but low brain 
serotonin levels children with ASD (McNamara et al., 2008; Zafeiriou et al., 2009). Additionally, 
higher serotonin levels in mothers of children have been described, indicating that the serotonin 
during pregnancy can cross the placenta membrane and reach the brain due to blood brain barrier 
being not completely formed. Due to serotonin’s role in early neurodevelopment, studies have 
begun to investigate the potential role or selective serotonin inhibitor us during pregnancy and 
the increased risk for developing ASD (Harrington et al., 2013). These observations led 
researchers to hypothesize that hyperserotonemia occurs during neurodevelopment in children 
with ASD which can lead to a later loss of serotonin terminals and axons (Yang et al., 2014). 
Even though the mechanisms by which serotonergic signaling impact behavior in children with 
ASD is not completely understood, targeting serotonin neurotransmission might be a future 
avenue for intervention (Lacivita et al., 2017).  
Other metabolites: Besides VFA and serotonin, other bacterial metabolites have been 
studied to a lesser extent in children with ASD. Ammonia concentrations were found to be 
elevated in fecal samples of children with ASD and various metabolites of bacterial metabolism 
of amino acids, carbohydrates and bile acids were altered, including an increase of 
taurocholenate sulfate and decrease in 5 amino-valerate (Wang et al., 2012, Ming et al., 2012). 




precursors are produced by bacterial metabolism, were observed (Yap 2012). 3-(3-hyrdroxy 
phenyl)-3-hydroxypropionic acid (HPHPA), a metabolic product of the genus Clostridium, was 
increased in urine samples of children with autism. It has been suggested that HPHPA could 
induce autism symptoms by depleting catecholamine concentrations in the brain (Keşli et al., 
2014). Other markers of bacterial metabolites (i.e., para-hydroxybenzoate, para-
hydroxyphenylacetate, 2-hydroxyphenylacetate, 3-indoleactate, tricarballylate) were abnormal in 
urine of children with ASD in a different study (Esparham et al., 2015). Additionally, in an 
animal model of ASD, specific bacterial metabolites (4-ethylphenylsulphate; 4EPS) caused 
ASD-related behaviors, proposing that bacterial metabolites could be a way of communication 
between the GI microbiota and brain in ASD (Hsiao et al., 2013). 
 
Gastrointestinal Symptoms in Children with ASD 
In addition to abnormal microbial composition and metabolites, GI distress, such as 
diarrhea, constipation or abdominal pain, is prevalent among children with ASD and has been 
suggested to contribute to behavioral problems and to correlate with symptom severity (Tomova 
et al., 2015; Adams et al., 2011a; Buie et al., 2010; Coury et al., 2012a; McElhanon et al., 2014; 
Horvath et al., 1999). Besides GI distress, GI functional abnormalities are also observed in 
children with ASD. This include reduced mRNA expression of carbohydrate digestive enzymes 
(sucrase isomaltase and maltase glucoamylase) and hexose transporters (SGLT1 and GLUT2), 
which can cause carbohydrate maldigestion and malabsorption increased intestinal permeability 
(Williams et al., 2011). In a prevalence study with over 14,000 individuals, a significant 
difference in the occurrence of bowel disorders between children with ASD versus non-affected 




with ASD) showed a greater prevalence of GI symptoms and children with ASD were more 
likely to report GI symptoms (e.g. constipation, food allergy/intolerance, diarrhea) in the first 3 
years of life (Penn et al., 2016; Bresnahan et al., 2015). Likewise, MIA offspring displayed GI 
symptoms similar to symptoms observed in human ASD (Hsiao et al., 2013). 
Determining an exact prevalence of GI disorders in the ASD population is challenging 
due to social communication difficulties in individuals with ASD and interpretation 
discrepancies of GI problems (de Theije et al., 2011). Likewise, the link between GI dysfunction 
and ASD symptoms is not well understood, but it is hypothesized to include intestinal 
inflammation, mitochondrial dysfunction or microbial dysbiosis. Mitochondrial dysfunction (e.g. 
mitochondrial enzymes or carriers) is prevalent in the ASD population and many mitochondrial 
diseases are associated with GI disorders (Rossignol & Bradstreet, 2008; Frye et al., 2015). Frye 
et al. also hypothesized that microbial dysbiosis could induce mitochondrial dysfunction and GI 
symptoms. For example, propionate, product of microbial fermentation, is known to influence 
mitochondrial metabolism and abnormalities in mitochondrial metabolism were observed in a 
propionate rodent model of ASD (Frye et al., 2015).  
Anecdotal reports of parents claim that GI problems and behavior symptoms manifest in 
parallel. One study reported that the onset of GI symptoms occurred before or at time of 
diagnosis with ASD in 67% of cases (Williams et al., 2011). The timing of onset was also 
associated with levels of Clostridiales, namely Lachnospiraceae and Ruminococcacaea, 
suggesting that timing of onset of GI symptoms relative to onset of ASD symptoms may be 
associated with increases in Clostridiales (Williams et al., 2011). Additionally, in children with 
ASD and comorbid GI symptoms, reduced carbohydrate digestive capacity can cause 




abundance of Bacteroidetes, Firmicutes, and Betaproteobacteria in the mucoepithelium 
(Williams et al., 2011). The resulting accumulation of nondigested carbohydrates in the intestine, 
in turn, could lead to intestinal inflammation and potentially contribute to ASD behavioral 
problems (Williams et al., 2011). Other associations between specific bacterial general and GI 
symtpoms were observed. Constipation was associated with higher levels of 
Escherichia/Shigella and Clostridium Cluster XVIII (Strati et al., 2017) and Sutterella was 
mostly increased in children with GI symptoms but not in those without (Williams et al., 2012). 
C. perfringens and the toxin-producing genes were found in higher abundances in children with 
ASD and co-morbid GI symptoms (Finegold et al., 2017). Although in non-ASD patients, 
changes in the intestinal microbiota are implicated to contribute to the development of GI 
disorders, Gondalia et al. (2012) found no differences in microbiota composition between 
children with ASD with or without GI dysfunction (Gondalia et al., 2012). 
Increased inflammatory responses and immune dysregulation might also play a part in the 
increased prevalence of GI symptoms in children with ASD. In a subset of children with ASD, 
inflammatory mucosal pathology, increased T-cell activation, increased cytokines and 
immunoglobulins and histological changes were found in in intestinal biopsies of children with 
ASD and co-morbid GI symptoms (Ashwood & Wakefield, 2006). In the peripheral blood and 
intestinal mucosa increased pro-inflammatory cytokines, increased TNFα, IFNγ, IL-4 and IL-5 
similar to levels found in neurotypical children with Chron’s Disease were found in children with 
ASD (Ashwood & Wakefield, 2006). Thereby, the inflammatory status might also be related to 
abnormal microbial profile. Luna et al (2017) found a unique mucosa-associated microbiome 
with an increased abundance of Clostridiales but a decrease in Dorea, Blautia and Sutterella in 




tryptophan levels. (Luna et al., 2017). The group identified relationships between microbial taxa, 
serotonin metabolites and inflammatory cytokines that could suggest a potential interconnection 
between GI symptoms, GI microbiota and peripheral immune or metabolic markers (Luna et al., 
2017).  
 
2.5 Nutrition and ASD 
Feeding Problems in Children with ASD 
Achieving adequate nutritional intake presents a big challenge in children with ASD due 
to GI symptoms, food allergies, metabolic abnormalities or problematic eating behaviors. 
Approximately 90% of children with ASD experience some sort of feeding-related concern and 
often present as multidimensional problems (Ledford & Gast, 2006, Nadon et al., 2011). In fact, 
the major reasons for referral of children with ASD to a Dietitian are concerns about food 
selectivity and dietary adequacy (Bowers, 2002). However, some eating problems might be able 
to be restored as older children with ASD tend to have less eating problems compared to younger 
children with ASD, potentially due to behavioral therapies (Laud et al., 2009).  
Evidence for an association between food selectivity and ASD symptom severity is not 
conclusive. Whereas some studies suggest that food selectivity and feeding problems were 
associated with higher rates of ASD symptoms as well as severity of temper tantrums (Crasta et 
al., 2014; Postorino et al., 2015; Dominick et al., 2007), other studies found no association 
between feeding difficulties and severity of social, communication and cognitive deficits 
(Johnson et al., 2014). It has been suggested that severity of ASD symptoms might related to 
topography and duration of refusal behavior but not necessarily directly to food selectivity 




of food selectivity used in the various studies as well as the methodology used to assess feeding 
problem behaviors (Postorino et al., 2015). For example, food selectivity can refer to picky 
eating, food refusal, limited food repertoires, excessive intake of a few foods and selective intake 
of certain food categories (Cermak et al., 2010). 
Picky eating, food refusal and food selectivity are commonly reported problematic eating 
behaviors and some children with ASD might eat as little as five foods (Cermak et al., 2010). 
Thereby, food selectivity is usually based on color, shape, texture or temperature of the food 
(Schreck et al., 2004). Likewise, children with ASD might require specific utensils, a particular 
food presentation or sitting at specific places at the table and tactile and oral defensiveness may 
result in difficulty with textures (Schreck et al., 2004; Cermak et al., 2010, Johnson et al., 2014). 
Picky eating behaviors might be a manifestation of repetitive behavior patterns, ritualistic or 
externalizing behaviors (Johnson et al., 2014). Others suggest that picky eating might be a 
reflection of the child’s resistance to change, inflexibility, sensory sensitivities, inadvertent 
reinforcement of negative mealtime behaviors, GI problems and oral motor delay (Johnson et al., 
2014, Cermak et al., 2010). Sensory sensitivities which are very common among children with 
ASD can negatively affect eating behaviors. However, more research is required to determine 
whether other factors such as parental preferences and family mealtimes can contribute to food 
selectivity in children with ASD (Cermak et al., 2010). Family mealtimes might especially be 
important as disruptive behaviors often seen in children with ASD can cause more stressful 
meals (Johnson et l., 2014). Additionally, parent behavior could model specific restricted diets 
and expose the child to a limited range of foods (Aponte & Romanczyk, 2016). Using regression 
analysis, one study found that family food preferences instead of ASD symptom severity was the 




Besides food selectivity other prevalent behavioral problems at mealtimes in children 
with ASD include eating fast, difficulty processing table foods, gagging/coughing on textures, 
not feeding self, taking long time to eat meals, not communicating when hungry, stressful and 
prolonged meal times and eating inadequate amounts (Bicer & Alsaffar, 2013; Malhi et al., 
2017). Likewise, children with ASD are more likely to present with food allergies and parental 
report of allergies include milk/dairy, nuts and fruits (Lyall et al., 2015; Gurney et al., 2006). 
Several studies have found that children with ASD eat fewer foods overall and a strong 
preference for starches, snack and processed foods, while rejecting fruits, vegetables and or 
protein is common in ASD (Bicer & Alsaffar, 2013; Al-Farsi et al., 2011, Malhi et al., 2017). 
Comparing fruits and vegetables intake of children with ASD to healthy controls showed that 
daily servings of fruits and vegetables were significantly lower in children with ASD (Marí-
Bauset et al., 2013; Schreck et al., 2004). The restrictive eating patterns and difficulties in other 
aspects of a healthy lifestyle (e.g. physical activity) due to impaired social interaction and 
communication, can lead to the development of malnutrition and research has reported higher 
rates of underweight, overweight and obesity in children with ASD compared to unaffected 
children (Bicer & Alsaffar, 2013; Sharp et al., 2013; Curtin et al., 2010). Obesity related 
complications (e.g. hypertension, diabetes) are also more prevalent among adults with ASD 
(Berry et al., 2015). 
Interestingly, eating problems from birth can be observed in 20-30% of children who 
were later diagnosed with ASD (Dominick et al., 2007). One study reported that overall children 
with a later diagnosis of ASD had more consultations for feeding problems in early life 
compared to children who did not get diagnosed (Olsson et al., 2013). Common early feeding 




(Edmond et al., 2010). Additionally, at 15 months of age diet of children later diagnosed with 
ASD were less varied than diets of typically developing children and the variety became 
progressively less with age (Edmond et al., 2010). Feeding problems early in life are especially 
of concern as feeding problems in childhood have been associated with poor growth, 
developmental outcomes and unwanted medical procedures (Johnson et al., 2014).  
 
Nutrient Deficiencies 
The restricted food intake, ritualized eating habits and problematic mealtime behaviors 
paired with malabsorption issues can have an impact on the nutritional status of children with 
ASD (Liu X, et al., 2016). Additionally, parents often adopt diets which anecdotally improved 
the behavior of some children without the guidance of a nutrition specialist which could put the 
kids at further risk of developing nutrient deficiencies. For example, following a gluten-
free/casein-free diet can put children at risk for insufficient intake of calcium because of 
eliminating dairy products from the diet. The impact on the nutritional status can be seen in 
intakes lower than the recommendation as well as nutrient deficiencies which can be detected in 
the blood of children with ASD. However, conflicting results can be found in the literature and 
studies are indicating that children with ASD have intakes above, below or same as children 
without ASD (Cermak, et al., 2010). Thereby, the lack of studies in comparing children with and 
without food selectivity, making it is difficult to determine whether food selectivity places 
children with ASD at risk for malnutrition.  
Micronutrients are important for neural development and brain functioning (Sandstead, 
2000). Thus, it has been suggested that micronutrient deficiencies could contribute to ASD 




with ASD compared to unaffected controls (Zimmer et al., 2012; Shmaya et al., 2015) and 
selective eaters among the ASD population are more likely to have inadequate intake in at least 
one nutrient (Zimmer et al., 2012). Case reports of children with ASD who were at risk for 
developing scurvy, rickets or ophthalmological conditions due to unrecognized nutrient 
deficiencies have been published (Niwa et al., 2012; Cole et al., 2011; Clark et al., 1993). In one 
of the case reports the child’s intake was limited to French Fries and water for several years 
which caused the development of vitamin A and vitamin D deficiencies (Clark et al., 1993). 
Decreased levels in whole blood, serum or plasma levels were found for pantothenic acid, folate, 
biotin, vitamin B12, vitamin D and vitamin E (Liu X, et al, 2016; Ranjan & Nasser, 2015; 
Zimmer et al., 2012). Magnesium, iodine, iron and chromium and selenium were found in lower 
concentrations in children with ASD compared to non-affected controls (Ranjan & Nasser, 
2015). Likewise, circulating levels of calcium were found in lower concentrations in children 
with ASD (Bicer & Alsaffar, 2013; Ranjan & Nasser, 2015; Zimmer et al., 2012) which is of 
concern due to the importance of calcium in supporting bone growth. Some nutrients might 
correlate with severity of ASD symptoms, for example, vitamin A or folate intake (Liu X, et al., 
2016). Interestingly, gender differences were observed in the blood levels of vitamin D levels in 
children with ASD with levels being lower in young males compared to females (Kočovská et 
al., 2014). 
Compared to the effect of feeding problems in the ASD population on micronutrient 
intakes and concentration, evidence for macronutrient inadequacies are less prominent. One 
study observed a decreased intake of macronutrients in children with ASD compared to healthy 
controls (Liu X, et al., 2016; Zimmer et al., 2012), whereas no difference in energy intake was 




children with ASD do not meet the recommendations for dietary fiber intake (Bicer & Alsaffar, 
2013) which can have a profound effect on microbial diversity. 
Fatty acids have been of increasing interest to ASD related research. For example, 
Docosahexaenoic acid (DHA) is important component of neural development, in maintenance of 
neural plasticity neuronal signaling and neurotransmitter uptake (Wainwright, 2002; Dufault et 
al., 2009). Concentrations of omega-3 fatty acids (DHA, APA) are lower in ASD children 
whereas omega-6 fatty acid levels in the plasma were reported to be higher (Ranjan & Nasser, 
2015; Esparham et al., 2015). Analysis of red blood cell phospholipids in children with ASD 
aged 3-17 years revealed a decrease of arachidonic acid (AA) and DHA and an increase in pro-
inflammatory prostaglandin E2 (Brigandi et al., 2015). Additionally, supplementation with 
omega-3 fatty acids in human and animal models might be efficacious in alleviating some 
symptoms of ASD, suggesting that omega-3 fatty acids could play a role in the etiology of ASD. 
Potential mechanisms explaining the abnormal levels of fatty acids in children with ASD include 
dysfunctional lipid metabolism, abnormalities in maintenance of phospholipid membranes or 
elevation of lipid peroxidation (Tamiji & Crawford, 2010).  
 
Dietary Interventions 
Due to the lack of effective medical treatment approaches, parents often seek alternative 
treatment options for their children after ASD diagnosis. Although there is often no convincing 
justification for the efficacy of alternative treatments, dietary changes that are considered risk 
free by the lay public are often adopted (Stewart et al., 2015). Animal and human studies have 
provided evidence for a potential dietary intervention in alleviating some symptoms of ASD. It 




after of ASD diagnosis (Levy et al., 2003). An expert panel has set guidelines for the nutritional 
management of GI symptoms in children with ASD (Berry et al., 2015). Specific considerations 
have to be taken into account when working with children with ASD because of the high 
prevalence of food selectivity and general feeding problems. For example, if the child suffers 
from constipation the types of fruits, vegetables and whole grains that the child is accepting in 
the diet need to be evaluated (Berry et al., 2015). A number of nutrition intervention strategies 
including gluten-free, casein-free diet (GFCF) or supplementation with omega-3 fatty acids, 
minerals or multivitamins have been explored to treat behavioral symptoms and comorbid GI 
distress. Some diets (e.g. GFCF, antioxidant diet or ketogenic diets) have shown an alleviation of 
behavior and GI symptoms associated with ASD, whereas others saw no behavioral differences 
compared to controls or even reported insufficient or excessive nutrient intake in response to 
interventions (Millward et al., 2008; Mousain Bosc, et al., 2006; Srinivasan et al., 2009; 
Knivsberg et al., 2002). 
Gluten-free/Casein-free diets: One of the most studied dietary interventions in children 
with ASD is the GFCF diet. The rationale behind the GCFC diet as a therapeutic intervention for 
children with ASD is the opioid-excess theory. This theory is based on the limited ability of 
children with ASD to break down gluten and casein coupled with the leaky gut theory which 
allows the peptides to translocate into periphery. In the CNS, the peptides can bind to opioid 
receptors and impact neural development, cognitive function, attention, learning and behavioral 
symptoms associated with ASD (Whiteley et al., 1999). Support to this theory stems from studies 
reporting increased antibodies against casein, gluten and gliadin (Vojdani et al., 2003). GFCF 
intervention studies have yielded mixed results. Knivsberg et al. (2002) demonstrated that 




communication and cognition compared to children with ASD not following a specialty diet and 
these improvements in autistic behaviors persisted in a one-year follow-up assessment 
(Knivsberg et al., 2002). In another randomized control trial, 12 months GFCF diet intervention 
improved in domains of social interaction and repetitive behaviors in children with ASD aged 4-
10 years (Whiteley et al., 2010). On the other hand, no improvement in behavior after GFCF 
intervention was observed in other studies (Elder et al., 2006; Johnson et al., 2011; Hyman et al., 
2016). In a 12-week intervention study in children age 2-16 years, no changes in behavioral and 
urinary metabolic outcomes were observed (Elder et al., 2006). Because elimination diets, 
including GFCF, can put children at risk for nutrient deficiencies, the use of such diets should be 
evaluated on a case-to-case basis and elimination of foods should only be implemented if either 
an allergy or intolerance to food allergens has been diagnosed or other GI symptoms due to food 
allergens are present in the child (Marí -Bauset et al., 2016; Lange et al., 2015). Additionally, the 
evidence present to date is weak because of diverse methodology between studies and the lack of 
an appropriate control group in some studies (Lange et al., 2015).  
Other Diets: Other dietary interventions that have been explored, including FODMAP 
(Fermentable Oligo-Di-Monosaccarides and Polyols), elimination diets, ketogenic diet, 
avoidance of food coloring/food additives or specific carbohydrate diet, show some 
improvements, but the evidence to support specialty diet as a therapeutic measurement is 
inconclusive (Berry et al., 2015). The theory behind ketogenic diet as a therapeutic measure for 
symptoms of ASD is the proposed mitochondrial dysfunction that can disrupt synaptic 
functioning and neuronal integrity in individuals with ASD. In a rodent model of ASD, 
adherence to a ketogenic diet improved social behaviors and mitochondrial metabolism (Ahn et 




reduced repetitive behavior in female mice, but only had limited effects in male mice (Ruskin et 
al., 2017). Human studies on the ketogenic diet also showed some improvement in social 
communication and other ASD-related behaviors (Evangeliou et al., 2003). In a pilot study of 6-
month diet intervention using the ketogenic diet, some improvement of ASD symptoms were 
observed in subjects with milder symptom severity (Evangeliou et al., 2003).  
Nutrition supplements: Nutrition supplements are also commonly used among the ASD 
population; the most commonly used supplements among the ASD population are 
multivitamin/mineral supplements (Stewart et al., 2015). However, most multivitamin/mineral 
supplements do not provide adequate amounts of micronutrients that children in ASD are 
typically deficient in (e.g. choline, potassium) (Stewart et al., 2015). Supplementation studies 
with specific micronutrients produced promising results. Because low levels of vitamin D in 
early childhood have been hypothesized to be an environmental risk factor for developing ASD, 
children with ASD often have low vitamin D intakes and blood levels of vitamin D have been 
found to be lower in children with ASD, vitamin D supplementation studies have gained 
increasing interest as a potential therapeutic option. Some vitamin D intervention studies show 
promising results (Mazahery et al., 2016). Additionally, vitamin D is neuroprotective through 
immunomodulatory properties, reduction of inflammatory cytokines and interaction with 
neurotransmitters (McGrath et al., 2001; Kalueff & Tuohimaa, 2007). In an animal model of 
ASD, vitamin D exhibited protective effects and ameliorated neurochemical and inflammatory 
aberrations associated with ASD-like behaviors (Alfawaz et al., 2014). On the other hand, in a 
randomized placebo-controlled trial with vitamin D supplementation for 20 weeks no effect on 
stereotypical behavior was observed (Kerley et al., 2017). Other vitamins that have been 




showed improvement in some behaviors after supplementation (Martineau et al., 1985; Dolske et 
al., 1993). Lastly, in a large trial of 141 children a vitamin/mineral multi-supplement improved 
the nutritional and metabolic status of children with ASD as well as some behaviors associated 
with ASD (Adams et al., 2011).  
Fatty acid supplementation: Most of the brain’s dry weight is composed of fat with 40% 
of polyunsaturated fatty acids (PUFAs) in the brain with an omega-3 fatty acid, docosahexaenoic 
acid (DHA) (Mazahery et al., 2017). Due to its high concentrations, the important role of PUFAs 
in supporting normal neurodevelopment and function as been recognized (Bourre et al., 1991) 
and the efficacy of fatty acid supplementation in managing some symptoms of ASD has gained 
an considerable amount of attention. Likewise, aberrations in lipid metabolism and deficiencies 
of some beneficial PUFAs have been reported in individuals with ASD (Ranjan & Nasser, 2015; 
Esparham et al., 2015). Rodents with autism-like behavior induced by valporic acid exposure 
supplemented with gamma-linolenic (GLA) acid were more protected from neuronal 
degeneration and loss compared to with alpha-linolenic acid (ALA) (Yadav et al., 2017). A 
recent meta-analysis including studies on omega-3 fatty acid supplementation found that omega-
3 supplementation improved autism-associated behaviors such as hyperactivity, lethargy and 
stereotypy but found no difference in social responsiveness (Cheng et al., 2017). A different 
meta-analysis concluded that omega-3 fatty acid supplementation improved social interaction 
and repetitive behaviors compared to placebo controls (Mazahery et al., 2017). The authors 
report that six open-label trials resulted in beneficial effects of PUFA supplementation whereas 
four randomized controlled trial produced inconclusive evidence (Mazahery et al., 2017). 




was reported due to the protective role of vitamin E against oxidative damage (Gumpricht & 
Rockway, 2013).  
Dietary interventions to target the GI microbiota: A healthy, nutrient-rich diet has been 
proven to support good mental health (O’Neil et al., 2013). Due to the profound effect of diet on 
the GI microbiota composition and the newly acquired knowledge about the gut-brain-
connection, the GI microbiota was proposed to be key mediator in the diet-brain health 
connection (Dawson et al., 2016). The connection between diet and brain mediated through the 
microbiota was demonstrated in a 4-week administration of a 125g-fermented milk product 
containing Bifidobacterium animalis subsp Lactis CNCM I-2494, Streptococcus thermophiles 
CNCM I-1630, Lactobacillus bulgaricus CNCM I-1632 and I-1519 and Lactobacillus lactis 
subsp Lactis CNCM I-1631 to healthy women which affected activity of brain regions that 
control processing of emotions and sensation. Additionally, consumption of 1.5 g/day of 
Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 by healthy men and women 
alleviated general signs of anxiety and depression. (Tillisch et al., 2013). Furthermore, highly 
processed foods can decrease microbial diversity and were linked to increased risk for mental 
disorder (Dawson et al., 2016). In an animal model, rodent maintained on a lean beef 
supplemented diet for 3 months showed marked diet-induced shifts in the GI microbiota 
diversity as well as improved reference and working memory and decreased anxiety-like 
behavior (Li et al., 2009). Due to the increasing knowledge in how GI microbes could potentially 
influence behavior and reports of microbial dysbiosis in children with ASD, dietary interventions 
to manipulate the GI microbiota to ameliorate some symptoms of ASD could be a promising 
therapeutic avenue. As previously described dietary interventions improved some behaviors in 




interventions on the GI microbiota compositions as a potential links. Likewise, a decrease in 
carbohydrate-fermenting bacteria in some studies suggests that dietary patterns could potential 
impact GI microbiota composition and behavior in children with ASD (Kang et al., 2013). In a 
murine model of ASD, ketogenic diet triggered a reduction of microbial abundance and reversed 
some microbial profiles seen in children with ASD, such as low Firmicutes/Bacteroidetes ratio, 
increased abundance of Akkermansia muciniphila and SCFA producing Clostridia species (C. 
coccoides and C. leptum (Newell et al., 2016). Lastly, the purpose of the specific carbohydrate 
diet, which is used by some parents to manage symptoms of ASD, is to alleviate symptoms of 
malabsorption and prevent growth of potentially pathogenic bacteria which could potentially 
affect symptomology (Gottschall, 2004).  
In summary, a multidisciplinary approach to working with a child with ASD and feeding 
problems is warranted. For example, occupational therapist can work on improving feeding 
behavior (i.e., by a sensory integration approach), dietitians can identify nutritionally adequate 
diets and psychologist can use behavioral approaches to increase child’s acceptance of foods 
(Cermak et al., 2010). Most studies on dietary supplementation have small sample numbers 
making it difficult to draw definite conclusions. Future larger randomized controlled clinical 
trials are needed to investigate the efficacy of diet as a therapeutic measure to management some 
symptoms of autism.  
Pre- and Probiotics use: Because of the health benefits commonly reported by pro- and 
prebiotics intake and new data suggesting a role of the microbiota in ASD symptomology, some 
clinical studies have explored the effect of probiotic supplementation on ASD symptoms and its 
use is highly discussed in the literature (Table 1.1). Some improvement of symptoms as well as 




after probiotic treatment (Tomova et al., 2015; Hsiao et al., 2013, Kałużna-Czaplińska & 
Błaszczyk, 2012; West et al., 2013; Russo, 2015). For example, children with ASD taking a 
probiotic mixture (Lactobacillus acidophilus, L. casei, L. delbruecki, Bifidobacterium longum, B. 
bifidum) with an immunomodulatory three times daily for 6 months, had improved GI function 
had decreased ASD symptom severity as well as an improvement of GI symptoms. Recently, the 
prebiotic B-GOS showed a positive modulation of the microbial community in an in vitro model 
using fecal inoculum of children with ASD (Grimaldi et al., 2017). Additionally, in an animal 
model of ASD amelioration of ASD-like symptoms after supplementation with B. fragilis were 
observed (Hsiao et al., 2013). Because of significant differences in the dose and intervention 
length between studies, it is difficult to provide definite recommendations on the amount and 
kind of probiotic to use. In addition, no dietary information was collected and not all groups 
analyzed microbiota changes after the probiotic treatment or included a control cohort. However, 
according to a physician’s survey, is recommended by one fifth of physicians in treating ASD 
symptoms (Critchfield et al., 2011; Golnik & Ireland, 2009). 
A new approach to manipulate the GI microbiota in order to manage some symptoms of 
ASD is the Fecal Microbial Transfer (FMT). FMT has been shown to be very efficacious in 
treating C. difficile infections in elderly patients. In an open-label study investigating the 
possibility of FMT in children with ASD showed improvements in GI symptoms, parents’ 
perceived behavior, overall severity of symptoms, social impairments as well as ASD-associated 
behaviors such as irritability, lethargy, stereotypy, hyperactivity and inappropriate speech (Kang 






2.6 The Microbiota-Gut- Brain Axis 
The microbiota-gut-brain axis has been described as a way of communication between 
the gut microbiota and the brain. The symbiotic relationship between GI microorganisms and its 
host has long been described and evidence for the involvement of the GI microbiota in critical 
body processes such as providing protection against pathogens, regulation and programming of 
the immune system and metabolism has been established (Forsythe et al., 2015; Kabat et al., 
2014; O’Hara & Shanahan, 2006). In recent years, emerging research highlighted the role of the 
microbiota in regulating the Central Nervous System (CNS) and influencing cognitive function 
and behavior. Germ-free (GF) and gnotobiotic (GN) animal models have been fundamental in 
establishing the connection between the GI microbiota and behavior. GF mice show a behavioral 
profile that is characterized by alterations in anxiety-like behavior, locomotor behavior, learning 
and memory, social cognition and social preference (Luczynski et al., 2016). On the cellular and 
molecular levels, GF mice exhibit aberrations in neuronal activity, neuroprotection (e.g. 
increased permeability of the blood brain barriers), expression of neurotransmitters and receptors 
and stress hormone signaling (Luczyncksi et al., 2016). Similarly, bacterial genera might also be 
associated with brain structure (Fernandez-Real et al., 2015). How changes in microbial 
composition relate to ASD symptom onset is not well understood, but may relate to the 
hormones and metabolites produced by the bacteria. Certain species of Clostridia that can 
produce neurotoxins have been found to be specific to individuals with ASD and were not 







The Role of the GI microbiota in Neurodevelopment 
Brain development extends into postnatal life, providing a window of vulnerability to 
external insults that could have lasting effects on cognition and behavior (Andersen, 2003). 
Additionally, many metabolic functions of the developing microbiota including metabolism of 
vitamins, amino acids and extracting energy form diet, are crucial for brain development (Selkrig 
et al., 2014). Because, the development of the GI microbiota occurs primarily during infancy 
parallel to brain development, the GI microbiota could play a principal role in neurodevelopment 
(Borre et al., 2014). Indeed, studies using GF mice showed a critical phase in the prenatal period 
in which the GI microbiota significantly influences neurodevelopment (Neufeld et al., 2011; 
Diaz Heijtz et al., 2011) and is crucial for the normal development of motor activity, anxiety 
behavior and social behavior (Diaz Heijtz et al., 2011; Desbonnet et al., 2014). Likewise, 
neurochemical abnormalities (e.g., GABA, BDNF) were observed in GF mice, suggesting that 
the microbiota plays a central role in brain development (Dinan et al., 2015). Additionally, a 
“normal” GI microbiota is important for normal development of the hypothalamic-pituitary-
adrenal stress system in mice and for myelination in prefrontal cortex (Sudo et al., 2004; Hoban 
et al., 2016). GF nice show increased levels of synaptic-related proteins as well as myelination 
proteins, suggesting that the GI microbiota could also be important for normal structural 
development of the brain (Heijtz, 2016). Accelerated brain growth has been associated with 
developmental delays in motor, language and cognitive function (Heijtz, 2016). Interestingly, 
some of the observed neurochemical and behavioral deficits can be reversed during a specific 
time after birth, suggesting that there is a neurodevelopmental window during which the GI 
microbiota has a profound effect on behavior and development (Buffington et al., 2016). 




animals undergoing recolonization after many weeks (Neufeld et al., 2011). In a similar study, 
reconstitution of microbiome in GF mice at 4 weeks but not at 8 weeks reversed social deficit 
(Buffington et al., 2016). Early life events that can alter the composition of the microbial 
community (e.g. antibiotic use, hospitalization, breastfeeding or route of birth, Caesarean 
section) are risk factors associated with higher incidences for developing ASD, suggesting that 
early life disturbances in the GI microbiota could contribute to the development of ASD (Niehus 
& Lord, 2006; Curran et al., 2015; Schultz, et al., 2006). 
 
Proposed Mechanisms for the Microbiota-Gut-Brain Communication in ASD 
Emerging evidence suggests that the GI microbiota plays a critical role in ASD, but 
research on the routes of the communication between the gut and brain are limited. In general, 
proposed mechanisms of the microbiota-gut-brain axis include neural, hormonal, immune and 
metabolic pathways and a number of systems might be involved simultaneously. For example, 
interaction between GI bacteria, bacterial metabolites, oxidative stress, dietary allergens, gut 
permeability and ASD symptoms was described in a connectivity model investigating 
mechanisms of the microbiota-gut-brain axis in ASD. Several possible pathways of the 
microbiota–brain interaction in ASD can be proposed as shown in Figure 1.2.  
GI abnormalities and dysfunction are frequently reported in children with ASD. Intestinal 
permeability was described in multiple studies with ASD patients which could be caused by 
changes in composition and metabolic activity of intestinal bacteria, genetic predisposition or 
dietary components (Bolte, 1998; de Magistris et al., 2010). The reduced integrity of intestinal 
barrier in turn could lead to increased absorption of toxins from the gut lumen, microbial 




The microbiota itself can also have direct effects on the brain by modulating the blood–
brain barrier (Collado et al., 2012). Many gram-negative bacteria contain lipopolysaccharides 
(LPS) on their cell wall which could potentially modulate peripheral tissues including the brain 
causing an increase in blood brain barrier permeability (Minami et al., 2007) and changes in the 
metabolism of neurotransmitters such as 5-HT in the brainstem (e.g. Bifidobacterium infantis) 
(Desbonnet et al., 2008). Similarly, animal models have demonstrated that the microbiota 
provides the brain with other neurotransmitters, such as GABA, acetylcholine and 
norepinephrine, and influences growth factors such as BDNF (Dinan et al., 2015). Food that 
escapes digestion by the host can be used by the GI microbiota as energy sources. The GI 
microbiota is able to release biologically active metabolites and precursors which can be 
transported by the blood or lymphatic system and act at distal sites such as the brain. This 
symbiosis marks one of the key mechanisms in the microbiome-brain communication. Bacterial 
metabolites with relevance to ASD symptomatology include the neurotransmitter serotonin (5-
HT) and VFAs.  
5-HT has been linked to processes such as social interaction and aggression (Nankova t 
al., 2014). Genetic, GI or immune changes have been proposed as potential contributing factors 
to the hyperserotonemia observed in children with ASD (Coutinho et al., 2007; Mulder et al., 
2010; Burgess et al., 2006); however, not all cases of hyperserotonemia in children with ASD 
can be explained by genetic variations. Clinical and preclinical studies have shown that the GI 
microbiota can influence peripheral and central tryptophan and 5-HT levels, which have the 
potential to regulate mood and cognition (Jenkins et al., 2016). 5-HT is produced by certain 
Lactobacillus, Streptococcus, and Lactococcus species (Özoğul et al., 2012) which have been 




synthesis in enterochromaffin cells and modulate concentrations in the colon and blood (Yano et 
al., 2015). Increased 5-HT production by some strains of the GI microbiota in ASD could deplete 
peripheral tryptophan availability, which corresponds with data showing decreased 5-HT 
synthesis capacity in children with ASD as well as reports showing a worsening in repetitive 
behaviors in individuals with ASD after tryptophan depletion (Chugani et al., 1999; McDougle et 
al., 1996). In addition, 5-HT cannot cross the blood-brain barrier and, thus, must be produced in 
serotonergic neurons from tryptophan. Similarly, due to the increased intestinal permeability 
more 5-HT produced in the GI tract could translocate into the systemic circulation and lead to the 
elevated levels of blood 5-HT (Gabriele et al., 2014; Ibrahim et al., 2009; de Magistris et al., 
2010; d’Eufemia et al., 1996). Lastly, higher levels of 5-HT in children with ASD can be linked 
intestinal inflammation often observed in children with ASD (Marler et al., 2016). 5-HT has 
been described to play an important role in intestinal inflammatory responses (Bischoff et al., 
2009). Although the cause and effect relationship between dysbiosis and intestinal inflammation 
is not yet fully understood, intestinal inflammation is associated with increased whole blood 5-
HT levels and alterations in the GI microbiome (Butto & Haller, 2016). Thus, it can be proposed 
that intestinal inflammatory response in children with ASD which is exacerbated by the GI 
microbiota can lead to a further increase in 5-HT levels and ultimately to upstream behavioral 
effects on the brain. Interestingly, administration of Bifidobacteria fragilis normalized plasma 
levels of 5-HT in an animal model of ASD (Yano et al., 2015) Likewise, ingestion of 
Bifidobacteria infantis by conventional rats resulted in changes of 5-HT metabolism in the brain 
stem and increased total plasma tryptophan levels (Neufeld et al., 2011; Desbonnet et al., 2008). 




supporting the role of 5-HT as a potential pathway whereby the GI microbiota and brain 
communicate in ASD.  
Although to date little is known about the effect of microbiota on hormones of the gut-
brain communication, it seems plausible that the GI microbiota can modulate hormonal signaling 
in the gut-brain-axis. Gut hormone and neuropeptide release from enteroendocrine cells can be 
regulated by the GI microbiota and gut hormones were proposed to influence cognitive processes 
(Schéle et al., 2013; Finger et al., 2010; Giordano et al., 2006; Holzer et al., 2012). For example, 
the release of peptide YY, which shows anxiolytic effects in rats, from intestinal L-cells is 
stimulated by SCFAs (Holzer et al., 2012, Berglund et al., 2003). Other bacterial metabolites 
could be involved in the pathophysiology of ASD. In an animal model of ASD, specific bacterial 
metabolites (4-ethylphenylsulphate; 4EPS) caused ASD-related behaviors, proposing that 
bacterial metabolites could be a way of communication between the GI microbiota and brain in 
ASD (Hsiao et al., 2013; De Angelis et al., 2013; Yap et al., 2010; Ming et al., 2012). 
Besides acting directly on the CNS, bacterial metabolites may contribute to ASD 
pathophysiology through alterations of genes associated with ASD mutations or genetic 
pathways. However, epigenetics mechanisms of the gut-brain-axis have not been extensively 
studies. It has been hypothesized that microbial products can affect chromatin plasticity, mediate 
gene-environment interactions or act as an epigenetic entity on its own (Stilling et al., 2014). 
Evidence for these hypotheses come from studies showing that the GI bacteria can influence host 
gene transcription by secreting proteins that can act as transcriptional regulators (Bierne, 2013) 
as well as studies describing the importance of the GI microbiota in neurodevelopment, 
development of the immune system as well as associations between microbial dysbiosis and 




Another potential mechanism linking the GI microbiome to behavior in ASD is via 
VFAs, most notably propionate, which can come from microbial carbohydrate fermentation or be 
part of food as food preservatives. Due to the ability to cross the blood brain barrier and 
modulate neurotransmission and behavior, VFAs have been proposed to be neurotoxic (De 
Vadder et al., 2014; El-Ansary et al., 2012). Elevated levels of propionate in the brain was 
correlated with decreased concentrations of linoleic, linolenic, arachidonic acid (ARA) and 
docosahexaenoic acid (DHA) (Thomas et al., 2010). Altered brain phospholipids and 
acylcarnitine profiles, glutathione depletion, neuroinflammation and oxidative stress were 
observed in rodents infused intracranially with propionate (El-Ansary et al., 2014; MacFabe et 
al., 2007). Individuals with impaired propionate metabolism also displayed neurodevelopmental 
abnormalities similar to symptoms of ASD (MacFabe, 2012, MacFabe, 2015). The precise 
mechanisms of how VFA alter behavior in ASD are unknown, but effects on mitochondrial 
function (e.g. Kreb’s cycle) or epigenetic alterations may be involved (Reigstad et al., 2015). In 
addition to direct effects on the brain, propionate has been shown to modulate 5-HT secretion in 
the gut and deplete 5-HT and dopamine levels in the brain, which could potentially contribute to 
the hyperserotonemia observed in children with ASD (El-Ansary & Al-Ayadhi, 2014; Reigstad 
et al., 2015, Al-Ghamdi et al., 2014). Likewise, VFAs can influence catecholaminergic, 
serotonergic and cholinergic signaling pathways potentially though promoting the release of 
calcium (Severson et al., 2003). VFAs can also alter host gene expression that have been 
implicated in ASD pathophysiology such as Fragile X Mental Retardation gene, neurexin 1 or 
alter genes of carnitine metabolism (Nankova et al., 2014). Interestingly, microbial genera that 
occur more frequently in children with ASD include propionate producers, such as Clostridia, 




addition, in a systems-level model increased levels of Bacteroides vulgatus were associated with 
increased propionate concentrations in the brain in animal models (Downs et al., 2014).  
The HPA-axis, a major integrative system for stress adaptation, was found to be another 
key pathway in the microbiome-brain communication. In a landmark study, Sudo et al. identified 
the crucial role of microbiota in the normal development of the HPA axis during the early 
postnatal period (Sudo, et al., 2004). Since then, several studies have shown the bidirectional 
nature of the HPA-axis (Sudo, 2012; O’Mahony et al., 2011; Gareau et al., 2007). Early life 
stressors that cause a disruption in the HPA axis regulation also produce long-term changes in 
the GI microbiota and a healthy microbiome is necessary to develop normal HPA-axis activity 
(de Weerth, 2017). Other preclinical studies demonstrated an exaggerated HPA axis response in 
GF mice (Luczynski et al., 2016). Pro- and prebiotic intervention studies in human subjects 
resulted in a decreased urinary cortisol, the end product of HPA axis activation, decreased 
cortisol stress reactivity and reduced cortisol awakening response (Schmidt et al., 2015; Allen et 
al., 2016; Messaoudi et al., 2011). Whether the GI microbiota is involved in regulating the HPA 
axis activity in the ASD population remains to be determined, but increased activity of the HPA 
axis in this population has been observed (Spratt et al., 2012). Likewise, the end-product of HPA 
axis activation, cortisol, was significantly higher in a subgroup of children with ASD compared 
to controls (Tordjman et al., 2014). 
The vagus nerve is another potential avenue of communication between the GI 
microbiota and the brain. Neural signals from the GI tract to the brain can be transmitted via the 
vagus nerve, dorsal ganglia root or somatosensory afferents (O’Mahony et al., 2011) Evidence 
for vagal mediated signaling from the GI microbiota to the brain comes from studies in which 




rhamnosus, Bifidobacterium longum) were abolished in vagotomized animals (Bravo et al., 
2011; Bercik et al., 2011). Two potential mechanisms for the effect of neuroactive bacteria on 
behavior and neurochemistry were proposed. First, vagal chemoreceptors that are innervating 
mucosal villi could be activated by bacterial metabolites that can be transported across the 
epithelial barrier such as SCFA or 5-HT (Forsythe et al., 2015). Second, vagal mechanoreceptors 
(i.e. intramuscular arrays and intraganglionic laminar endings) could sense intestinal motility 
changes induced by some beneficial bacteria (Forsythe et al., 2015).  
Lastly, the immune system has been implicated as a mediator of the communication 
between the GI microbiota and behavior. The microbiota could affect microglia development 
directly and can influence the development of the immune system through various microbial 
signals (Rea et al., 2016; Kabat et al., 2014; Golnik et al., 2009; Thaiss et al., 2016). For 
example, pattern recognition receptors can recognize microbial cell components and metabolites 
and can adjust the immune response accordingly (Thaiss et al., 2016). In addition, disturbance of 
the gastrointestinal tract can lead to increased permeability of the intestinal barrier, allowing 
immune cells (e.g. lymphocytes) and cytokines to translocate to the circulation. In the brain, 
these immune cells can elicit an immune response by increasing the permeability of the BBB or 
binding to epithelial cells (de Theije et al., 2011). In children with ASD, altered immune function 
and increased levels of cytokines and other inflammatory proteins has been described (Rodrigues 
et al., 2014; Ashwood et al., 2010). Thereby, the concentration of cytokines correlated with 
severity of communication deficits and behavior dysfunction (Ashwood et al., 2010). 
Neuroimmune pathways have been discussed to contribute to ASD symptomology via the gut-
brain axis (de Theije et al., 2011). De Theije et al. proposed that ASD-associated cytokines 




response in the brain, thereby influencing behavior. In a mouse model of psychosocial stress, 
immunization with the bacterium Mycobacterium vaccae promoted better coping in a social 
stress environment potentially through activation of T-regulatory cells (Reber et al., 2016). 
Because the microbiome has been shown to be involved in the regulation and development of the 
immune system, altered GI microbiota associated with GI inflammation might thereby not only 
contribute to GI disturbances in children with ASD, but also influence behavioral problems 
through immune cells translocation into the circulation (Collado et al., 2012; Kabat et al., 2014). 
A positive correlation between expression of interferon signaling-associated genes in the blood 
and abundance of Faecalibacterium in the feces of children with ASD could suggest that 
abundance of Faecalibacterium and Blautia might be involved in the dysfunction of systemic 
immunity that is often observed in children with ASD (Inoue et al., 2016). Endotoxin, a bacterial 
LPS that can cause neuronal cell death and neuroinflammation, was not only increased in serum 
of adult patients with ASD but also predicted deficits in the social communication domain of the 
patients (Emanuele et al., 2010). Through application of a systems level model, it was suggested 
that the mucosal immune response to bacteria leads to increased systemic inflammatory 
cytokines which in turn alter the gut and blood brain barrier permeability, allowing translocation 
of toxins, microbiota and bacterial metabolites into the periphery and the brain (Downs et al., 
2014).  
Mechanisms underlying the microbiota-brain communication in ASD are heavily 
investigated. Progress in the understanding of these mechanisms will allow for new opportunities 
for therapeutic early interventions to ameliorate some symptoms of ASD and potentially prevent 
other neurodevelopmental deficits and brain disorders. Future research delineating the 




communication and may identify new therapeutic interventions for neurological diseases such as 
ASD. Thereby, the use of GF and Gnotobiotic (GN) animal models will be of fundamental 
importance. The use of GN rodent models has led to significant processes in defining how the GI 
microbiota regulates body processes, including gut-to-brain communication. However, rodent 
models are limited by several important physiological and metabolic differences from humans. 
Therefore, the piglet model is the preferred model for studying human-related host-microbe 
interactions, due to its similarity to humans in anatomy and physiology (Puiman & Stoll, 2008; 
Patterson et al., 2008). 
 
Role of Nutrition in the Microbiota-to-Brain Communication 
Diet is a major environmental factor regulating the establishment, maturation and 
maintenance of GI microbiota diversity and abundance (Kang et al., 2014; Thaiss et al., 2016; 
David et al., 2014; Wu et al., 2011). Indeed, more than 50% of microbial changes can be 
attributed to diet (Zhang et al., 2010). Although nutrition plays an important role in shaping the 
GI microbiota and nutrition interventions are commonly used to treat some symptoms of ASD, 
studies published lack in systematically investigating the effect of dietary habits of children with 
ASD on the GI microbiota composition (Table 1.2). Only Son et al. collected dietary 
information and analyzed macronutrient content of the diet (Son et al., 2015). However, short- as 
well as long-term dietary changes can alter the microbial community substantially and children 
with ASD are often picky eaters, which can have a fundamental effect on the GI microbiota (Wu 
et al., 2011; Finegold et al., 2002; Martins et al., 2008); thus, it is important to understand how 




An interrelationship between dietary intake, neurodevelopment, and cognitive function 
has been demonstrated in healthy children and most results are attributed to the direct effect of 
dietary components on the central nervous system (Khan etl al., 2015; Khan et al., 2015a). 
Adequate nutrition has been implied as an important aspect in the treatment and etiology of some 
psychiatric disorders (Sarris et al., 2015). Thereby, the interaction between diet and behavior 
could be due to altered metabolism of dietary components and changes in metabolic products as 
well as direct interaction of the GI microbiota with enteric neurons (Hanstock et al., 2004; 
Furness et al., 1999). When transferring microbiota of mice fed either a high fat or chow diet to, 
mice receiving microbiota from high fat fed mice showed increased anxiety like behavior 
compared to mice receiving microbiota from chow-fed mice (Bruce-Keller et al., 2015), 
suggesting that diet-induced changes in the GI microbiota could lead to neurological and 
behavioral changes. Similarly, inoculation of GI microbiota from undernourished children to GF 
mice caused changes in host metabolism and the immune system, giving additional evidence that 
diet-induced microbiota composition affects host systems and processes (Kau et al., 2015).  
The role of microbial changes through dietary modification on cognitive processes is not 
well described. In malnourished individuals it has been hypothesized that the microbiome is 
causally related to neurological abnormalities (Goyal et al., 2015). Thereby, cognitive 
abnormalities in children that are undernourished might relate to immature GI microbiota. This 
hypothesis is supported by evidence demonstrating that normal GI microbiota is required for 
healthy brain development, the bi-directional signaling pathway between the gut and the brain 
through nerves innervating the GI tract, and the observation that abnormal GI microbiota can 
result in abnormalities of behavior, cognitive function, structural and neurochemical 




in GI microbiota could contribute to observed behavioral changes (Li et al., 2009, Pyndt 
Jørgensen et al., 2014). For example, rodent fed a meat-containing diet had an increase microbial 
diversity as well as improved working and reference memory (Li et al., 2009). A high fat diet 
caused an increase in the abundance of Firmicutes and a decrease in the abundance Bacteroidetes 
in mice that went along with a decrease in memory function (Jørgensen et al., 2014). Other 
studies confirmed the effect of high calorie diets on brain function with co-occurring changes in 
the GI microbiota composition (Magnusson et al., 2015). Interestingly, one study found that 
feeding a high-fat or high-sucrose diet to rodents resulted in higher percentages of Clostridiales 
and Bacteroidales, two bacteria orders that have been found to be altered in children with ASD, 
compared to control mice. Behaviorally, these mice also displayed poorer cognitive flexibility 
compare to mice fed a normal chow diet (Mangusson et al., 2015). A Western-style diet, which is 
characterized by high fat intake, negatively affected anxiety-like behavior and memory 
capabilities and was associated with an increased ratio of Firmicutes to Bacteroides as well as an 
increase in Proteobacteria and Spirochaetes (Ohland et al., 2013). Lastly, vitamin and mineral 
supplementation which was successful in alleviating some symptoms of ASD could also affect 
the microbiota composition. For example, rodents treated with a magnesium deficient diet had a 
decrease in bacterial diversity as well as altered anxiety-like behavior (Jørgensen et l., 2015).  
A limited amount of studies investigating the potential of dietary interventions to impact 
cognitive function through the microbiota is available. Associations studies demonstrated that 
intake of highly processed foods can decrease microbial diversity and was linked to increased 
risk for mental disorder (Dawson et al., 2016). Pro- and prebiotic supplementation in human 
subjects are prominent ways to manipulate the microbiota and investigating the effect on brain 




and decreased waking cortisol response (Messaoudi et al., 2011) and probiotic supplementation 
with Lactobacillus rhamnosus GG in early childhood was protective against development of 
ADHD and Asperger Syndrome at 13 years of age (Pärtty et al., 2015). This study suggests that 
manipulation of GI microbiota early in life could protect against development of 
neurodevelopmental disease 
In ASD, the GI microbiota could provide a potential link between diet and ASD 
symptomology. First, dietary interventions and probiotic supplementation alleviate some ASD 
symptoms and normalized some systemic bacterial metabolites in an animal model of ASD. 
Second, VFA that are altered in children with ASD and can elicit ASD-like behavior in animal 
models are a major product of bacterial carbohydrate fermentation. Fiber (e.g., inulin, pectin) 
present in fruits and vegetables, which is usually low in the diet of children with ASD, decreased 
propionate production in vitro (Yang et al., 2013). Thus, the substrate available could drive 
microbial activity in ASD. Lastly, the GI microbiota is capable of producing 5-HT from the 
amino acid tryptophan and regulating the availability of dietary tryptophan. 
Including diet history and detailed diet diaries to clarify relationship between diet patterns 
and GI microbiota is important to investigate the correlation between nutrient intake and changes 
in microbiome. Because the diet of children with ASD is often characterized by a lack in variety, 
an inadequate amount of fiber containing foods and increased amount of sugar containing foods, 
investigating a relationship between diet and microbial dysbiosis could lead to new potential pre- 
or probiotic interventions to alleviate symptoms. Future well-designed clinical trial on dietary 
interventions could be very fruitful in delineating the potential of diet-induced changes in 
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Possible pathways of the microbiome-brain interaction in ASD can be proposed. Food that 
escapes digestion by the host can be used by the GI microbiota as energy sources. In turn, 
bacterial metabolites (e.g. SCFAs, 5-HT) are produced that can be used for physiological 
functions by the host. (1); Bacterial metabolites with relevance to ASD symptomology include 
5’HT and SCFA. 5’HT is produced by certain Lactobacillus, Streptococcus and Lactococcus 
strains (Özoğul et al., 2012). Microbial genera that are greater in children with ASD include 
propionate producers, such as Clostridia, Bacteroidetes and Desulfovibrio (Finegold et al., 2010; 
Parracho et al., 2005). Increased 5’HT production by the microbiota could lead to tryptophan 
depletion and contribute to hyperserotonemia observed in ASD. (2); Bacterial metabolites can be 
translocated into systemic or lymphatic system, transported to the brain and cause behavioral and 
chemical changes. In addition, abnormal intestinal permeability in children with ASD could  
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Figure 2.2 (cont.) 
allow passive diffusion of metabolites (de Magistris et al., 2010) (3); Although 5’HT is 
predominantly produced from EC-cells in enterocytes, its secretion can be stimulated by SCFAs 
which could increase the amount 5’HT is released into the circulation (Reigstad et al., 2015) (4); 
When reaching the brain SCFAs can have neurotoxic effects and propionate could elicit ASD 
like behavior in animal models (de Vadder et al., 2014; MacFabe, 2012) (5); The microbiome 
itself can have direct effects on the brain by modulating the BBB and causing changes in the 
metabolism of 5’HT in the brainstem (e.g. Bifidobacterium infantis) (Collado et al., 2012; 
Desbonnet et al., 2008). (6); Certain strains of the GI microbiota have been shown to influence 
the activity of the HPA axis (Sudo et al., 2012; Sudo, 2004; Gareau et al., 2007). In children with 
ASD, increased activity of HPA axis as well as increased levels cortisol in the circulation were 
observed (Tordjman et al., 2014). (7); The vagal mediated signaling from the GI microbiota to 
the brain can be transmitted through vagal chemoreceptors on mucosal villi that are activated by 
bacterial metabolites (e.g. 5’HT, SCFA) or by vagal mechanoreceptors which sense motility 
changes induced by some bacterial species (Forsythe et al., 2015) (8); The microbiome can 
influence the development of the immune system through various microbial signals (Kabat et al., 
2014; Golnik & Ireland, 2009; Thaiss et al., 2016). For example, pattern recognition receptors 
(PPRs) can recognize microbial cell components and metabolites and adjust the immune 
response accordingly (Thaiss et al., 2016). In addition, disturbance of the GI tract can lead to 
increased permeability of the intestinal barrier allowing immune cells (e.g. lymphocytes) and 
cytokines to translocate in the circulation (9); In the brain, these immune cells can elicit immune 
response by increasing permeability of BBB or binding to epithelial cells (de Theije et al., 2011). 
(10)  
Abbreviations: 5’HT: serotonin, SCFA: short chain fatty acids; EC-cells: enterochromaffin cells; 
GI: gastrointestinal; BBB: blood brain barrier 
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Table 2.2 Dietary information provided in human studies investigating microbiota composition 
in ASD children. 
 
Publication Dietary Information Provided 
Horvath et al. (1999) GF/CF diet 
Finegold et al. (2002) "Many of the patients were on a GF/CF diet” 
Parracho et al. (2005) Varied or restricted (GF/CF) diet 
Wang et al. (2011) GF/CF diet, probiotics, antibiotics 
Adams et al. (2011) probiotic use, seafood and fish oil 
consumption 
Kang et al. (2013) "information on special diets (e.g. GF/CF, 
nutritional supplements, 
probiotics, seafood)" 
Son et al. (2015) Dietary information collected for 7 days prior 
to collection of stool samples; analyzed total 
kcal, protein, fat carbohydrate, fat, fiber, 
sugar 











Fecal Microbiome Composition and Stability in 4- to 8-Year Old Children is Associated 
with Dietary Patterns and Nutrient Intake2 
 
Abstract  
Background/Aims: Previous studies have reported that dietary intake can shape the microbiota 
composition and stability in adults. How long-term dietary intake shapes microbiota composition 
and stability in young children is poorly understood.  
Methods: Herein, the temporal variability in stool microbiota composition in relation to habitual 
dietary patterns of 4 to 8 year-old children (n=22) was investigated. Fecal samples were collected 
at baseline, 6 weeks and 6 months. Bacterial composition and volatile fatty acids were assessed 
by 16S rRNA sequencing and gas-chromatography, respectively. Nutrient intake was assessed 
using 3-day food diaries and dietary patterns were empirically derived from a food frequency 
questionnaire.  
Results: Using a factor loading of >0.45 for a food group to be a major contributor to the overall 
dietary pattern, two dietary patterns were found to be associated with distinct microbiome 
composition. Dietary Pattern 1 (DP1), characterized by intake of fish, protein foods, refined 
carbohydrates, vegetables, fruit, juice and sweetened beverages, kid’s meals and snacks and 
sweets, was associated with higher relative abundance of Bacteroidetes, Bacteroides and 
Ruminococcus and lower abundance of Bifidobacterium, Prevotella, Blautia and Roseburia. 
Dietary Pattern 2 (DP2), characterized by intake of grains, dairy and legumes, nuts and seeds, 
was associated with higher relative abundance of Cyanobacteria and Phascolarctobacterium and 
                                                 
2 This article appeared in its entirety as Berding K, Holscher HH, Arthur AE, Donovan SM. Association of dietary 
patterns with composition and stability of the gut microbiota in children. J Nutr Biochem. 2017. 20:56:165-174. This 
article is reprinted with the permission of the publisher. 
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lower abundance of Dorea and Eubacterium. Fruit and starchy foods were present in both 
patterns, but were more associated with DP1 and DP2, respectively. Temporal stability of 
microbiota over a 6-month period was associated with baseline dietary patterns.  
Conclusion: Understanding how dietary intake contributes to microbiota composition and 
stability in early life in important for dietary recommendations and designing clinical 
interventions for microbiota-associated diseases. 
 
3.1 Introduction  
The human gastrointestinal (GI) microbiota is a complex community containing an 
estimated 500 species and approximately 3 million bacterial genes, which benefit the host by 
providing protection against pathogens and programming the immune response (Weinstock, 
2012; Kabat et al., 2014; Servin, 2004). Recent research has revealed that the GI microbiota is 
also involved in brain development and cognitive processes and microbial dysbiosis has been 
associated with various cognitive disorders, including Autism Spectrum Disorder (Son et al., 
2015; Kang et al., 2013; Andersen, 2003; Diaz Heijtz et al., 2011; Berding & Donovan, 2017). 
Diet is considered one of the most influential environmental factors in determining the 
composition of the gut microbiota. It has been hypothesized that due to shifts in dietary habits in 
the modern culture, diet-induced microbial changes are involved in diseases such as 
inflammatory bowel disease, allergies or other autoimmune diseases (De Filippo et al., 2010). It 
has been suggested that longer-term dietary patterns can change the microbiota over a longer 
period of time that short-term changes in dietary habits cannot accomplish (David et al., 2014). 
Dramatic short-term changes over 5-days in intakes of dietary fat, protein, and fiber has been 
shown to impact the composition and function of the human GI microbiota, while habitual 
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dietary patterns are thought to be more notably associated with long-term stability of the 
microbiota (Lozupone et al., 2012; Wu et al., 2011). In one study, a short-term (10 days) dietary 
intervention did not lead to a change the bacterial enterotype that was associated with an 
individual’s long-term dietary patterns (Wu et al., 2011). Thus, the interest in investigating the 
impact of dietary patterns on the composition of the microbiota has led to crucial advancements 
in the understanding of how habitual eating patterns affects the bacterial profile.  
Studies in humans and other mammals have shown that the gut microbiota composition 
can be clustered based on diet (herbivore, omnivore or carnivore) (Muegge et al., 2011). 
Additionally, individuals following a vegetarian diet have higher phylogenetic diversity 
compared to diet patterns rich in meat or mixed diets (Ley et al., 2008). Greater diversity is 
associated with greater potential for resistance to change, which suggests that a plant-based diet 
may be more beneficial in maintaining stable GI microbiota throughout environmental 
challenges. The abundance of Bacteroides has been associated with higher intakes of animal 
protein, amino acids and saturated fatty acids, whereas the abundance of Prevotella was 
associated with high intakes of carbohydrates, fibers and simple sugars (Wu et al., 2011). Dietary 
patterns, such as the Western Dietary Pattern which is characterized by high-fat/high-sugar 
foods, have been associated with poorer health outcomes and increased risks for developing 
metabolic disease, including obesity, type 2 diabetes, and cardiovascular disease, compared to 
dietary patterns that are higher in whole foods, fruits and vegetables (Albenberg & Wu, 2014). 
Diet-induced changes in microbiota composition can lead to increased risk of developing certain 
diseases (e.g., inflammatory bowel diseases), whereas a healthier long-term dietary pattern may 
be more beneficial in promoting a microbial profile that could potentially protect against diseases 
(Albenberg & Wu, 2014). For example, dietary patterns of obese individuals were associated 
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with microbial gene diversity and quantity which might impact host metabolic and inflammatory 
markers (Koenig et al., 2011).   
The microbiota undergoes rapid changes in the first years of life (Bergström et al., 2014). 
Although previous studies have suggested that the gut microbiota becomes relatively stable and 
resembles that of an adult at 3 years of age, other studies suggest that the gut microbiota might 
have a more prolonged development, lasting into pre-adolescence (Palmer et al., 2007; 
Yatsunenko et al., 2012; Hollister et al., 2015; Agans et al., 2011). Given that the GI microbiota 
can potentially contribute to the development of diseases in genetically at-risk individuals, it is 
important to understand whether specific long-term dietary patterns are associated with a more 
beneficial microbiota that could show a higher resiliency to environmental challenges. Therefore, 
the goal of this longitudinal observational study was to investigate the GI microbial composition 
of children aged 4-8 years and determine whether associations exist between microbial 
composition and specific dietary patterns. We hypothesized that children with an eating pattern 
containing fiber-rich foods such as fruits, vegetables, legumes, and whole grains, would be 
associated with a more diverse microbiota which would be more stable over time, whereas a diet 
high in animal products and processed foods would be associated with less beneficial bacterial 
composition (e.g., butyrate producers, bacterial species known to protect against pathogens) and 
would be more variable over time.  
 
3.2 Materials and Methods  
Participants and Baseline Questionnaire  
Children between 4 and 8 years-of-age (n=22) were recruited in the Champaign-Urbana, 
IL area between April 2016 and September 2016. Subjects were recruited as part of a larger 
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study currently being conducted in the laboratory. Data presented herein was selected to serve as 
a pilot analysis to investigate the impact dietary patterns on the GI microbiota in children. All 
subjects were free of functional digestive disorders, had not used antibiotics, probiotics or 
prebiotic in the 3 months prior to enrollment in the study, did not take any medication and did 
not follow any special diet (e.g., gluten-free/casein-free diet). Parents completed a baseline 
questionnaire including questions regarding their child’s age, gender, early feeding practices, 
mode of delivery, nutritional supplement use, height and weight. The height, weight and BMI of 
the participants were converted to percentiles according to the CDC growth charts for both male 
and female participants. Questionnaires at the 6-week and 6-month time points included 
questions on newly introduced medications and changes in gastrointestinal health in order to 
control for potential impact on changes in GI microbiota. Participants provided oral assent and 
their legal guardians provided written consent in accordance with the ethical standards of the 
Institutional Review Board of the University of Illinois at Urbana-Champaign.  
 
Fecal Sample Collection, DNA Extraction and 16S rRNA Sequencing and Analysis 
For each subject, freshly-voided morning stool samples were collected at enrollment 
(baseline), 6-weeks and 6-months post-baseline for the analysis of the fecal microbiota and 
volatile fatty acids (VFA) concentrations. Stool samples were collected into a plastic commode 
specimen collection system (Fisher Scientific, Waltham, MA). Parents were provided with 
gloves and a sterile spoon to transfer ~5 to 10 g of freshly-voided fecal material into a sterile 50 
mL conical tube. All samples were immediately placed in the participant’s freezer (-20°C) until 
transported to the laboratory within 30 min of sample collection. All samples were stored in the 
laboratory at -80°C prior to analysis. 
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Microbial DNA was extracted from stool using a bead beating method followed by a 
combination of QIAamp Fast DNA Stool Mini Kit (Qiagen, Valencia, CA) and the FastPrep-24 
System (MP Biomedicals, Carlsbad, CA), as previously described (Li et al., 2012). DNA 
concentration was measured using a NanoDrop 1000 spectrophotometer. Amplification of the V3 
to V4 regions (ca. 430 bp) of 16S rRNA gene was performed using dual-index paired-end 
sequencing approach using primers F357 and R805 (Klindwirth et al., 2013). The AccuPrime™ 
Taq DNA Polymerase System (Life Technologies, Grand Island, NY) was used for PCR 
amplification in a DNAEngine (Bio-Rad, Hercules, CA). The amplicons were mixed in 
equimolar concentration and sequenced at the W. M. Keck Center at the University of Illinois, 
Urbana-Champaign. Paired-end sequencing (2 x 300 bp) was performed with an Illumina MiSeq 
(Illumina, Inc., San Diego, CA) using version 3 chemistry.  
The 16S rRNA sequences were processed and analyzed using the QIIME 1.9.1 
bioinformatics package (Caporaso et al., 2010). Briefly, sequences were demultiplexed and 
clustered into operational taxonomic units (OTUs) using the closed-reference OTU picking 
algorithm with default parameters against the Greengenes 13_8 reference OTU database at a 
97% similarity level. Singletons and OTUs with an abundance lower than 0.005% were removed 
(Bokulich et al., 2013) prior to rarefying the OTU table to a sampling depth of 39,140 sequences 
per sample using the alpha_rarefaction command. The rarefied PTU table was used for 
subsequent analysis.  
 
VFA Analysis 
Sample preparation for VFA analyses was performed as follows: fecal material (0.1 g) 
was weighed and mixed with 0.4 mL of 3.25% m-Phosphoric acid solution in a 2 mL 
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microcentrifuge tube. Samples were vortexed to disperse the sample in solution. After an 
incubation time of 30 min, samples were frozen over night at -20°C. The next day, the samples 
were thawed and centrifuged in microfuge tubes at 13,000×g for 10 min. The supernatant was 
transferred into gas chromatography vials. 
The VFA concentrations were analyzed by a Hewlett-Packard 5890A Series gas 
chromatograph and a glass column (180 cm 3 4 mm i.d.), packed with 10% SP-1200/1% H3PO4 
on 80/100 mesh Chromosorb WAW (Superlco). Oven temperature, detector temperature, and 
injector temperature were set at 1258°C, 1758°C, and 1808°C, respectively. VFA production was 
calculated as VFA concentrations of substrate-containing tubes minus the VFA content of blank 
tubes divided by substrate weight expressed on a dry matter basis (Li et al., 2012). 
 
Dietary Patterns 
A revised version of the semi-quantitative Youth and Adolescent Food Frequency 
Questionnaire (YAQ) was completed by the parents to estimate their child’s usual food and 
beverage intake over the past year (Bandini et al., 2010). The questionnaire was modified for 
parent report as previously described (Bandini et al., 2010). The revised YAQ contained 156 
food items, compared with the original 169. The original YAQ has been tested for 
reproducibility and validity (Rockett et al., 1997). Parents were asked to estimate the frequency 
with which their children consumed a specified portion size of each of the foods listed over the 
preceding year. The questionnaire has five possible responses ranging from “never or less than 
once per month” to “more than 4 times per week”. The 156 foods items were grouped a priori 
into 13 food groups (e.g. fruits, vegetables, grains, sweets) (Appendix B). using methods similar 
to those described in previous studies of dietary patterns and disease (Evans et al., 2012). Parents 
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completed the YAQ at all three sample collection time points. However, for purpose of this 
analysis only baseline dietary patterns were included. To estimate the number of servings of any 
food group, each response was converted to the corresponding frequency factor (Harvard T.H 
Chan School of Public Health Nutrition Department’s Food Group Serving Table) and summed 
over all the food items to get the average servings of a specific food group per day.  
 
3-Food Diary  
To monitor short-term nutrient intake prior to fecal sample collection, a 3-day dietary 
food record was completed at each sample collection time point the 3 days prior to sample 
collection. The parents were asked to report all types and quantities of food and beverages 
consumed by their children during the three-day (two week days, one weekend day) period prior 
to each fecal sample collection. Parents were trained by a member of the research team on how 
to record their child’s meal on the food record. Additionally, parents were provided with a 
detailed description of how to keep a food record. After collection of the food record a member 
of the research team followed up with the parent if additional detail was needed. The food diary 
data were analyzed using the Nutrition Data System for Research (NDSR, Minneapolis, MN, 
2014) software.  
 
Assessment of Gastrointestinal Symptoms  
Parents completed a questionnaire assessing the severity of their child’s GI symptoms, 
including constipation, diarrhea, stool smell, flatulence and abdominal pain in an adapted version 
of the Gastrointestinal (GI) Severity Index (Adams et al., 2011a). Scores for each item were 
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summed to determine an overall severity score. Additionally, stool consistency was assessed 
using the Bristol Stool Chart (Lewis & Heaton, 1997).  
 
Statistics 
Descriptive statistics (means and frequencies) were generated for all demographic and 
epidemiologic variables of study participants. Dietary patterns data derived from the YAQ were 
derived using Principal Component Analysis and Factor Analysis with Varimax rotation. 
Retention of the number of factors in the final analysis was based on Eigenvalues ≥ 2, percentage 
of variability explained, interpretability of factors and Scree plots. Food groups with a factor 
loading >0.45 were considered significant contributors to each overall dietary pattern. Factor 
scores were calculated for each participant by summing the reported frequency of intake for each 
food in a food group standardized by the factor loadings. Scores for dietary patterns were 
calculated for each participant and stratified as either falling above or below the median. All 
subsequent data presented in the manuscript was analyzed for significant differences between the 
two groups (above vs. below median).  
Differences in microbial community structure were evaluated with principal coordinate 
analysis (PCoA) and permutational multivariate analysis (PERMANOVA) of variance using 
weighted and unweighted UniFrac distance in the QIIME software. Differences between the 
groups for each dietary pattern in alpha-diversity (Chao1, Shannon Index and observed OTUs), 
relative abundance of individual phyla and genera, VFA and nutrient intake data derived from 
the 3-day food records at the baseline sample collection were analyzed using Wilcoxon Rank 
Sum Test. Categorical variables were analyzed for significant differences using Chi-Square Test. 
Longitudinal dynamics in the microbiota composition and changes in dietary intake derived from 
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the 3-day food record were analyzed for significant differences between the two groups (above 
vs. below median) using mixed models. Normally distributed data were analyzed using the 
PROC MIXED procedure and non-normally distributed outcomes were analyzed using PROC 
GLIMMIX procedure. Each model for the microbiota analysis was controlled for factors known 
to affect the gut microbiota composition including age, gender, BMI, season of sample collection 
and dietary fiber intake as well as nutrients whose intake changed significantly over the 6 months 
study period. Correlations between specific food groups and bacterial abundance were assessed 
using Spearman correlation coefficient. Data are expressed as mean ± SD. Level of significance 
was set at p≤0.05 and p≤0.10 was considered a trend. All data were analyzed using SAS 9.4 
(SAS Institute, Cary, NC). 
 
3.3 Results 
Participant Characteristics  
A sample of 22 subjects was selected for analysis for this manuscript. All three samples 
were collected from 20 subjects; however, 2 subjects failed to provide a sample at the 6-months 
sample collection. Thus, 22 samples were collected for baseline and 6 weeks and 20 samples 
were collected for the 6-month time point. The study population demographics are shown in 
Table 3.1. The mean age of participant was 5.9 ±1.3 years and most participants were male 
(63%) than female. The participants self-identified as Caucasian (64%), Asian (14%), Black or 
African American (14%), and Hispanic or Latino (9%). Parents of participants were well 
educated with 77% having either a college degree or post-graduate work. Most participants had 
been exclusively breastfed (45%) for at least 6 months or were breast-fed in combination with 
formula (50%). Fifty-nine percent were delivered vaginally, 32% were delivered by emergency 
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cesarean-section, and 9% by planned cesarean-section. The mean BMI for female participants 
was 17 (85th percentile), whereas the mean BMI for male participants was 16.4 (75th percentile). 
Half of the parents reported that their child was taking a multivitamin at the time on enrollment 




Dietary Patterns at Baseline  
Using factor loading analysis, two distinct dietary patterns were identified at baseline. 
Dietary Pattern 1 (DP1) was characterized by an intake of fish, refined carbohydrates, 
vegetables, juice and sweetened beverages, protein foods, kid’s meals, condiments and snack and 
sweets. Dietary Pattern 2 (DP2) was characterized by an intake of grains, dairy and legumes, nuts 
and seeds. Fruit and starchy foods were present in both patterns, but were more associated with 
DP1 and DP2, respectively. A factor loading matrix can be found in Table 3.2.  
 
Dietary Patterns, Participant Characteristics, Microbiota Composition and VFA 
Concentration at Baseline  
Participant characteristics, nutrient intakes and bacterial abundance dichotomized by 
category of factor score (above or below the median) for each dietary pattern are shown in 
Tables 3.3-3.5. Factor scores were derived by summing the reported frequency of intake for each 
food in a food group standardized by the factor loadings for each participant. A median was 
calculated and scores were stratified as either falling above or below the median for each dietary 
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pattern. No significant differences in age, gender, BMI, race or nutritional supplement use were 
across factor score categories for either dietary pattern.  
No differences in the alpha- or beta-diversity or VFA concentrations at baseline between 
factor score categories in either dietary pattern were observed.  However, the dietary patterns 
were associated with differences in GI microbiota profiles. Participants that fell above the 
median in the DP1 had a significantly higher intake of daily servings of fruits, vegetables, 
refined carbohydrates, fish and kids’ meals, but a lower intake in servings per day of juice and 
sweetened beverages and grain foods. Participants that fell above the median in DP1 also 
consumed more cholesterol and trans fatty acids, but less vitamin A and whole grains. The 
bacterial profile of participants above the median in DP1 was characterized by higher relative 
abundances of Rikenellaceae, Bacteroidetes, Bacteroides, Lachnospira, Ruminococcus, and 
Hafnia, but lower relative abundances of Clostridiaceae, Erysipelotrichaceae, Bifidobacterium, 
Prevotella, Staphylococcus, Streptococcus, Blautia, Roseburia, and Campylobacter compared to 
children that fell below the median.  
Children that fell above the median in the DP2 had lower intakes of servings per day of 
vegetables, but higher intakes of legumes, nuts and seeds, dairy foods, and snacks and sweets. 
Nutrient data from the 3-day food diary showed that children above the median in the DP2 also 
consumed more total saturated fatty acids and calcium, but less vitamin C compared to children 
that fell below the median. The bacterial profile of children above the median for DP2 was 
associated with lower relative abundances of Cyanobacteria and higher relative abundances of 




Changes in Dietary Intake and Food Group Intake from Baseline to 6-Month Based on 3-Day 
Food Diary 
Nutrient intake from the 3-day food records were analyzed for changes over the 6-month 
period to determine the potential impact on the variability of the gut microbiota over time. 
Children falling above the median in the DP1 tended to have the highest intakes of riboflavin 
(p=0.07), selenium (p=0.09), sodium (p=0.07) and lowest intake of Kid’s meals (p=0.0008) at 
the 6-week time point. Additionally, an increase in consumption of grains (p=0.003) was 
observed. Children falling below the median in DP1 tended to consume more animal protein 
(p=0.09), but less vegetable protein (p=0.02), and omega-3 fatty acids (p=0.07) at the 6-week 
time point. Additionally, a decrease in vitamin D intake (p=0.03) and an increase in Kid’s meals 
(p<0.0001), and fish (p=0.09) over the 6-month study period was observed in children falling 
below the median in DP1.  
Overall, there were no significant changes in macro- or micronutrient intake for children 
falling below the median in the DP2. However, an increase in consumption of snack and sweet 
(p=0.05), vegetables (p=0.09), fruit (p<0.0001), legumes (p=0.09) and juice and sweetened 
beverages (p=0.04) was observed in children falling below the median in DP2. Children that had 
scores above the median in the DP2 tended to have an increase in total protein intake (p=0.09), 
intake of fruit (p=0.003) and fish (p=0.003) over the 6-month period and had the highest intake 
of animal protein (p=0.02) at the 6-week time point. Likewise, consumption of vitamin D 
(p=0.0002) and selenium (p= 0.07) were also highest at the 6-week time point in children falling 





Microbiota Stability over 6-Month based on Dietary Pattern 
Significant changes in the bacterial phyla and genera over the entire study period based 
on dietary pattern are shown in Table 3.6. There was no statistically significant difference in 
alpha- or beta-diversity in either dietary pattern over the 6-month period (data not shown). 
Participants below the median in the DP1 tended to have a decrease in the abundance of 
Verrucomicrobia from baseline to 6-weeks and 6-months. At the genus level, children below the 
median in the DP1 tended to have a decrease in the relative abundance of Paraprevotella, and 
Lachnospira. Examining longitudinal stability of the gut microbiota based on DP1 showed that 
children above the median did not show any significant changes in the composition on the phyla 
level.  
Overall, children above the median in DP1 had more changes in the abundance of 
bacterial phyla and genera compare with children below the median. At the phyla level, changes 
in the abundance of Actinobacteria and Bacteroidetes were observed, with Actinobacteria 
showing the lowest and Bacteroidetes having the highest abundance at the 6-week point. 
Abundance of Firmicutes increased over the 6-months study period in children above the median 
in DP1. At the genus level, the abundance of Bifidobacterium and Streptococcus tended to be 
lowest at the 6-week time point in children above the median in DP1. Likewise, the abundance of 
Roseburia significantly decrease over the 6-months period. The abundance of Lachnospira was 
significantly higher at the 6-week time point compared to baseline and 6-month time point in 
children below the median. Children below the median showed a significant decrease in the 
abundance of Cyanobacteria and Verrucomicrobia over the 6-month study period with the 6-




VFA Concentrations at Baseline Based on Dietary Pattern and Longitudinal Changes 
VFA concentrations did not differ between above or below the median group in either 
dietary pattern (Table 3.5). Longitudinal changes of VFA concentrations are shown in Figure 
3.1. Acetate concentration was significantly increased (p=0.05) from baseline to 6 months in 
children above the median in the DP1. Alternatively, butyrate concentrations significantly 
increased (p=0.03) in children below the median in the DP1. In DP2 there was no change in the 
concentration of any VFA in children below the median, but acetate (p=0.01) and butyrate 
(p=0.02) concentrations significantly increased from baseline to 6 months in the group of 
children above the median.  
There were no changes in the concentrations of propionate or the branch-chain fatty acids 
(valerate, isovalerate or isobutyrate) in either dietary pattern.  
 
GI Severity Index and Bristol Stool Chart 
Children above the median in DP1 tended to have higher GI severity index scores 
compared to children below the median (p=0.07). In DP2, children below the median had higher 
(p=0.004) GI severity scores than children above the median. We also performed regression 
analysis to assess whether specific bacterial genera and phyla that were higher in the respective 
groups could predict the GI severity score. A trend (p=0.08) for predicting GI severity based on 
Cyanobacteria and Phascolarctobacterium relative abundance was observed for DP2. There 
were no statistically significant differences in stool consistency based on the Bristol Stool Chart 
criteria.  
 
Correlations between Food Groups and Microbiota Abundance 
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Correlations between fiber intake and intake of specific food groups with microbial 
diversity and abundance were analyzed for the whole cohort using baseline data. Only baseline 
data were used for this analysis due to the ability to control for factors such as probiotic, 
antibiotic or medication use. Several associations between fiber intake and intake of specific 
food groups were found. The strongest correlations are shown in Figure 3.2. Servings per day of 
refined carbohydrates were negatively correlated with Chao 1 Diversity Index (ρ=-0.48; p=0.03). 
Servings per day of snacks and sweets was negatively correlated the Shannon Diversity Index 
(ρ=-0.41; p=0.05). Both Bacteroides (ρ=0.66; p=0.008) and Bacteroidetes (ρ=0.52; p=0.01) 
abundance were positively correlated with the servings of fruit per day.  
 
3.4 Discussion  
Habitual dietary patterns have been shown to influence the composition and long-term 
stability of the gut microbiota in adults, but the association between dietary patterns, microbial 
composition, and stability of the GI microbiota in children is poorly understood. To fill this gap, 
we used exploratory Principal Component Analysis to investigate dietary patterns derived from a 
food frequency questionnaire and the impact on microbiota composition. Two distinct microbiota 
profiles existed based on dietary patterns. Furthermore, a dietary pattern characterized by higher 
intakes of vegetables, fruit and grains and lower intakes of starchy foods and juice and sweetened 
beverages was associated with a greater microbiota stability over a 6-month period. These 
observations correspond to our hypothesis that a dietary pattern containing fiber-rich foods, 
including fruits, vegetables and grain, will be associated with a more stable microbiota 
composition. Thus, different long-term eating patterns in children aged 4-8 years result in 
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distinct microbial profiles and might have different effects on the temporal variability of the 
microbiota.  
Overall, the macronutrient intake of this study population was characterized by higher 
than recommended intake of calories from fat (~35% of total calories compared to AMDR 25-
35%) and from saturated fats (~13% of total calories compared to recommended 7%), but lower 
than recommended intakes of calories from protein (~16 % of total calories compared to AMDR 
10-30%). Likewise, fiber intake averaged at 15 g at all 3 time points, which is ~ 69% of 
recommended intake. On the other hand, sodium intake was at 130% of the Dietary Reference 
Intakes. These observations are similar to previous studies showing that children in the U.S. 
exceed amounts of recommended intakes of total fat, saturated fat and sodium, but consume well 
below the recommendations for daily fiber intake (Bronner, 1996; McGill & Devareddy, 2015). 
Children in the U.S. also often fail to meet the dietary guidelines for fruit, vegetable and whole 
grain intake. In some food groups, including vegetables and whole grains, children in the U.S. 
are only meeting half the recommended intake per 1000 kcals (Frazier-Wood et al., 2016). Only 
10% of U.S. children consume recommended amounts of fruit and vegetables (Krebs-Smith et 
al., 2010), which is similar to results from this study. Overall, children consumed less than the 
recommended servings per day of fruit, vegetables, legumes and seeds, and whole grains, but 
exceeded the recommended 2-3 servings per day for dairy foods. The similarities in dietary 
intake of children in this study to nationally-representative populations could suggest that our 
microbiota findings could be generalizable to young children in the U.S. However, our small 
sample size does not allow for a definite conclusion but could serve as preliminary evidence for 
future larger scale studies. Interestingly, most children with a Hispanic background fell in the 
below median group in DP1, which was characterized by low intakes of fruits and vegetables, 
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but higher intakes of juice and sweetened beverages. Previous reports found that fruit or 
vegetable intake differed by race and ethnicity (Kirkpatrick et al., 2012) and children with a 
Hispanic background often did not meet recommendations for fruits and vegetables (Basch et al., 
1994).  
Understanding the long-term variability of the GI microbiota is important as resistance to 
environmental stressors and rapid return to a baseline state are key features of a healthy 
microbiome (Bajaj et al., 2012). Although extreme shifts in dietary macronutrient and fiber 
intakes are associated with short-term changes in the gut microbiota, most studies have found 
that these shifts are reversible and that the GI microbiota returns to baseline composition 
(Lozupone et al., 2011; Li et al., 2017). Variation in the microbiota is associated with non-dietary 
factors; thus, age, gender, race, BMI and season of sample collection were included as co-
variates in our analyses (Hollister et al., 2015; Dominianni et al., 2015). Additionally, nutrients 
and food groups that were shown to be different between the time points and introduction of any 
medication or changes in GI health were included as co-variates. Other studies found that 
environmental factors can affect the abundance of specific microbial genera in an otherwise 
stable bacterial core in adults (Bäckhed et al., 2012; Rajilić‐Stojanović et al., 2013; Martínez et 
al., 2013) and bacteria that are lower abundance might be more transient and prone to temporal 
variations than predominant phyla of the bacterial core (Durbán et al., 2012; Vanhoutte et al., 
2004; Caporaso et al., 2011). We hypothesized that a dietary pattern characterized by high fiber-
foods would be associated with a more diverse and stable microbiota over time. In this study, we 
did not observe changes in alpha- or beta-diversity based on dietary pattern. However, we 
observed changes in the abundance of less prominent bacterial phyla based on the DP1 but not 
DP2. In DP1, the abundance of Verrumicrobia and Fusobacteria varied over the 6-month period, 
88 
 
whereas in DP2, variation in the abundance of Actinobacteria, Bacteroidetes, Firmicutes, 
Cyanobacteria and Verrucomicrobia were observed. Children falling above the median in DP1 
had the least changes at the phyla and genera level, whereas children above the median in DP2 
showed the greatest changes. These results suggest that an eating pattern defined by relatively 
high intakes of high fiber foods such as fruits, vegetables and grains, but lower intakes of starchy 
foods and juice and sweetened beverages and might be associated with a more stable microbiota. 
Higher variability in microbiota composition over a 6-months period was observed in a dietary 
pattern characterized by lower intakes of vegetables, but higher intakes of animal products such 
as protein and dairy foods. These results could be of significance as less variability in microbiota 
composition has been associated with greater resistance to pathogen invasion (Ley et al., 2008). 
We did not find significant differences in intakes of processed foods between the two dietary 
patterns. This could be in part attributed to the a priori selection of foods to include in each food 
group which was based on previously published methods. For example, French Fries, which are 
often high in the diet of American children, was grouped together in a group with other refined 
carbohydrates such as white bread or bagels.  
Besides changes in microbial composition, determining variability in microbial 
metabolites concentration could have important health implications as some short chain fatty 
acids have been associated with GI health (Macfarlane & Macfarlane, 2012). Herein, we 
observed an increase in acetate concentrations in children falling above the median in DP1 and 
an increase in butyrate concentration in children with scores below the median in DP1. In DP2, 
increases in acetate and butyrate concentrations were observed in children falling above the 
median. Some of the changes in the VFA concentrations observed herein could potentially be 
attributed to changes in dietary intake as well as changes in the microbiota composition. 
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Although not statistically significant, some bacteria known to produce VFA numerically 
increased in this study include Bifidobacterium, Faecalibacterium and Ruminoccous. Previous 
studies have reported fluctuations in VFA concentrations over the course of the day (Kaczmarek 
et al., 2017) and in response to dietary interventions (Vanegas et al., 2017); however, to the best 
of our knowledge no studies have investigated fluctuations in VFA over a longer period of time. 
SCFA have been suggested to be involved in communication pathways of the microbiota-gut-
brain axis and higher SCFA concentrations were reported in fecal samples of children with ASD 
(Wang et al., 2012). Additionally, one study found significant associations between higher fecal 
butyrate concentrations and emotional problems (Michels et al., 2016). On the other hand, 
increased production of SCFA has also been proposed in maintaining colon health (Clausen & 
Mortensen, 1995). Thus, temporal variability in VFA concentrations could be associated with 
changes in host responses. In our study no changes in GI health were observed and no 
information on behavioral aspects was collected. Therefore, the significance of these changes 
remains to be determined. However, the data presented herein could provide preliminary 
evidence for future larger studies investigating changes in VFA concentrations in relation to host 
health.  
A novel finding of the current study is the observation of distinct bacterial profiles based 
on dietary patterns, even though differences in alpha- or beta-diversity as well as VFA 
concentrations were not observed. Defining a healthy microbiota is important due of the ability 
of the gut microbiota to affect host health and behavior (Burokas et al., 2015). Establishing a 
definition for a healthy microbiota is difficult and to date no clear understanding of a “beneficial 
microbiota” has been established (Linares et al., 2016). However, bacteria thought to be 
beneficial can exert positive health benefits on the host such as supporting the immune system 
90 
 
and protecting against pathogens. In our study, some of the bacterial genera and phyla that 
differed between the two groups in DP1 have been implicated to benefit host health. Children in 
the above median in DP1 had higher levels of Rikenellaceae, Erysipelotrichaceae, Bacteroidetes, 
Bacteroides, Lachnospira, Ruminococcus, and Hafnia, but lower levels of Clostridiaceae, 
Bifidobacterium, Prevotella, Staphylococcus, Streptococcus and Roseburia. Even though 
beneficial effects are associated with higher abundance of Bacteroides, such as supporting 
development of immune tolerance and avoidance of allergy and asthma, some negative 
associations have also been reported. For example, Bacteroides could have negative effects due 
to its virulence factors causing infection after colonic contamination of abdominal cavity or 
tissues or GI illness due to production of enterotoxins (Wexler, 2007). Previous studies reported 
a higher abundance of Bacteroides in individuals following a Western-style diet, which is 
characterized by intakes high in protein and fats similar to intakes for children above the median 
in DP1 (Wu et al., 2011). Interestingly, we also found that a higher fruit intake was correlated 
with a higher abundance of Bacteroides and Bacteroidetes and intake of refined carbohydrates 
was negatively associated with the relative abundance of Bifidobacterium. Similarly, other 
studies have also shown that a diet rich in fruit and legumes resulted higher abundance of 
Bacteroidetes (De Filippo et al., 2010). We have previously shown that the abundance of 
Ruminoccocus can negatively predict brain N-acetylaspartate, a marker of neuronal health, 
concentration through the levels of serum cortisol, which could impact neurodevelopmental 
disorders (Mudd et al., 2017). Likewise, Lachnospira has been found to be enriched in 
individuals with Inflammatory Bowel Syndrome (IBS), but could also potentially protect against 
the development of asthma (Claassen-Weitz et al., 2016; Rode et al., 1981). Even though no 
differences in butyrate concentrations at baseline between the groups in DP1 were observed, one 
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of the potential benefits of a greater abundance of Roseburia could be through the production of 
butyrate in the colon, which is the preferred substrate for colonocytes and has been associated 
with prevention of colitis and colorectal cancer (Pryde et al., 2002; Jacobasch et al., 1999). 
Additionally, Roseburia was present in higher abundance in lean compared to obese subjects 
(Aguirre et al., 2016). Health benefits of Prevotella include improved glucose tolerance and 
improved gastrointestinal health (Monk et al., 2017) and Prevotella has been shown to be 
decreased in children with ASD (Kang et al., 2013). Bifidobacterium is generally associated with 
beneficial effects to human health, including prevention of colorectal cancer, treating 
gastrointestinal disorders such as diarrhea or IBD or anxiolytic like effects (O’Callaghan & van 
Sinderen, 2016; Savignac et al, 2015).  
In DP2, fewer differences were found between the microbiota composition of children in 
the above and below median groups. Children above the median had higher fecal Dorea, 
Eubacterium, and SMB53, but lower levels in Cyanobacteria and Phascolarctobacterium 
compared to the below median group. Individuals with a higher abundance of Dorea were more 
resistant to Campylobacter infection (Kampmann et al., 2016) whereas individuals who became 
Campylobacter positive had higher abundance of Phascolarctobacterium (Dicksved et al., 2014). 
Lastly, Eubacterium could potentially inhibit growth of harmful bacteria through its butyrate 
producing capabilities (Gibson & Roberfroid et al, 1995). Thus, the microbial profile associated 
with DP2 may be beneficial in protecting against potential pathogenic infections. These results 
oppose our hypothesis that a dietary pattern higher in animal products will be associated with a 
less beneficial microbiota. However, processed food such as refined carbohydrates was not 
different between the groups. Additionally, children above the median in DP2 also had high 
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intakes of legumes, nuts and sees which are rich in fiber and could potentially offset some of the 
microbial differences elicited by high intakes of animal products.  
Manipulating the GI microbiota has become a promising target for the interventions to 
treat symptoms of certain diseases, including ASD. Probiotic supplementation has shown some 
promising results in alleviating some symptoms of ASD (Berding & Donovan, 2017). De Filippo 
and co-workers hypothesized that a long-term dietary pattern rich in polysaccharides in children 
living in Burkina Faso shapes the GI microbiota in a fashion that protects against inflammation 
and noninfectious colonic diseases (De Filippo et al. 2010). Likewise, changing dietary intake for 
2 years restored a dysbiotic microbiota in obese individuals (Haro et al., 2017). Herein, we report 
higher GI severity index scores in the above median group in DP1, which also had higher 
relative abundance of Lachnospira and lower abundance of Bifidobacteria. Similarly, higher 
abundance of Lachnospira species and lower abundance of Bifidobacteria was reported in 
individuals with bloating or abdominal pain (Zhang et al., 2015).  
This study was limited by the small sample size which did not allow for enough statistical 
power to assess associations of interest using robust, multiple regression models. The short time 
between the sample collections is also a limitation. Dietary intake was based on parent self-
report using food diaries and food frequency questionnaires, which are susceptible to 
measurement error and systemic biases in estimate food intake (Willett, 2011). Additionally, our 
study design only allows for assessment of association and no inferences regarding causality can 
be made. Therefore, using animal models or human intervention trials in the future will be 
important in delineating the causality between GI microbiota and host health in h.  
Despite these limitations, this is the first study to use the approach of a Principal Component 
Analysis to define eating patterns and the relationship to microbiota in children. This approach 
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could provide valuable insight in future studies investigating diet as a moderator for the impact 
of microbiota on host physiology, cognitive function, and behavior. Additionally, our study 
contributes to the limited knowledge of temporal microbial variability in children.  
In conclusion, the microbiota composition of children aged 4-8 years is distinct based on 
specific dietary patterns. Furthermore, some dietary patterns may be associated with more stable 
microbial profile than others. Dietary patterns are important in predicting the long-term 
composition of the GI microbiota and it has been suggested that an individual’s bacterial 
communities can affect the responses to a specific intervention (Ley et al., 2008). Thus, 
understanding which dietary patterns are associated with a more stable microbiota can be 




3.5 Tables and Figures  
 
Table 3.1 Demographic characteristics of all study participants (n=22) at baseline  
 
Characteristic Mean ± SD or n  
Age (years) 5.9±1.3 









Black or African American 






Early Feeding Practice (n) 
Exclusively Breast-fed  


















17.03±2.5 (85th percentile) 
16.4±3.2 (75th percentile) 








Table 3.2 Factor Loading Matrix 
 
Food Group Dietary Pattern 1 Dietary Pattern 2 
Fish 0.81* -0.09 
Refined Carbohydrates 0.75* -0.03 
Vegetables 0.70* 0.06 
Juice and Sweetened Beverages 0.67* 0.02 
Protein Foods  0.64* 0.37 
Kids Meals 0.52* 0.39 
Condiments 0.48* 0.32 
Snack and Sweets 0.45* 0.37 
Fruit 0.57* 0.47* 
Starchy Foods 0.45* 0.61* 
Grains -0.13 0.86* 
Dairy 0.17 0.61* 
Legumes, Nuts and Seeds -0.04 0.60* 
*Factor loading >0.45 is considered to be a major contributor to the overall dietary pattern; Food 
groups in which factor loadings are >0.45 for both dietary pattern are assigned to dietary pattern 




Table 3.3 Participant characteristics by scores above or blow the median at baseline 
 
 Dietary Pattern 1 Dietary Pattern 2 


















































Current Nutritional Supplement Use (%) 27 27 18 32 
GI Severity Index 0.82±0.75 0.36±0.67† 0.15±0.4 1.0±0.77* 




















Data are expressed as Mean ± SD or n; p-values were obtained by Wilcoxon Rank Sum Rest and Chi-Square Test. Values within same 
dietary pattern and row are significant at *p<0.05 and †p<0.1 
GI, gastrointestinal; BMI, body mass index  
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Table 3.4 Baseline food and nutrient intakes of participant characterized as consuming above or below the median in dietary pattern 1 
and dietary pattern 2 
 
 Dietary Pattern 1 Dietary Pattern 2 






Below Median  
(n=11) 




Legumes, Nuts, Seeds 
Starchy Foods 




































































Total saturated fatty acids (g) 
Total Trans Fatty acids (g) 
Vitamin A (μg) 
Vitamin C (mg) 
Calcium (mg) 

































Total Dietary Fiber (g) 16±8 15±4 16±8 16±3 
Soluble Dietary Fiber (g) 5±2 5±1 4±2 5±1 
Insoluble Dietary Fiber (g) 12±6 11±3 11±8 11±3 
Pectins (g) 2±1 2±1 2±2 2±1 
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Table 3.4 (cont.) 
 
Data are expressed as Mean ± SD; p-values were obtained by Wilcoxon Rank Sum Rest and Chi-Square Test; Values within same 
pattern and row are significant at *p<0.05 and †p<0.1; Only nutrient intake that showed significant difference between the groups are 





Table 3.5 Baseline bacterial abundance and VFA concentrations of participants characterized as consuming above or below the 
median in dietary pattern 1 and dietary pattern 2 
 
 Dietary Pattern 1 Dietary Pattern 2 
Characteristic Above Median (n=11) Below Median (n=11) Above Median (n=11)  Below Median (n=11) 










































































































































Table 3.5 (cont.)     
 Dietary Pattern 1 Dietary Pattern 2 





















Data are expressed as Mean ± SD; p-values were obtained by Wilcoxon Rank Sum Rest and Chi-Square Test; Values within same 
dietary pattern and row are significant at *p<0.05 and †p<0.1; Only bacteria that showed significant difference between the groups of 
dietary patterns are shown.  




Table 3.6 Relative abundance of bacterial genera in stool at baseline, 6 weeks and 6 months post-baseline of participant characterized 
as consuming above or below the median in dietary pattern 1 (a) and dietary pattern 2 (b) 
 
a) Dietary Pattern 1 
 Above Median Below Median 
Bacterial genus (% of 
sequences) 











































Fusobacteria 0±0 0.003±0.006 0.01±0.003 0±0* 0.006±0.007* 0.01±0.006* 
Data expressed as Mean±SD; *p≤0.05; †p≤0.1; p.b. – post-baseline; Only genera with abundance >0.05% were analyzed 
 
b) Dietary Pattern 2 
 Above Median Below Median 
Bacterial genus (% of 
sequences) 






























































Cyanobacteria 0.004±0.008 0.02±0.06 0.09±0.25 0.02±0.02* 0.008±0.02* 0.005±0.007* 
Verrucomicrobia 6.39±13.66 3.42±6.5 1.07±20.3 6.75±9.84† 0.37±0.61† 4.76±9.75† 
Data expressed as Mean ± SD; *p≤0.05; †p≤0.1; p.b. – post-baseline; Only genera with abundance >0.05% were analyzed
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Figure 3.1 Volatile fatty acid concentrations at baseline and 6 months post-baseline 
a) VFA concentrations at baseline and 6 months based on Dietary Pattern 1 
 
 
b) VFA concentrations at baseline and 6 months based on Dietary Pattern 2.  
 
 



















































Acetate Butyrate  
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Figure 3.2 Correlation between intake of specific food group and abundance of bacteria 
 
a) Bacteroides and intake     b) Bacteroidetes and intake 




c) Chao 1 Index and intake of    d) Shannon Index and intake 




Spearman Correlation coefficient for selected food groups derived from the YAQ and bacteria 














































































































Differences in Microbiota Composition and VFA Concentrations Between Children with 
ASD and Unaffected Controls and Relationship to Symptom Severity3 
 
Abstract 
Background/Aims: An increasing number of studies report differences in the fecal microbiota 
composition and volatile fatty acids (VFA) between children with Autism Spectrum Disorder 
(ASD) and unaffected controls. Additionally, increasing evidence shows that specific bacterial 
taxa can influence some symptoms of ASD.  
Methods: We investigated the fecal microbiota composition in children with ASD (n=26) and 
unaffected controls (n=32) aged 2-7 years. Fecal samples were collected and microbiota 
composition was analyzed using 16S rRNA sequencing and Real-Time qPCR. VFAs were 
analyzed using gas chromatography. Social deficit scores in children with ASD were measured 
using the Pervasive Developmental Disorder Behavior Inventory-Screening Version (PDDBI-
SV). Generalized linear mixed models were used to analyze differences in microbiota and VFA 
concentrations between the groups. Regression analysis was performed to investigate whether 
individual microbiota could predict social deficit scores.  
Results: Overall, β-diversity differed between the groups and observed OTUs were higher in 
children with ASD. Regarding the microbiota abundances, differences on the phyla, family, 
order and genera level were observed. Namely, children with ASD had higher levels of 
Firmicutes, Clostridiales, Clostridiaceae, Peptostreptococcaceae, Coriobacteriaceae, Clostridium, 
SMB53, and Roseburia but lower levels of Bacteroidetes, Rikenellaceae, Butyrivibrio, 
Faecalibacterium, Dialister, and Bilophila compared to controls. Furthermore, higher 
                                                 
3 Berding K, Donovan SM. Diet and Feeding Behavior are Related to Microbiota Composition in Children with 
Autism Spectrum Disorder. Front Neurosci. 2018. Under Review.  
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concentrations of acetate, propionate and butyrate were detected in children with compared to 
controls. Lastly, we found that Peptostreptococcaceae and Faecalibacterium predicted social 
deficit scores in children with ASD as measured by the PDDBI-SV.  
Conclusion: In conclusion, this study contributes to the growing knowledge of microbial 
dysbiosis in children with ASD and provides new evidence for the impact of individual bacterial 
taxa on some symptoms of ASD.  
 
4.1 Introduction 
In recent years, the involvement of the gastrointestinal (GI) microbiota in cognitive and 
neurodevelopmental disorders, such as anxiety, depression and Autism Spectrum Disorder 
(ASD), has become increasingly recognized as a potential pathway of affecting symptom 
manifestation. In ASD, aberrations at the phyla and genus level between children with and 
without ASD have been described. For example, several studies have shown higher abundance of 
Bacteroidetes and Proteobacteria, but lower abundances of Firmicutes, Actinobacteria and 
Verrucomicrobia (Finegold et al., 2010; Kang et al., 2013; De Angelis et al., 2013). On the 
genera level significant reductions in the relative abundances of Prevotella, Coprococcus, 
Enterococcus, Lactobacillus, Streptococcus, Lactococcus, Staphylococcus, Ruminococcus and 
Bifidobacteria in children with ASD compared to non-affected controls have been reported 
(Kang et al., 2013; De Angelis et al., 2013; Wang et al., 2011). Conversely, the genera 
Clostridium, Sutterella and Desulfovibrio were increased in children with ASD (Finegold et al., 
2010; Kang et al., 2013; Parracho et al., 2005). Furthermore, associations between the abundance 
of specific bacteria and ASD symptom severity have been described. A lower ratio of 
Bacteroidetes-to-Firmicutes and a higher abundance of Clostridium and Desulfovibrio were 
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positively associated with severity of ASD symptoms (Tomova et al., 2015). Besides differences 
in the fecal microbiota, deviations in microbial products between children with ASD and 
unaffected controls have also been observed. Previous studies found elevated Volatile Fatty Acid 
(VFA) concentrations in stool, urine and serum of children with ASD (Wang et al., 2012) and 
administration of propionate has been shown to induce autism-like behaviors in rodents 
(MacFabe et al., 2011), suggesting that some VFA could be a way of communication between 
the GI microbiota and the brain in ASD.  
Even though emerging evidence suggests that the GI microbiota might be involved in 
ASD symptomology, more carefully controlled studies are necessary to define an “ASD 
microbiome”. Effects of probiotic, antibiotic or medication use, specialty diets or presence of 
functional GI disorders on the GI microbiota composition are often overlooked. Likewise, 
studies describing the relationship between specific GI bacteria taxa and ASD symptoms are 
limited. Therefore, the goal of this study was to investigate the microbiota composition of 
children with ASD and unrelated controls, controlling for recent probiotic, antibiotic or 
medication use, specialty diets and functional GI disorders. Additionally, food diaries were 
collected to control for the impact of nutrition on the GI microbiota composition. Lastly, the 
relationship between GI microbiota and ASD symptoms was investigated. We hypothesize that 
children with ASD will have a different microbiota composition and VFA concentrations 
compared to unaffected controls and that individual bacterial taxa will predict the severity of 
some symptoms of ASD.  
 
4.2 Materials and Methods 
Participants and Questionnaire 
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Children diagnosed with ASD (ASD) between 2 and 7 years-of-age (n=26) were recruited 
from different sites across Illinois, Indiana, Ohio, Missouri, Kentucky, and Iowa between April 
2016 and October 2017. Age- and sex-matched unrelated control subjects (CONT) were 
recruited in the Champaign-Urbana area. All subjects were free of functional digestive disorders, 
had not used antibiotics, probiotics or prebiotic in the 3 months prior to enrollment in the study, 
did not take any medication and did not follow any special diet (e.g., gluten-free/casein-free 
diet). Parents completed an online questionnaire including questions regarding their child’s age, 
gender, early feeding practices, mode of delivery, nutritional supplement use, gastrointestinal 
symptoms, height and weight. Parents also answered questions on their perception of child’s 
feeding problems based on information obtained from previously published results (“Do you 
consider your child to be a picky eater” (Taylor et al., 2015), “Does your child have a repetitive 
eating pattern (i.e., likes to eat the same foods)” (Cornish, 1998) and “Does your child currently 
include more than 20 foods in his or her diet” (Nadon et al., 2011; Cornish, 1998). The height, 
weight and BMI of the participants were converted to percentiles according to the CDC growth 
charts for both male and female participants. Participants provided oral assent and their legal 
guardians provided written consent in accordance with the ethical standards of the Institutional 
Review Board of the University of Illinois at Urbana-Champaign.  
 
Fecal Sample Collection, DNA Extraction and 16S rRNA Sequencing and Analysis 
For each subject, freshly-voided morning stool samples were collected for the analysis of 
the fecal microbiota and VFA concentrations. Stool samples were collected into a plastic 
commode specimen collection system (Fisher Scientific, Waltham, MA) or directly from the 
diaper. Parents were provided with gloves and a sterile spoon to transfer ~5 to 10 g of freshly-
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voided fecal material into a sterile 50 mL conical tube. All samples were immediately placed in 
the participant’s freezer (-20°C) until transported to the laboratory. All samples were stored in 
the laboratory at -80°C prior to analysis. 
Microbial DNA was extracted from stool using a bead beating method followed by a 
combination of QIAamp Fast DNA Stool Mini Kit (Qiagen, Valencia, CA) and the FastPrep-24 
System (MP Biomedicals, Carlsbad, CA). Briefly, 180-220 mg of stool were weighed into a 
Lysing Matrix E tube and 1 mL of Inhibit EX buffer was added to the sample. The tubes were 
shaken using the FastPrep-24 system, before being incubated at 95C for 5 minutes. Samples 
were centrifuged and the supernatant was added to 25 L of Proteinase K. After adding 400 L 
Buffer AL, the mixture was incubated at 70C for 10 minutes. 400 L of ethanol were added to 
the lysate. The lysate was then applied to the QIAmp spin column and centrifuged. 500 L of 
Buffer AW1 and AW2 were then added to the column which was then centrifuged again. Lastly, 
180-220 L Buffer ATE was added to the column to dilute the DNA. DNA concentration was 
measured using the Nanodrop.  
Amplification of the V3 to V4 regions (ca. 430 bp) of 16S rRNA gene was performed 
using dual-index paired-end sequencing approach using primers F357 and R805 (Klindworth et 
al., 2013). The AccuPrime™ Taq DNA Polymerase System (Life Technologies, Grand Island, 
NY) was used for PCR amplification in a DNAEngine (Bio-Rad, Hercules, CA). The amplicons 
were mixed in equimolar concentration and sequenced at the W. M. Keck Center at the 
University of Illinois, Urbana-Champaign. Paired-end sequencing (2 x 300 bp) was performed 
with an Illumina MiSeq (Illumina, Inc., San Diego, CA) using version 3 chemistry.  
The 16S rRNA sequences were processed and analyzed using the QIIME 1.9.1 
bioinformatics package (Caporaso et al., 2010; Bokulich et al., 2013). Sequences were 
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demultiplexed and clustered into operational taxonomic units (OTUs) using closed-reference 
OTU picking with default parameters against the Greengenes 13_8 reference OTU database at a 
97% similarity level. Singletons and OTUs with an abundance lower than 0.005% were removed 
prior to rarefying to a sampling depth of 49,446 sequences per sample for subsequent analysis. 
- and - diversity were calculated using QIIME. Taxonomy summary was performed using the 
core diversity script in QIIME.  
 
Real-time Polymerase Chain Reaction 
RT qPCR specific bacteria. Bacterial genomic DNA was analyzed for total bacteria, 
Lactobacillus spp., Bifidobacterium spp., Prevotella, Clostridium perfringens and C. difficile 
using primer/probe sequences and annealing temperatures shown in Table 4.1. These specific 
bacterial genera were chosen based on the ability to produce VFA or propionate (Prevotella spp.) 
as well as their notion as beneficial and harmful bacteria (Louis et al., 2007; Macfarlane & 
Macfarlane, 2012).  
Real-time qPCR was performed in Quant Studio 6 and 7 Flex Real-Time PCR System 
(Thermo Fisher Scientific, Waltham, MA) using SYBR Green assays. Each reaction contained 
5μL of 2x Power SYBR Green PCR Master Mix (Applied Biosystems), 1μL of bovine serum 
albumin (New England Biolabs, Ipswich, MA) at 1 mg/mL (final concentration 100μg/ml), 0.5 
μmol/L of each primer and 1μL of water. 8μL of PCR mix and 2 μL of sample containing 10 ng 
of DNA (Lactobacillus spp., Bifidobacterium spp., Prevotella, C. perfringens, C. difficile) and 




The cycling conditions were 50°C for 2 minutes, 95°C for 10 minutes, 40 cycles of 95°C 
for 15 seconds, primer-specific annealing temperature for 20 seconds and 72°C for 45 seconds. 
Standard curves (5x100 – 5x107 gene copies per reaction) were prepared using purified PCR 4 
TOPO-TA plasmids (Life Technologies, Carlsbad, CA) containing 16S rRNA genes of 
Eubacterium hallii 27751 (total bacteria), Lactobacillus rhamnosus 53103 (Lactobacillus spp.),  
Bifidobacterium longum 15007 (Bifidobacterium spp.), Prevotella ruminicola 19189 
(Prevotella), C. perfringens 13124 (C. perfringens) and C. difficile 9689 (C. difficile). Data was 
analyzed using QuantStudio Design Analysis Software 1.3 (Thermo Fisher Scientific). Results 
are presented as the log10 of the number of copies per gram of wet sample.  
 
RT qPCR for mmDA and BCoAT. In addition, bacterial genomic DNA was analyzed for 
the detection of bacterial genes present in the methylmalonyl-CoA decarboxylase (mmdA) gene 
in the succinate pathway of propionate production and the butyryl-CoA:acetate CoA 
acyltransferase (BCoAT) gene in the butyrate production pathway. These pathways appear to be 
the most abundant pathways used for propionate and butyrate formation by the bacteria 
inhabiting the human gastrointestinal tract (Louis et al., 2010; Reichardt et al., 2014). Sample 
preparation and analysis was performed as described above. The primer/probe sequences and 
annealing temperatures are shown in Table 4.1. Briefly, real-time qPCR was performed with 
5μL of 2x Power SYBR Green PCR Master Mix, 0.5 μmol/L of each primer and 1μL of water 
and bovine serum albumin at 1 mg/mL. 8μL of PCR mix and 2 μL of sample containing 20 ng 
DNA were plated on a MicroAmp Optical 384-well reaction plate. mmdA and BCoAT genes 
were quantified in parallel with a universal 16S rRNA gene. Data was analyzed using 
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Sample preparation for VFA analyses was performed as follows: fecal material (0.1 g) 
was weighed and mixed with 0.4 mL of 3.25% m-Phosphoric acid solution in a 2 mL 
microcentrifuge tube. Samples were vortexed to disperse the sample in solution. After an 
incubation time of 30 min, samples were frozen over night at -20°C. The next day, the samples 
were thawed and centrifuged in microfuge tubes at 13,000×g for 10 min. The supernatant was 
transferred into gas chromatography vials. 
The VFA concentrations were analyzed by a Hewlett-Packard 5890A Series gas 
chromatograph and a glass column (180 cm 3 4 mm i.d.), packed with 10% SP-1200/1% H3PO4 
on 80/100 mesh Chromosorb WAW (Superlco). Oven temperature, detector temperature, and 
injector temperature were set at 1258°C, 1758°C, and 1808°C, respectively. VFA production was 
calculated as VFA concentrations of substrate-containing tubes minus the VFA content of blank 
tubes divided by substrate weight expressed on a dry matter basis (Li et al., 2012).  
 
ASD Symptoms Severity Assessment  
Parents were asked to complete the Pervasive Development Disorder Behavior Inventory 
Screening Version (PDDBI-SV) (PAR, Inc., Lutz, FL) in order to assess the social deficit 
symptom severity. The PDDBI-SV was developed for clinicians as a tool to quickly screen 
children at risk for ASD, but can also be used to assess ASD symptom severity for research 
purposes (Cohen, 2011). The PDDBI-SV is an 18 item parent questionnaire developed for 
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children ages 18 months to 12.5 years. It is an abbreviated version of the PDD Behavior 
Inventory (PDDBI) which is a reliable and validated assessment tool. Nine questions from the 
Social Pragmatic Problems domain and nine questions from the Social Approach Behaviors from 
the original PDDBI were used to develop the screening version. The PDDBI-SV produces one 
composite score, the Social Deficit (SOCDEF) score. Each question has five response options 
that are rated on a Likert scale. In the Social Pragmatic Problem domain the answers a scored 
according to 0 “Does not show behavior”, 1 “Rarely shows behavior”, 2 “Sometimes/Partially 
shows behavior”, 3 “Usually/typically shows behavior’ and “Don’t understand”. In the Social 
Approach Behaviors domain items are reverse-scored The answers are scored by summing the 
ratings and yield an overall T score for the severity of ASD symptoms. The T score is grouped 
into six levels of severity. Level 1 (unlikely) range from <22 to 30; level 2 (borderline) ranges 
from 21 to 35, level 3 (mild) ranges from 36 to 40, level 4 (moderate) ranges from 41 to 59, level 
5 (severe) ranges from 60 to 69 and level 6 (extreme) ranges from 70 to >80. A T score of 50 is 
defined as typical of children with ASD. As the SOCDEF score increases, social communication 
skills worsen and challenging behaviors increase.  
 
Assessment of Gastrointestinal Symptoms and Stool Consistency 
The severity of GI symptoms was assessed for constipation, diarrhea, stool smell, 
flatulence and abdominal pain in an adapted version of the GI Severity Index. This version has 
previously been used in a study investigating GI health in children with ASD (Adams et al., 
2011). Parents assessed their child’s severity of constipation, diarrhea, stool smell, flatulence and 
abdominal pain on a scale from 0 to 2. Scores for each item were summed to determine an 
overall severity score.  
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Additionally, average stool consistency was assessed using the Bristol Stool Chart (Lewis 
& Heaton, 1997). The Bristol Stool Chart categorizes the stool into seven categories, ranging 
from separate hard lumps (Type 1) to liquid consistency with no solid pieces (Type 7). The 
Bristol Stool chart also allows for classification of presence of constipation (Type 1) and diarrhea 




3-Day Food Diary 
To monitor short-term nutrient intake prior to fecal sample collection, a 3-day dietary 
food record was completed the 3 days prior to sample collection. The parents were asked to 
report all types and quantities of food and beverages consumed by their children during the 
three-day (two week days, one weekend day) period prior to each fecal sample collection. 
Parents were trained by a member of the research team on how to record their child’s meal on the 
food record. Additionally, parents were provided with a detailed description of how to keep a 
food record. After collection of the food record a member of the research team followed up with 
the parent if additional detail on food consumption was needed. The food diary data were 
analyzed using the Nutrition Data System for Research (NDSR, Minneapolis, MN, 2014) 
software to assess nutrient intake and for comparison to recommended intakes (i.e. 
Recommended Daily Allowance, Adequate Intake). In addition, information on food 
intolerances, food avoidance and nutritional supplement use, including pre- and probiotics, and 





All data were analyzed using SAS 9.4 (SAS Institute, Cary, NC). Descriptive statistics 
(means and frequencies) were generated for all demographic and epidemiologic variables of 
study participants. Differences in categorical variables were analyzed for significant differences 
using the Fischer’s Exact test. 
Differences in microbial community structure were evaluated with principal coordinate 
analysis (PCoA) and permutational multivariate analysis (PERMANOVA) of variance using 
weighted and unweighted UniFrac distance in the QIIME software. Linear Discriminant Effect 
size (LEfSe) analysis was used to detect differentially abundant microbial taxa between ASD and 
control subjects (Segata et al., 2011). LEfSe uses a non-parametric factorial Kruskal-Wallis test 
with an α-level of 0.05 to determine differential distribution of taxa among the groups. Then a 
LDA model is build using identified microbial taxa and effect size for the significantly different 
taxa is estimated. The threshold on the logarithmic LDA score for discriminative feature was set 
to 3.0. A higher LDA score for a taxon corresponds to a more significant relationship. LEfSe was 
performed using the website http://huttenhower.sph.harvard.edu/galaxy .  
Differences between the groups in α-diversity (Chao1, Shannon Index and observed 
OTUs), relative abundance of individual phyla, families, orders and genera, and VFA were 
analyzed using mixed models. Factors known to influence the microbiota composition including 
age, gender, BMI, season of sample collection and dietary fiber intake were included as co-
variates in each model. Model fit was assessed using the chi-square-to-df ratio. Values <2 were 
indicate an appropriate model fit.  
Multiple Linear Regression was utilized to investigate whether individual microbiota or 
VFA can predict SOCDEF scores. Model adequacy was tested for each model including the 
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independent variables identified through stepwise regression. Variance Inflation Factor (VIF) 
was calculated to determine whether multicollinearity is present in the model. Correlations 
between the independent variables were tested and normality of the residuals was measured 
using Shapiro-Wilk. Variance homogeneity was tested by SPEC test and the Durbin-Watson test 
was applied to test for residual correlation. Cook’s D was calculated for each model to determine 
the influence of individual observations. Variables with a Cook’s D greater than 0.5 were 
excluded from the model. The Mallow’s Cp value was calculated and plots were reviewed to 
assess the goodness of fit for each model.  
Pearson and Spearman correlation was performed to analyze the relationship between 
VFAs and SOCDEF scores. Data are expressed as mean ± SD or median (interquartile range 
(IQR)). Level of significance was set at p≤0.05 and p≤0.10 was considered a trend.  
 
4.3 Results   
Enrollment and Baseline Samples Collected  
Initially, 34 children were enrolled in the CONT group and 41 ASD group. However, 
samples were collected from 32 (94%) CONT subjects and 26 (63%) ASD subjects. After 
enrollment in the study, parents of subjects were contacted via E-mail or phone multiple times to 
confirm their interest in collecting baseline samples. After contacting the parents 3 times, the 
child was excluded from the study.  
 
Demographics of Study Population 
The study population demographics for each group are shown in Table 4.2. The mean 
age of the ASD group was 4.1±1.6 years and the control group 3.9±1.3 years and did not differ 
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significantly between the groups. Gender and race/ethnicity did not differ between the groups. 
Most participants were male (ASD: 18 male vs. 6 female; CONT 19 male vs. 13 female) and 
most participants self-identified as Caucasians (ASD 68%, CONT 63%). No differences between 
the groups were noted in parental marital status, annual income or health care coverage. In the 
CONT group, parents had higher levels of education (p=0.001) compared to parents of the ASD 
group. The mean BMI for female participants in the ASD group was 15.1 (50th percentile) and in 
the CONT group was 16.8 (82nd percentile). The mean BMI for male participants in the ASD 
group was 16.8 (70th percentile) and in the CONT group was 16.3 (75th percentile). In the CONT 
group, 53% of the parents reported that the child was taking a nutritional supplement, whereas 
only 23% of parents reported nutritional supplement use in the ASD group. Most participants 
were born between 37-42 weeks of gestation. In the CONT group 75% were born vaginally 
compared to only 42% in the ASD group. Likewise, participants in the CONT group were more 
likely to be exclusively breast-fed (p=0.03) compared to the ASD group. In both groups, most 
parents denied frequent use of antibiotics early in life. Regarding their eating behavior, children 
with ASD were less likely (p=0.0007) to have more than 20 foods in their diet compared to the 
CONT group. Likewise, parents of over half of the children in the ASD group (57%) identified 
their child as having a repetitive eating pattern compared to 40% of the CONT group; however, 
this was not statistically different. 
Additional characteristics of children with ASD are shown in Table 4.3. The average 
SOCDEF T score was 52 which is categorized into the level 4 (out of 6) moderate symptoms 
category. The average age of parents noticing changes in their child’s behavior was 1.4 years and 
the average age of diagnosis was 2.4 years. About 70% of children in the ASD group are 
receiving some form of behavior therapy (e.g., Applied Behavior Analysis, Speech therapy, 
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occupational therapy), about 65% report to have sensory issues and 55% are using some form of 
Complementary and Alternative Medicine (e.g., Mind Body Medicine, Nutritional Supplements).  
 
GI Severity and Stool Consistency 
Presence of GI symptoms was reported in 69% of children with ASD and 46% of 
unrelated control children. GI symptoms severity was about twice as high (p=0.002) in the ASD 
group compared to CONT. Specifically, children with ASD had higher scores for stool smell 
(p=0.006); flatulence (p=0.04) and abdominal pain (p=0.07). 
Likewise, stool consistency measured by the Bristol stool chart differed significantly 
(p=0.05) between the groups. In the ASD group, about one third of the children had harder type 
stools (Type 1-3), about half have normal stool (Type 4) and one fifth had softer type stools 
(Types 5-7). In the CONT, one half of the children had harder type stools and the other half had 
normal stools. GI symptom severity was not associated with SOCDEF scores. The results are 
shown in Table 4.4.  
 
Microbiota Composition  
16S rRNA sequencing: Principal Coordinate Analysis (PCoA) of weighted and unweighted 
UniFrac are shown in Figure 4.1. PERMANOVA analysis indicated that overall bacterial 
communities differed between ASD and CONT group (p=0.02) based on unweighted UniFrac, 
but not on weighted UniFrac distance. α-diversity tended to differ between the groups when 
measured as observed OTUs (p=0.08). There were no differences on other measures of α-
diversity (Chao 1 Index, Shannon Index, Simpson Index) between the groups (Table 4.5).  
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To identify which specific bacteria differed between the groups, the sequences were 
classified against the Greengenes Database. At the phyla level (Figure 4.2), children with ASD 
had a lower abundance of Bacteroidetes (p=0.07) but higher abundance of Firmicutes (p=0.03) 
compared to CONT. Additionally, the abundance of Clostridiales (p=0.07) was higher, whereas 
the abundance of Streptophyta (p=0.08) was lower in children with ASD compared to CONT. On 
the family level, children with ASD had significantly higher abundance of Coriobacteriaceae 
(p=0.04), Clostridiaceae (p=0.07) and Peptostreptococcaceae (p=0.05), but a lower abundance of 
Rikenellaceae (p=0.005) compared to CONT children. On the genus level, increased abundances 
of Clostridium, SMB53, and Roseburia, but decreased abundances of Butyrivibrio, 
Faecalibacterium, Dialister and Bilophila were observed in children with ASD. Abundance of 
all bacteria can be found in Table 4.6.  
LEfSe Analysis: To identify taxa that were most differentially abundant between the 
groups, LEfSe was applied to assess the effect size of each enriched taxon. The most abundant 
taxa (LDA score >3) in children with ASD were Prevotella, Collinsella, Megamonas and 
Clostridium, whereas Rikenellaceae was most enriched in the CONT group. (Figure 4.3).  
qPCR results: The abundances of total bacteria, Lactobacillus spp., Bifidobacterium spp., 
Prevotella, C. perfringens and C. difficile are shown in Figure 4.4. The abundances of 
Bifidobacterium spp. (p=0.04) and C. perfringens were higher (p=0.009) in the CONT group 
compared to the ASD group. The density of total bacteria, Prevotella spp., and Lactobacillus 
spp. did not differ between the groups. C. difficile was only detected in one sample in the ASD 
(log10 gene copy number: 5.42) and two samples in the CONT group (log10 gene copy number: 
6.22) (detection limit: 5.24 in Log scale). In CONT children, a trend for greater relative BCoAT 




VFA Concentration  
Higher concentration of acetate (p=0.02), propionate (p=0.04) and butyrate (p=0.03) were 
observed in the ASD group compared CONT (Figure 4.5). There was no statistical significant 





Microbiota Predicts SOCDEF Score 
In order to understand the relationship between the microbiota and metabolic products, 
we applied multiple linear regression to analyze whether individual microbiota or microbial 
products could predict the SOCDEF scores.  
Due to the high number of variables, we used stepwise regression to assist in identifying 
potential independent variables for predicting SOCDEF scores. For independent variables to stay 
in the model entry and stay levels were 0.05 and 0.1, respectively. α-diversity, relative 
concentration of BCoAT and mmDA as well as VFA concentrations did not reach the 
significance level and, thus, were not included in the model. With regard to bacterial family, 
order, phyla and genera, Peptostreptococcaceae, Lactobacillus and Dialister and 
Faecalibacterium were identified as significant predictors for SOCDEF score.  
Model adequacy was tested for each model including the independent variables identified 
through stepwise regression. Lactobacillus and Dialister reached a VIF of greater than 2 and, 
thus, were excluded from the model. Independent variables were not correlated, and all residuals 
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were normally distributed at p<0.05. Variances were homogenous as tested by SPEC test and the 
Durbin-Watson test showed no residual correlation. A summary of the fitted models can be 
found in Table 4.7. Age, gender, season, height, weight and BMI were included as co-variates in 
the model. After quality control, the remaining microbiota in the model, namely 
Peptostreptococcaceae and Faecalibacterium produced an adjusted R2 of 0.36 (F(5,18)=5.96; 
p=0.009) for the prediction of SOCDEF score. Thereby, Peptostreptococcaceae (β=0.33) and 
Faecalibacterium (β=0.63) positively predicted SOCDEF scores.  
 
 
GI Symptoms and Stool Consistency are Related to Microbiota Composition  
Association between bacterial taxa and GI symptom severity and stool consistency are 
shown in Table 4.8.  
In children with ASD, positive correlations were observed between GI symptom severity 
and abundance of Firmicutes, Bacteroidales, Rikenellaceae, Clostridiaceae, Methanobrevibacter, 
Butyricimonas, Enterococcus and Holdemania, whereas negative correlations were observed 
between GI symptom severity and abundance of Bacteroidetes, Cyanobacteria, Streptophyta, and 
Bacteroides. Differences in microbiota composition based on stool consistency were also 
observed. Children with ASD and harder (Type 1-3) stool consistency had higher abundance of 
Holdemania (p=0.01) compared to children with normal (Type 4) and softer (Type 5-7) stools.  
In CONT, higher levels of Alistipes (p=0.05) were observed in children with harder stool 
types, Streptophyta (p=0.05) was higher in children with normal stool types, and Dialister 
(p=0.01) was lowest in children with harder stools. Negative correlations were observed between 
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Streptococcus, Lachnospiraceae, Blautia, and Coprococcus and GI severity symptoms and a 
positive correlation between Bilophila and GI severity symptoms.  
 
4.4 Discussion  
An increasing number of studies are aimed at deciphering the relationship between the GI 
environment and ASD symptomology, specifically focusing on the GI microbiota composition. 
Here, we report differences in the β-diversity as well as observed OTUs between children with 
ASD and unaffected controls. Additionally, variation in the abundance of bacteria at the phyla, 
family, order and genus level was observed consistent with previously published literature. 
Interestingly, the abundances of Peptostreptococcaceae and Faecalibacterium were identified as 
significant positive predictors for SOCDEF score. Furthermore, children with ASD had higher 
total GI symptoms severity scores. These findings contribute to the growing body of evidence 
that the microbiota of children with ASD differs from unaffected controls and could potentially 
affect severity of symptoms associated with ASD.  
Children with ASD commonly present with GI symptoms which include chronic 
diarrhea, abdominal discomfort, constipation or food intolerance and some of these symptoms 
may contribute to behavioral symptoms (Coury et al., 2012; Adams et al., 2011a). Although 
higher scores of GI symptoms were found herein, (Adams et al., 2011a, Horvath et al., 1999), no 
correlations between GI symptom severity and social deficits scores were observed. One 
explanation for the lack of association could be the relatively low level of GI symptom severity 
in this study population. The overall score of GI symptom severity of children in this study was 
lower in comparison to other studies using the same GI symptom scale. Specifically, Adams et 
al. reported GI symptoms severity at 3.9 out of 6-point scale, whereas children in this study 
122 
 
averaged a severity index of 2 on the same 6-point scale (Adams et al., 2011a). Some of this 
discrepancy might be explainable by the difficulty of obtaining exact GI symptom severity due to 
communication deficits in children with ASD (de Theije et al., 2011). A lack of association 
between GI and ASD symptoms could stem from the PDDBI-SV scale only assessing social 
deficit symptoms but not the severity or presence of repetitive behaviors. This scale was chosen 
due to the young age of some participants and the lack of other reliable tools to measure ASD 
symptoms in children under the age of 4. Thus, other behaviors associated with ASD might show 
stronger relationships with GI symptoms.  
The abundance of specific microbiota in correlation with the presence of GI symptoms 
has been discussed in the literature. For example, Sutterella and C. perfringens was mostly 
increased in children with ASD and concurrent GI symptoms and constipation has been 
associated with higher levels of Escherichia/Shigella and Clostridium cluster XVIII (Strati et al., 
2017; Adams et al., 2011a). Here, positive correlations between GI symptom severity and the 
abundance of Firmicutes, Bacteroidales, Rikenellaceae, Clostridiaceae, Methanobrevibacter, 
Butyricimonas, Enterococcus and Holdemania were observed, whereas negative correlations 
were found between GI symptom severity and the abundance of Bacteroidetes, Cyanobacteria, 
Streptophyta, and Bacteroides. Some of these taxa have been associated with GI symptoms in 
human studies. For example, Methanobrevibacter, a methane producing bacteria, has been 
associated with flatulence in humans and may be related to pathogenesis of some digestive tract 
symptoms (Seo et al., 2017; Pimentel et al., 2012).  
In addition to GI symptoms, stool consistency also provides information on an 
individual’s GI health. A previous study assessing stool consistency in children with ASD 
showed that 29% of children had loose or mushy stools (Levy et al., 2007). Overall, the stool 
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consistency differed between the groups and about half of the children in the ASD group 
reported harder or softer stools, indicating the potential presence of digestive problems in this 
group. Furthermore, children with ASD and harder stools also tended to have higher abundance 
of Holdemania. Previous studies demonstrated that bacterial richness decreased with decreasing 
firmness of the stool which could partly be explained by the changes in transit time and thus 
availability of food sources to the microbiota (Vandeputte et al., 2015). Other studies found more 
abundant Prevotella in subjects with looser stools, whereas the Ruminococcaceae-Bacteroides 
group was more prominent in subjects with harder stools. Additionally, abundances of 
Methanobrevibacter, Akkermansia, Oxalobacter and Butyricimonas increased with increased 
stool firmness, whereas Bacteroides abundance increased with more loose stools (Vandeputte et 
al., 2015).  
The microbiota-gut-brain axis has gained increased attention in recent years as a way to 
describe the interaction between the GI microbiota and brain function. Microbial dysbiosis has 
been identified in ASD and other psychological and psychiatric diseases, including depression 
and anxiety, even though some studies do no support the hypothesis that the GI microbiota might 
be involved in ASD symptomology (Gondalia et al., 2012). Differences in bacterial diversity as 
well as in fecal VFA concentrations between children with ASD and unaffected controls have 
been reported (De Angelis et al., 2013; Tomova et al., 2015; Son et al., 2015). Recently, other 
species in the GI tract (e.g., fungi) were investigated for their ability to impact some symptoms 
of ASD (Strati et al., 2017) and interest in the microbiota composition of the proximal GI tract in 
children with ASD is rising (Kushak et al., 2017). In this study, measures of β-diversity as well 
as observed OTUs were significantly different between the groups. There are limited reports on 
differences in β-diversity between children with ASD and unaffected controls and results do not 
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indicate a clear trend yet (Son et al., 2015; Strati et al., 2017). Associations between β-diversity 
and behavior (sociability level, high intensity pleasure and activity level) in children without 
ASD have been described (Christian et al., 2015). Here, we saw a clearer separation in β-
diversity between the groups based on unweighted UniFrac distances, suggesting that the 
presence and absence of bacterial OTUs, but not the relative abundance, could contribute more 
significantly to the observed alterations. This observation is supported by the increased number 
of observed OTUs in children with ASD, which represents the number of unique OTUs present 
in the sample. Thus, the number of species but not the relative abundance might be more 
significantly different between children with ASD and unrelated controls. Previous studies have 
described increased and decreased α-diversity in children with ASD (Son et al., 2015; Kang et 
al., 2013; Finegold et al., 2010). Even though richness and diversity are often considered 
important in resisting invasion of potential pathogenic microbes, it has been hypothesized that 
increased microbial richness in individuals with ASD could be associated with the presence of 
more harmful bacteria which could contribute to some symptoms of ASD (Kang et al., 2013). 
Here, we observed that some bacterial genera that were present in children with ASD were not 
detected in samples of unaffected controls, such as Lactobacillus, Leuconostoc, Lactococcus, 
Sarcina, Eubacterium, Peptococcus, Megasphaera and Campylobacter, indicating the absence 
and presence of lower abundance bacteria could potentially be of importance in ASD 
symptomology and warrants further investigation.   
Bacteroidetes and Firmicutes are the two most abundant phyla in the human GI tract (Qin 
et al., 2010) and disruption of the Firmicutes-to-Bacteroidetes ratio has been implicated in 
several states of intestinal or systemic inflammation, such as obesity, Type 1 Diabetes and IBS 
(Ley et al., 2006; Frank et al., 2007; Verdam et al., 2013; Pellegrini et al., 2017). Food 
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sensitization in children was also associated with lower numbers of Bacteroidetes but higher 
numbers of Firmicutes (Chen et al., 2016). In ASD, no clear trend in the Firmicutes-to-
Bacteroidetes ratio has been described (Strati et al., 2017; Williams et al., 2011; Tomova et al., 
2015; Finegold et al., 2010; Kang et al., 2013; El Aidy et al., 2017). Here, an increased 
abundance of Firmicutes and a decreased abundance of Bacteroidetes in children with ASD was 
observed. The Firmicutes-to-Bacteroidetes ratio could be linked to two potentially underlying 
mechanisms in the symptomology of ASD, including the serotonergic signaling system and 
oxidative stress. First, Firmicutes abundance could be involved in maintaining GI 5-HT 
homeostasis (El Aidy et al., 2017). A disruption in the serotonergic signaling system in children 
with ASD has been proposed, elevated levels of whole blood and platelet 5-HT are consistently 
observed (Gabriele et al., 2014) and GI changes have been suggested to contribute to the 
hyperserotonemia observed in children with ASD (Anderson et al., 1987; Hanley et al., 1977; 
Schain & Freedman, 1961). Second, mice exposed to oxidative stress, which has been implicated 
in the development and pathophysiology of ASD, exhibited a shift to a higher Firmicutes but 
lower Bacteroidetes abundance (Zhao et al., 2018; Chauhan & Chauhan, 2006; Ashwood et al., 
2006). Thus, the Firmicutes-to-Bacteroidetes ratio could have some implications for ASD 
symptoms, but more research is needed to identify potential mechanisms.  
Positive correlations between the bacterial family Coriobacteriaceae and reactive oxygen 
species were found in infants, suggesting that Coriobacteriaceae could be involved in host 
inflammatory status (Qasem et al., 2017). Higher levels of Coriobacteriaceae in children with 
ASD compared to unrelated controls were observed in this and previous studies (De Angelis et 
al., 2013). Coriobacteriaceae could be involved in host lipid and bile acid metabolism and strong 
correlations between abundance of Coriobacteriaceae and hepatic triglycerides were identified 
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(Lahti et al., 2013; Stenman et al., 2013; Claus et al., 2011). An inverse relationship between 
Coriobacteriaceae and HDL levels as well as an increase in Coriobacteriaceae in response to a 
Western-style or high-fat diet in rodents has been documented (Martínez et al., 2009). 
Additionally, species of the Coriobacteriaceae family seem to colonize mucosal surfaces and 
affect epithelial cell metabolism (Clavel et al., 2013). Thereby, Coriobacteriaceae could disrupt 
the intestinal epithelial barrier and lead to GI barrier dysfunction (Stenman et al., 2013), which 
has previously been described in children with ASD (de Magistris et al., 2010). Members of the 
family Coriobacteriaceae have also been implicated in chronic inflammatory conditions and 
pathologies such as obesity, IBD, colon cancer and bacteremia and might be key microbes that 
contribute to differences in the microbiota composition between patients with colorectal cancer 
and healthy controls (Clavel et al., 2013; Chen et al., 2012; Zhang et al., 2009). Interestingly, 
breast-fed infants had lower levels of Coriobacteriaceae compared to formula-fed infants 
(Harmsen et al., 2000). Considering the benefits of breastfeeding in development of the 
microbiota, immune system and the brain, lower levels of Coriobacteriaceae could potentially be 
advantageous for immune and brain function. In a study investigating the effect of whole grains 
consumption on immunological improvements in adults, subjects with lower Coriobacteriaceae 
abundance had greater reductions in the pro-inflammatory cytokine IL-6 after the intervention, 
indicating that the abundance of that family might predict an individual’s immunological 
response (Martínez et al., 2013).  
In the present study, higher abundance of Clostridium in children with ASD was 
observed. Additionally, Clostridiales as well as Peptostreptococcaceae and Clostridiaceae, two 
families within the order of Clostridiales, were also increased in children with ASD. Much 
interest has been given to the role of the class Clostridia and the genus Clostridium in ASD 
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symptomology (Finegold, 2008). In fact, the first bacterium hypothesized to influence some 
symptoms of ASD was Clostridium tetani in 1998 (Bolte, 1998). Another study two years later 
described that Clostridium species might be of importance in the reoccurrence of ASD symptoms 
after temporal improvements by vancomycin treatment (Sandler et al., 2000). Since then 
Clostridium clusters have frequently been isolated from feces of children with ASD (Song et al., 
2004) and higher levels of these clusters as well as other Clostridial counts in fecal and ileal 
samples have been described (De Angelis et al., 2013; Grimaldi et al., 2017; Finegold et al., 
2010; Finegold et al., 2002; Finegold, 2008; Williams et al., 2011). Likewise, maternal 
separation and prenatal exposure to valproic acid caused a concurrent increase in the abundance 
of Clostridiales and deficits in social and repetitive behaviors in mice (El Aidy et al., 2017; de 
Theije et al., 2014). Diet-induced increases in Clostridiales abundance was also related to poorer 
cognitive flexibility in mice (Magnusson et al., 2015). Several hypotheses for the involvement of 
Clostridial species in ASD pathophysiology and symptom development have been proposed, 
including infection of immunosuppressed, at-risk children with Clostridial spores from the 
environment and production of enterotoxins and neurotoxins by Clostridium species (Finegold, 
2008). An increased abundance of Clostridiales in children who developed GI symptoms around 
the same time of ASD diagnosis could also support the infection hypothesis (Williams et al., 
2011). Likewise, Clostridiales could potentially impact the serotonergic signaling system through 
regulating the transcription of tryptophan hydroxylase 1 (Reigstad et al., 2015; Yano et al., 
2015). Transferring GI microbiota that included Clostridiales from non-obese diabetic mice to 
control mice induced social avoidance behavior and myelination changes in the prefrontal cortex 
in recipient mice (Gacias et al., 2016). Moreover, metabolic products of some Clostridia species, 
such as propionate and 3-(3-hydroxxy phenyl)-3-hydroxypropionic acid, have been found in 
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increased concentration in urine and feces of children with ASD (Keşli et al., 2014; Wang et al., 
2012). Surprisingly, bacterial density as assessed by qPCR showed increased numbers of C. 
perfringens in control children (Finegold et al., 2017). However, not all strains within C. 
perfringens could be considered to be harmful bacteria; thus, future studies delineating which 
strains within C. perfringens could potentially contribute to some symptoms of ASD.  
In this study, we also observed increases in SMB53 and Roseburia, but decreases in 
Rikenellaceae, Butyrivibrio, Faecalibacterium, Dialister, and Bilophila in children with ASD. 
Several health benefits have been associated with the bacterial genera Roseburia, mostly due to 
its butyrate-producing abilities that can affect colonic motility, maintain immunity and exert anti-
inflammatory properties (Tamanai-Shacoori et al., 2017). Additionally, Roseburia abundance 
was positively correlated with mood in healthy adults (Li et al., 2016) and reduced abundance 
has been reported in patients with IBS and Ulcerative Colitis (UC) (Shah et al., 2016). However, 
other studies have also shown that Roseburia in obese subjects is positively correlated with Body 
Mass Index and systemic inflammation (Verdam et al., 2013) and higher levels of Roseburia 
have been observed in children with food sensitization (Chen et al., 2016). Roseburia could be 
also be involved in the development of insulin resistance in mice fed a high-fat, high-sugar diet 
(Org et al., 2015), suggesting that the physiological effects of Roseburia could depend on 
substrate availability. Rikenellaceae, which was found to be reduced in children with ASD, was 
previously positively associated with High Intensity Pleasure and activity level in boys (Christian 
et al., 2015) and was depleted after the onset of colitis in dextran sulfate sodium (DSS) treated 
mice (Osaka et al., 2017). In line with our results, the abundance of Dialister and Bilophila was 
previously shown to be decreased in children with ASD (Finegold et al., 2010; Strati et al., 
2017). Bilophila wadsworthia, a pathobiont in the human GI tract, is often detected in higher 
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abundances in patients with inflammatory bowel disorders, suggesting a role of species in this 
genus in GI health (Devkota & Chang, 2016). Additionally, previous studies have shown that 
Bilophila abundance is susceptible to dietary interventions or prebiotic supplementation in 
conjunction with improved GI health (Vandeputte et al., 2017; Veiga et al., 2014). Increased 
abundance of Dialister were linked to decreased levels of the pro-inflammatory cytokine IL-6 
after supplementation with whole grains (Martínez et al., 2013).  
LEfSe method was used to identify bacterial taxa that are most enriched and could 
potentially be used as biomarkers among each group (Segata et al., 2011). LEfSe analysis 
couples standard statistical tests for significance with additional tests for biological consistency 
and effect relevance to determine OTUs that most likely to explain differences between classes 
(Segata et al., 2011). Additionally, the effect size provides an estimation of the magnitude 
observed for each feature. LEfSe analysis confirmed the enrichment of Clostridium in the ASD 
group and Rikenellaceae in the CONT group identified by analysis with generalized linear mixed 
models. Additionally, enrichment of Prevotella, Collinsella, and Megamonas in children with 
ASD was identified using LEfSe. The abundance of Prevotella could be involved in shaping 
brain structure and responses, as previous studies have found associations with Novelty Seeking 
and Reward Dependence as measures of temperament, negative emotional responses, reduced 
activation of the hippocampus and greater white matter connectivity and hippocampal volume in 
healthy adults (Kim & Park, 2017; Tillisch et al., 2017). Little is known about the effect of 
Megamonas on the human hosts, but increased Megamonas abundance in obese subjects (Chiu et 
al., 2014) could suggest a role of these genera in inflammatory processes. Collinsella has 
previously been shown to be increased in children with ASD (De Angelis et al., 2013, Inoue et 
al., 2016; Strati et al., 2017) and higher levels of Collinsella were observed in inflammatory 
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diseases such as colorectal cancer, Type 2 Diabetes Mellitus and food sensitization (Lambeth et 
al., 2015; Chen 2016).  
The mechanisms of the communication between the GI microbiota and ASD symptoms 
are poorly understood. One study has shown that microbial dysbiosis in an animal model of ASD 
was associated with alterations in the metabolic pathways that have also been reported in 
affected children (Lim et al., 2017). Some bacterial metabolites of interest in ASD 
symptomology are VFAs. VFAs are fermentation products of bacterial carbohydrate (acetate, 
propionate, butyrate) and protein (isobutyrate, isovalerate, valerate) digestion and several health 
benefits have been associated with the production of VFAs by the GI microbiota. More than 85% 
of butyrate produced by the GI microbiota is usually used by colonocytes as an energy source for 
cell proliferation and differentiation (Bergman, 1990) and is, therefore, important in maintaining 
the health and integrity of colonic mucosa (Scheppach, 1994). Increased butyrate concentrations 
have also been proposed to prevent development of colitis (Segain et al., 2000), ameliorate 
mucosal inflammation, oxidative stress, and strengthen the intestinal epithelium and motility 
(Canani et al., 2011). However, some adverse effects of VFAs have also been reported, 
specifically propionate. Propionate can activate the immune response and lead to immune 
dysfunction (Frye et al., 2017), which might be a strong component in the etiology of ASD (Masi 
et al., 2017). Furthermore, SCFAs including propionate can induce serotonin production 
(Reigstad et al., 2015). Hyperserotonemia has been reported in children with ASD and is 
suggested as a potential metabolic marker for ASD diagnosis (Gabriele et al., 2014). In children 
with ASD, aberrations in fecal VFA levels with increased propionate concentrations have been 
reported (Adams et al., 2011a; De Angelis et al., 2013). In the context of our study, acetate, 
propionate and butyrate concentrations were significantly higher in children with ASD compared 
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to unaffected controls. It is important to remember that elevated fecal concentrations of these 
VFAs could be due to increased fermentation of substrates, but could also be explained by 
decreased absorption or high transit time of food (Schwiertz et al., 2010). Thus, increases in fecal 
concentrations of VFAs do not necessarily represent the environment in the GI tract. 
Importantly, some butyrate-producing bacteria such as Butyrivibrio and well as the relative 
abundance of the butyrate-regulating gene BCoAT and the propionate-producing-gene mmDA 
were decreased in children with ASD. Thus, the increased fecal SCFA concentrations in the 
children with ASD in this cohort might not be due to increased production, but could mirror a 
decreased absorption and utilization by colonocytes. In order to provide new insight into the 
relationship between fecal VFA concentrations and intestinal health, future studies should 
investigate fecal VFA concentrations in conjunction with makers of intestinal permeability. 
Additionally, in vitro experiments investigating the VFA producing capabilities of the microbiota 
in children with ASD are warranted.  
There is now growing evidence for an association between individual bacteria and some 
symptoms of ASD. For example, bacterial richness and lower Bacteroidetes-to-Firmicutes ratio 
were related to ASD symptoms (Kang et al., 2013; Tomova et al., 2015). On the genera level, 
positive correlations between Desulfovibrio abundance and repetitive restrictive behaviors 
(Tomova et al., 2015) as well as between Clostridium, Prevotella and Coprococcus presence and 
ASD symptoms (Iovene et al., 2017; Kang et al., 2013) have been described. Here, using 
regression analysis, we identified that the abundance of Peptostreptococcaceae and 
Faecalibacterium were strong positive predictors of the social deficit scores in children with 
ASD. Neither of these taxa have previously been associated with symptoms of ASD.  
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Relative abundance of Faecalibacterium can reach up to 15% in some individuals and is 
one of the most abundant butyrate producing bacteria (Hold et al., 2003; Flint et al., 2012). 
Therefore, a role of Faecalibacterium in health and disease has been suggested. F. prausnitzii, to 
date the only known species within the Faecalibacterium genus, is usually regarded as a 
beneficial bacterium due to its anti-inflammatory properties (Quevrain et al., 2016), 
improvements of GI barrier function (Carlsson et al., 2013) and support of mucosal immune 
homeostasis (Hornef & Pabst, 2016). In patients with UC and Chron’s diseases lower abundance 
of Faecalibacterium has been observed, potentially due to the production of reactive oxygen 
species and presence of pathogenic bacteria (Miquel et al., 2013; Swidsinksi et al., 2008). 
Previously a positive correlation between expression of interferon signaling-associated genes in 
the blood and abundance of Faecalibacterium in the feces of children with ASD was reported, 
suggesting that abundance of Faecalibacterium might be involved in the dysfunction of systemic 
immunity that is often observed in children with ASD (Inoue et al., 2016). In this study, children 
with ASD overall had lower levels of Faecalibacterium, potentially indicating the presence of an 
inflammatory state. On the other hand, other studies demonstrated that Faecalibacterium could 
be associated with some disease states, suggesting that potentially the presence of other species 
within the Faecalibacterium genus could be of importance (Swidsinski et al., 2008, Hansen et 
al., 2012), For example, a correlation of Faecalibacterium with obesity and diabetes was 
observed (Furet et al., 2010) and a subspecies of F. prausnitzii might play in a role in onset of 
atopic dermatitis in infants potentially (Song et al., 2016; Zheng et al., 2016). Likewise, children 
with food sensitization harbored higher concentrations of Faecalibacterium (Chen et al., 2016) 
and an association with Faecalibacterium with negative mood and fatigue interference was 
described (Li L., et al., 2016; Paulsen et al., 2017).  
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The second bacterium found to be associated with social deficits scores in children with 
ASD in this cohort is Peptostreptococcaceae. Peptostreptococcaceae is a family within the order 
of Clostridiales and encompasses species such as C. difficile and other pathogenic clostridia 
(Milani et al., 2016). Although some studies suggest that Peptostreptococcaceae could contribute 
to GI homeostasis (Fan et al., 2017), higher abundances in patients with IBD, Ulcerative Colitis, 
and colorectal cancer were reported (Lavelle et al., 2015; Chen et al., 2012). Furthermore, an 
overrepresentation of Peptostreptococcaceae in a mice model of colitis and associated with 
intestinal mucosal ulceration suggests an association between that family and an inflammatory 
status (Denis et al., 2016; Nagy-Szakal et al., 2013). Lastly, correlations between 
Peptostreptococcaceae and the right inferior segment of the circular sulcus in patients with IBS, a 
region for somatosensory and motor function, indicate the potential of this family to impact brain 
and behavior (Labus et al., 2017).  
In conclusion, the results reported herein contribute to the growing knowledge of 
microbial dysbiosis in children with ASD. We have found similar results to previously described 
differences in the microbial composition, VFA concentration and GI symptoms between children 
with ASD and siblings or unrelated controls. Although the GI microbiota in children with ASD 
in this study harbors some species that are associated with health benefits and is depleted in 
others which were linked to an inflammatory status, reductions in microbiota that exert a positive 
effect on the host are also observed. Thus, the role of these individual microbiota within an 
“ASD microbiome” require further investigation, potentially using animal models. Similar to 
previous studies, we observe an increased abundance of Clostridum in children with ASD. 
Although we did not find significant associations between Clostridium abundance and ASD 
symptoms, a family within the Clostridiales order, Peptostreptococcaceae positively predicted 
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social deficit symptoms. Due to strict exclusion criteria, this study had a relatively small sample 
size, so some results might not offer generalizable information. However, the strict exclusion 
criteria allowed us to exclude children from the study with recent probiotic, antibiotic or 
medication use as well as children following any specialty diets or having diagnosed digestive 
disorders, which are all factors known to influence the microbiota composition. Thus, some of 
the differences reported herein might be inherent to ASD symptomology. Future studies should 
investigate whether specific dietary patterns or nutrients are related to differences in the 
microbiota composition of children with ASD. While this study did not allow us to draw 
conclusions on causation relationships between the GI microbiota and ASD, these results 
demonstrate a microbial dysbiosis in children with ASD and that individual bacteria can predict 
the severity of some symptoms of ASD. Thus, the findings reported here could provide 
preliminary evidence for future intervention strategies to target specific bacterial strains that are 
more strongly related to some symptoms of ASD.  
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4.5 Tables and Figures 
Table 4.1 Primer for Real-time quantitative analysis of microbial populations 
Target Group Primer Sequence (5’ – 3’) Annealing 
Temperature (°C) 
Reference 





et al, 2002 






Kok et al, 
1996 




60 Kok et al, 
1996 



































Table 4.2 Demographic characteristics of all study participants 
 
Characteristic ASD (n=26) CONT (n=32) p-value 














Race/Ethnicity (n (%)) 
Caucasian 
Asian 
Black of African American 



































Parents Level of Education (n (%)) 
High School 
Some College or Technical School 
College Graduate 













Annual Income (n (%)) 
Less than $20,000 
$20,000 to $60,000 
$60,000 to $80,000 
$80,000 to $100,000 
More than $100,000 
















Health Care Coverage (n (%))   NS 
Private paid by employer 












Weight (kg) 20.5±7.8 21±0.7 NS 
Height (meters) 1.07±0.1 1.10±0.15 0.08 
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Table 4.2 (cont.) 
Characteristic ASD (n=26) CONT (n=32) p-value 






































Early Feeding Mode (n (%)) 
Breast-fed only 






























10 (31 %) 
22 (69%) 
0.1 
























Table 4.3 Characteristics of children with ASD  
 
Characteristics Mean ± SD Comments  
Average SOCDEF T score1 52±9 
 
(Level 4 – moderate) 
Average age to see changes in behavior 
(years) 
1.44±0.69  
Average age of diagnosis (years) 2.4±1.3  






Most Common: ABA, 
Speech therapy, physical 
therapy, occupational 
therapy, music therapy, 
social integration  

















Data expressed as mean±SD or n 
1Social deficit score measured by PDDBI-SV; range of T-scores: <22-30 Level 1 (unlikely); 31-
35 Level 2 (borderline); 36-40 Level 3(mild); 41-59 Level 4 (moderate); 60-69 Level 5 (severe); 
70->80 Level 6 (extreme) 
CAM, Complementary and Alternative Medicine 





Table 4.4 Differences in GI Severity scores and stool consistency between children with ASD 
































Stool Consistency (n)2 
Type 1 (separate hard lumps) 
Type 2 (sausage shaped but lumpy) 
Type 3 (sausage-shaped with cracks on surface) 
Type 4 (smooth and soft) 
Type 5 (soft blobs) 
Type 6 (mushy) 


















Data expressed as median (IQR) or n 
1GI severity scores were derived from the GI severity index (possible range 0-7) 





Figure 4.1 Principal co-ordinate analysis based on unweighted UniFrac Distance (a) and 
weighted UniFrac Distance (b) generated from fecal samples of children with ASD (ASD) and 
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Table 4.5 α-Diversity measures between children with ASD (ASD) and unaffected controls 
(CONT). 
 
Diversity/Richness Measure ASD (n=26) CONT (n=32) p-value 
Shannon Index 5.5 (5.1-5.7) 5.4 (4.9-5.7) NS 
Simpson Index 0.95 (0.91-0.96) 0.94 (0.92-0.95) NS 
Observed OTUs 580 (539-607) 553 (495-580) 0.08 
Chao 1 Index 527 (475-562) 500 (442-536) NS 
Data expressed as median (IQR)  






Figure 4.2 Pie graphs depicted the abundance of bacterial phyla in feces of in children with ASD 



















































Table 4.6  
 
a) Relative abundances of bacterial taxa detected in feces of children with ASD (ASD) and 
unaffected controls (CONT). 
Phyla ASD (n=26) CONT (n=32) p-value 
Euryarchaeota 0.0009 (0.0006-0.003) 0 (0-0.001) NS 
Actinobacteria 3.1 (1-9.8) 7.62 (1.05-16.73) NS 
Bacteroidetes 46.7 (16.7-55.5) 53.4 (42.3-63.2) 0.07 
Cyanobacteria 0 (0-0.002) 0.002 (0-0.01) NS 
Firmicutes 45.8 (37.8-66.2) 36.5 (30.5-48.7) 0.03 
Fusobacteria 0 (0-0) 0 (0-0) NS 
Proteobacteria 0.47 (0.13-1.25) 0.65 (0.25-1.26) NS 
Tenericutes 0 (0-0) 0 (0-0) NS 
Verrucomicrobia 0.17 (0.02-2.65) 0.4 (0.01-7.65) NS 
 
Order ASD (n=26) CONT (n=32) p-value 
Bacteroidales 0 (0-0) 0 (0-0) NS 
Streptophyta 0.008 (0.003-0.02) 0.002 (0-0.01) NS 
Clostridiales 2.99 (2.11-6.41) 2.23 (1.4-3.36) 0.07 
RF32 0.09 (0.01-0.13) 0 (0-0.002) NS 
RF39 0 (0-0) 0 (0-0) NS 
 
Family ASD (n=26) CONT (n=32) p-value 
Coriobacteriaceae 0.04 (0.007-0.21) 0.01 (0.002-0.03) 0.04 
RF16 0 (0-0) 0 (0-0) NS 
Rikenellaceae 0.53 (0.05-3.56) 2.94 (0.98-6.58) 0.005 
S24-7 0 (0-0) 0 (0-0) NS 
Barnesiellaceae 0.02 (0.006-0.79) 0.03 (0.006-1.82) NS 
Christensenellaceae 0.002 (0-0.05) 0.002 (0-0.02) NS 
Clostridiaceae 0.29 (0.14-1.5) 0.17 (0.08-0.44) 0.07 
EtOH8 0 (0-0) 0 (0-0) NS 
Lachnospiraceae 7.1 (5.6-11.1) 6.03 (3.8-9.2) NS 
Peptostreptococcaceae 0.04 (0.01-0.07) 0.02 (0.009-0.03) 0.05 
Mogibacteriaceae 0.01 (0-0.04) 0.01 (0.002-0.03) NS 
Erysipelotrichaceae 0.34 (0.16-1.02) 0.26 (0.13-1.02) NS 
Enterobacteriaceae 0.02 (0.002-0.23) 0.02 (0.005-0.09) NS 
 
Genera ASD (n=26) CONT (n=32) p-value 
Archea – Euryarchaeota     
Methanobrevibacter 0.0009 (0.0006-0.003) 0 (0-0.001) NS 
Actinobacteria    
Bifidobacterium 1.88 (0.56-4.52) 1.54 (0.58-3.00) NS 
Adlercreutzia 0.05 (0.009-0.21) 0.04 (0-0.19) NS 
Collinsella 0.26 (0.009-1.68) 0.04 (0.004-0.09) NS 
Eggerthella 0.05 (0.02-0.09) 0.03 (0.006-0.11) NS 
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Table 4.6 (cont.)     
Genera ASD (n=26) CONT (n=32) p-value 
Slackia 0 (0-0.001) 0 (0-0.002) NS 
Bacteroidetes    
Bacteroides 29.4 (13.3-46.7) 37.97 (51.6-55.3) NS 
Parabacteroides 0.88 (0.19-3.29) 1.46 (0.27-3.25) NS 
Prevotella 0.02 (0.01-0.10) 0.009 (0.006-0.02) NS 
Alistipes 0.0003 (0-0.002) 0.001 (0-0.009) NS 
Butyricimonas 0 (0-0.0005) 0 (0-0) NS 
Odoribacter 0.009 (0.0007-0.15) 0.06 (0.003-0.37) NS 
Paraprevotella 0 (0-0.0007) 0 (0-0.001) NS 
Firmicutes    
Staphylococcus 0.0008 (0.003-0.02) 0.007 (0.003-0.01) NS 
Enterococcus 0 (0-0.001) 0 (0-0.001) NS 
Lactobacillus 0.0007 (0-0.002) 0 (0-0.001) NS 
Leuconostoc 0 (0-0) 0 (0-0) NS 
Lactococcus 0.0009 (0-0.007) 0.002 (0-0.009) NS 
Streptococcus 0.11 (0.07-0.49) 0.15 (0.05-0.35) NS 
Turicibacter 0.02 (0.003-0.16) 0.02 (0.002-0.04) NS 






0.07 (0.02-0.22) 0.02 
SMB53 1.16 (0.55-3.39) 0.56 (0.34-1.48) 0.07 
Sarcina 0.0008 (0.0006-0.02) 0 (0-0) NS 
Eubacterium 0.07 (0.01-0.13) 0.03 (0.02-0.06) NS 
Anaerostipes 0.04 (0.01-0.08) 0.05 (0.006-0.09) NS 
Blautia 1.34 (0.65-2.72) 0.85 (0.56-1.59) NS 
Butyrivibrio 0.008 (0.001-0.02) 0.02 (0.005-0.09) 0.003 
Coprococcus 3.73 (1.99-4.75) 2.64 (1.49-3.75) NS 
Dorea 0.78 (0.57-1.39) 0.71 (0.38-1.07) NS 
Lachnospira 0.15 (0.02-0.61) 0.38 (0.09-0.63) NS 
Roseburia 0.46 (0.27-0.75) 0.29 (0.08-0.51) 0.01 
Peptococcus 0 (0-0) 0 (0-0) NS 






0 (0-0.003) NS 
Faecalibacterium 6.59 (3.47-11.96) 10.59 (7.04-16.17) 0.05 
Oscillospira 0.41 (0.29-0.55) 0.43 (0.25-0.66) NS 
Ruminococcus 1.99 (0.67-3.08) 1.58 (0.57-3.79) NS 
Acidaminococcus 0 (0-0) 0 (0-0.0005) NS 
Dialister 0.12 (0.008-0.72) 0.64 (0.32-1.63) 0.005 
Megamonas 0.001 (0.0007-0.003) 0 (0-0.001) NS 
Megasphaera 0 (0-0.0006) 0 (0-0) NS 
Phascolarctobacteri
um 
0.006 (0-0.18) 0.0007 (0-0.003) 
NS 
Succiniclasticum 0 (0-0) 0 (0-0) NS 
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Table 4.6 (cont.)    
Genera ASD (n=26) CONT (n=32) p-value 
Veillonella 0.006 (0.002-0.03) 0.02 (0.005-0.05) NS 
Catenibacterium 0 (0-0) 0 (0-0) NS 
Coprobacillus 0 (0-0.03) 0 (0-0.006) NS 
Holdemania 0.006 (0-0.01) 0.007 (0.003-0.02) NS 
Fusobacteria    
Fusobacterium 0 (0-0) 0 (0-0) NS 
Proteobacteria    
Sutterella 0.09 (0.02-0.37) 0.28 (0.08-1.14) NS 
Bilophila 0.003 (0.006-0.02) 0.006 (0-0.08) 0.04 
Campylobacter 0 (0-0) 0 (0-0) NS 
Haemophilus 0.003 (0.001-0.05) 0.01 (0.002-0.08) NS 
Verrucomicrobia    
Akkermansia 0.17 (0.02-2.65) 0.41 (0.01-7.65) NS 
Data expressed as median (IQR) 





Figure 4.3 LDA score histogram from LEfSe analysis depicting enrichment of most abundant 



























Figure 4.4 Bacterial densities in feces of ASD and CONT children measured by qPCR 
 




















































Figure 4.4 (cont.) 
 















Data is expressed as Median (IQR) 





































Median (IQR) *p≤0.05  
CONT, unaffected controls; ASD, Autism Spectrum Disorder; DMB, dry matter basis; IQR, 







Table 4.7 Regression analysis model showing fecal bacterial taxa predicting social deficit scores.  
Bacteria expressed as relative abundance derived from 16S rRNA sequencing. SOCDEF scores: social deficit scores derived from 






Standard Error t-Value P-value Squared Semi-partial 
Corr Type II 
Intercept 43.5  3.02 14.41 <.0001 . 
Faecalibacterium 0.9 0.63 0.27 3.39 0.003 0.35 
Peptostreptococcaceae 14.1 0.33 7.96 1.77 0.09 0.09 
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Table 4.8 Bacterial abundance and GI symptoms/stool consistency 
a) Correlation between Bacteria and GI symptom severity in children with ASD 
Bacterial Taxa ρ p-value 
Bacteroidetes -0.46 0.02 
Cyanobacteria -0.43 0.03 
Firmicutes 0.44 0.02 
Streptophyta -0.43 0.03 
Bacteroidales 0.40 0.04 
Rikenellaceae 0.44 0.02 
Clostridiaceae 0.41 0.04 
Methanobrevibacter 0.39 0.05 
Bacteroides -0.43 0.03 
Butyricimonas 0.45 0.02 
Enterococcus 0.38 0.05 
Holdemania 0.41 0.04 
 
b) Difference in Holdemania abundance based on stool consistency in children with ASD 
Stool Type Holdemania abundance p-value 
Soft 0.005 (0.0004-0.01) 0.01 
Normal 0.003 (0-0.01)  
Hard 0.007 (0.002-0.02)  
 
c) Correlation between Bacteria and GI symptom severity in unaffected control children  
Bacterial Taxa ρ p-value 
Streptococcus -0.39 0.03 
Lachnospiraceae -0.39 0.03 
Coprococcus -0.45 0.01 
Blautia -0.34 0.06 
Bilophila 0.32 0.08 
 
d) Difference in bacterial abundance based on stool consistency in unaffected control children  
Bacterial taxa Soft Normal Hard p-value 
Streptophyta 0 (0-0) 0.005 (0.001-0.03) 0 (0-0.004) 0.05 
Alistipes 0 (0-0) 0 (0-0.002) 0.004 (0.002-0.03) 0.05 
Dialister 3.15 (3.15-3.15) 0.87 (0.58-1.81) 0.32 (0.005-0.53) 0.01 
Data expressed as median (IQR)  
stool type was assessed using the Bristol stool chart; hard: type 1-3, normal: type 4, soft: type 5-
7; GI severity score was assessed using GI severity index 








Nutrition, GI Microbiota and Microbial Metabolites in Children with ASD4  
 
Abstract 
Background/Aims: Diet is considered one of the most influential environmental factors in 
determining the composition of the gastrointestinal (GI) microbiota. Increasing reports describe a 
microbial dysbiosis in children with Autism Spectrum Disorder (ASD) and the impact of some 
bacterial taxa on some symptoms of ASD has been recognized. Likewise, children with ASD are 
often described as picky eaters and decreased intakes of fiber-rich foods, including fruits and 
vegetables, have been reported. Differences in nutrient intakes between children with ASD and 
unaffected controls are often observed. However, the impact of diet on the microbiota in children 
with ASD has not been explored.  
Methods: Herein, differences in diet between children with ASD and unrelated controls as well 
as the influence of feeding behavior, habitual dietary patterns and short-term nutrient intakes on 
the microbiota composition in children with ASD was investigated. Additionally, dietary 
moderators of the association between microbiota abundance and social deficit score were 
analyzed. Fecal samples, 3-day diet records and a food frequency questionnaire (FFQ) were 
collected from children with ASD (n=26) and unrelated controls (n=32) aged 2-7 years. Social 
deficit scores were assessed using the Pervasive Developmental Disorder Behavior Inventory-
Screening Version (PDDBI-SV). Bacterial composition was assessed by 16S rRNA sequencing 
and quantitative PCR.  
Results: Lower intakes of insoluble fiber, pectin, vitamin C, and dairy, but higher intakes of 
snacks and sweets were observed in children with ASD. Feeding behaviors (i.e., picky eating, 
                                                 
4 Berding K, Donovan SM. Diet and Feeding Behavior are Related to Microbiota Composition in Children with 
Autism Spectrum Disorder. Front Neurosci. 2018. Under Review 
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repetitive eating behavior, diet variety) were associated with unique microbial profiles and VFA 
concentrations. For example, higher abundances of Clostridiales were higher in children with 
ASD and repetitive eating patterns and reduced diet variety. Dietary patterns (DP) were 
empirically derived the FFQ. In children with ASD two DPs were identified. DP1, characterized 
by intakes of vegetables, starchy vegetables, legumes, nuts and seeds, fruit, grains, juice and 
dairy, was associated with lower abundance of Enterobacteriaceae, Lactococcus, Roseburia, 
Leuconostoc, and Ruminococcus. DP2, characterized by intakes of fried foods, Kid’s meals, 
condiments, protein foods, snacks and starchy foods was associated with higher abundance of 
Barnesiellaceae, Alistipes, and lower abundance of Streptophyta as well as higher concentrations 
of propionate, butyrate, isobutyrate, valerate, and isovalerate. Moderation analysis revealed no 
significant moderation effect of diet on the microbiota-symptom interaction in ASD and social 
deficit socres were not associated with diet-induced microbial profiles. However, some GI 
symptoms were related to microbiota profiles linked to feeding behaviors and dietary patterns. 
Conclusion: These results document that nutrient intake and dietary patterns affect the GI 
microbiota and GI symptoms in children with ASD. However, additional research is required to 




The gastrointestinal (GI) microbiota is influenced by a variety of environmental factors, 
including geographical region, presence of pets in the household and dietary factors. It has been 
estimated that more than 50% of microbial changes can be attributed to diet (Zhang et al., 2010). 
Studies in humans and other mammals have shown that the GI microbiota composition can be 
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clustered based on diet (herbivore, omnivore or carnivore) (Muegge et al., 2011). Short-term 
changes of dietary intake over a 5-day period have shown to impact the composition and 
function of the human GI microbiota, while habitual dietary patterns are thought to be more 
notable associated with long-term stability of the gut microbiota (David et al., 2014; Wu et al., 
2011). In one study, a short-term (10 days) dietary intervention did not lead to a change the 
bacterial enterotype that was associated with an individual’s long-term dietary patterns (Wu et 
al., 2011). Additionally, we have previously demonstrated that habitual dietary patterns are 
associated with a distinct microbial profile and microbial stability over a 6 months period in 
children 4-8 years of age (Berding et al., 2017).  
Aberrations in the GI microbiota in children with Autism Spectrum Disorder (ASD) have 
been reported and associations between specific microbial genera and some symptoms of ASD 
were described (Tomova et al., 2015). Likewise, differences in nutrient intake and dietary 
patterns between children with ASD and unaffected controls are commonly observed. Achieving 
adequate nutrition intake often presents a challenge in children with ASD and some nutrient 
deficiencies have been identified (Ledford & Gast, 2006; Liu X, et al., 2016). Picky eating, food 
selectivity and food refusal are common behaviors observed in children with ASD and some 
children might eat as little as five foods (Cermak et al., 2010). Picky eating behaviors might be a 
manifestation of repetitive behavior patterns, ritualistic or externalizing behaviors (Johnson et al., 
2014). Others suggest that picky eating might be a reflection of the child’s resistance to change, 
inflexibility, sensory sensitivities, inadvertent reinforcement of negative mealtime behaviors, GI 
problems and oral motor delay (Johnson et al., 2014; Cermak et al., 2010).  
Diet-induced changes in microbiota composition can lead to increased risk of developing 
certain diseases (e.g., inflammatory bowel diseases), whereas a healthier long-term dietary 
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pattern may be more beneficial in promoting a microbial profile that could potentially protect 
against diseases (Albenberg & Wu, 2014). An interrelationship between dietary intake, 
neurodevelopment, and cognitive function has been demonstrated in healthy children and most 
results are attributed to the direct effect of dietary components on the central nervous system 
(Khan et al., 2015; Khan et al., 2015a). However, the role of microbial changes induced by 
dietary modification in influencing cognitive processes is not well described. In malnourished 
individuals it has been hypothesized that the microbiome is causally related to neurological 
abnormalities (Goyal et al., 2015). A few animal models have shown that diet-induced changes 
in the GI microbiota could contribute to observed behavioral changes (Li et al., 2009; Pyndt 
Jørgensen et al., 2014). For example, rodent fed a meat-containing diet had an increase microbial 
diversity as well as improved working and reference memory (Li et al., 2009). Other studies 
confirmed the effect of high calorie diets on brain function with co-occurring changes in the GI 
microbiota composition (Magnusson et al., 2015). A Western-style diet, which is characterized 
by high fat intake, negatively affected anxiety-like behavior and memory capabilities and was 
associated with an increased ratio of Firmicutes-to-Bacteroides as well as an increase in 
Proteobacteria and Spirochaetes (Ohland et al., 2013).  
Knowing the impact of diet on the microbiota composition as well as the often limited 
nutritional intake in children with ASD, it is surprising that previous research analyzing the 
microbiota in this population is insufficient in informing about the effect of diet on the 
microbiota composition. To fill this gap, the goal of this study was to systematically investigate 
the impact of dietary patterns and nutrient intake on the GI microbiota in children with ASD and 
test whether specific dietary factors could moderate the relationship between the GI microbiota 
and some symptoms of ASD. We hypothesized that children with ASD with a dietary pattern 
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high in fruit, vegetables and grains will harbor a more beneficial microbiota compared to a 
children with a dietary pattern high in animal and processed foods. We further hypothesized that 
healthy food groups will have a more favorable moderating effect on the relationship between 
specific bacterial taxa and symptoms of ASD compared to unhealthy food options. 
 
5.2 Materials and Methods  
Study Design, Participants, Fecal Sample Collection and Analysis, 3-Day Food Diary, and 
Assessment of ASD Symptoms 
The study design, participant recruitment and sample collection are described in Chapter 
3. Fecal samples for microbiota and VFA analysis were collected and analyzed as referred to in 
Chapter 3. Likewise, nutrient intake measured by 3-day food records and ASD symptom 
information were collected as described in Chapter 3. 
 
Food Frequency Questionnaire 
A revised version of the semi-quantitative Youth and Adolescent Food Frequency 
Questionnaire (YAQ) was completed by the parents to estimate their child’s usual food and 
beverage intake over the past year (Bandini et al., 2010). The questionnaire was modified for 
parent report as previously described and has been used in the ASD population to assess food 
selectivity (Bandini et al., 2010). The revised YAQ contained 156 food items, compared with the 
original 169. For example, food items such as coffee or alcoholic drinks were excluded from the 
questionnaire due to the age of the participants. The original YAQ has been tested for 
reproducibility and validity (Rockett et al., 1997). Parents were asked to estimate the frequency 
with which their children consumed a specified portion size of each of the foods listed over the 
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preceding year. The questionnaire had five possible responses ranging from “never or less than 
once per month” to “more than 4 times per week”. The 156 foods items were grouped a priori 
into 13 food groups (e.g. fruits, vegetables, grains, sweets) (Appendix B) based on general 
dietary guidelines for children and using methods similar to those described in previous studies 
of dietary patterns and disease (Evans et al., 2012). To estimate the number of servings of any 
food group, each response was converted to the corresponding frequency factor (Harvard T.H 
Chan School of Public Health Nutrition Department’s Food Group Serving Table) and summed 
over all the food items to get the average servings of a specific food group per day.  
 
Statistics 
All data was analyzed using SAS 9.4 (SAS Institute, Cary, NC). All data was expressed 
as mean  SD. Level of significance was set at p<0.05.  
Differences between groups in nutrient and food group intake were analyzed using mixed 
models. Model fit was assessed using the chi-square-to-df ratio. Values <2 were indicate an 
appropriate model fit. Relationships between nutrient and food group intake and microbiota 
composition were initially analyzed using Spearman correlation.  
Dietary patterns data derived from the YAQ were analyzed using Principal Component 
Analysis and Factor Analysis with Varimax rotation. Retention of the number of factors in the 
final analysis was based on Eigenvalues ≥ 2, percentage of variability explained, interpretability 
of factors and Scree plots. Food groups with a factor loading >0.35 were considered significant 
contributors to each overall dietary pattern. Factor scores were calculated for each participant by 
summing the reported frequency of intake for each food in a food group standardized by the 
factor loadings. Scores for dietary patterns were calculated for each participant and stratified as 
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either falling above or below the median. Differences in microbiota composition, VFA 
concentrations and nutrient intake between participants falling above or below the median for 
each dietary pattern were analyzed using mixed models.  
Hierarchical multiple regression was performed to determine whether food groups or 
nutrients can moderate the relationship between the GI microbiota and ASD symptoms. Dietary 
variables was denoted as the moderator variable, bacterial genera was denoted as the independent 
variable and social deficit scores were denoted as the dependent variable. In order to avoid 
multicollinearity variables were mean centered by subtracting the sample mean from each 
participant’s score. Using stepwise regression, dietary factors and microbiota abundance were 
identified that significantly predict SOCDEF symptoms. Entry and stay levels were 0.05 and 0.1, 
respectively, for independent variables to stay in the model. For each model identified through 
stepwise regression model adequacy was tested. Variance Inflation Factor (VIF) was calculated 
to determine whether multicollinearity is present in the model. Variables with a VIF of greater 
than 2 were removed from the model. Additionally, correlations between the independent 
variables were tested. Normality of the residuals was measured using Shapiro-Wilk. The SPEC 
test was used to test homogeneity of Variances and the Durbin-Watson test assessed residual 
correlation. Lastly, Cook’s D was calculated for each model to determine the influence of 
individual observations. The Mallow’s Cp value was calculated and plots were reviewed to 
assess the goodness of fit for each model. Following the identification and model adequacy 
testing of significant independent variables, moderation analysis was performed using the 
Process macro available in SAS (Hayes, 2012). Age, gender, season, height, weight and BMI 
were included as co-variates in the model. A moderating effect occurs when R2 significantly 
increases after adding the interaction term and the interaction term shows a significant effect. A 
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complete moderation occurs when the predictor and moderator variable are not significant after 
the interaction term was added to the model. If the predictor and moderator variable remain 
significant, then a partial moderation occurred with significant main effects. Significant 
interactions were probed using the simple slope analysis and followed-up with the Johnson-
Neyman (J-N) technique (Bauer & Curran 2005; Hayes & Matthes, 2009). Simple slopes (i.e., 
standardized β) analysis estimates the conditional effect of the independent variable (microbiota) 
when the moderator (diet) is equal to the mean as well as plus and minus one standard deviation 
from the mean (Hayes, 2012). The J-N technique is then applied to identify regions of the 
moderator where the effect of the independent on the dependent variable is significant. This 
technique can be applied when the moderator is a continuum and avoids arbitrary selection high, 




Nutrient intake derived from the 3-day food record of both groups is shown in Table 5.1. 
Overall, there was no difference in macronutrient intake between the ASD and CONT group. 
Total dietary fiber intake did not differ between the groups; however, children with ASD tended 
to have a lower intake of insoluble dietary fiber (p=0.09), but higher intake of pectin (p=0.09) 
compared to CONT. With regard to vitamins and minerals, the only difference was observed in 
intake of vitamin C, with the ASD group having lower (p=0.01) intakes compared to CONT 
children. 
 
Intake of Servings per Day of Food Groups Differs between Groups 
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Besides differences in the intake of nutrients, some differences in the intake of servings 
per day of specific food groups derived from the YAQ were observed (Table 5.2). Children with 
ASD tended to eat fewer servings per day of dairy (p=0.05), but more servings per day of snacks 
(p=0.09) and sweets (p=0.1) compared to CONT children.  
 
Relationship between Microbiota or VFA and Food Groups or Nutrient Intake 
In order to investigate whether different food groups or nutrients are associated 
differently with microbiota composition among the two groups, we used Spearman correlation to 
analyze potential relationships. Several correlations for each group between nutrient and food 
group intake and microbiota abundance and VFA concentrations were observed (Supplemental 
Table 5.1 and 5.2).  
 
Associations between Picky Eating Behavior and Repetitive Eating Pattern and Microbiota 
Composition in Children with ASD 
In order to analyze potential differences in the gut microbiota composition based in 
eating behavior of children with ASD, we investigated the microbiota composition and VFA 
concentration between children with ASD based on parent report of picky eating and repetitive 
eating patterns. Surprisingly, no differences in SOCDEF and total GI severity scores based on 
picky eating behavior or repetitive eating pattern were found. However, we found differences in 
the nutrient and food group intake as well as microbiota composition based on picky eating 
behavior and repetitive eating patterns (Table 5.3).  
Picky Eating Behavior: Children with ASD described as picky eaters had higher 
abdominal pain scores compared to non-picky eaters. In regard to nutrition, children described as 
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picky eaters had lower intakes of total fat, monounsaturated fatty acids, and protein foods, but 
higher intakes of juice. Regarding the microbiota composition, children with picky eating 
behavior had higher abundance of Coriobacteriaceae and EtOH8. On the genera level, children 
described as picky eaters had higher abundance of Ruminococcus and Holdemania, but lower 
relative abundance of Bacteroides and Phascolarctobacterium. Lastly, higher concentrations of 
isobutyrate and isovalerate were observed in children with ASD described as picky eaters.  
Including 20 Foods in Diet: Children with ASD that included less than 20 foods in their 
diet had a higher BMI compared to children with ASD who included more than 20 foods in their 
diet. Likewise, higher scores of total GI severity, flatulence and abdominal pain were observed in 
children including less than 20 foods in their diet. In regard to their nutritional intake, children 
eating 20 foods or less had lower intakes of pectin, vitamin C, niacin, vitamin B6, folate and 
selenium, but higher intakes of added sugars. Regarding the microbiota composition, children 
with 20 foods or less in the diet had higher levels of Actinobacteria, Coriobacteriaceae, 
Clostridiales, Bifidobacterium, Collinsella, Lactobacillus, and Acidaminococcus, but lower 
abundances of Bacteroidetes, Cyanobacteria, Eggerthella, Bacteroides, Dialister and 
Anaerotuncus. Concentrations of valerate tended to be higher in children with ASD who include 
less than 20 foods in their diet.  
Repetitive Eating Pattern: Children with ASD and repetitive eating patterns had a higher 
BMI. Nutritionally, children with repetitive eating patterns had lower intake of pectin, vitamin C, 
potassium, and copper. On the bacterial order level, lower abundance of Streptophyta but higher 
abundances of Clostridiales were observed in children with repetitive eating patterns. 
Additionally, children with ASD and repetitive eating patterns had higher abundance of 
Coriobacteriacea and Actinobacteria, but lower abundance of Verrucomicrobia and 
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Cyanobacteria. Lastly, on the genus level children with repetitive eating behaviors had higher 
levels of Collinsella and Butyrivibrio, but lower abundance of Adlercreutzia, Eggerthella, 
Dialister, Coprobacillus and Akkermansia.  
 
Dietary Patterns, Participant Characteristics, Microbiota Composition and VFA 
Concentration in ASD Group  
Dietary Patterns in both groups: Using factor analysis, two distinct dietary patterns for 
the both groups were identified. In children with ASD, Dietary Pattern 1 (DP1-ASD) was 
characterized by an intake of vegetables, legumes, nuts and seeds, fruit, starchy vegetables, 
grains, juice and dairy. Dietary Pattern 2 (DP2-ASD) was characterized by an intake of fried 
foods, Kid’s meals, condiments, protein foods, snacks and starchy foods. Refined carbohydrates 
were present in both dietary patterns but were more associated with DP1-ASD. Fish, sweets and 
sweetened beverages were not significantly associated with either dietary pattern.  
In the CONT group, one Dietary Pattern (DP1-CONT) was characterized by intakes of 
sweets, Kid’s meals, fried foods, snacks, starchy foods, dairy and sweetened beverages, whereas 
Dietary Pattern (DP2-CONT) was characterized by intakes of fish, vegetables, protein foods, 
fruit, and juice. Refined carbohydrates contributed significantly to both dietary patterns, whereas 
grains, starchy vegetables, condiments and legumes, nuts and seeds did not contribute 
significantly to either dietary pattern. The factor loading matrix can be found in Table 5.4. 
Dietary patterns, nutrient intake and microbiota composition in ASD group: For the ASD 
group, participant were dichotomized by category of factor score (above or below the median) in 
order to analyze differences in participant characteristics, nutrient intakes, VFA concentration 
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and bacterial abundance based on long-term dietary pattern (Tables 5.5 – 5.7). No differences in 
participant characteristics (e.g., age, gender etc.) based on dietary patterns were observed.  
In DP1-ASD, children above the median had higher intakes of fruit, vegetables, legumes, 
nuts and seeds, refined carbohydrates and starchy vegetables, but lower intakes of sweets 
compared to children falling below the median. Additionally, children above the median in DP1-
ASD had higher intake of folate, vitamin E, vitamin A and insoluble dietary fiber but lower 
intakes of vitamin B12. Additionally, we children above the median in DP1 lower abundance of 
Enterobacteriaceae, Lactococcus, Roseburia, Leuconostoc and Ruminococcus compared to 
children below the median. No significant differences in VFA concentrations at baseline between 
factor score categories in DP1-ASD were observed.  
In DP2-ASD, children above the median had lower intakes of vegetables, legumes, nuts 
and starchy vegetables. Furthermore, children above the median in DP2-ASD had higher intakes 
of vitamin B12 as well as total and refined grains, but lower intake of niacin and vitamin B6 
compared to children below the median in DP2-ASD. Additionally, children above the median in 
DP2-ASD had higher abundance Barnesiellaceae and Alistipes and lower abundance of 
Streptophyta. Higher levels of propionate, isobutyrate, valerate and isovalerate were observed in 
children above the median in DP2-ASD.  
 
Dietary patterns, nutrient intake and microbiota composition in CONT group: For the 
CONT group, participant characteristics, VFA concentration and bacterial abundance 
dichotomized as falling above or below the median based on dietary patterns are shown in 
Tables 5.8-5.10. In DP1-CONT children above the median tended to have a higher BMI 
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compared to children below the median. There was no difference in participant characteristics in 
either dietary pattern.  
In DP1-CONT, children above the median consumed higher amounts of refined 
carbohydrates, sweets, snacks, dairy foods, and Kid’s meals as well as, but lower intake of 
vitamin B12, zinc, and soluble dietary fiber. Higher abundances of Eubacterium as well as higher 
concentrations of valerate were observed in children above the median in DP1-CONT. 
In DP 2-CONT, children above the median had higher intakes of fruit, starchy vegetables, 
protein foods, snacks, fish, and grain food as well as higher amounts of total fat, saturated fatty 
acids, omega-3 fatty acids, and sodium, but lower intakes of refined grains. The microbial profile 
in children above the mean in DP2-CONT was characterized by higher abundance of 
Cyanobacteria, Rikenellaceae, Streptophyta, Enterobacteriaceae and Coprobacillus, and lower 
abundance of Verrucomicrobia and Akkermansia.  
 
Moderation Analysis  
Moderation analysis was performed to determine whether dietary intake influences the 
interaction between the GI microbiota and ASD symptoms using hierarchical multiple 
regression. In Step 1, using stepwise regression, Lactobacillus, Peptostreptococcaceae, Dialister 
and Faecalibacterium were determined to significantly predict SOCDEF scores (Table 5.11a). 
In Step 2, using regression analysis calcium and total grain intake were identified as significantly 
predictors of SOCDEF scores (Table 5.11b). Additionally, eating behavior measures were tested 
for predicting SOCDEF scores. Neither repetitive eating patterns nor including twenty foods in 
the diet or picky eating behavior were significant predictors of SOCDEF scores.  
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There was no significant interaction between the nutrient intake variables and bacterial 
abundance in predicting SOCDEF symptoms. Thus, no moderation effect of dietary components 
on the relationship between bacterial taxa and SOCDEF scores occurred.  
 
5.4 Discussion  
Differences in the GI microbiota composition between children with ASD and unaffected 
controls are increasingly described and are suggested to influence some symptoms of ASD. 
Likewise, picky eating and inadequate nutrient intake are commonly reported in children with 
ASD (Cermak et al., 2010). Even though diet represents a major environmental factor for 
influencing the GI microbiota composition, studies investigating the microbiota in children with 
ASD lack in systematically describing the diet-microbiota interaction. Therefore, we collected 
information on dietary habits (food frequency questionnaire, 3-day food record) as well as fecal 
samples from children with ASD and unaffected controls to investigate how nutrient intake and 
dietary patterns impact the GI microbiota composition. Additionally, specific nutrients or food 
groups were analyzed for their potential to moderate the microbiota-brain connection in ASD. To 
the best of our knowledge, this is the first study reporting an association between dietary intake 
and microbiota composition in children with ASD.  
Achieving adequate nutritional intake presents a big challenge in children with ASD due 
to GI symptoms, food allergies, metabolic abnormalities or problematic eating behaviors. 
Approximately 90% of children with ASD experience some sort of feeding-related concern 
which often present as multidimensional problems (Ledford & Gast, 2006; Nadon et al., 2011). 
Here, we report lower intake of dairy foods, insoluble fiber, pectin and vitamin C, but higher 
intakes of snacks and sweets in children with ASD compared to unaffected controls. Several 
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studies have found that children with ASD have a strong preference for starches, snack and 
processed foods, while rejecting fruits, vegetables or protein (Bicer & Alsaffar, 2013; Al-Farsi et 
al., 2011; Mahli et al., 2017). In contrast to reports outlining that the total mean average of 
nutrient deficiencies is higher in children with ASD (Zimmer et al., 2012; Shmaya et al., 2015), 
participants in both groups in this study met the Dietary Reference Intakes for 4-to-8-year old 
children for most vitamins and minerals except for potassium, vitamin D, vitamin E, and choline. 
Furthermore, children with ASD did not meet the RDA for vitamin K intake and consumption of 
fewer foods from the dairy food group were observed in children with ASD (Shearer et al., 1982; 
Schreck et al., 2004; Herndon et al., 2008). One explanation for the lower intake of dairy foods 
in children with ASD in this study could be the current trend for using the Gluten-free/Casein-
free (GFCF) diet in the ASD population. The interest in the GFCF diet stems for the theory that 
children with ASD have a limited ability to break down gluten and casein. Undigested gluten and 
casein can then translocate into the periphery, bind to opioid receptors in the Central Nervous 
System and impact neuronal development, cognitive function, attention, learning and behavioral 
symptoms associated with ASD (Whiteley et al., 1999). Even though clinical studies using GFCF 
diets for ameliorating some symptoms of ASD have not provided conclusive evidence for its 
efficacy (Knivsberg et al., 2002; Whiteley et al., 2010; Elder et al., 2006), the GFCF diet is still 
widely used in the ASD community. Thus, even though children following a specialty diet 
(including GFCF diet) were excluded from the study, parents of children with ASD could still 
have offered less dairy foods to their children. Although low intake of dietary fiber in children 
with ASD has been reported (Bicer & Alsaffar, 2013), here only the intake of insoluble dietary 
fiber and pectin, but not total dietary fiber differed significantly between the groups. This might 
be attributable to the fact that children in both groups only consumed about 65% of the 
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recommended amounts of fiber. Additionally, children in both groups consumed only about half 
of the recommended 3 servings per day of vegetables and only about 20% of the total grains 
were consumed as whole grains, which are both high-fiber food sources. This observation is in 
line with reports that children in the United States often consume inadequate amounts of dietary 
fiber and fail to meet dietary guidelines for fiber-rich foods, such as fruit, vegetables and whole 
grains (McGill & Devareddy, 2015; Frazier-Wood et al., 2016). Although dietary intake differed 
between children with ASD and unaffected controls in this cohort, the differences did not reach 
the extent as often described in the literature.  
Previously published studies lack in systematically investigating the effect of dietary 
habits of children with ASD on the composition of the GI microbiota. Of the studies analyzing 
the GI microbiota composition in children with ASD, only Son et al. collected dietary 
information and analyzed the macronutrient intake of study participants (Son et al., 2015). Other 
studies only collected information on specialty diets (Horvath et al., 1999; Finegold et al., 2002; 
Parracho et al., 2005; Kang et al., 2013; Wang et al., 2011) or probiotic and supplement use 
(Wang et al., 2011; Adams et al., 2011a; Kang et al., 2013). Kang et al. concluded that dietary 
intake of children with ASD was not significantly correlated with bacterial abundance (Kang et 
al., 2013); however, the researchers only assessed dietary intake by asking whether the child was 
following a GFCF diet, used probiotics or nutrition supplements or consumed seafood. In order 
to investigate the impact of nutrient and food intake on the microbiota and microbial products, 
we first performed simple correlation analysis to determine whether dietary intake correlates 
with individual bacterial taxa and VFA concentrations. Not surprisingly, we found correlations 
between intake of specific nutrients and the abundance of microbiota and VFA concentrations in 
both children with ASD and unaffected controls. It is commonly known that the GI microbiota 
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and bacterial metabolites are associated with nutrient intake and dietary patterns. Some bacteria 
commonly affected by dietary intake are Bifidobacterium spp, Lactobacillus spp, Bacteroides 
spp, Alistipes, Bilophila, Clostridium, Roseburia, Eubacaterium, Enterococcus, 
Faecalibacterium prausnitzii, Akkermansia muciniphila, Escherichia coli, Helicobacter pylori, 
and Streptococcus spp (Singh et al., 2017). Thereby, different food groups and different 
macronutrients can have distinct effects on the microbiota composition and microbial 
metabolites. For example, dairy intake was negatively associated with species richness and 
diversity, whereas vegetable intake increased Lachnospira abundance and fruit intake decreased 
Firmicutes-to-Bacteroidetes ratio and Ruminococcus gnavus abundance (Smith-Brown et al., 
2016). Irregardless of the protein source, general protein consumption correlates with overall 
bacterial diversity. Bacterial genera such as Clostridium, Bacteroides and Lactobacillus contain 
proteases that can break down undigested protein (Rawlings et al., 2013). Increased animal 
protein intake corresponded to higher abundances of Bacteroides and Alistipes (De Filippo et al., 
2010) and a high-beef diet resulted in higher counts of Bacteroides and Clostridia in human 
subjects (Singh et al., 2017). Additionally, a diet high in protein but low in carbohydrate reduced 
the concentration of Roseburia, Eubacterium rectale and butyrate (Russell et al., 2011). 
Likewise, these alterations in specific bacterial taxa associated with protein consumption can be 
linked to changes in the host physiology (Singh et al., 2017). The amount and type of fat both 
can also shape the composition and diversity of the GI microbiota. For example, a high-fat diet 
causes a decrease in the abundance of lactic acid bacteria, but an increase Clostridiales and 
Bacteroides, whereas a low-fat diet was associated with increases in concentrations of 
Bifidobacterium (Singh et al., 2017). Mice fed lard, a source of saturated fat, had an increase in 
Bacteroides, Turicibacter and Bilophila, whereas an increase in beneficial bacteria such as 
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Bifidobacterium, Lactobacillus, Streptococcus and A. muciniphila was observed in animals fed 
fish oil, a source high in unsaturated fats (Caesar et al., 2015). Carbohydrate is the most widely 
studied macronutrient regarding the ability to impact the GI microbiota. Indigestible 
carbohydrates, such as dietary fiber, are fermented by the GI microbiota and have the potential of 
modulating its composition. A diet higher in dietary fiber can increase bacterial abundance and 
richness and beneficial bacteria such as Lactobacillus, Bifidobacteria and Roseburia, but 
decrease harmful bacteria such as Clostridia (Singh et al., 2017). Associations between 
macronutrient intake and bacterial abundance previously reported are in line with correlations 
observed herein. For example, daily intake of servings of protein positively correlated with 
Bacteroides abundance in children with ASD, whereas total protein intake positively correlated 
with Alistipes and Clostridiales in control children. Furthermore, total fat consumption was 
positively correlated with Clostridium in control children. In children with ASD, insoluble fiber 
negatively correlated with Clostridiales abundance and pectin consumption was negatively 
correlated with Clostridiaceae abundance. Interestingly, in children with ASD abundance of 
Faecalibacterium positively correlated with unhealthy food group (fried food), but negatively 
correlated with a beneficial food (fruit). Previous research has shown that a healthy dietary 
pattern, the Mediterranean diet, increased the abundance of F. prausnitzii (Haro et al., 2016). 
These results provide first evidence that nutrient and food group intake influence the microbiota 
composition and VFA concentration in children with ASD and suggest that dietary intake should 
be considered when analyzing microbial composition in this population.  
Next, we investigated whether picky eating behavior or repetitive eating patterns were 
associated with a distinct dietary intake and microbiota composition in children with ASD. Picky 
eating behaviors and repetitive eating pattern are commonly observed in children with ASD and 
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potentially pose another point of influence on the microbiota composition (Provost et al., 2010; 
Diolordi et al., 2014). In this study population, about half of the children with ASD were 
perceived by their parents as being picky eaters or having a repetitive eating pattern. Picky eating 
behavior is characterized by strong food preferences and rejecting new foods (Taylor et al., 
2015). Assessment of picky eating ranges from a single item questions to more complex 
questionnaires (Taylor et al., 2015). Some single item questions include “Is your child a picky 
eater” which was utilized to assess picky eating in this study (Mascola et al., 2010). Research has 
consistently demonstrated that picky eaters have less variety in their diet compared to non-picky 
eaters (Taylor et al., 2015). Because diet variety has previously been measured by including 20 
food groups in the diet (Quick et al., 2014), we also measured diet variety by asking parents 
whether the child’s diet includes 20 or more foods. Limited data investigating the differences in 
nutrient intake between picky eaters and non-picky eaters among children with ASD is available. 
One study showed that children with ASD described as selective eaters ate fewer total food, but 
information on nutrient intake was not available (Tanner et al., 2015). Likewise, children with 
ASD and severe food selectivity did not meet the recommended amounts of some nutrients and 
children with restricted diets had poor protein intake and deficiencies in essential amino acids 
(Arnold et al., 2003). Children with ASD following a restricted diet also had worse Healthy 
Eating Index scores and the intake of some vitamins, minerals and grains was lower compared to 
children with ASD who were non-selective eaters (Graf-Myles et al., 2013). In children without 
ASD, it is commonly observed that picky eaters have reduced intakes of fruit and vegetables, 
whole grain products, fish and other seafood, but higher intakes of meat, savory snacks and 
confectionery compared to their peers (Taylor et al., 2015). Additionally, intakes of energy, 
vitamin E, folate and dietary fiber have been reported to be lower in picky eaters (Taylor et al., 
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2015). Interestingly, one study investigating the nutrient intake between picky eaters among 
children with ASD and unaffected controls found no differences between the groups (Lockner et 
al., 2008), suggesting that picky eating behavior but not necessarily ASD status can impact 
nutrient intake.  
Herein, among children with ASD those described by their parents as being picky eaters 
had lower intakes of total fat, monounsaturated fatty acids, and protein foods, but higher intakes 
of juice. Generally, consuming fewer calories from fat is regarded a healthier dietary pattern; 
however, the type of fat consumed is important when considering the effects on the body. For 
example, saturated fats can increase inflammation, metabolic disease and the risk of developing 
coronary heart disease and stroke (Kennedy et al., 2009; Nettleton et al., 2017), whereas 
unsaturated fats exert anti-inflammatory properties and promote a lean and metabolically healthy 
phenotype (Buckley & Howe, 2009; Lunn & Theobald, 2006). Some of the differences in the 
microbiota composition observed could be attributed to the differences in nutrient intake. Among 
children with ASD those with picky eating behavior had higher abundance of Coriobacteriaceae, 
EtOH8, Ruminococcus and Holdemania, but lower relative abundance of Bacteroides and 
Phascolarctobacterium as well as higher concentrations of isobutyrate and isovalerate. Some of 
these abundances of bacteria have been described in the literature as being associated with host 
physiology, suggesting that the microbiota of children with ASD who are picky eaters could be 
less beneficial. Higher abundance of Bacteroides has shown to support development of immune 
tolerance and avoidance of allergy and asthma (Wexler, 2007) and some mucolytic 
Ruminococcus species (e.g., R. gnavus and R. torgues) have been observed to be increased in 
patients with Chron’s Disease and Ulcerative Colitis (Png et al., 2010). Abundance of 
Holdemania correlated with clinical indicators of impaired lipid and glucose metabolism 
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(Lippert et al., 2017), while higher Phascolarctobacterium abundance can have beneficial effects 
on the host by producing VFA (Louis et al., 2010) and is correlated with positive mood (Li et al., 
2016). Lastly, higher concentrations of isobutyrate and isovalerate could suggest microbial 
metabolic changes and increased dietary energy extraction form the microbiota in picky eaters 
among children with ASD. Whether isobutyrate is beneficial or harmful remains to be 
determined (Jost et al., 2014). In states of low butyrate concentrations, colonocytes can 
metabolize isobutyrate (Jaskiewicz et al., 1996) and the microbiota of patients with IBS 
produced 25% more branched chain fatty acids compared to healthy individuals (Van Nuenen et 
al., 2004).  
Similar to observations based on picky eating behaviors, differences in nutrient intake 
and microbiota composition among children with ASD and limited diet variety were detected. 
Interestingly, children with ASD consuming less than 20 foods in their diet had a higher BMI 
and GI severity scores compared to children eating more than 20 foods. Regarding nutritional 
intake, children with ASD who are consuming less than 20 foods in their diet had lower intakes 
of pectin, vitamin C, niacin, vitamin B6, folate and selenium, but higher intake of added sugars. 
Pectin is a soluble fiber that can be fermented by the GI microbiota to yield SCFA. Pectin has 
been postulated to maintain the balance of the GI microbiota (Licht et al., 2010) and can have a 
significant effect at the individual species level (Chung et al., 2016). For example, pectin 
utilization is widespread among the Bacteroides genus (Dongowski et al., 2000), which was 
decreased in children with ASD including less than 20 foods in their diet. Higher abundance of 
Actinobacteria as well as Bifidobacterium, which also belongs to the phylum Actinobacteria, 
were detected in children with ASD including less than 20 foods in their diet. Actinobacteria 
abundance was found to be higher in children with Attention Deficit/Hyperactivity Disorder 
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(Aarts et al., 2017) and was associated with brain structure and function in humans (Fernandez 
Real et al., 2015). Bifidobacterium is regarded as a beneficial microbe due to its ability to 
improve epithelial barrier function, to reduce allergic symptoms, to prevent pathogen infections, 
and to produce bioactive metabolites such as SCFA, vitamins or polyunsaturated fatty acids 
which contribute to intestinal function and immune modulation (Hidalgo-Cantarana et al., 2017; 
Bottacini et al., 2014). However, higher abundance of Bifidobacterium could also indicate a less 
mature microbiota composition since Bifidobacterium is shown to decrease with age (Ottman et 
al., 2012). Furthermore, abundance of Bifidobacterium could be involved in the dopaminergic 
signaling pathway, thus potentially impacting brain activity and behavior (Aarts et al., 2017). 
Another genus, Lactobacillus, that is associated with health benefits, such as decreased 
inflammation, protection against pathogen, manipulating of host’s immune response, vitamin 
synthesis, improvement of nutrient absorption and enhanced barrier function (Patten & Laws, 
2015; Madsen et al., 1999), was increased in children with ASD who had less than 20 foods in 
their diet. Due to the benefits from the bacteria itself as well as their metabolic products (Patten 
& Laws, 2015), Lactobacillus and Bifidobacterium are among the most frequently used strains in 
probiotic products (Otles et al., 2003). Despite the increased abundance of some beneficial 
bacteria in children with ASD who consume less than 20 foods in their diet, other bacterial taxa 
have been implicated to have negative effects on host health. Lower abundance of Bacteroidetes 
has been noted in children with food sensitization (Chen et al., 2016) as well as in mice exposed 
to oxidative stress (Zhao et al., 2018). Importantly, oxidative stress was also postulated to be 
involved in the development of ASD symptoms (Chauhan & Chauhan, 2006; Ashwood & 
Wakefiled, 2006). A lower proportion of Bacteroidetes as well as Bacteroides, as observed in 
children with ASD and less than 20 foods in their diet, may also be related to obesity (Ley et al., 
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2005; Johnson et al., 2017; Haro et al., 2016). Intriguingly, some health outcome measures (i.e., 
BMI) were higher in children who have less than 20 foods in their diet. The abundance of 
another potentially pathogenic bacteria, Clostridiales, was also higher in children with ASD and 
less than 20 foods in their diet. The abundances of Clostridiaceae and Clostridium are often 
associated with ASD and species within the Clostrdiaceae family could potentially affect ASD 
symptomology by producing entero- and neurotoxins (Finegold, 2008). On the genus level, 
higher abundance of Collinsella was observed which has also been related to inflammatory 
diseases such as colorectal cancer (Chen et al., 2012), Type 2 Diabetes Mellitus (Lambeth et al., 
2015) and food sensitization (Chen et al., 2016). Higher levels of Acidaminococcus could 
potential be detrimental to intestinal function (Gough et al., 2015) and enterocyte proliferation 
due to its ability to use glutamate as a sole energy source. Glutamate is an important amino acid 
for intestinal barrier function, amino acid metabolism and nitrogen balance (Rogosa, 1969). 
Likewise, the presence of Dialister was a significant predictor for the treatment response in 
children with IBS (Shaw et al., 2016). Lastly, Anaerotruncus in conjunction with other genera 
has been found to attenuate inflammation by stimulating regulatory T-cells in a mouse model of 
colitis (Atarashi et al., 2013; Joosens et al., 2011).  
Repetitive eating patterns, defined as the preference for eating the same foods, resulted in 
differences in nutrient intake and microbiota composition. Similar to children consuming less 
than 20 foods in their diet, children with repetitive eating patterns had a higher BMI and GI 
severity scores and consumed lower amounts of pectin, vitamin C, potassium, and copper. The 
microbial profile associated with repetitive eating patterns were characterized by lower 
abundance of Streptophyta, Verrucomicrobia, Cyanobacteria, Adlercreutzia, Eggerthella, 
Dialister, Coprobacillus and Akkermansia, but higher abundances of Actinobacteria, 
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Clostridiales, Coriobacteriacea, Collinsella and Butyrivibrio. Despite the higher abundance of 
beneficial bacteria such as Butyrivibrio, children with ASD and a repetitive eating pattern had 
higher GI severity scores. This observation could partly be explained by the abundances of some 
bacteria that have been linked to potential negative consequences for the host such as 
Clostridiales or Collinsella. The abundance of Coriobacteriaceae was associated with an 
increased inflammatory status (Qasem et al., 2017), increased pro-inflammatory cytokines, 
altered activities of antioxidant enzymes (Chauhan & Chauhan, 2006) and inflammatory diseases 
such as IBD or colon cancer (Clavel et al., 2013). Additionally, species within the 
Coriobacteriaceae family could potentially disrupt the epithelial barrier and lead to GI 
dysfunction by colonizing mucosal surfaces (Stenman et al., 2013; Turnbaugh, 2012). 
Akkermansia is a mucin-degrading bacterium that has been suggested to be a marker for GI 
health (Png et al., 2010; Swidsinski et al., 2011), due to the high abundance in healthy mucosa, 
the involvement in inducing immune response pathways, chemotaxis, cell adhesion and 
maturation of B- and T-cells and influencing the expression of genes involved in metabolic and 
signaling pathways (Derrien et al., 2011). Lastly, a decreased abundance Adlercreutzia was 
found in children with IBS (Shaw et al., 2016).  
Third, we investigated the effect of long-term dietary patterns on the microbiota 
composition in children with ASD. Habitual long term dietary patterns have been suggested to 
influence the GI microbiota more dramatically than short term nutrient changes and might be 
associated with long-term stability (Lozupone et al., 2012; David et al., 2014; Wu et al., 2011). 
Microbiota composition can be clustered based on dietary habits (Muegge et al., 2011) and 
healthier long-term dietary patterns, i.e., increased consumption of fruits, vegetables and whole 
grains and less intake of processed foods, simple carbohydrates and fried foods are associated 
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with a microbial profile that could potentially protect against diseases (Albenberg & Wu, 2014). 
We have previously shown that a dietary pattern characterized by intake of fish, protein foods, 
refined carbohydrates, vegetables, fruit, juice and sweetened beverages, kid’s meals and snacks 
and sweets, was associated with higher relative abundance of Bacteroidetes, Bacteroides and 
Ruminococcus and lower abundance of Bifidobacterium, Prevotella, Blautia and Roseburia. A 
dietary pattern characterized by intake of grains, dairy and legumes, nuts and seeds, was 
associated with higher relative abundance of Cyanobacteria and Phascolarctobacterium and 
lower abundance of Dorea and Eubacterium (Berding et al., 2018). Diets such as the Western-
style diet, Gluten-free diets, vegan, vegetarian or Mediterranean diets can influence the 
microbiota composition. In healthy individuals, following a Gluten-free diet caused a decrease in 
Bifidobacterium, C. lotuseburense, F. prausnitzii and Lactobacillus and an increase in 
pathogenic bacteria including Enterobacteriaceae and E. coli (De Palma et al., 2009; Singh et al., 
2017). Mediterranean diet, which is rich in dietary fiber and antioxidants, can increase total 
bacteria, Bifidobacterium, Lactobacillus, Prevotella and Roseburia and fecal SCFA (Singh et al., 
2017; De Filippis et al., 2015). Defining long-term dietary pattern associated with a microbial 
profile that could have beneficial effects on some symptoms of ASD could provide new 
guidelines for future longer term treatment strategies. Here we described two dietary patterns in 
children with ASD that are linked to a distinct microbiota composition.  
In a healthier dietary pattern DP1-ASD, children above the median had higher intakes of 
fruit and vegetables, legumes, nuts and seeds, refined carbohydrates and starchy vegetables, but 
lower intakes of sweets compared to children falling below the median. Additionally, children 
above the median in DP1-ASD had higher intake of folate, vitamin E, vitamin A and insoluble 
dietary fiber but lower intakes of vitamin B12. Children falling above the median in DP1-ASD 
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also had lower abundance of Enterobacteriaceae, Lactococcus, Roseburia, Leuconostoc and 
Ruminococcus compared to children below the median. These abundances could be indicative of 
a less beneficial microbial profile. For example, in children with ASD, Enterobacteriaceae levels 
was highest in ASD group compared to unaffected controls and children with Pervasive 
Developmental Disorder not otherwise specified (De Angelis et al., 2013). Higher abundance of 
Enterobacteriaceae was proposed as marker of microbiota dysbiosis and epithelial dysfunction 
(Shin et al., 2015) and increased abundance of members of the Enterobacteriaceae family is often 
observed in patients with Chron’s Disease and Ulcerative Colitis (Frank et al., 2007). 
Furthermore, the abundance of Enterobacteriaceae in mice fed a high-fat diet was correlated with 
an increase in endotoxin concentrations (Kim et al., 2012). Albeit the often positive impacts of 
Lactococcus, Leuconostoc and Roseburia on the host physiology, in some conditions there 
bacteria could exert negative consequences for the host. Some reports of Leuconostoc bacteremia 
(Casanova-Roman et al., 2003; Ishiyama et al., 2011) might denote species within this genus as 
opportunistic pathogens and pathogenic properties of Leuconostoc species in the pediatric 
population who are already immunocompromised have been reported (Scano et al., 1999; 
Florescu et al., 2008). Additionally, Leuconostoc might be implicated in causing some human 
disease (Barreau & Wagener, 1990) and two species, L. mesenteroides and L. carnosum were 
higher in patients with Celiac disease (Sanz et al., 2007). Roseburia, known for its health 
benefits elicited by the production of butyrate (Tamanai-Shacoori et al., 2017), was shown to be 
positively correlated with BMI and systemic inflammation in obese subjects (Verdam et al., 
2013) and could be involved in the development of insulin resistance in mice fed a high-fat high-
sugar diet (Org et al., 2015). These observations suggest the physiological effects of Roseburia 
and other beneficial microbes could depend on the substrate availability and presence of other 
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microbes. Considering the relatively healthier eating behavior, mirrored by higher intakes of 
fruit, vegetables, legumes nuts and seeds and insoluble fiber in children above the median in 
DP1-ASD, the lower abundance of Lactococcus, Leuconostoc and Roseburia in children above 
the median in DP1-ASD might not be of physiological importance.  
In an unhealthier dietary pattern DP2-ASD, children that fell above the median had lower 
intakes of vegetables, legumes, nuts and starchy vegetables and had higher intakes of total and 
refined grains compared to children below the median in DP2-ASD. This unhealthier eating 
pattern was associated with a microbiota composition that harbored more less beneficial 
microbes. Barnesiellaceae, which was increased in children above the median in DP2-ASD, was 
associated with sedentary lifestyles and predicted by the percentage of body fat (Bressa et al., 
2017). Furthermore, the abundance of Alistipes might be associated with increased abdominal 
pain, GI inflammation, systemic infections and major depressive disorder (Naseribafrouei et al., 
2014; Jiang 2015; Moschen et al., 2016; Boente et al., 2000). Interestingly, children above the 
median had higher levels of propionate, and the branched chain fatty acids isobutyrate, valerate 
and isovalerate. Increased VFAs have been reported in children with ASD (Wang et al., 2012). 
The exact mechanism is unknown, but some studies suggest that VFAs could play a role in ASD 
pathophysiology (Thomas et al., 2012; MacFabe, 2011; Foley et al., 2015). Even though children 
above the median in DP2 displayed an unhealthier eating pattern and a less beneficial 
microbiota, no differences were observed in measures of host physiology, such as GI symptoms 
or social deficit scores.  
Contrary to our hypothesis, no associations between diet-induced microbial profile and 
social deficit scores were observed. A direct correlation between nutrients (e.g., vitamin A or 
folate) and severity of ASD symptoms has been reported (Liu X, et al., 2016). A healthy, 
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nutrient-rich diet has been proven to support good mental health (O’Neil et al., 2013; Khan et al., 
2015). Due to the profound effect of diet on the GI microbiota composition and the newly 
acquired knowledge about the gut-brain-connection, the GI microbiota was proposed to be key 
mediator in the diet-brain health connection potentially through direct interaction of the GI 
microbiota and its metabolic products with enteric neurons (Hanstock et al., 2004; Furness et al., 
1999; Dawson et al., 2016). A decrease in microbial diversity caused by consumption of highly 
processed foods was linked to increased risk for mental disorder (Dawson et al., 2016). In an 
animal model, supplementation with lean-beef caused marked diet-induced shifts in the GI 
microbiota diversity as well as improved reference and working memory and decreased anxiety-
like behavior (Li et al., 2009). Likewise, high calorie or high fat diets impacted brain function 
with co-occurring changes in the GI microbiota composition (Magnusson et al., 2015; Bruce-
Keller et al., 2015). Interestingly, one study found that feeding a high-fat or high-sucrose diet to 
rodents resulted in increased percentages of Clostridiales and Bacteroidales, two bacteria orders 
that have been found to be altered in children with ASD. Behaviorally, these mice also displayed 
poorer cognitive flexibility compare to mice fed a normal chow diet (Magnusson et al., 2015). A 
Western-style diet, which is characterized by high fat intake, negatively affected anxiety-like 
behavior and memory capabilities and was associated with an increased ratio of Firmicutes to 
Bacteroides as well as an increase in Proteobacteria and Spirochaetes (Ohland et al., 2013). 
Lastly, rodents treated with a magnesium deficient diet had a decrease in bacterial diversity as 
well as altered anxiety-like behavior (Jørgensen et al., 2014). In human subjects, associations 
studies demonstrated that intake of highly processed foods can decrease microbial diversity and 
was linked to increased risk for mental disorder (Dawson et al., 2016). Pro- and prebiotic 
supplementation are prominent ways to manipulate the microbiota and investigate the effect on 
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brain function. Supplementation with galactooligosaccharides stimulated the growth of 
Bifidobacterium and decreased waking cortisol response (Messaoudi et al., 2011) and probiotic 
supplementation with Lactobacillus rhamnosus GG in early childhood was protective against 
development of ADHD and Asperger Syndrome at 13 years of age (Pärtty et al., 2015). Due to 
the increasing knowledge of how GI microbes could potentially influence behavior in children 
with ASD, dietary interventions to manipulate the GI microbiota to ameliorate some symptoms 
of ASD could be a promising therapeutic avenue. Fro example, the purpose of the specific 
carbohydrate diet, which is used by some parents to manage symptoms of ASD, is to alleviate 
symptoms of malabsorption and prevent growth of potentially pathogenic bacteria which could 
potentially affect symptomology (Gotschall, 2004). Even though we did not find associations 
between a core symptom of ASD, social deficit scores, and diet-induced microbial profiles, 
scores for some GI symptoms were associated with dietary patterns and eating behavior, 
suggesting that some eating behaviors could potentially affect GI health through the microbiota 
in the ASD population. The commonly observed GI symptoms in the ASD population have been 
suggested to contribute to behavioral problems and to correlate with symptom severity (Tomova 
et al., 2015; Adams et al., 2011a; Buie et al., 2010; Coury et al., 2012a; McElhanon et al., 2014; 
Horvath et al., 1999); thus, promoting an eating pattern that promotes a microbial profile 
associated with fewer GI symptoms in the subpopulation of children with ASD and co-morbid 
GI problems might be a potential therapeutic avenue to alleviate some associated symptoms of 
ASD. However, future studies using more comprehensive GI assessment tools are needed to 
confirm the results reported herein.  
The lack of association between social deficit scores and measures of diet-induced 
microbial profiles (i.e., feeding problems, dietary patterns, moderation analysis) could partly be 
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attributable to the small sample size. Likewise, it could be possible that repetitive or restrictive 
behaviors or other externalizing behaviors (i.e., aggression or irritability) associated with ASD 
could be more significantly impacted by the microbiota composition. Previous studies 
demonstrated that problematic eating behaviors could be a manifestation of repetitive behaviors, 
ritualizing or externalizing behaviors of ASD instead of social communication deficit (Johnson et 
al., 2014). Furthermore, one study investigating the relationship between individual bacterial 
taxa and symptoms of ASD found that Desulfovibrio was strongly correlated with the 
restricted/repetitive behavior subscale score (Tomova et al., 2015). Due to the age of the 
participants in this study, only social deficits were measured as the PDDBI-SV is one of the only 
validated parent questionnaire that is available for children under the age of 4. Likewise, it could 
be possible that other environmental factors contribute to the observed microbial dysbiois in 
ASD that could be associated with some symptoms of ASD. Thus, larger studies in the future 
should include measurements of all symptoms of ASD and consider other environmental factors 
known to influence the microbiota in order to provide more evidence for a relationship between 
diet-microbiota-symptoms in children with ASD.  
Although the results presented in this study provide a new evidence for an impact of diet 
on microbiota in children with ASD, they are limited by the relatively small sample size of the 
population as well as the measurement of only social deficit symptoms of ASD. Additionally, 
dietary intake was based on parent self-report using food diaries and food frequency 
questionnaires, which are susceptible to measurement error and systemic biases in estimate food 
intake. Even though evidence for an association between food selectivity and ASD symptom 
severity is not conclusive, the reported observations could also be limited in that children with 
more severe ASD symptoms might be exert more picky eating behaviors or have more repetitive 
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eating patterns. Whereas some studies suggest that food selectivity and feeding problems were 
associated with higher rates of ASD symptoms as well as severity of temper tantrums (Crasta et 
al., 2014; Postorino et al., 2015; Dominick et al., 2007), other studies found no or limited 
association between feeding difficulties and severity of social, communication and cognitive 
deficits (Johnson et al., 2014; Tanner et al., 2015). It has been suggested that the severity of ASD 
symptoms might be related to topography and duration of refusal behavior, but not necessarily 
directly to food selectivity (Aponte et al., 2016). Using regression analysis, one study found that 
family food preferences instead of ASD symptom severity were the strongest predictors of 
child’s food preferences (Schreck et al., 2006). Some of these discrepancies in study findings 
could be due to different definitions of food selectivity used in the various studies as well as the 
methodology used to assess feeding problem behaviors (Postorino et al., 2015). For example, 
food selectivity can refer to picky eating, food refusal, limited food repertoires, excessive intake 
of a few foods and selective intake of certain food categories (Cermak et al., 2010). Here, we 
report several instances in which social deficit scores were not related to eating behavior. First, 
we did not find any differences in children above or below the median in social deficit scores 
based on dietary patterns. Second, we did not see differences in social deficit scores based on 
picky eating behavior or repetitive eating patterns.  
Despite these limitations, using various approaches new evidence for a relationship 
between diet and microbiota in ASD is reported, which have not previously been described in the 
ASD population. This approach could provide valuable insight for future studies aimed at 
deciphering the relationship between microbiota and ASD symptoms. Dietary intervention trials 
in children with ASD considering the baseline microbiota and investigating changes in the 
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microbiota that could relate to changes in some symptoms of ASD are needed to further 




5.5 Tables  
Table 5.1 Comparison of nutrient intake between children with ASD (ASD) and unaffected 
controls (CONT).  
Variable ASD (n=26) CONT (n=32) p-value 
Macronutrients:    
Energy (kcal) 1349 (1103-1627) 1457 (1343-1734) NS 
Total Fat (g) 49 (36-58) 54 (43-63) NS 
Omega-6 Fatty Acids (g) 10.2 (7.5-13.3) 10.3 (8.5-12.6) NS 
Omega-3 Fatty Acids (g) 0.9 (0.8-1.3) 1.1 (0.8-1.3) NS 
SFA (g) 16 (12-22) 4 (2.9-5.0) NS 
MUFA (g) 17 (13-20) 18 (15-23) NS 
PUFA (g) 11 (8-15) 12 (9-14) NS 
Total Carbohydrate (g) 176 (147-220) 194 (159-225) NS 
Total Sugars (g) 81 (56-94) 84 (67-100) NS 
Added Sugars (g)  43 (28-49) 41 (32-50) NS 
Total Grains (oz 
equivalents) 
5.1 (4.3-6.9) 5.9 (4.4-6.7) NS 
Whole Grains (oz 
equivalents) 
0.7 (0.4-1.3) 1.0 (0.4-1.9) NS 
Refined Grains (oz 
equivalents) 
4.4 (2.9-5.1) 4.2 (3.2-5.7) NS 
Total Protein (g) 49 (35-62) 52 (42-62) NS 
Dietary Fiber    
Total Dietary Fiber (g) 10 (9-17) 15 (11-17) NS 
Soluble Dietary Fiber (g) 3.5 (2.8-5.3) 4 (3-5) NS 
Insoluble Dietary Fiber (g) 6.8 (6-10.6) 9.8 (7.8-11.9) 0.09 
Pectin (g) 1.3 (1.1-1.7) 1.9 (1.2-2.5) 0.09 
Vitamins     
Vitamin A (μg) 435 (277-651) 369 (281-531) NS 
Vitamin D (μg) 3.1 (1.4-5.9) 4.4 (3.5-6.3) NS 
Vitamin E (mg) 6.2 (4.2-8.1) 5.1 (4.2-6.8) NS 
Vitamin K (μg) 33 (21-49) 44(35-56) NS 
Vitamin C (mg) 38 (29-57) 62 (46-115) 0.01 
Thiamin (mg) 1.2 (0.9-1.4) 1.3 (1.0-1.6) NS 
Riboflavin (mg) 1.4 (1.1-1.8) 1.6 (1.3-1.9) NS 
Niacin (mg) 14 (12-19) 15 (11-19) NS 
Pantothenic Acid (mg) 3.5 (2.6-3.9) 3.5 (2.8-4.2) NS 
Vitamin B6 (mg) 1.2 (0.9-1.5) 1.1 (0.9-1.5) NS 
Folate (μg) 238 (194-320) 276 (232-363) NS 
Vitamin B12 (μg) 3 (2.1-3.9) 3.2 (2.5-4.4) NS 
Choline (mg) 198 (135-247) 200 (150-253) NS 
Minerals    
Calcium (mg) 739 (451-958) 772 (586-980) NS 
Phosphorus (mg) 816 (599-1100) 930 (580-980) NS 
Magnesium (mg) 169 (131-231) 193 (174-227) NS 
Iron(mg) 9.9 (7.7-13.1) 9.9 (8.5-13.8) NS 
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Table 5.1 (cont.)    
Variable ASD (n=26) CONT (n=32) p-value 
Zinc (mg) 6.4 (4.5-7.6) 7.6 (6.1-8.7) NS 
Copper (mg) 0.7 (0.5-1.0) 0.8 (0.6-1.0) NS 
Selenium (mg) 64 (55-81) 72 (62-85) NS 
Sodium (mg) 1928 (1635-2245) 1983 (1548-2502) NS 
Potassium (mg) 1502 (1074-2170) 1796 (1446-1969) NS 
Manganese (mg) 1.9 (1.6-2.5) 2.4 (1.8-3.5) NS 
Data expressed as Median (IQR) 
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Table 5.2 Differences in intake of food groups between children with ASD (ASD) and 
unaffected controls (CONT).  
 
Food Group ASD (n=26) CONT (n=32) p-value 
Fruit 2.1 (1.0-3.0) 2.0 (1.5-3.0) NS 
Vegetables 0.7 (0.3-1.71) 1.1 (0.7-1.9) NS 
Legumes, Nuts, Seeds 0.1 (0-0.4) 0.24 (0.16-0.44) NS 
Starchy Foods 0.2 (0.08-0.32) 0.2 (0.1-0.4) NS 
Starchy Vegetables 0.5 (0.2-0.9) 0.4 (0.3-0.6) NS 
Juice  0.8 (0-1.0) 0.14 (0.08-0.8) NS 
Sweetened Beverages 0 (0-0.08) 0.08 (0-0.16) NS 
Grains 0.7 (0.08-0.94) 0.7 (0.4-1.0) NS 
Refined 
Carbohydrates 
0.9 (0.6-1.4) 0.9 (0.6-1.2) NS 
Fried Foods 0.2 (0.1-0.4) 0.2 (0.08-0.3) NS 
Protein 1.1 (0.4-1.8) 1.0 (0.7-1.6) NS 
Dairy 3.2 (1.8-4.0) 4.7 (3.1-5.5) 0.05 
Snack  0.9 (0.5-1.6) 0.6 (0.4-1.0) 0.09 
Sweets 1.7 (1.2-2.7) 1.4 (1.1-2.0) 0.1 
Kid’s Meal 0.7 (0.2-0.9) 0.8 (0.5-1.5) NS 
Fish 0 (0-0.1) 0.08 (0-0.2) NS 
Condiments 0.14 (0-0.4) 0.2 (0.08-0.6) NS 





Table 5.3 Differences in nutrient intake and microbiota composition between children with ASD 
characterized by picky eating behavior, including 20 foods in diet and repetitive eating pattern.  
 
a. Picky Eating Behavior 
Variable Yes (n=13) No (n=13) p-value 











Weight (kg)  21.5±10.2 19.0±3.3 NS 
Height (meters) 1.04±0.02 1.02±0.01 NS 
BMI (kg/m2) 17.1±3.1 17.4±1.9 NS 
SOCDEF T-Score1  54±11 51±8 NS 




























Total Fat (g) 45 (35-52) 55 (45-64) 0.09 
Monounsaturated Fatty Acids (g) 13.5 (11.5-17.6) 18.2 (16.9-24.4) 0.06 
Food groups4    
Juice (servings/day) 0.9 (0.8-1.0) 0.08 (0-0.8) 0.02 
Protein Foods (servings/day) 0.8 (0.3-1.7) 1.6 (0.9-2.2) 0.06 




Coriobacteriaceae 0.31 (0.02-1.12) 0.02 (0.002-0.05) 0.02 
EtOH8 0 (0-0.06) 0 (0-0) 0.08 
Genera    
Bacteroides 15.5 (8.6-29.22) 37.3 (29.6-47.0) 0.05 
Ruminococcus 3.05 (1.9-6.9) 0.9 (0.17-2.1) 0.07 
Holdemania 0.01 (0.002-0.02) 0.001 (0-0.007) 0.02 
Phascolarctobacterium 
0.03 (0.0008-0.09) 0.002 (0.0008-
0.36) 0.09 
VFA* (μmole/g DMB)    
Isobutyrate 7.82 (5.51-13.54) 5.78 (3.1-7.6) 0.08 
Isovalerate 11.4 (6.3-20.4) 7.4 (4.5-11) 0.08 
Data expressed as mean±SD; *data expressed as median (IQR) 
1SOCDEF, social deficit score measured by PDDBI-SV 
2GI severity scores were derived from the GI severity index (possible range 0-7) 
3Nutrition intake was collected by 3-day food record  
4Food groups derived from Youth and Adolescence Food Frequency Questionnaire  
VFA, volatile fatty acids 
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Table 5.3 (cont.) 
 
b. 20 Foods in diet  
Variable Yes (n=12) No (n=14) p-
value 
Age (years) 4.1±1.5 4.3±1.5 NS 










Weight (kg) 17.7±3.6  22.9±9.9 NS 
Height (meters) 1.02±0.02 1.07±0.02 NS 
BMI (kg/m2) 15.9±1.5 18.3±2.9 0.02 
SOCDEF T-Score1  53±8 52±11 NS 




























Pectin (g) 1.4 (1.1-2.8) 1.2 (1.06-1.6) 0.08 
Vitamin C (mg) 54 (33-98) 31 (24-41) 0.07 
Niacin (mg)  16 (13-21) 12 (10-14) 0.01 
Vitamin B6 (mg) 1.2 (1.04-2.0) 1.14 (0.88-1.29) 0.05 
Folate (μg) 243 (189-401) 226 (201-265) 0.06 
Selenium (mg) 67 (60-80) 58 (45-84) 0.07 
Added Sugars (g) 29 (24-39) 36 (22-47) 0.03 





Actinobacteria 1.7 (0.7-2.9) 6.3 (3.1-13.6) 0.009 
Bacteroidetes 55.2 (45.6-60.5) 39.7 (13.1-48.4) 0.03 
Cyanobacteria 0.0007 (0-0.007) 0 (0-0) 0.05 
Order    
Streptophyta 0.0007 (0-0.007) 0 (0-0) 0.02 
Family    
Coriobacteriaceae 0.03 (0.005-0.07) 0.11 (0.007-0.9) 0.09 
Clostridiales 2.66 (1.55-3.37) 3.61 (2.66-7.17) 0.02 
Genus    
Bifidobacterium 0.96 (0.37-2.52) 2.58 (1.06-6.00) 0.06 
Collinsella 0.02 (0.006-0.21) 1.21 (0.31-4.2) 0.05 
Eggerthella 0.1 (0.05-0.37) 0.02 (0.01-0.05) 0.03 
Bacteroides 40.2 (25.7-55.9) 25.8 (8.6-36.0) 0.08 
Lactobacillus 0 (0-0) 0.001 (0-0.01) 0.09 
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Table 5.3 (cont.)    
Dialister 0.62 (0.12-1.29) 0.008 (0.003-0.01) 0.04 
Variable Yes (n=12) No (n=14) p-
value 
VFA* (μmole/g DMB)    
Valerate 4.16 (1.08-8.6) 6.8 (4.7-8.1) 0.09 
Data expressed as mean±SD; *data expressed as median (IQR) 
1SOCDEF, social deficit score measured by PDDBI-SV 
2GI severity scores were derived from the GI severity index (possible range 0-7) 
3Nutrition intake was collected by 3-day food record  
VFA, volatile fatty acids 
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Table 5.3 (cont.) 
 
c. Repetitive Eating Behavior 
Variable Yes (n=14) No (n=12) p-
value 









Weight (kg) 22.3±9.5 17.6±3.4 NS 
Height (meters) 1.07±0.01 1.14±0.01 NS 
BMI (kg/m2) 18.1±2.8 15.8±1.4 0.03 
SOCDEF T-Score1  54±8 51±10 NS 

























Nutrient Intake3  
  
 
Pectin (g) 1.2 (1.0-1.6) 1.6 (1.2-2.9) 0.09 
Vitamin C (mg) 33 (25-43) 84 (33-99) 0.02 
Potassium (mg) 1340 (1034-1982) 1844 (1475-2394) 0.08 
Copper (mg) 0.64 (0.49-0.75) 0.94 (0.75-1.24) 0.008 
Bacterial abundance* (% of sequences)     
Phyla    
Actinobacteria 5.8 (1.5-14.5) 2.7 (1.0-3.04) 0.02 
Verrucomicrobia 0.09 (0.02-0.72) 3.99 (0.02-6.7) 0.06 






0 (0-0.003) 0.08 
Family    
Clostridiales 3.6 (2.7-7.4) 1.9 (0.9-3.2) 0.09 
Coriobacteriaceae 0.08 (0.02-0.76) 0.01 (0.002-0.39) 0.04 
Genera    
Adlercreutzia 0.06 (0.04-0.19) 0.006 (0.001-0.39) 0.09 
Collinsella 0.96 (0.14-4.26) 0.08 (0.005-0.25) 0.08 
Eggerthella 0.03 (0.01-0.07) 0.14 (0.06-0.56) 0.06 
Butyrivibrio 0.01 (0.005-0.03) 0.14 (0.003 (0-0.01) 0.04 
Dialister 0.009 (0.003-0.44) 0.56 (0.01-0.9) 0.07 
Coprobacillus 0 (0-0) 0.0004 (0-0.01) 0.09 
Akkermansia 0.09 (0.02-0.72) 3.98 (0.02-6.71) 0.06 
Data expressed as mean±SD; *data expressed as median (IQR) 
1SOCDEF, social deficit score measured by PDDBI-SV 
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Table 5.3 (cont.) 
 
2GI severity scores were derived from the GI severity index (possible range 0-7) 
3Nutrition intake was collected by 3-day food record  





Table 5.4 Factor Loading Matrix for dietary patterns of three groups at baseline 
a. ASD group 
Food Group Dietary Pattern 1 Dietary Pattern 2 
Vegetables 0.88* 0.02 
Starchy Vegetables 0.79* 0.16 
Legumes, Nuts and Seeds 0.78* 0.08 
Fruit 0.73* 0.13 
Grains 0.56* -0.002 
Juice  0.45* 0.13 
Dairy 0.36* 0.13 
Fried Foods 0.13 0.67* 
Kids Meals -0.07 0.67* 
Condiments 0.14 0.64* 
Protein Foods 0.23 0.62* 
Snacks -0.33 0.59* 
Starchy Foods 0.32 0.42* 
Refined Carbohydrates 0.72* 0.50* 
Fish -0.03 0.21 
Sweets 0.11 0.05 
Sweetened Beverages -0.29 0.26 
 
b. CONT group  
Food Group Dietary Pattern 1 Dietary Pattern 2 
Sweets 0.83* 0.05 
Kid’s Meals 0.82* 0.15 
Fried Food 0.79* 0.07 
Snacks 0.78* -0.34 
Starchy Foods 0.71* -0.01 
Dairy 0.54* 0.09 
Sweetened Beverages 0.37* 0.24 
Fish -0.10 0.84* 
Vegetables -0.06 0.77* 
Protein Foods 0.02 0.75* 
Fruit 0.24 0.72* 
Juice 0.24 0.44* 
Refined Carbohydrates 0.46* 0.50* 
Starchy Vegetables 0.25 0.34 
Condiments 0.24 0.32 
Grains 0.28 0.06 
Legumes, Nuts and Seeds -0.05 0.19 
*Factor loading >0.35 is considered to be a major contributor to the overall dietary pattern; Food 
groups in which factor loadings are >0.35 for both dietary pattern are assigned to dietary pattern 




Table 5.5 Participant characteristics by scores above or below the median in ASD group 
 
 Dietary Pattern 1 Dietary Pattern 2 
Characteristic Above Median (n=13) Below Median (n=13) Above Median (n=13) Below Median (n=13) 
















































Supplement Use n (%) 
6 5 6 5 
Picky Eater n (%) 5 6 6 5 
>20 foods in diet 8 4 4 8 
Repetitive Eating Pattern 
n(%) 
7 9 9 7 






























































Table 5.5 (cont.)     
SOCDEF T-score 52±10 52±9 50±6 54±12 
Data are expressed as Mean ± SD or n; *data expressed as median (IQR); Values within same dietary pattern and row are significant 




Table 5.6 Baseline food and nutrient intakes of participant in ASD group characterized as consuming above or below the median in 
dietary pattern 1 and dietary pattern 2 
 
 Dietary Pattern 1 Dietary Pattern 2 








Food Groups Intake (servings 
per day) 
Vegetables 
















































Vitamin E (mg) 6.5 (4.5-9.7) 5.8 (3.4-7.9)* 5.8 (4.2-7.8) 6.5 (4.5-9.5) 
Vitamin B12 (mg) 2.9 (2.2-3.8) 3.0 (2.1-4.0)* 3.0 (2.8-3.4) 2.5 (3.1-4.0)† 
Vitamin A (mg) 
Niacin (mg)  
Vitamin B6 (mg) 
Total Grains (g) 































Soluble Dietary Fiber (g) 4.9 (3.1-5.4) 3.6 (2.4-4.3) 3.3 (2.4-5.2) 3.5 (3.1-5.4) 
Insoluble Dietary Fiber (g) 7.3 (6.4-10.6) 6.3 (4.9-10.5)† 6.5 (6.1-7.3) 7.4 (6.0-10.6) 
Pectin (g) 1.2 (1.1-1.8) 1.5 (1.1-1.7) 1.3 (1.1-1.7) 1.3 (0.9-1.8) 
Data are expressed as median (IQR); Values within same pattern and row are significant at *p<0.05 and †p<0.1; Only nutrient intake 
that showed significant difference between the groups are shown; Food groups intake derived from YAQ; Nutrient intake derived 




Table 5.7 Baseline bacterial abundance and VFA concentrations of participants in ASD group characterized as consuming above or 
below the median in dietary pattern 1 and dietary pattern 2 
 
 Dietary Pattern 1 Dietary Pattern 2 
Characteristic Above Median (n=13) Below Median (n=13) Above Median (n=13)  Below Median (n=13) 












































































































Table 5.8 Participant characteristics by scores above or below the median in CONT group 
 
 Dietary Pattern 1 Dietary Pattern 2 
Characteristic Above Median 
(n=15) 





















































Current Nutritional Supplement Use n 
(%) 
6 7 5 8 
Picky Eater n (%) 3 7 5 5 
>20 foods in diet 14 14 14 14 
Repetitive Eating Pattern n(%) 5 8 5 8 
GI Severity Index* 0 (0-1) 1 (0-2) 1 (0-2) 0 (0-1.5) 




















Data are expressed as Mean ± SD or n; *data expressed as median (IQR); Values within same dietary pattern and row are significant 





Table 5.9 Baseline food and nutrient intakes of participant in CONT group characterized as consuming above or below the median in 
dietary pattern 1 and dietary pattern 2. 
 
 Dietary Pattern 1 Dietary Pattern 2 
 Above Median  
(n=16) 
Below Median  
(n=16) 


































































Total Fat (g)  
Saturated Fatty Acids (g) 
Omega-3 Fatty Acids (g) 










































Soluble Dietary Fiber (g) 3.5 (2.3-4.8) 4.9 (3.9-5.2)* 3.8 (2.7-4.9) 4.5 (3.3-5.3) 
Insoluble Dietary Fiber 
(g) 
9.8 (7.7-12.1) 10 (8.4-12.5) 9.8 (5.0-11.9) 10 (8.5-12.6) 
Pectin (g) 1.6 (0.8-2.2) 2.3 (1.6-2.8)† 2.0 (0.8-2.5) 1.9 (1.4-2.5) 
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Table 5.9 (cont.)  
 
Data are expressed as Median (IQR); Values within same pattern and row are significant at *p<0.05 and †p<0.1; Only nutrient intake 
that showed significant difference between the groups are shown; Food groups intake derived from YAQ; Nutrient intake derived 





Table 5.10 Baseline bacterial abundance and VFA concentrations of participants in CONT group characterized as consuming above or 
below the median in dietary pattern 1 and dietary pattern 2 
 
 Dietary Pattern 1 Dietary Pattern 2 
Characteristic Above Median (n=13) Below Median (n=13) Above Median (n=13)  Below Median (n=13) 












































































































Table 5.11 Summary of moderation analysis procedure 
 
a) Fecal microbiota predict SOCDEF scores (dependent variable) 
Step Variable Entered Variable 
Removed 
No. of variables included Partial R2 Model R2 C(p) F Value P-value 
1 Faecalibacterium None 1 0.2669 0.2669 26.3313 8.01 0.0097 
2 Lactobacillus None 2 0.1748 0.4418 17.2805 6.58 0.0181 
3 Peptostreptococcaceae None 4 0.0933 0.6581 7.6087 5.19 0.0345 
4 Dialister None 5 0.0571 0.7152 6.0000 3.61 0.0736 
Fecal microbiota (independent variable) presented as relative abundance  
 
b) Dietary factors predict SOCDEF scores (dependent variable).  
Step Variable Entered Variable Removed No of Variables Included Partial R2 Model R2 C(p) F Value P-value 
1 Total Grain None 1 0.35 0.35 9.37 11.77 0.002 
2 Calcium None 2 0.12 0.47 5.59 4.75 0.04 




Table 5.12 Hierarchical regression analysis testing for potential moderating role of dietary 
factors in the relationship between microbiota and SOCDEF scores 
 
Outcome Variable β ∆R2 p-value 95% CI 
Total Grains Intake 1.0  0.005 1.1,5.3 
Faecalibacterium abundance 0.62  0.1 -0.26, 2.36 
Total Grains x Faecalibacterium abundance 0.08 0.04 0.24 -0.26,0.07 
     
Total Grains Intake 0.87  0.002 1.31, 4.94 
Peptostreptococcaceae Abundance 20.32  0.91 -40.25, 
44.80 
Total Grains Intake x Peptostreptococcaceae 
abundance 
2.84 0.005 0.69 -7.11, 4.78 
     
Calcium Intake 0.01  0.80 -0.02, 0.03 
Faecalibacterium abundance 0.92  0.14 -0.5, -3.3 
Calcium x Faecalibacterium abundance 0.001 0.03 0.38 -0.01,0.01 
     
Calcium Intake 0.008  0.55 -0.02, 0.01 
Peptostreptococcaceae Abundance 42.77  0.16 -26.98, 
152.09 
Calcium Intake x Peptostreptococcaceae 
abundance 
0.04 0.07 0.23 -0.13, 0.03 
CI= Confidence Interval; All regression coefficients are unstandardized; all predictors were 





5.6 Supplementary Tables 
 
Supplemental Table 5.1 Correlations between Nutrients and Food groups and microbiota 
 















𝞺 0.37 0.43 -0.40 0.39 -0.42 -0.45 -0.45 








𝞺 0.34 -0.34 0.35 





























0.35 0.34 0.36 0.44 0.34 -0.38 -0.38 -
0.42 
-0.35 -0.46 -0.46 




















𝞺 0.54 -0.35 -0.40 -0.41 -0.34 -0.51 0.51 0.54 -0.43 




























𝞺 0.34 -0.34 0.36 0.43 0.35 -0.45 0.36 -0.39 0.40 -0.49 0.40 -0.49 
p-value 0.08 0.09 0.07 0.03 0.08 0.02 0.07 0.05 0.04 0.01 0.04 0.01 





Supplemental Table 5.1 (cont.) 




































0.38 0.34 -0.45 -0.45 -0.42 -0.33 0.34 0.35 0.35 -0.35 -
0.38 
-0.38 -0.39 


















































































𝞺 -0.43 0.33 -0.62 -0.40 -0.35 -0.46 -0.55 -0.41 0.39 -0.39 -0.40 -0.36 -0.44 0.34 






































𝞺 0.36 0.45 -0.42 -0.34 -0.35 -0.53 -0.39 -0.40 0.49 -0.45 -0.45 -0.48 -0.34 0.39 
p-value 0.07 0.02 0.03 0.09 0.08 0.01 0.05 0.04 0.01 0.02 0.02 0.01 0.09 0.05 
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𝞺 0.42 0.42 0.37 0.35 0.55 0.34 0.45 0.41 -0.49 0.54 -0.40 0.37 0.54 -0.40 
p-
value 


















































0.43 0.57 0.40 0.3
5 







0.03 0.00 0.04 0.0
8 

















































0.04 0.02 0.00 0.01 0.01 0.10 0.01 0.02 0.01 0.02 0.01 0.02 
Food Groups Intake 
Fruit S247 Faecalibacterium 
𝞺 0.33 -0.39 





















𝞺 -0.56 0.42 -0.37 -0.38 0.35 -0.47 -0.44 0.43 -0.46 
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Supplemental Table 5.1 (cont.) 













































0.56 -0.41 -0.38 -0.35 -0.42 -0.52 -0.55 -0.42 0.36 -0.58 -0.55 0.49 




























-0.35 -0.49 -0.38 0.37 -0.34 -0.34 0.46 -0.34 0.46 
p-value 0.08 0.0
6 





S247 Lactobacillus Ruminococcaceae Enterobacteriaceae Actinobacteria Bacteroidete
s 
𝞺 -0.56 0.33 -0.34 0.41 -0.35 -0.53 0.33 
p-value 0.00 0.10 0.09 0.04 0.08 0.01 0.09 




𝞺 0.35 0.40 0.56 0.34 0.53 0.50 0.55 -0.35 






























𝞺 0.44 0.44 0.34 0.49 0.42 0.52 -0.63 0.53 0.43 0.54 -0.43 
p-value 0.02 0.02 0.09 0.01 0.03 0.01 0.00 0.01 0.03 0.00 0.03 




Supplemental Table 5.1 (cont.) 
Grains S247 Streptococcus Dialister Coprobacillus 
𝞺 0.34 -0.34 0.45 -0.41 
p-value 0.09 0.09 0.02 0.04 
Refined Carbohydrates Streptococcus Holdemania 
𝞺 -0.39 -0.42 





















𝞺 -0.41 0.43 -0.33 -0.40 0.43 0.46 -0.41 0.39 -0.43 
























𝞺 0.50 -0.36 0.34 -0.36 -0.43 -0.39 -0.36 0.54 -0.48 -0.39 -0.38 









































𝞺 0.41 -0.40 -0.47 0.33 0.38 0.61 0.49 0.39 0.47 -0.44 -0.64 0.34 0.45 0.35 
p-value 0.04 0.04 0.02 0.10 0.06 0.00 0.01 0.05 0.02 0.02 0.00 0.09 0.02 0.08 
Sweets Bacteroid
es 
Prevotella RF16 Alistipes Odoribacter Blautia Peptococcus Ruminococcaceae Faecalib
acterium 
𝞺 -0.35 0.42 0.38 0.38 0.34 0.35 -0.36 -0.36 0.33 
p-value 0.08 0.03 0.05 0.06 0.09 0.08 0.07 0.07 0.09 
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𝞺 0.38 0.42 0.49 0.36 0.38 0.50 0.33 0.39 0.34 0.37 -0.43 -0.54 













𝞺 0.34 -0.34 -0.35 -0.35 -0.36 -0.33 -0.38 -0.38 
p-value 0.09 0.09 0.08 0.08 0.07 0.10 0.05 0.05 
Condiments Eggerthella Megasphaera Veillonella Fusobacterium RF32 Haemophilus Fusobacteria 
𝞺 -0.34 0.47 -0.37 -0.48 -0.36 -0.39 -0.48 










































𝞺 0.42 0.37 -0.33 -0.38 -0.36 -0.45 0.46 -0.33 0.40 -0.33 
p-
value 





















































𝞺 -0.38 0.34 -0.31 -0.42 -0.42 -0.34 -0.33 0.40 0.34 



































































































Supplemental Table 5.1 (cont.) 
Starch Odoribacter Lactobacillus Lactococcus Anaerostipes Anaerotruncus Succiniclasticum RF32 Sutterella 
𝞺 0.33 -0.37 -0.48 -0.41 -0.36 -0.34 -0.35 0.36 


















𝞺 -0.47 -0.31 0.46 -0.33 -0.52 -0.43 -0.61 0.43 
















𝞺 -0.38 -0.34 -0.31 -0.54 -0.53 0.31 0.35 
































































0.02 0.09 0.00 0.05 0.09 0.01 0.03 0.09 0.64 0.00 0.01 0.84 0.02 
Pectins Alistipes Turicibacter Anaerostipes Coprococcus Anaerotruncus Ruminococcus Erysipelotrichaceae_Eubacter
ium 
𝞺 0.31 -0.42 -0.35 0.20 -0.38 -0.32 -0.48 
p-value 0.10 0.02 0.06 0.28 0.04 0.08 0.01 
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WholeGrains Pseudoramibacter_Eubacterium Anaerotruncus Phascolarctobacterium 
𝞺 0.31 -0.35 -0.33 
p-value 0.09 0.06 0.08 
RefinedGrains Lactobacillus Faecalibacterium RF32 
𝞺 -0.39 -0.01 -0.44 
p-value 0.03 0.97 0.01 
Fruit Pseudoramibacter_Eubacterium Dialister 
𝞺 -0.35 0.41 

















𝞺 0.32 -0.47 -0.33 -0.53 0.39 -0.32 0.31 
p-
value 
0.09 0.01 0.07 0.00 0.03 0.08 0.09 
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-0.46 -0.32 -0.31 -0.55 -0.32 0.33 -0.31 0.36 0.35 0.45 -0.40 -0.40 
p-value 0.0
1 













































𝞺 -0.31 0.50 -0.42 -0.42 0.32 -0.52 -0.43 -0.32 -0.35 -0.32 0.37 0.41 0.48 0.41 
p-
value 
0.09 0.01 0.02 0.02 0.08 0.00 0.02 0.08 0.06 0.08 0.05 0.02 0.01 0.02 
Starchy Vegetables Alistipes Lachnospiraceae Oscillospira Dialister 
𝞺 0.07 0.31 -0.41 -0.34 
p-value 0.70 0.09 0.03 0.06 
Juice Rikenellaceae Lachnospiraceae Butyrivibrio Faecalibacterium Mogibacteriaceae 
𝞺 0.39 -0.31 -0.36 -0.41 0.31 
p-value 0.03 0.09 0.05 0.02 0.09 
Sweetened Beverages Alistipes Oscillospira Dialister Phascolarctobacterium Catenibacterium RF32 
𝞺 -0.43 0.42 0.33 -0.38 0.41 -0.36 

































































0.00 0.10 0.02 0.08 0.06 0.10 0.02 0.04 0.02 0.00 0.02 0.01 0.06 0.
01 
Refined Crabohydrates  Slackia Rikenellaceae Anaerotruncus Oscillospira Dialister Catenibacterium 
𝞺 -0.51 0.42 0.34 0.31 0.31 0.40 














































-0.34 -0.55 -0.42 -0.39 -0.35 -0.35 0.42 -
0.39 




















𝞺 -0.32 -0.31 -0.40 0.39 -0.43 0.37 0.32 
p-
value 
0.09 0.09 0.03 0.03 0.02 0.04 0.08 
Dairy Pseudoramibacter_Eubacterium Anaerotruncus Succiniclasticum 
𝞺 -0.31 0.35 0.32 























































































































































































































𝞺 0.35 -0.33 -0.35 -0.39 -0.37 -0.34 0.32 -0.31 0.32 -0.31 
p-
value 
0.05 0.07 0.06 0.03 0.04 0.06 0.09 0.09 0.09 0.09 
Condiments Adlercreutzia Streptococcus Dialister 
𝞺 0.41 0.34 0.31 
p-value 0.02 0.07 0.10 
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Supplemental Table 5.2 Correlation between VFA and Food and nutrient intake for all groups 
at baseline 
 
a. ASD group  
Food/Nutrient VFA ρ p-value 
Dairy Acetate 0.33 0.09 
Sweetened Beverages Isobutyrate  0.35 0.08 
Starchy Vegetables Isovalerate -0.35 0.08 
Grains Isovalerate -0.36 0.07 
Starchy Foods Valerate  0.38 0.06 
Energy Isobutyrate -0.43 0.03 
Energy Isovalerate -0.41 0.04 
Total Fat Isobutyrate -0.37 0.06 
Total Fat Isovalerate -0.35 0.08 
Total Carbohydrate Isobutyrate -0.46 0.02 
Total Carbohydrate Isovalerate -0.44 0.03 
Total Dietary Fiber Isobutyrate -0.43 0.03 
Total Dietary Fiber Isovalerate -0.41 0.04 
Total Dietary Fiber Valerate -0.34 0.09 
Soluble Dietary Fiber Isobutyrate -0.46 0.02 
Soluble Dietary Fiber Isovalerate -0.42 0.03 
Pectins Isobutyrate -0.39 0.05 
Pectins Isovalerate -0.38 0.06 
Pectins Valerate -0.48 0.01 
 
b. CONT group 
Food/Nutrient VFA ρ p-value 
Sweetened Beverages Acetate 0.31 0.09 
Sweetened Beverages Butyrate 0.45 0.01 
Sweetened Beverages Isobutyrate 0.42 0.02 
Sweetened Beverages Isovalerate 0.41 0.02 
Sweetened Beverages Valerate 0.59 0.0005 
Snacks Acetate  0.33 0.07 
Snacks Propionate 0.32 0.07 
Snacks Butyrate 0.3 0.09 
Snacks Isobutyrate 0.34 0.06 
Snacks Isovalerate 0.34 0.06 
Snacks Valerate 0.37 0.04 
Dairy Propionate 0.38 0.03 
Kid’s Meals Propionate 0.3 0.09 
Fruit Isobutyrate 0.41 0.02 
Fruit Isovalerate 0.43 0.01 
Starchy foods Isobutyrate 0.31 0.08 
Starchy foods Isovalerate 0.33 0.09 
Starchy foods Valerate 0.38 0.03 
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Supplemental Table 5.2 (cont.)    
Food/Nutrient VFA ρ p-value 
Refined Carbohydrates Isovalerate 0.34 0.06 
Refined Carbohydrates Isobutyrate 0.33 0.07 
Condiments Acetate 0.31 0.08 
Condiments Butyrate 0.41 0.02 
Condiments Isobutyrate 0.41 0.02 
Condiments Isovalerate 0.39 0.02 
Condiments Valerate 0.44 0.01 
Total Dietary Fiber Valerate -0.34 0.07 
Soluble Dietary Fiber Valerate -0.35 0.06 
Insoluble Dietary Fiber Valerate -0.34 0.07 
Pectins Valerate -0.33 0.07 
Refined Grains Acetate 0.35 0.06 
Refined Grains Butyrate 0.35 0.06 
Refined Grains Isobutyrate 0.35 0.06 
Refined Grains Isovalerate 0.32 0.09 








CHAPTER 6  
Longitudinal Dynamics in Fecal Microbiota Composition in Children with ASD and 
Association with Dietary Patterns  
 
Abstract 
Background/Aims: The gastrointestinal (GI) microbiota undergoes changes throughout time and 
variability in composition is observed within the course of a day or over weeks. Environmental 
factors such as diet have been shown to influence long-term microbial stability and microbial 
stability was associated with disease states. Microbial dysbiosis is often observed in children 
with Autism Spectrum Disorder (ASD); however, little is known about temporal stability as well 
as the impact of dietary patterns on the microbial stability in children with ASD. Likewise, 
whether microbial variability is related to ASD symptoms is unknown.  
Methods: The temporal variability in stool microbiota composition in relation to dietary habits 
in children with ASD (ASD, n=26) and unaffected controls (CONT, n=32) aged 2-7 years was 
investigated. Fecal samples were collected at baseline, 6-weeks and 6-months. Bacterial 
composition was assessed using 16S rRNA sequencing. Volatile fatty acid (VFA) concentrations 
were analyzed using gas chromatography. Nutrient intake was assessed using a 3-day food diary 
and dietary patterns were empirically derived from a food frequency questionnaire. Social deficit 
scores (SOCDEF) were assessed using the Pervasive Developmental Disorder Behavior 
Inventory-Screening Version (PDDBI-SV). Gastrointestinal (GI) symptoms were assess using 
the GI severity index.  
Results: Overall, temporal variability in microbial structure and membership did not differ 
between the groups. However, fluctuations in different microbial taxa and microbial metabolites 
were observed in the two groups. Specifically, abundances of Clostridiaceae, Streptophyta, 
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Eggerthella, Clostridium, Roseburia and Dialister showed significant variations in ASD over the 
6-month study period. In CONT, changes in abundances of Enterobacteriaceae, Clostridiaceae, 
and Enterococcus were observed. Regarding VFA, concentration of all SCFA (acetate, 
propionate, butyrate) and BCFA (isobutyrate, isovalerate and valerate) decreased in children 
with ASD over time, whereas only acetate concentration increased in CONT children over a 6-
month period. Variability in community membership measured by median unweighted UniFrac 
distance negatively correlated with median SOCDEF T-scores. Additionally, different bacterial 
taxa contributed to microbial stability in the two groups. Clostridiales, Ruminococcaceae, 
Lactococcus, Turicibacter, Dorea, and Phascolarctobacterium were components of a more 
stable microbiota community in children with ASD whereas Barnesiellaceae, Adlercreutia, 
Faecalibacterium, Sutterella and Bilophila were components of the stable microbiota in CONT 
children. Lastly, dietary measures were associated with long-term stability of the microbiota in 
both groups. In children with ASD, a dietary pattern characterized by vegetables, starchy 
vegetables, legumes, nuts and seeds, fruit, grains, juice and dairy was associated with changes in 
species diversity (Shannon Index) and richness (Chao 1 Index), abundance of Erysipelotricaceae, 
Clostridium, Oscillospira and Dorea as well as concentrations of propionate, butyrate, 
isobutyrate and isovalerate. A dietary pattern characterized by intakes of fried foods, kid’s meals, 
protein foods, condiments, snacks and starchy foods was associated with variations in microbiota 
structure, abundance of Cyanobacteria, Erysipelotrichaceae, Clostridium, and Oscillospira as 
well as changes in the concentration of all VFAs. No changes in SOCDEF and GI severity scores 
were observed over the 6-month study period. 
Conclusion: Microbiota composition varies over time in children with ASD and might be related 
to dietary intake and social defict scores. Future studies investigating the physiological effect of 
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the changes in specific microbial taxa as well as metabolites are needed to delineate the impact 
on ASD symptomology.  
 
6.1 Introduction 
During the first year of life, the gastrointestinal (GI) microbiota undergoes rapid changes 
(Koenig et al., 2011). Although previous studies have suggested that the GI microbiota becomes 
relatively stable and resembles that of an adult at 3 years of age (Bergström et al., 2014; Palmer 
et al., 2007; Yatsunenko et al., 2012, other studies suggest that the GI microbiota might have a 
more prolonged development, lasting into pre-adolescence (Hollister et al., 2015). One study 
reported 70% stability in microbiota composition over the 18-months in children aged 2-18 
years, with Bacteroidetes showing the highest compositional stability followed by Proteobacteria 
(de Meij et al., 2016). Other studies have shown that even in adults the microbiota composition 
can be highly variable and changes over the course of a day (Kaczmarek et al., 2017) or weeks 
(Caporaso et al., 2011; Flores et al., 2014) have been reported. Thereby, bacteria that are lower 
abundance might be more transient and prone to temporal variations than predominant phyla of 
the bacterial core (Durbán et al., 2012; Vanhoutte et al., 2004; Caporaso et al., 2011). 
Increasing reports show that the GI microbiota differs between children with Autism 
Spectrum Disorder (ASD) and unaffected controls; however, longer term variability in the ASD 
population has not previously been studied. Understanding the long-term variability of the GI 
microbiota is important as resistance to environmental stressors and greater resistance to 
pathogen invasion and a rapid return to a baseline state are key features of a healthy microbiome 
(Bäckhed et al., 2012; Ley et al., 2008). Previous studies have linked a greater microbiota 
instability to certain disease states (e.g., Crohn’s disease) (Mättö et al., 2013; Maukonen et al., 
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2006; Scanlan et al., 2006). Although extreme shifts in the intake of dietary macronutrient and 
fiber are associated with short-term changes in the GI microbiota, most studies have found that 
these shifts are reversible and that the GI microbiota returns to a baseline composition (David et 
al., 2014, Li et al., 2017). We have previously identified a dietary pattern that was characterized 
by higher intakes of vegetables and lower intakes of snacks, sweets and dairy food to be 
associated with a greater microbial stability over a 6-month period, showing a direct relationship 
between dietary patterns and temporal variability of the microbiota in children (Berding et al., 
2018).  
Given the new evidence showing that specific microbes could contribute to some 
symptoms of ASD, identifying long-term dietary patterns that could potentially promote the 
development of a more beneficial microbiota composition could be important advances in the 
understanding of the microbiota-brain connection in ASD. We hypothesize that children with 
ASD will have more variability in their microbiota compared to unaffected controls. We further 
hypothesize that in children with ASD a dietary pattern characterized by higher intakes of 
healthy foods such as fruits, vegetables and grains will be associated with a more stable 
microbiota composition. Lastly, more microbial variability will be associated with more severe 
ASD symptoms.  
 
6.2 Materials and Methods  
Study Design, Participants, Fecal Sample Collection and analysis, 3-day Food Diary, and 
Assessment of ASD Symptoms 
The study design, participant recruitment and sample collection details are described in 
Chapter 4. Additional samples were collected 6-weeks and 6-months after baseline sample 
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collection. Fecal samples for microbiota and VFA analysis were collected and analyzed as 
described in Chapter 4. Likewise, nutrient intake measured by 3-day food records and the Youth 
and Adolescence Food frequency questionnaire as well as information on ASD and GI symptoms 
were collected as described in Chapter 5. 
 
Statistics 
All data were analyzed using SAS 9.4 (SAS Institute, Cary, NC). Baseline dietary 
patterns were derived as previously described (Chapter 5). 
The 16S rRNA sequences were processed and analyzed using QIIME 1.9.1 
bioinformatics software as previously described (Chapter 4). Sequences were rarefied to a 
sampling depth of 36,565 sequences per sample for subsequent analysis.  
Variability in diversity measures (α- and β-diversity) was assessed for participants who 
provided all three sample (ASD n=22; CONT n=29). Variability of α-diversity (within an 
individual over time) was assessed by calculating the coefficient of variation (CV=standard 
deviation/mean) for Chao 1 index, observed OTUs and Shannon index (Shade et al., 2013). 
Higher values indicated a more variable community. The median weighted and unweighted 
UniFrac distances for each individual over time were calculated to determine the variability in 
community composition over time (Flores et al., 2014). Higher median values correspond to 
more variability whereas lower median values are indicative of a more stable microbial 
community.  
For both groups, the study population was divided into stability classes (falling above or 
below the median based on median weighted UniFrac distances) in order to determine which 
bacteria could contribute to the stability or instability of the overall composition (Flores et al., 
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2014; Galloway- Peña et al., 2017). Children falling above the median were denoted as less 
stable whereas children below the median were denoted as more stable.  
In order to determine the impact of factors on changes in the microbiota composition, 
microbiota variability was analyzed based on baseline dietary patterns (as described in Chapter 
5), introduction of specialty diets and severity of social deficit symptoms. Regarding dietary 
patterns, children were dichotomized as falling above or below the median in each dietary 
pattern. Additionally, children in the ASD group were dichotomized by introducing specialty 
diets over the 6-month period and were grouped according to baseline severity of ASD 
symptoms (i.e., moderate or severe). Differences in outcome measures were analyzed using 
mixed models including participant as a repeated effect. Model fit was assessed using the Chi-
square-to-df ratio. Values <2 were indicative of an appropriate model fit (Kaczmarek et al., 
2017). Factors known to influence the microbiota composition including age, gender, BMI, 
season of sample collection, introduction of medication or probiotics and specialty diet as well as 
food groups and nutrients that changed significantly over the 6-month period were included as 
co-variates. Spearman correlation was used to investigate relationships between variability and 
ASD symptoms. Data are expressed as median (IQR) or mean ± SD. Level of significance was 
set at p≤0.05 and p≤0.10 was considered a trend. 
 
6.3 Results  
Enrollment and Attrition Rate of Study Population 
The enrollment and attrition rate of study participants is shown in Table 6.1. In the 
CONT group, all subjects provided samples at the 6-week time point and 29 subjects provided 
samples at the 6-month time point. In the ASD group, one subject failed to provide a stool 
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sample at the 6-week time point and 4 subjects failed to provide samples at the 6-month time 
point. Thus, for the ASD group, 25 samples were collected at the 6-week time point and 22 
samples were collected at the 6-month time point. Each analysis described below was also 
conducted only including children who completed all three sample collections (data not shown). 
Statistically, these analyses did not differ from the analyses including the full cohort; thus, the 
data including all subjects is reported herein.  
 
Introduction of Medication, Specialty Diets or Probiotics  
Introduction of medication, specialty diets and probiotics by group are shown in Table 
6.2. In ASD, one child took medication within a month prior to the 6-week time point and three 
children took medication prior to the 6-month time point. These medications included Clonidine, 
Conerta (stimulant), and Namenda (cognitive enhancing medicine). In CONT, three children 
took medication within a month prior to the 6-week sample collection and one child prior to the 
6-month sample collection. These medications included cold relief medication and other 
antibiotics. Regarding specialty diets, no children in the CONT group started a specialty diets. In 
the ASD group four children were following a specialty diet at the 6-week sample collection and 
seven children at 6-month time point. These diets included the gluten-free/casein-free diet and 
other exclusions diets (i.e., decrease sugar alcohols and fructose). Probiotics were not introduced 
in either of the groups.  
 
GI Symptoms, Stool Consistency and ASD Symptoms 
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GI symptoms (Figure 6.1) and stool consistency (Table 6.3) as measured by the Bristol 
stool chart did not change in either group over the 6-month time period. Additionally, no 
significant changes on SOCDEF T-scores were observed in the ASD group (Figure 6.2).  
 
Nutrient Intake from Baseline to 6-Month Post-Baseline  
Nutrient intake from the 3-day food records were analyzed for changes over the 6-month 
period to determine the potential impact on the temporal variability of the GI microbiota. 
Nutrients that changed significantly over the 6-month period are shown in Table 6.4 a.  
In the ASD group, a decrease in intake of total carbohydrate (p=0.04), vitamin A 
(p=0.02), vitamin E (p=0.04), and magnesium (p=0.02) was observed. Additionally, intakes of 
linoleic acid (p=0.02), total sugars (p=0.03) and added sugars (p=0.01) changed during the 6-
month period with the highest intakes reported at the 6-week sample collection. In the CONT 
group, no significant changes in nutrients were observed.  
 
Food Group Intake from Baseline to 6-Month Post-Baseline 
Regarding intake of food groups, no changes were observed in the ASD group. In the 
CONT group, intake of starchy vegetables (p=0.01) and protein foods (p=0.0001) increased from 
baseline to 6-week and 6-month post-baseline with the highest intake at the 6-week time point. 
Intakes of all food groups for both groups are shown in Table 6.4b.  
 
Differences in Temporal Microbial Diversity Between the Groups  
Temporal variability within each group quantified by the coefficient of variation (CV) did 
not differ between the groups (Figure 6.3). Likewise, temporal variability in community 
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membership (unweighted UniFrac) and structure (weighted UniFrac) did not differ between the 
groups (Figure 6.4).  
 
 
Temporal Microbial Diversity and Composition within Each Group 
Abundance of individual bacterial taxa that differed significantly between the three time 
points in both groups can be found in Table 6.5. There were no differences in measures of 
species richness (Chao 1 Index and observed OTUs) and diversity (Shannon and Simpson Index) 
or in bacterial abundance at the phyla level over 6-month period in either group. Additionally, 
diversity between time points measured by β-diversity did not differ in either group.  
Analyzing changes in specific microbial taxa showed that different bacteria changed over 
a 6-month period in each group. In ASD children, abundance of Streptophyta (p=0.07) and 
Dialister (p=0.07) increased whereas abundances of Clostridiaceae (p=0.01), Clostridium 
(p=0.003), and Roseburia (p=0.02), decreased over the 6-month study period, with the highest 
abundance of Clostridiaceae and Roseburia being observed at the 6-week time point.  
In CONT children, an increase in the abundance of Enterobacteriaceae (p=0.01) and 
Enterococcus (p=0.08) was observed over the 6-month study period.  
 
Association between Microbial Variability and ASD Symptoms 
Interestingly, in children with ASD variability based on community membership 
(unweighted UniFrac) tended to be negatively correlated (ρ=-0.38; p=0.07) with median 
SOCDEF scores over the 6-month period (Figure 6.5). The diversity within each child with ASD 




VFA Concentrations from Baseline to 6-Month Post-Baseline 
Concentration of all VFAs at baseline and 6-month post-baseline can be found in Figure 
6.6a and 6.6b. In ASD, a statistically significant decrease in the concentration of acetate 
(p=0.01), propionate (p=0.05), butyrate (p=0.02) and isobutyrate (p=0.01) and a trend for a 
decrease in isovalerate (p=0.05) and valerate (p=0.09) concentrations was observed. In CONT, 
the concentration of acetate (p=0.07) tended to increase over the 6-month study period.  
 
mmdA and BCoAT Gene Expression 
The ratios of mmDA and BCoAT to total 16S rRNA at baseline, 6-week and 6-month 
post-baseline are shown in Figure 6.6 c and d. There was no statistically significant difference 
in the expression of mmDA and BCoAT in either group.  
 
Bacterial Taxa Contributing to Stability of Microbial Structure  
 In order to determine whether specific bacterial taxa could contribute to a more or less 
stable microbial structure, differences in the average relative abundance of bacterial taxa 
between children dichotomized by stability category (more stable vs. less stable) were assessed.  
 
ASD group: Figures 6.7 (a-l) represent all bacterial taxa that were significantly different 
between stability categories in children with ASD. Coriobacteriaceae (p=0.06) was more 
abundant in children with ASD categorized as having a less stable microbiota based on median 
weighted UniFrac distance. On the other hand, Clostridiales (p=0.008), Ruminococcaceae 
(p=0.05), Lactococcus (p=0.002), Turicibacter (p=0.01), Dorea (p=0.008) and 
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Phascolarctobacterium (p=0.005) were more abundant on average in children with ASD whose 
microbiota structure is temporally more stable over a 6-month period. Measures of bacterial 
richness and diversity did not differ between children categorized by having a more or less stable 
microbiota (data not shown). SCODEF T and GI symptoms severity scores did not change in 
either stability category.  
 
CONT group:  Diversity and richness measures as well as bacterial taxa that significantly 
differed based on stability category in CONT children are shown in Table 6.6. Children with a 
more stable microbial community had higher species richness based on Chao1 index (p=0.07) 
and higher species diversity as measured by the Shannon index (p=0.06) compared to children 
with a less stable microbiota. Verrucomicrobia (p=0.02), Enterobacteriaceae (p=0.09) and 
Akkermansia (p=0.002) were more abundant in CONT children with a more unstable microbiota. 
On the other hand, Barnesiellaceae (p=0.06), Adlercreutzia (p=0.005), Faecalibacterium 
(p=0.02), Sutterella (p=0.002), and Bilophila (p=0.06) were more abundant in CONT children 
with a more stable microbiota community over the 6-month study period.  
 
Dietary Factors Contributing to Microbial Stability 
 In order to determine whether specific dietary factors could contribute to a more stable 
microbial profile, differences in the average intake of food groups and nutrients based on 
stability class were investigated. 
 
ASD group: Table 6.7 shows the dietary intake that could contribute to microbial 
stability in children with ASD. Children with ASD that had a more stable microbial community 
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had higher intakes of fish (p=0.03) and total protein (p=0.04) whereas children with ASD 
categorized as having lower microbial stability had higher intakes of snacks (p=0.07) and 
condiments (p=0.03) 
 
CONT group:  Dietary intake based on the category of microbial stability in CONT 
children is shown in Table 6.6. CONT children with a more stable microbiota had higher intakes 
of whole grains (p=0.008), vegetables (p=0.05), sweetened beverages (p=0.08), fish (p=0.01) and 
condiments (p=0.03), whereas children with a less stable microbiota had higher intakes of kid’s 
meals (p=0.009).  
 
Microbiota Composition and VFA Concentration Based on Introduction of Specialty Diets in 
Children with ASD 
In order to investigate whether the introduction of a specialty diet impacts microbiota 
dynamics, the microbiota composition over the 6-months period was analyzed in the context of 
specialty diets. Overall microbial structure and membership (median weighted and unweighted 
UniFrac distances) as well as within sample diversity (CV of α-diversity matrices) was not 
impacted by the introduction of specialty diets.  
Regarding nutrient intake, children with ASD that were following a specialty diet (SPEC) 
at the 6-week and 6-month time-points had decreased intakes of vegetables (p=0.09) and 
increased intakes of fish (p=0.06) at those time points. Additionally, decreased intakes of added 
sugars (p=0.02) were observed (Table 6.8). Children with ASD who did not start following a 
specialty diet (NO-SPEC) during the duration of the study had decreases in intake of vitamin E 
(p=0.04) and sodium (p=0.06) as well as increased intake of folate (p=0.08) (Table 6.8).  
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A summary of changes in bacteria and VFA concentrations based on specialty diet can be 
found in Table 6.9. Children in the SPEC group had significant changes in abundance of 
Actinobacteria (p=0.04), Clostridiaceae (p=0.02), and Bifidobacterium (p=0.005) whereas 
children in the NO-SPEC group had significant changes in the abundance of Bacteroidetes 
(p=0.06) and Clostridium (p=0.002).  
Lastly, NO-SPEC children had significant decreases in in the concentration of propionate 
(p= 0.01), butyrate (p=0.002) and isobutyrate (p=0.05). On the other hand, SPEC children had 
significant decreases in acetate concentrations (p=0.04).  
There were no changes in SOCDEF T- or GI symptoms scores in either group over the 6-
month period. 
 
Nutrient and Food Group Intake, Microbiota Stability and VFA Concentrations over 6-Month 
Period Based on Baseline Dietary Patterns 
Changes in intake of nutrients and food groups as well as microbial stability and changes 
in VFA concentrations over the 6-month study period were investigated based on dietary patterns 
for both study groups. Description of dietary patterns can be found in Table 5.4 (pp. 195). 
Briefly, in children with ASD, Dietary Pattern 1 (DP1-ASD) was characterized by an intake of 
vegetables, legumes, nuts and seeds, fruit, starchy vegetables, grains, juice and dairy. Dietary 
Pattern 2 (DP2-ASD) was characterized by an intake of fried foods, kid’s meals, condiments, 
protein foods, snacks and starchy foods. In the CONT group, Dietary Pattern 1 (DP1-CONT) 
was characterized by intakes of sweets, kid’s meals, fried foods, snacks, starchy foods, dairy and 
sweetened beverages, whereas Dietary Pattern 2 (DP2-CONT) was characterized by intakes of 
fish, vegetables, protein foods, fruit, and juice. 
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ASD – Dietary pattern 1: There was no difference in temporal variability of community 
membership (unweighted UniFrac) or structure (weighted UniFrac) based on DP1-ASD (Figure 
6.8a). Likewise, temporal variability in α-diversity did not differ based on DP1-ASD (Table 
6.10).  
In DP1-ASD, intake of servings per day of fruit (p=0.04), vegetables (p=0.06) and juice 
(p=0.07) as well as intake of total carbohydrates (p=0.09) and added sugars (p=0.03) tended to 
decrease over the 6-month study period in children above the median (Table 6.11a). Regarding 
the microbiota composition, an increase in the relative abundance of Erysipelotrichaceae 
(p=0.05) and a decrease in the abundance of Clostridium (p=0.03) was observed. (Table 6.12a). 
VFA concentrations did not change in children above the median in DP1-ASD (Figure 6.9a).  
More changes in nutrient and food group intake and microbiota composition were 
observed in children below the median in DP1-ASD. An increase in servings per day of legumes, 
nuts and seeds (p=0.01), juice (p=0.09) and refined carbohydrates (p=0.001) as well as a 
decrease in vitamin A (p=0.01), folate (p=0.05), phosphorus (p=0.07) and refined grains 
(p=0.07) was observed in children below the median in DP1-ASD (Table 6.11a). Regarding the 
microbiota composition, species diversity based on Shannon index (p<0.0001) as well as species 
richness based on Chao1 Index (p=0.04) decreased in children below the median in DP1-ASD. 
Additionally, abundance of Clostridium (p=0.01), Oscillospira (p=0.002) and Dorea (p=0.05) 
decreased over the 6-month study period in children below the median in DP1-ASD (Table 
6.12a). Lastly, concentrations of propionate (p=0.08), butyrate (p=0.02), isobutyrate (p=0.09) 
and isovalerate (p=0.06) decreased in children below the median in DP1-ASD (Figure 6.9b).  
ASD – Dietary pattern 2: Community structure variability (median weighted UniFrac) 
tended (p=0.07) to differ based on DP2-ASD. Children above the median in DP2-ASD tended to 
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have higher variability (higher median values) compared to children below the median (Figure 
6.8b). There was no difference based on DP2-ASD in median unweighted UniFrac or temporal 
variability of α-diversity (Table 6.10). 
In DP2-ASD, children with ASD falling above the median had decreased intakes of 
protein foods (p=0.06), vitamin A (p=0.01), vitamin B12 (p=0.07) and sodium (p=0.04) over the 
6-month study period (Table 6.11b). Regarding the microbiota composition, a decrease in the 
abundance of Erysipelotrichaceae (p=0.07), Clostridium (p=0.005) and Oscillospira (p=0.008) 
was observed (Table 6.12a). Additionally, concentrations of propionate (p=0.08), butyrate 
(p=0.02), isobutyrate (p=0.02), isovalerate (p=0.02) and valerate (p=0.04) decreased in children 
above the median in DP2-ASD (Figure 6.9c).  
Children falling below the median in DP2-ASD had increased intakes of refined 
carbohydrates (p=0.04) and decreased intakes of vitamin E (p=0.05) and added sugars (p=0.06) 
(Table 6.11b). The microbial profile was characterized by a decrease in Cyanobacteria (p=0.07), 
and Clostridium (p=0.06) (Table 6.12a). Acetate (p=0.04) and propionate (p=0.02) 
concentrations decreased significantly in children falling below the median in DP2-ASD (Figure 
6.9d).  
SOCDEF and total GI severity scores did not significantly change in either dietary 
pattern in children with ASD.  
CONT – Dietary pattern 1: There were no differences based on median weighted or 
unweighted UniFrac or in α-diversity based on either dietary pattern in unaffected controls (data 
not shown). 
Children above the median in DP1-CONT had an increased intake of servings per day of 
protein foods (p=0.03) as well as total protein (p=0.09), vitamin B12 (p=0.06), and sodium 
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(p=0.07) and a decreased intake of servings per day of snacks (p=0.08) and added sugars 
(p=0.004). Additionally, intakes of manganese (p=0.02) and whole grains (p=0.06) increased 
from baseline to 6-weeks, but then decreased at the 6-month time point and were lower 
compared to baseline intakes (Table 6.13a). The microbial profile of children above the median 
in DP1-CONT was characterized by a decrease of Parabacteroides (p=0.03) (Table 6.14a).  
Nutritionally, intakes of servings per day of fruit (p=0.03) and grains (p=0.07) increased 
while intake of servings per day of fried food (p=0.04) decreased in children below the median in 
DP1-CONT. Likewise, intake of vitamin D (p=0.02), riboflavin (p=0.03), vitamin B12 (p=0.08) 
and selenium (p=0.06) decreased over the 6-month study period in children below the median in 
DP1-CONT (Table 6.13a). Furthermore, a decrease in Butyrivibrio (p=0.03) and Veilonella 
(p=0.04) was observed in children below the median in DP1-CONT (Table 6.14a).  
 
CONT – Dietary pattern 2: Intake of vitamin K (p=0.02), vitamin C (p=0.006) and added 
sugars (p=0.09) decreased in children above the median in DP2-CONT, with the intake of added 
sugars being lowest at the 6-week time point (Table 6.13b). Children above the median in DP2-
CONT showed a decrease in relative abundance of Proteobacteria (p=0.07) and Slackia 
(p<0.001) (Table 6.14b).  
Regarding food group intake, increased consumption of servings per day of fruit 
(p=0.01), refined carbohydrates (p=0.06) and protein foods (p=0.004) while decreased 
consumption of legumes, nuts and seeds (p=0.002) was observed. Furthermore, an increased 
consumption of total fat (p=0.02), SFA (p=0.05) and vitamin K (p=0.07) as well as a decreased 
consumption of whole grains (p=0.006) was detected in children below the median in DP2-
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CONT (Table 6.13b). Bacterial abundances did not significantly change over the 6-month period 
in children below the median in DP2-CONT (Table 6.14b).  
VFA concentration or GI severity index did not change in either dietary pattern in the 
CONT group (data not shown). 
 
Temporal Microbiota Composition and Diversity Based on Severity of Social Deficit Symptoms 
In order to analyze whether the longitudinal stability of the GI microbiota is associated 
with social deficit severity, children with ASD were dichotomized based on baseline level of 
severity of social deficit scores (i.e., mild, moderate or severe). Only two children fell into the 
mild severity category of SOCDEF scores; thus, longitudinal dynamics for the mild category was 
not included in this analysis.  
There was no difference in the amount of children starting a specialty diets based on 
symptoms severity. Four children in the moderate category and two children with severe social 
deficits started a specialty diet. Regarding medication use, one child with moderate and two 
children with severe social deficits introduced medication over the 6-month study period.  
The results for changes in microbiota, VFA concentration and nutrition can be found in 
Tables 6.15 and 6.16. There were no differences in microbiota composition over the 6-month 
period in α-diversity or at the phyla level in either severity group.  
Regarding the nutritional intake, children with ASD and moderate levels of social deficit 
had a decrease in intake of vitamin A (p=0.04), vitamin B12 (p=0.06), sodium (p=0.07) and 
added sugars (p=0.07). In children with moderate levels of social deficits, an increase in 
Staphylococcus (p=0.07) and decrease in Clostridium (p=0.006), Sarcina (p=0.02) and 
Haemphilus (p=0.05) was observed. Additionally, concentrations of propionate (p=0.02), 
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butyrate (p=0.01), isobutyrate (p=0.007) and isovalerate (p=0.03) decreased over the 6-month 
study period.  
There were no changes in food group and nutrient intake in children with ASD and 
severe levels of social deficits. In children with severe levels of social deficits, abundances of 
Clostridiaceae (p=0.09) and Methanobrevibacter (p=0.01) increased from baseline to 6-weeks 
and decreased from 6-weeks to 6-months post-baseline. Regarding VFA concentrations, acetate 
(p=0.03), propionate (p=0.01), and butyrate (p=0.003) levels decreased over the 6-month study 
period.   
 
6.4 Discussion  
Microbial stability is defined as the “ability to respond to perturbations by resisting 
change and returning to the original state” (Holling, 1973). Thereby, higher microbial stability is 
associated with a healthier microbiota due to the ability to maintain bacterial function and to 
resist environmental stressors (Bäckhed et al., 2012; Coyte et al., 2015). Short-term intra-
individual variability during weeks or months and over the course of a day have been reported 
(Caporaso et al., 2011; Flores et al., 2014; Kaczmarek et al., 2017), with different body sites 
showing various degrees of variation (Flores et al., 2014). Some studies suggest that a stable 
individual microbial core containing predominant microbial taxa exists (Jalanka-Tuovinen et al., 
2011; Li et al., 2013; Jalanka, 2014; Lozupone et al., 2012). Thereby, microbial diversity was a 
predictor of a more stable microbiota (Flores et al., 2014). Additionally, a stable microbiota with 
high levels of commensal bacteria could be important in protecting against infection by 
pathogens (Galloway-Peña et al., 2017) whereas low abundance members may contribute more 
significantly to the variation in the microbiome (Li et al., 2013; Faith et al., 2013). One study 
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found that over a 5-year period 60% of sequences were persistently present and species within 
the phyla Bacteroidetes and Actinobacteria were the most stable (Faith et al., 2013). 
Furthermore, Clostridiaceae and Lactobacillaceae seemed to be more abundant in individuals 
with a high microbial variability, whereas Bacteroidaceae was most abundant in stable 
individuals (Flores et al., 2014). Likewise, the degree of variation in the microbiome might be 
specific to each individual, meaning that microbial taxa that are stable in one individual might 
undergo more variation in another indivudual (Jalanka, 2014).  
Understanding microbial dynamics is important to define stable states of the microbiota 
and to inform potential interventions that could promote health by stabilizing the microbial 
community (Lozupone et al., 2012; Flores et al., 2014). Perturbations of the microbial 
equilibrium could potentially lead to an unhealthy host status (Moya & Ferrer, 2016; Lozupone 
et al., 2012) as microbial instability has been linked to certain diseases (Li et al., 2013; Mättö et 
al., 2013). For example, a greater instability was found in patients with IBS and Crohn’s disease 
(Mättö et al., 2013; Maukonen et al., 2006; Scanlan et al., 2006). Increasing evidence supports 
microbial dysbiosis in children with ASD and some studies suggest that specific bacterial taxa 
might be associated with some symptoms of ASD (Tomova et al., 2015; Kang et al., 2013). 
However, little is known about the microbial stability in children with ASD and whether it could 
be linked to on symptom severity. Additionally, various environmental factors such as host 
health (Claesson et al., 2012), genetics (Khachatryan et al., 2008), age and diet (Berding et al., 
2018) are known to influence the abundance of bacterial taxa. Dramatic changes in short-term 
dietary intake can rapidly modify the composition and function of the GI microbiota (David et 
al., 2014). On the other hand, habitual dietary patterns have been shown to influence the stability 
GI microbiota composition (Berding et al., 2018). Achieving a balanced dietary intake can often 
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be challenging in children with ASD (Ledford & Gast, 2006) and dietary interventions (i.e., 
gluten free/casein free diet) are commonly used by parents in an effort to alleviate some 
symptoms of ASD (Marí-Bauset et al., 2016). However, how habitual dietary patterns are 
potentiality correlated with the microbiota stability in children with ASD is unknown.  
To fill these gaps, three fecal samples as well as information on dietary habits from 
children with ASD and unaffected controls were collected over a 6-month period. Microbial 
stability in relation to dietary patterns, use of specialty diets and severity of ASD symptoms was 
investigated to further elucidate the relationship between diet, microbiota and symptoms of ASD. 
Changes in the microbiota composition of children with ASD and unaffected control children 
were observed, with different bacterial taxa contributing to a stable microbiota composition in 
both groups. Additionally, in children with ASD microbial stability was associated with dietary 
interventions, level of ASD symptom severity and baseline dietary pattern and food intake. 
However, no direct association with severity of social deficits was observed. Thus, this study 
supports the hypothesis that long-term eating patterns in children with ASD have different 
effects on the temporal variability of the microbiota, but additional research is needed to further 
delineate the potential impact on symptoms of ASD.  
Recent studies have linked microbial stability to certain diseases and potentially mood (Li 
et al., 2013; Mättö et al., 2005; Maukonen et al., 2006; Scanlan et al., 2006; Kong et al., 2012; Li 
L et al., 2016). Here, contrary to our hypothesis, the overall diversity within an individual, as 
well as variability in community structure and membership across time did not differ between 
children with ASD and unaffected controls. Likewise, the previously reported temporal changes 
in the α- and β-diversity of study populations were not observed in either group (Flores et al., 
2014). Yet, other studies have reported that the microbial community might be relatively stable 
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over time (Huttenhower et al., 2012; Costello et al., 2009; Martínez et al., 2013a). Even though 
overall microbial structure did not change significantly, changes in individual bacteria as well as 
in microbial metabolites were observed. In children with ASD changes in the abundance of 
bacteria at the order (e.g., Streptophyta), family (e.g., Clostridiaceae) and genus (e.g., 
Clostridium, Roseburia) level were detected. The interest of Clostridaceae and Clostridium in 
ASD symptomology has previously been described (Chapter 2). Briefly, higher abundances of 
Clostridium are often observed in the ASD population (De Angelis et al., 2013; Grimaldi et al., 
2017) and it has been hypothesized that Clostridium can contribute to ASD symptoms potentially 
due to the production of entereo- and neurotoxins (Finegold, 2008). Other bacteria that were 
shown to increase over the 6-month study period could also have health implications. Higher 
levels of Dialister were reported in children with appendicitis (Jackson et al., 2014) and it has 
been found to be one of the most abundance bacterial taxa in IBD (Lopetuso et al., 2008). 
Additionally, increased abundance of Dialister was associated with increased temperament in 
boys (Christian et al., 2015). On the other hand, Roseburia, which decreased in children with 
ASD, has been recognized for its ability to affect colonic motility, maintain immunity and 
exerting anti-inflammatory properties through the production of butyrate (Tamanai-Shacoori et 
al., 2017) and positive associations with mood have been reported in adults (Li L et al., 2016). 
The physiological significance of these bacterial changes observed in this ASD population, 
especially Clostridium, is unknown. Here, we did not see changes in the symptom severity of 
social deficits or GI symptoms. Thus, future studies potentially collecting samples more 
frequently and including a larger sample size are needed to investigate temporal variability in 
children with ASD and the impact on health outcomes. 
238 
 
Remarkably, we also see changes in all VFA concentrations in children with ASD, but 
only increases in acetate concentration in CONT children. These variations could be due to 
changes in the capacity of the bacteria to produce VFAs as well as to changes in absorption by 
the host. Here, we did not find significant changes in the mmDA and BCoAT genes in children 
with ASD, suggesting that the decrease in fecal VFA concentrations could be due increased 
absorption by the host rather than decreased production by the bacteria. Previous research has 
indicated that considering stability based on microbiota function is important (Lozupone et al., 
2012), as compositional changes might not reflect functional changes due to functional 
redundancy (Moya & Ferrer, 2016). Changes in microbial metabolites such as VFAs could have 
important health implications since associations between host health and VFAs have been 
established (Macfarlane & Macfarlane, 2012). Higher levels of VFAs were observed in children 
with ASD (Wang et al., 2012) and it was demonstrated that isovalerate correlated with symptoms 
of depression (Szczesniak et al., 2015). The structural similarity between valerate and the 
neurotransmitter GABA (Lacher et al., 2007) makes valerate a potential candidate to interfere 
with neurotransmission (Szczesniak et al., 2015). Even though it remains to be elucidated 
whether isobutyrate is harmful or beneficial to colonocytes, it has been demonstrated that 
isobutyrate can be metabolized under low butyrate conditions (Jaskiewicz et al., 1996). Thus, 
fluctuations in VFA concentrations could be associated with host responses due to the impact of 
VFAs on GI health (Clausen et al., 1995) and the potential as serving as a messenger in the 
communication between the GI microbiota and brain (Berding & Donovan, 2016). However, no 
changes in social deficit or GI symptoms were not detected herein; thus, future studies are 




Some studies have aimed at identifying bacterial taxa that could potentially contribute to 
a more stable microbiome (Flores et al., 2014; Galloway-Peña et al., 2017). These studies have 
found that a higher temporal stability of oral and GI microbiome in cancer was associated with 
presence of commensal bacteria such as Akkermansia and absence of pathogenic-associated 
bacteria such as Staphylococcus and Streptococcus (Galloway-Peña et al., 2017). Here, we 
observe that children with ASD with a more stable microbiome harbored a distinct microbial 
community compared to children with a less stable microbiome. Thereby, destabilizing bacteria, 
such as Coriobacteriaceae, could be associated with pathogenic effects. Species within the 
Coriobacteriaceae family could potentially disrupt the epithelial barrier and lead to barrier 
dysfunction by colonizing the mucosal surfaces and affecting the epithelial cell metabolism 
(Clavel et al., 2014; Stenman et al., 2012; Turnbaugh, 2012). Furthermore, Coriobacteriaceae 
was positively correlated with reactive oxygen species and might be involved in the host 
inflammatory status and chronic inflammatory conditions (Qasem et al., 2017; Clavel et al., 
2014; Chen et al., 2012; Zhang et al., 2009). On the other hand, microbial genera with a 
potentially stabilizing effect in the ASD population (i.e., Lactococcus, Turicibacter, 
Phascolartobacterium, Dorea) were described in the literature as beneficial symbionts. Lactic 
acid bacteria such as Lactococcus could have beneficial functions through production of anti-
microbial compounds, modulation of the host’s immune response (Soomro et al., 2002; 
Lukjancenko et al., 2012) and counteracting the virulence factor of pathogenic bacteria such as 
Staphylococcus aureus (Nouaille et al., 2014). Low abundance of Phascolartobacterium was 
associated with the presence of inflammation in IBD (Bajer et al., 2017) and Dorea was 
associated with better cognition and decreased inflammation in a model of hepatic 
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encephalopathy (Bajaj et al., 2012), suggesting potential anti-inflammatory effects of these 
genera.  
Surprisingly, in this cohort Clostridiales was more abundant in children with ASD and a 
more stable microbiota. Negative health effects have been associated with Clostridiales and 
Clostridium species within this order and the abundances has have previously been linked to 
ASD (Luna et al., 2017). Additionally, abundance of Clostridiales was shown to be increased in 
children with ASD who developed GI symptoms at or around the same time of ASD diagnosis, 
suggesting that this order could potentially contribute to symptom development (Williams et al., 
2011). Previous studies have reported that Clostridiaceae, a family within the order of 
Clostridiales, was more prevalent in adults with a more variable microbiota composition over a 
3-month period (Flores et al., 2014). However, other genera and species within Clostridiales 
could potentially have beneficial effects. For example, it has been shown that the decrease in one 
member of the Clostridiales order (Clostridiales Incertae Sedis XI) could be associated with the 
development of C. difficile infections (Vincent et al., 2013). Clostridiales also includes sensitive 
oxygen species which could potentially be associated with improving GI barrier function and 
reducing the production of reactive oxygen species in inflammatory states (Darnaud et al., 2017; 
Ma et al., 2018). Additionally, species within Clostridiales can stimulate the production of 
cytokines and induce regulatory T-cells which can improve intestinal dysbiosis, reduce 
inflammation and protect against colitis and allergic responses (Narushima et al., 2014; Atarashi 
et al., 2013) Commensal genera within the order of Clostridiales include Coprococcus, Blautia, 
Pseudobutyrivirbrio, Ruminococcus, Roseburia and Oscillospira which have been associated 
with health benefits and can ferment carbohydrates and amino acids to produce anti-
inflammatory metabolites (Stefka et al., 2014). Thus, future studies at the species level are 
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required to delineate which species within the Clostridiales order could potentially promote a 
more stable microbiome in children with ASD. Likewise, further research is warranted to 
elucidate whether a stable microbiota is more beneficial in children with ASD. Since 
Clostridiales has been associated with ASD symptomology, it could be hypothesized that a stable 
microbiota that is high in bacteria such as Clostridiales might actually be less beneficial in 
children with ASD.  
In the unaffected control group, different bacterial taxa were identified as stabilizing and 
destabilizing bacteria. Pathogenic bacteria such as Enterobacteriaceae contributed more to an 
unstable microbiota whereas bacteria generally regarded as beneficial such as Barnesiellaceae, 
Adlercreutzia and Facelibacterium contributed more to a stable microbiota. A microbiota rich in 
Barnesiellaceae might be protective against bloodstream infections (Montassier et al., 2016) and 
Adlercreutzia abundance was associated with leanness (Ziętak et al., 2016). Likewise, 
Faecalibacterium is usually regarded as a beneficial bacterium due to its anti-inflammatory 
properties (Quevrain et al., 2015), improvements of GI barrier function (Carlsson et al., 2013) 
and support of mucosal immune homeostasis (Hornef & Pabst, 2016). Similar to previously 
published literature, species diversity and richness was associated with a more stable microbiota 
over the 6-month period in unaffected control children (Flores et al., 2014). Surprisingly, this 
relationship was not observed in children with ASD. Thus, further investigation of this 
association is warranted, but it could indicate that diversity might affect stability differently 
depending on the health state of the host.  
Besides only investigating changes in the microbiota, we were also interested in 
analyzing whether microbial stability in children with ASD can be associated with symptom 
severity as previous studies have demonstrated that microbial stability could be associated with 
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health outcomes such as functional bowel disorders (Maukonen et al., 2006; Mättö et al., 2005). 
Contrary to our hypothesis we observed that children with ASD who have less changes in 
presence and absence of OTUs (based on unweighted UniFrac distance) had higher social deficit 
scores. Although less variability is considered to be more beneficial due to the ability to maintain 
bacterial functions over time and to resist pathogen invasion (Coyte et al., 2015), less variability 
in ASD could correspond to a constant presence of pathogenic bacteria that could affect 
symptomology. Appearance and disappearance of some bacteria has previously been reported 
(Martínez et al., 2013) and here, although not statistically different, we observe that some 
bacterial genera such as Sarcina, Leuconostoc or Megamonas were not detected at some time 
points but were detected at other time points in children with ASD.  
Investigating variations in bacterial taxa associated with symptom severity could 
potentially provide evidence for interventions to promote health by targeting the stability of 
specific bacteria. Here, we provide preliminary evidence for an association between changes in 
bacterial taxa and ASD symptoms. First, when comparing children with ASD based on social 
deficit symptom severity, different patterns of changes of bacteria in children with moderate vs. 
severe symptoms were observed. For example, Clostridium abundance decreased over the 6-
month period in children with moderate symptoms, but didn’t show significant variations in 
children with severe symptoms. Second, different health implications could be attributed to the 
bacteria that changed in children with moderate or severe social deficits. For example, Sarcina 
which decreased in the moderate severity group was associated with infection in Celiac Disease 
(Karakuş & Lırsaçlıoğlu, 2014) and could contribute to disease in humans (Lam-Himlin et al., 
2011). Methanobrevibacter which increased in children with severe symptoms has been linked to 
constipation (Lurie-Weinberger & Gophna, 2015), flatulence (Seo et al., 2017) and could 
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contribute to development of chronic constipation in IBS (Pimentel et al., 2012). It is also 
interesting to note that no changes in nutritional intake were observed in children with severe 
ASD symptoms. Although this could be due to the relatively small group size (n=7), it could also 
indicate that changes in the microbiota in severe cases of ASD could be independent of dietary 
intake and might be inherent to ASD itself. Once again, future studies with a bigger sample size 
are required to further explore this relationship.  
Next, we set to explore the impact of diet on the microbial stability in children with ASD 
in order to identify potential environmental influences in promoting microbial stability. 
Therefore, we employed several analyzes on the microbial stability in the context of diet, dietary 
patterns and introduction of specialty diet to shed some light on the diet-microbiota stability 
relationship. Unique microbial profiles based on dietary patterns and specialty diets were 
observed and food groups associated with a more stable microbiota composition were identified.  
First, we provide preliminary evidence that dietary interventions were associated with 
some temporal microbial variability in this cohort of children with ASD. The interest in studying 
the effect of specialty diets on the GI microbiota stems for the wide usage of these diets among 
individuals with ASD. Due to the lack of effective medical treatment approaches, parents often 
seek alternative treatment options for their children after ASD diagnosis. Although there is often 
no convincing justification for the efficacy of alternative treatments, dietary changes that are 
considered risk free by the lay public are often adopted (Stewart et al., 2015). It has been 
estimated that one-third of children have been treated with some dietary intervention after of 
ASD diagnosis (Levy et al., 2003). A number of nutrition intervention strategies including 
gluten-free/casein-free (GF/CF) diet, ketogenic diet, or Fermentable Oligosaccharides, 
Disaccharides, Monosaccharides and Polyols (FODMAP) diet have been explored to treat 
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behavioral symptoms and comorbid GI distress. Some dietary interventions specifically focus on 
targeting the GI microbiota in order to manage some symptoms of ASD. For example, the 
purpose of the specific carbohydrate diet (excludes grains, processed foods, starchy vegetables, 
canned vegetables, flour, sweeteners and milk products), which is used by some parents to 
manage symptoms of ASD, is to alleviate symptoms of malabsorption and prevent growth of 
potentially pathogenic bacteria which could potentially affect symptomology (Gotschall, 2004). 
Delineating how these diets shape on the GI microbiota could provide information on the 
potential mechanisms whereby dietary interventions affect some symptoms of ASD. In healthy 
individuals, following a gluten-free diet caused a decrease in beneficial bacteria such as 
Bifidobacterium, C. lotuseburense, F. prausnitzii and Lactobacillus and an increase in 
pathogenic bacteria including Enterobacteriaceae and E. coli (De Palma et al., 2010; Singh et al., 
2017). Likewise, the ketogenic diet can reduce total microbiota abundance and composition in a 
mice model (Newell et al., 2016) and following a low FODMAP diet could reduce the 
abundance of total bacteria as well as Akkermansia muciniphila, Bifidobacterium or 
Actinobacteria (Halmos et al., 2014; Bennet et al., 2017). Previous studies investigating the 
microbiota composition in children with ASD have collected information in dietary interventions 
of the subjects, but did not investigate its potential impact on the GI microbiota composition 
(Horvath et al., 1999; Finegold et al., 2002; Parracho et al., 2005; Wang et al., 2011; Kang et al., 
2013) Here, four children with ASD were following a specialty diet at the 6-week sample 
collection and seven children at 6-month time point, with the most prominent specialty diet being 
the GF/CF diet. Even though microbial structure and membership were not influenced by a 
specialty diet status in this cohort, the introduction of a dietary intervention could have induced 
some potentially favorable changes in children with ASD such as the increase in Actinobacteria 
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and Bifidobacterium. Bifidobacterium is generally regarded as beneficial (Patten & Laws, 2015) 
and Actinobacteria was related to protection against pathogens and maintenance of the immune 
system (Gosalbes et al., 2011). Regarding VFA concentrations, reduction of acetate 
concentrations seemed to have been driven more significantly by introduction of specialty diets 
whereas the concentrations of propionate, butyrate and isobutyrate decreased independent of 
introduction of specialty diet. Since these microbial metabolites could be involved in the 
microbiota-to-brain communication in ASD, future research is needed to determine whether 
dietary interventions can decrease these communicators on a physiologically relevant level. 
Because of the low sample number and differences in dietary interventions among the children, it 
is difficult to define whether the microbiota might be a moderator of dietary interventions used to 
manage ASD symptoms. Additionally, even though changes in the microbiota composition based 
on specialty diet were demonstrated herein, no changes in symptoms of ASD were observed. 
Thus, more research is needed to determine whether these diets can be used as a way to manage 
some symptoms of ASD through the microbiota composition.  
Second, since previous studies have shown that a dietary pattern characterized by intake 
of healthier foods was associated with greater microbial stability in healthy children (Berding et 
al., 2018), we investigated in more detail which dietary factors could be linked to microbial 
variability in children with ASD. In children below the median in the healthier DP1, reduction of 
species richness and diversity was observed, suggesting that the diversity within an individual 
could be more impacted in children scoring low on a healthy eating pattern. Moreover, 
community structure measured by weighted UniFrac distance tended to change more in children 
above the median in DP2-ASD, indicating that an unhealthier dietary pattern rich in animal-
based and processed foods might have a more significant impact on the relative abundance of 
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bacteria in this population. This observation is in accordance with previous literature suggesting 
that the relative abundance of bacterial taxa that are persistently present in the GI tract might be a 
more significant contributor to temporal dynamics (Flores et al., 2014). Furthermore, animal-
based diets were shown to increase β-diversity in humans (David et al., 2014) and individuals 
following a Western-diet had a decreased diversity compared to individuals following a plant-
based diet (Conlon & Bird, 2014). 
Although only a few bacterial taxa were changed in association with dietary patterns in 
children with ASD, some of the shifts were distinct for each dietary pattern. For example, a 
decreased intake of healthy food such as fruit and vegetables in children above the median in 
DP1-ASD coincided with an increase in potentially pathogenic bacteria such as 
Erysipelotrichaceae. Erysipelotrichaceae could be correlated with inflammation (Kaakoush, 
2015) and immunomodulation (Palm et al., 2014) and was more abundant in patients with 
intestinal diseases (Mancabelli et al., 2017). Interstingly, the abundance of Erysipelotrichaceae  
decreased in children above the median in DP2. Likewise, DP2-ASD was associated with 
changes in Cyanobacteria. Little is known about the function of Cyanobacteria in the human GI 
tract, but some evidence suggests that species within this phylum might be able to produce 
neurotoxins that might contribute to neurological disease in humans (Brenner, 2013). 
Furthermore, differences in VFA concentrations were observed based on dietary patterns, 
suggesting that the overall the functional capability to produce VFA could also be affected by 
habitual dietary intake in children with ASD.  
Although unique microbial associations were observed based on two dietary patterns in 
children with ASD, the decrease in abundances of Oscillospira and Clostridium were associated 
with both dietary patterns. The observation that the abundance of Clostridium varied over the 6-
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month study period seemingly independent of dietary factors could suggest that Clostridium 
abundance potentially the impact on ASD symptoms might depend on other factors besides diet. 
Future investigations into this relationship are required to determine which factors could 
potentially influence the temporal variability of Clostridium. Likewise, no associations with 
social deficits scores were observed, so that it is not possible at this point to draw conclusions 
regarding the physiological importance of temporal Clostridium variations in the ASD 
population.  
Even though two similar dietary patterns were observed in CONT children, namely a less 
dietary pattern including food groups such as sweets, fried food, snacks and sweetened 
beverages, and one healthier dietary pattern that included fish, vegetables, and fruit, different 
microbial profiles associated with these patterns were observed. The unhealthier dietary pattern 
in CONT children was associated with a decrease in Proteobacteria and Slackia, whereas the 
healthier dietary pattern was associated with a decrease in Parabacteroides, Butyrivirbio and 
Veillonella. Additionally, when analyzing the association between diet and microbiota structure 
based on weighted UniFrac distance, dietary components that to contribute to a more or less 
stable microbial community differed in the groups. Whereas whole grains, vegetables, fish and 
condiments contributed to a stable microbiota in control children, in children with ASD fish and 
total protein intake contributed more to a stable microbiota, but snacks and condiments were 
more significantly associated with an unstable microbiota. Thus, if different dietary components 
can contribute differently to the microbiota stability based on different health statuses warrants 
further investigation.  
Overall, less variations than expected were observed in overall structure and abundance 
of bacterial taxa in children with ASD. The lack of significant changes in individual bacterial 
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taxa could be explained by the relative stability of the microbiota based on - and - diversity 
matrices. Additionally, the lack of significant variations could be due to the small sample size as 
well as the limited amount of samples collected for each participant and the time between 
collection time points. Additionally, since no associations with GI symptoms or social deficit 
scores were observed throughout the analyses, the physiological relevance of the temporal 
variability observed in microbial taxa and metabolites remains to be determined. The lack of 
association could be due to the relative stability of ASD symptoms over time. A recent meta-
analysis suggests that ASD symptoms might be remarkably stable over time (Bieleninik et al., 
2017); thus, as expected overall ASD symptoms did not change during the study period. 
Likewise, the lack of associations with social deficit scores could be due to the potential stronger 
impact of the microbiota on other symptoms of ASD (i.e., repetitive behaviors) as well as on 
other associated symptoms (e.g., irritability). Future studies including a larger number of subjects 
with more frequent stool sampling and measuring other symptoms of ASD are needed to further 
identify the microbial stability in this population and to analyze how microbial variability 
potentially impacts symptoms of ASD. Likewise, some changes in microbiota composition 
observed in the ASD population as a whole did not change based on dietary patterns or specialty 
diet. Thus, future studies should explore other factors that could potentially contribute to these 
changes. 
Despite these limitations, the results reported herein provide preliminary evidence that 
the microbiota composition of children with ASD can vary over time, that diet can play an 
important role in determining stability of microbiota in this population and that varaibiaity might 
be associated with some symptoms associated with ASD. Future studies investigating the 
longitudinal dynamics in the GI microbiota and factors contributing to stability or instability are 
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warranted. For example, in this study we observe that the variability in abundance of some 
bacteria was only associated with diet or symptom severity, but the abundance of other bacteria 
(e.g., Clostridium) was significantly associated with all categories investigated herein. Our 
analyses are strengthened by including factors known to influence thee microbiota composition, 
such as changes in dietary intake and medication (Maier & Typass, 2017) as covariates in the 
longitudinal analysis. To the best of our knowledge, this is the first study investigating 
longitudinal dynamics of the GI microbiota in children with ASD. Understanding the 
environmental factors determining the functional and compositional changes in the GI 
microbiota could provide important evidence for the development of intervention strategies for 




6.5 Tables and Figures 
 
Table 6.1 Enrollment and attrition rate of study 
 



























Group Number of 
subjects 
enrolled 
Number of Samples 
collected at Baseline 
Number of 
samples collected 
at 6 weeks 
Number of 
samples collected 
at 6 months 
Control 34 32 32 29 
ASD 41 26 25 22 
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Table 6.2 Percentage of participants introducing medication, specialty diets or probiotics over 
the study period  
 
 Medication use in 
month before sample 
collection 
Following Specialty Diet 
at sample collection 
Probiotic use in month 
before sample 
collection 
Group 6 Weeks 6 Months 6 Weeks 6 Months 6 Weeks 6 
Months 
ASD 1 3 4 7 0 0 
CONT 3 1 0 0 0 0 






Figure 6.1 GI severity index scores1 over 6-month period in children with ASD and controls  
 
 







































Data expressed as median (IQR)  
1GI severity scores were derived from the GI severity index (possible range 0-7);  
CONT, unaffected controls; ASD, Autism Spectrum Disorder; p.-b. post-baseline 
 
p = ns 
 
p = ns 
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Table 6.3 Stool consistency in children with ASD (ASD) and unaffected controls (CONT) over a 6-month period 
 
 ASD CONT  


















Type 1 (separate hard lumps) 0 0 1 1 1 1 
Type 2 (sausage shaped but 
lumpy) 
5 3 2 3 8 3 
Type 3 (sausage-shaped with 
cracks on surface) 
5 6 
 
4 13 9 12 
Type 4 (smooth and soft) 12 13 12 15 14 11 
Type 5 (soft blobs) 2 0 2 0 0 0 
Type 6 (mushy) 2 1 0 0 0 1 
Type 7 (watery) 0 0 0 0 0 0 
1Stool consistency was measured using the Bristol Stool chart; Data expressed as n; no statistical difference in 
























Data expressed as mean ± SD 























p = ns 
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Table 6.4 Nutrient and food group intake at baseline, 6-weeks post baseline and 6-months post-
baseline for children with ASD (ASD) and controls (CONT) 
 
a) Nutrient intake that differed significantly across time in children with ASD (ASD)  
 




6 months p.-b. 
(n=22) 
Macronutrients    
Total carbohydrate (g) 175 (147-220) 171 (135 (221) 149 (109-201)* 
Total sugars (g) 81 (56-94) 71 (58-92) 61 (41-90)* 
Added sugars (g) 36 (23-42) 33 (23-52) 19 (12-27)* 
    
Micronutrients    
Vitamin A (μg) 435 (228-651) 337 (221-485) 259 (160-328)* 
Vitamin E (mg) 6.2 (4.2-8.1) 5.7 (3.8-7.0) 5.1 (3.5-6.3)* 
Magnesium (mg) 169 (132-231) 148 (124-226) 143 (127-194)† 
 
 
b) Food and Nutrient intake that differed significantly across time CONT  
 






6 months p.-b. 
(n=29) 
Starchy Vegetables 0.4 (0.3-0.6) 0.5 (0.4-1.8) 0.6 (0.5-0.8)* 
Protein Food 1.0 (0.7-1.6) 1.6 (1.1-2.3) 1.3 (1.1-1.9)* 
Data expressed as median (IQR); p-value in same group and row indicated differences at 
*p≤0.05; †p≤0.1; Food groups derived from Youth and Adolescence Food Frequency 





Figure 6.3 Temporal variability as measured by coefficient of variation (CV) in diversity within 







































p = ns  
p = ns  
p = ns  p = ns  
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Figure 6.4 Plots of variability measured by unweighted (A) and weighted UniFrac (B) distance 





































p = ns  
p = ns  
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Table 6.5 Measures of relative abundance of bacterial genera in feces that differed significantly 
between baseline, 6 weeks post-baseline and 6 months post-baseline in children with ASD 
(ASD) and unaffected controls (CONT) 
 
a) Bacterial variations in children with ASD 
 






6 months p.-b. 
(n=22) 
Bacterial order     
Streptophyta 0 (0-0.001) 0 (0-0.005) 0.002 (0-0.02)† 
Bacterial family     
Clostridiaceae 0.28 (0.14-1.5) 0.53 (0.16-1.47) 0.25 (0.08-0.49)* 
Bacterial genus    
Firmicutes    
Clostridaceae_ 
Clostridium 
0.33 (0.05-0.66) 0.19 (0.07-0.42) 0.06 (0.03-0.14)* 
Roseburia 0.46 (0.27-0.72) 0.58 (0.36-0.89) 0.29 (0.14-0.89)* 
Dialister 0.12 (0.007-0.72) 0.13 (0.007-1.5) 0.02 (0.005-1.9)† 
 
b) Bacterial variations in CONT 
 






6 months p.-b. 
(n=29) 
Bacterial family     
Enterobacteriaceae 0.02 (0.007-0.12) 0.02 (0.01-0.39) 0.03 (0.005-0.11)† 
Bacterial genus     
Firmicutes    
Enterococcus 0 (0-0.001) 0 (0-0.002) 0.001 (0-0.002)† 






Figure 6.5 Association between social deficit scores and temporal variability based on 


























































ρ = -0.38 
p = 0.07 
260 
 
Figure 6.6 VFA concentrations at baseline and 6-months p.-b. in children with ASD (ASD) and 
unaffected controls (CONT) 
 
 
a) SCFA  






















































































Median (IQR); *p≤0.05; †p≤0.1 
CONT, unaffected controls; ASD, Autism Spectrum Disorder; DMB, dry matter basis; SCFA, 
short chain fatty acids; BCFA, branch chain fatty acids; mmDa, methylmalonyl CoA 

























































































Data expressed as median (IQR); * p≤0.05; †p≤0.1; Individuals in the ASD group were assigned to a category of stability based 




Table 6.6 Bacterial abundance and nutrient and food groups contributing to stability categories 
in unaffected controls  
 
 Less stable (n=13) More stable (n=13) 
Bacterial richness/diversity   
Chao 1 Index 446 (410-482) 473 (413-507)† 
Shannon Index 4.9 (4.3-5.5) 5.2 (4.8-5.6)† 
 
Bacterial abundance (% of 
sequences) 
  
Verrucomicrobia 1.88 (0.03-10.8) 0.4 (0.01-1.3)* 
Adlercreutzia 0.004 (0-0.07) 0.06 (0.001-0.19)* 
Faecalibacterium 8.7 (5.9-12.8) 12.9 (8.5-18.4)* 
Sutterella 0.26 (0.003-0.63) 0.31 (0.13-1.65)† 
Bilophila 0 (0-0.1) 0.1 (0-0.07)† 
Akkermansia 1.88 (0.03-10.7) 0.39 (0.01-1.3)* 
 
Food group (servings/day)1 
  
Vegetables 2.0 (1.8-3.2) 2.5 (1.8-3.1)† 
Sweetened beverages 0.12 (0.08-1.7) 0.18 (0.08-0.26)† 
Kid’s meals 1.6 (1.1-2,1) 0.9 (0.5-1.3)* 
Fish 0.06 (0.06-0.3) 0.18 (0.12-0.3)* 




Whole grains (g) 0.84 (0.35-1.45) 0.95 (0.39-2.5)† 
Data expressed as median (IQR); *p≤0.05; †p≤0.1; Individuals in the ASD group were assigned 
to a category of stability based on falling above or below the median of median weighted 
UniFrac distances 
1Food groups derived from food frequency questionnaire 






Table 6.7 Nutrient and food groups contributing to stability categories in children with ASD 
 
 Less stable (n=13) More stable (n=13) 
Food group (servings/day)1   
Snacks 1.0 (0.5-2.0) 0.7 (0.4-1.3)† 
Fish 0 (0-0.14) 0.04 (0-0.14)* 




Total protein (g) 43 (34-49) 52 (31-68)* 
Data expressed as Median (IQR); *p≤0.05; †p≤0.1; Individuals in the ASD group were assigned 
to a category of stability based on falling above or below the median of median weighted 
UniFrac distances 
1Food groups derived from food frequency questionnaire 





Table 6.8 Nutrient and food group intake in children with ASD at baseline, 6-weeks and 6-
months post-baseline based on introduction of specialty diets 
 
a) Changes in nutrients in children with ASD starting a specialty diet (n=7) during the study  
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Food group (servings/day)    
Vegetables 0.7 (0.3-1.6) 0.5 (0.3-0.9) 0.5 (0.2-0.9)† 
Fish 0.06 (0.06-0.12) 0.12 (0.06-0.18) 0.18 (0.06-0.3)† 
Nutrient intake    
Added sugars (g) 36 (23-44) 30 (23-41) 18 (13-24)* 
 
 
b) Changes in nutrients in children with ASD without specialty diet (n=19)  
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Nutrient intake    
Vitamin E (μg) 3.8 (4.2-8.1) 6.0 (5.2-7.4) 5.2 (3.5-6.3)* 
Folate (μg) 242 (201-311) 237 (160-315) 163 (134-235)† 
Sodium (mg) 2010 (1687-2261) 1606 (1475-1957) 1887 (1468-2151)* 






Table 6.9 Microbiota composition and VFA concentration in children with ASD at baseline, 6-
weeks and 6-months post baseline based on introduction of specialty diets 
 
a) Changes in microbiota composition and VFA concentration in children with ASD following 
specialty diet (n=7) 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Bacteria (relative 
abundance) 
   
Actinobacteria 2.4 (0.6-6.3) 5.3 (1.4-8.3) 8.2 (4.1-9.5)* 
Clostridiaceae 3.7 (0.09-10.2) 2.4 (0.6-5.7) 0.3 (0.06-1.8) † 
Bifidobacterium 0.7 (0.5-1.3) 2.9 (1.1-5.8) 3.2 (0.03-1.8)* 
 
VFA (μmole/g DMB) 
   
Acetate 142 (90-260) . 84 (68-143)* 
 
 
b) Changes in microbiota composition and VFA concentration in children with ASD not 
following specialty diet (n=19) 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Bacteria (relative 
abundance) 
   
Bacteroidetes 48.4 (17.5-55.6) 37.5 (15.0-46.9) 39 (1.1-44.7)* 
Clostridium 0.2 (0.05-0.68) 0.1 (0.04-0.32) 0.05 (0.009-
0.14)* 
 
VFA (μmole/g DMB) 
   
Propionate 61 (50-84) . 32 (28-59)* 
Butyrate 64 (42-76) . 59 (15-74)* 
Isobutyrate 7.2 (3.6-10.0) . 5.5 (4.2-9.9)* 
Data expressed as median (IQR); within same group and row, significant at *p≤0.05; †p≤0.1; 





Figure 6.8 Differences in weighted and unweighted UniFrac distances based on dietary patterns 
in children with ASD 
 








































Median (IQR); †p≤0.1; dietary patterns were derived from a food frequency questionnaire using 
principal component and factor analysis (Chapter 5)
 





Table 6.10 Variation of coefficient of variation (CV) based on dietary patterns in children with ASD 
 
 Dietary Pattern 1 Dietary Pattern 2 
Measure Above median (n=13) Below median (n=13) Above median (n=13) Below median (n=13) 
Chao1 Index CV       0.05 (00.04-0.08) 0.05 (0.03-0.13) 0.05 (0.02-0.09) 0.05 (0.04-0.11) 
Observed OTUs CV 0.08 (0.06-0.14) 0.08 (0.02-0.18) 0.07 (0.03-0.12) 0.08 (0.05-0.14) 
Shannon Index CV 0.06 (0.05-0.09) 0.08 (0.04-0.14) 0.07 (0.06-0.1) 0.07 (0.03-0.13) 
Simpson Index CV 0.03 (0.01-0.04) 0.03 (0.01-0.04) 0.02 (0.01-0.03) 0.03 0.01-0.04) 
Data expressed as Median (IQR) 
Dietary patterns were derived from the Youth and Adolescence Food Frequency Questionnaire using principal component and factor 





Table 6.11 Food group and nutrient intake at baseline, 6 weeks post-baseline and 6 months post-
baseline based on dietary pattern in children with ASD  
 
a) Dietary pattern 1 above median 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Food Group (servings per day)1    
Fruit 3.0 (2.7-3.6) 2.5 (1.6-2.7) 1.9 (1.4-2.7)* 
Vegetables 1.7 (0.9-2.4) 0.7 (0.6-1.1) 0.9 (0.7-1.3)† 
Juice 0.8 (0.0-0.9) 0.8 (0.06-0.8) 0.12 (0.06-0.51)† 
Nutrient2    
Total carbohydrate (g) 194 (143-220) 173 (162-194) 133 (102-182)† 




b) Dietary pattern 1 below median 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Food Group (servings per day)1    
Legumes, nuts and seeds 0.1 (0.1-0.16) 0.1 (0.1-0.3) 0.22 (0.1-0.9)* 
Juice 0.84 (0.12-1.04) 0.8 (0.12-1.0) 1.0 (0.8-1.0)† 
Refined carbohydrates  0.9 (0.5-1.1) 1.4 (1.2-1.5) 1.1 (0.9-1.9)* 
Nutrient2    
Vitamin A (μg) 326 (277-428) 299 (170-473) 175 (81-445)* 
Folate (μg) 242 (202-294) 182 (105-389) 195 (134-235)† 
Phosphorus (mg) 792 (676-992) 616 (456-971) 646 (471-862)† 
Refined grains (g) 4.6 (3.7-5.1) 3.3 (2.2-3.9) 3.5 (2.3-4.7† 
Data expressed as median (IQR); *p≤0.05; †p≤0.1; p.b. – post-baseline; 1Food groups derived 



















Table 6.11 (cont.) 
 
c) Dietary Pattern 2 above median  
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Food group (servings per day)1    
Protein foods 1.8 (1.1-2.2) 1.6 (0.8-2.3) 1.1 (0.5-1.3)† 
Nutrients2    
Vitamin A (μg) 412 (282-565) 395 (198-488) 252 (96-445)* 
Vitamin B12 (μg) 3.0 (2.8-3.4) 2.1 (1.4-3.0) 2.3 (1.5-3.4)† 






d) Dietary Pattern 2 below median 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Food group (servings per day)1    
Refined carbohydrates 0.9 (0.6-1.2) 1.1 (0.9-1.4) 1.5 (0.9-1.8)* 
Nutrients2    
Vitamin E (μg) 6.5 (4.5-9.5) 5.6 (4.2-7.4) 4.2 (3.5-5.7)* 
Added sugars (g) 31 (24-37) 26 (24-49) 18 (9.5-26.3)* 
Data expressed as median (IQR); *p≤0.05; †p≤0.1; p.b. – post-baseline   
1Food groups derived from food frequency questionnaire 






Table 6.12 Relative abundance of bacterial genera in feces at baseline, 6 weeks and 6 months 
post-baseline based on dietary patterns in children with ASD 
a) Dietary Pattern 1 above median 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Bacterial taxa (% of sequences)    
Erysipelotrichaceae 0.3 (0.12-0.98) 0.98 (0.22-1.23) 0.9 (0.33-1.44)† 
Clostridium 0.33 (0.11-0.66) 0.11 (0.07-0.33) 0.09 (0.03-0.11)† 
 
b) Dietary Pattern 1 below median 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Bacterial richness/diversity     
Shannon Index 5.7 (5.2-6.1) 5.3 (5.0-5.8) 4.8 (4.3-5.3)† 
Chao 1 Index 524 (442-535) 486 (472-532) 450 (357-535)† 
Bacterial taxa (% of sequences)    
Clostridium 0.23 (0.05-0.49) 0.26 (0.09-0.50) 0.05 (0.03-0.11)† 
Oscillospira 0.37 (0.29-0.56) 0.15 (0.11-0.37) 0.14 (0.07-0.25)* 
Dorea 0.87 (0.59-1.36) 0.54 (0.41-0.97) 0.48 (0.27-1.06)† 
 
c) Dietary Pattern 2 above median 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Bacterial taxa (% of sequences)    
Erysipelotrichaceae 1.00 (0.31-1.29) 0.77 (0.43-1.06) 0.29 (0.12-1.67)† 
Clostridiaceae_Clostridium 0.23 (0.05-0.49) 0.28 (0.06-0.44) 0.05 (0.03-0.14)† 
Oscillospira 0.38 (0.37-0.52) 0.28 (0.13-0.40) 0.17 (0.13-0.29) † 
 
d) Dietary Pattern 2 below median 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Bacterial taxa (% of sequences)    
Cyanobacteria 0 (0-0.007) 0.001 (0-0.005) 0.002 (0-0.02)† 
Clostridiaceae_Clostridium 0.42 (0.17-0.66) 0.13 (0.08-0.39) 0.07 (0.02-0.16)† 
Data expressed as median (IQR); within same group and row, significant at *p≤0.05; †p≤0.1; 
p.b. – post-baseline 
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Figure 6.9 VFA concentrations at baseline and 6-months p.-b. based on dietary pattern in 
children with ASD 
 
a) Dietary pattern 1 – above median 


















b) Dietary Pattern 1 – Below Median  






























Figure 6.9 (cont.) 
 
c) Dietary Pattern 2 – Above Median 

















d) Dietary Pattern 2 – Below Median 
 

















Median (IQR); *p≤0.05; †p≤0.1; Dietary patterns were derived from food frequency 
questionnaire and principal component analysis (Chapter 5); CONT, unaffected controls; ASD, 
Autism Spectrum Disorder; DMB, dry matter basis; SCFA, short chain fatty acids; BCFA, 











Table 6.13 Food group and nutrient intake at baseline, 6 weeks post-baseline and 6 months post-
baseline based on dietary pattern in CONT children 
 
a) Dietary pattern 1 above median 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Food Group (serving per day)1    
Protein 0.9 (0.5-1.7) 1.9 (1.2-2.6) 1.5 (1.1-2.2)* 
Snacks 0.9 (0.6-1.5) 0.7 (0.5-1.2) 0.5 (0.3-0.6)† 
Nutrient2    
Protein (g) 48 (34-56) 53 (47-74) 58 (42-63)† 
Vitamin B12 (μg) 2.7 (2.0-3.4) 3.2 (2.1-5.1) 3.6 (3.1-4.4)† 
Sodium (mg) 1673 (1380-2458) 2109 (1549-3352) 2044 (1730-
2919)* 
Manganese (mg) 2.4 (1.9-3.5) 2.0 (1.4-3.3) 1.9 (1.4-2.6)* 
Added sugars (g) 40 (28-44) 31 (26-41) 24 (15-36)* 
Whole grains (g) 0.7 (0.4-1.7) 0.5 (0.3-1.2) 0.4 (0.09-1.2)† 
 
 
b) Dietary pattern 1 below median. 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Food Group (serving per day)1    
Fruit 1.9 (1.4-2.2) 1.8 (1.0-2.3) 2.5 (2.1-2.6)* 
Grains  0.6 (0.5-1.0) 0.7 (0.5-0.99) 0.8 (0.6-1.0)† 
Nutrient2    
Vitamin D (μg) 4.99 (3.8-6.4) 4.3 (2.5-6.5) 2.5 (2.2-4.4)* 
Riboflavin (μg) 1.7 (1.4-1.9) 1.6 (1.3-1.9) 1.3 (1.2-1.6)* 
Vitamin B12 (μg) 3.5 (3.2-5.1) 3.5 (2.2-4.4) 3.1 (2.1-3.6)† 



















Table 6.13 (cont.)  
 
c) Dietary Pattern 2 above median 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Nutrients2    
Vitamin K (μg) 51 (38-73) 51 (33-77) 34 (25-47)* 
Vitamin C (μg) 67 (48-131) 53 (29-74) 37 (21-54)* 
Added sugars (g) 33 (27-44) 28 (17-40) 27 (15-50)† 
 
 
d) Dietary Pattern 2 below median 
 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Food group (servings per day1    
Fruit  1.7 (1.3-2.0) 1.8 (1.4-2.9) 2.5 (2.1-3.0)* 
Legumes, nuts, and seeds 0.3 (0.2-0.7) 0.3 (0.2-0.9) 0.2 (0.16-0.28)* 
Refined carbohydrates 0.8 (0.5-1.2) 0.7 (0.6-0.9) 1.2 (0.2-1.9)† 
Protein 0.8 (0.6-1.3) 1.2 (0.9-2.1) 1.3 (1.2-1.7)* 
Nutrients2    
Total fat (g) 51 (42-56) 54 (48-71) 60 (46-68)* 
SFA (g) 17 (13-22) 19 (15-28) 21 (14-31)* 
Vitamin K (μg) 36 (23-50) 42 (25-81) 54 (37-73)† 
Whole grains (g) 1.6 (0.8-2.6) 0.8 (0.3-1.4) 0.9 (0.5-1.2)* 
Data expressed as Median (IQR); *p≤0.05; †p≤0.1; p.b. – post-baseline;  
1Food groups derived from food frequency questionnaire 






Table 6.14 Relative abundance of bacterial genera in feces at baseline, 6 weeks and 6 months 
post-baseline based on dietary patterns in CONT children 
 
a) Dietary Pattern 1 above median 
Bacterial taxa (% of sequences) Baseline 6-weeks p.-b. 6 months p.-b. 
Parabacteroides 1.8 (0.7-3.4) 1.2 (0.6-2.0) 1.0 (0.2-1.5)† 
 
b) Dietary Pattern 1 below median 
Bacterial taxa (% of 
sequences) 
Baseline 6-weeks p.-b. 6 months p.-b. 
Butyrivibrio 0.02 (0.001-0.07) 0.02 (0.004-0.05) 0.01 (0.002-0.02)* 
Veillonella 0.02 (0.01-0.05) 0.01 (0.001-0.04) 0.004 (0.001-0.03)* 
 
c) Dietary Pattern 2 above median 
Bacterial taxa (% of 
sequences) 
Baseline 6-weeks p.-b. 6 months p.-b. 
Proteobacteria 0.84 (0.41-1.74) 0.59 (0.16-1.91) 0.36 (0.22-1.06)* 
Slackia 0 (0-0) 0 (0-0) 0.001 (0-0.002)† 
Data expressed as median (IQR); within same group and row, significant at *p≤0.05; †p≤0.1; 





Table 6.15 Nutrient intake at baseline, 6-weeks and 6-months post baseline in children with 
moderate ASD symptoms  
 
Nutrient intake1 Baseline 6-weeks p.-b. 6 months p.-b. 
Vitamin A (μg) 473 (277-651) 331 (225-502) 252 (160-306)* 
Vitamin B12 
(mg) 
2.9 (2.2-3.5) 2.6 (1.6-3.2) 2.3 (1.5-2.6)† 
Sodium (g) 1987 (1635-2261) 1606 (1313-2179) 1445 (1272-
2125)† 
Added sugars (g) 36 (26-44) 31 (17-45) 17 (13-24)† 
Data expressed as median (IQR); *p≤0.05; †p≤0.1 in same group and row significant;  
1nutrient intake derived from 3-day food diary 





Table 6.16 Microbiota composition and VFA concentration in children with ASD at baseline, 6-
week and 6-month post-baseline based on severity of SOCDEF symptoms 
 
a) Microbiota and VFA changes in children with moderate social deficit symptoms 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Bacteria (relative 
abundance) 
   
Staphylococcus 0.009 (0.004-0.02) 0.02 (0.006-0.07) 0.007 (0.002-0.09)† 
Clostridium 0.38 (0.11-0.68) 0.14 (0.07-0.46) 0.05 (0.02-0.14)* 
 
VFA (μmole/g (DMB)) 
   
Propionate 53 (38-82) . 36 (24-42)* 
Butyrate 61 (37-73) . 23 (22-31)* 
Isobutyrate 7.2 (5.5-10.0) . 4.6 (2.4-5.9)* 
Isovalerate 11 (6.4-15.0) . 6.4 (3.96-7.6)* 
 
 
b) Microbiota and VFA changes in children with severe social deficit symptoms 
 Baseline 6-weeks p.-b. 6 months p.-b. 
Bacteria (relative 
abundance) 
   
Clostridiaceae 0.97 (0.51-3.74) 1.62 (0.51-3.82) 0.35 (0.3-0.38)† 
Methanobrevibacter 0.0007 (0.0007-0.002) 0 (0-0.001) 0 (0-0.009)* 
 
VFA (μmole/g (DMB)) 
   
Acetate 253 (134-344) . 106 (92-127)* 
Propionate 56 (51-84) . 30 (26-38)* 
Butyrate 75 (64-80) . 41 (20-50)* 
Data expressed as median (IQR); *p≤0.05; †p≤0.1 in same group and row significant; VFA, 








Summary and Future Directions 
 
This research study aimed to further our understanding of the potential importance of 
dietary intake on the microbiota-brain connection in children with ASD. Previously published 
research has demonstrated that the GI microbiota differs between children with ASD and 
unaffected controls, that bacterial taxa can influence some symptoms of ASD and that dietary 
intake is often challenging in children with ASD. However, prior to this research no one study 
had combined these individual measurements in one research project. Here, for the first time, we 
demonstrate the impact of diet on the microbiota as well as long-term variability patterns in 
children with ASD.  
To first investigate whether the ASD population of this study also harbors a “dysbiotic” 
microbiome that could potentially impact some symptoms of ASD, the first part of this research 
project investigated microbiota composition and microbial metabolites using16S rRNA 
sequencing, quantitative Polymerase Chain Reaction and gas chromatography (Chapter 4). In 
support of our hypothesis and consistent with the literature, the microbiota composition of 
children with ASD differed from unaffected controls and higher concentrations of volatile fatty 
acids (VFAs) were noted. Specifically, higher abundances of Clostridiaceae, Clostridiales and 
Clostridium were observed in children with ASD, which are bacterial taxa of high interest in 
ASD symptomology. Likewise, Peptostreptococaceae and Faecalibacterium were two bacterial 
taxa identify to positively predict social deficit scores.  
Next, the impact of dietary factors on the GI microbiota composition and potential three-
way interactions between diet-microbiota-ASD symptoms were investigated using correlation 
analysis, dietary pattern analysis, association with feeding problems (i.e., picky eating) and 
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moderation analysis (Chapter 5). First, we found that bacteria shown to differ between the groups 
(e.g., Clostridiales) and those positively predicting social deficit scores (i.e., Faecalibacterium) 
showed strong correlations with food (e.g., fruit, fried food) and nutrient (e.g., insoluble dietary 
fiber) intake, suggesting that dietary intake could contribute to the microbial differences 
observed in children with ASD. Second, feeding problems often observed in children with ASD 
(e.g., picky eating or repetitive eating pattern) were associated with unique microbial abundances 
and VFA concentrations. And third, in support of our hypothesis, a dietary pattern characterized 
by high intakes of healthy foods such as fruits, vegetables, legumes, nuts and seeds and grains 
was associated with microbial taxa known to exhibit beneficial effects on the host. On the other 
hand, an unhealthier dietary pattern defined by high intakes of fried food, kid’s meals, snacks 
and protein food harbored a microbial profile that was represented by potentially harmful 
bacteria and also demonstrated higher concentrations of VFAs. Contrary to our hypothesis, diet-
induced microbial profiles showed no relationship with social deficit symptoms, but associations 
with GI symptoms were observed. This lack of association might be due to the number of 
children included in the study or the ASD symptoms measured. Previous studies have reported 
that the GI microbiota might be more strongly correlated with other symptoms of ASD (i.e., 
restricted and repetitive behaviors). 
Lastly, longitudinal samples were analyzed in order to investigate temporal microbial 
variability and the impact of diet on microbiota stability in children with ASD (Chapter 6). 
Confirming our hypothesis we found that dietary measures were associated with long-term 
stability of the microbiota and that an unhealthier dietary pattern showed greater variability in 
microbial structure. However, contrary to our hypothesis, the microbial profile of children with 
ASD was not more variable when compared to unaffected controls, but both group exhibited 
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unique stabilizing and destabilizing microbial taxa. Also discordant to our hypothesis we found 
that less variability in the presence and absence of OTUs was correlated with more severe social 
deficit symptoms in children with ASD. This observation could potentially attributed to the 
constant presence of bacteria hypothesized to influence ASD symptomology (i.e., Clostridium).  
Taken together, the results presented herein demonstrate that the GI microbiota 
composition as well as microbial stability is strongly influenced by dietary intake in children 
with ASD. Thus, future research investigating the microbiota composition of children with ASD 
should consider collecting information on dietary intake to delineate whether the microbial 
differences observed in children with ASD are due to dietary factors or are inherent to ASD 
itself. The data presented in this dissertation can serve as preliminary evidence for several future 
research studies. Overall, studies using larger sample sizes are required to define an “ASD 
microbiome” and to provide sufficient power to demonstrate the importance in considering 
dietary intake when analyzing the GI microbiota composition.  
First, studies measuring other symptoms of ASD (e.g., restricted/repetitive behaviors) and 
potentially using better tools to measure ASD symptoms (e.g., Autism Diagnostic Interview – 
Revised or ADOS) are needed to further understand whether diet can be a moderator of the 
microbiota-brain connection. Due to the young age of the children in this cohort, the PDDBI-SV 
was the best validated tool available to quantify ASD symptoms in children under the age of 4. 
While this tool can be used in research (Cohen, 2011), it is limited by the ability to only measure 
social deficit symptoms. Previous studies have indicated that restricted and repetitive behaviors 
might be more influenced by the microbiota composition (Tomova et al., 2015). Measuring other 
symptoms of ASD and utilizing similar analytic approaches to the ones described herein can 
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provide more important information on the diet-microbiota-ASD symptom connection and could 
provide further evidence to potentially use diet as a managing strategy for ASD symptoms. 
Second, future research should also focus on further investigating the microbial stability 
in children with ASD and determine whether microbial changes can be linked to symptom 
changes. Although previous research has indicated that microbial stability is more beneficial 
(Bäckhed et al., 2012), herein we observed the opposite relationship, indicating that children 
with ASD and less microbiome variability had higher social deficit scores. Assessing whether 
this relationship can be observed in other cohorts is important to determine whether it is of 
importance in ASD symptomology. Future studies collecting samples more frequently could 
provide more valuable evidence. Likewise, previous research has shown that the onset of ASD 
symptoms could be associated with GI disturbance and higher levels of Clostridiales (Williams 
et al., 2011). Thus, future studies investigating the microbiota of at-risk children (i.e., siblings of 
children with ASD) could delineate whether changes in the microbiota composition could 
contribute to the development of ASD symptoms.  
Third, associations between feeding behavior (e.g., picky eating, repetitive eating 
patterns, specialty diet) and microbiota composition and variability were based on single item 
questions that were answered by the parents. Thus, these associations hold some bias due to the 
nature of the questions. Future studies using home observations or detailed questionnaires (e.g., 
Brief Autism Mealtime Behavior Inventory (Lukens and Linscheid, 2008) to assess foods 
included in the diet will provide more unbiased information on the impact of exhibited feeding 
problems on the microbiota.  
Finally, due to the observational nature of this dissertation, it was not possible to 
investigate a cause-and-effect relationship between ASD and the microbiota. Therefore, future 
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studies are needed to investigate underlying mechanisms of the microbiota-brain axis in children 
with ASD and delineate how the higher abundance of some bacteria could potentially influence 
symptomology. Thereby, gnotobiotic animal models could be of fundamental importance. 
Likewise, randomized controlled trials investigating the potential of dietary interventions in the 
management of some symptoms of ASD should collect fecal samples in order to investigate 
whether the GI microbiota could be a potential link between diet and symptoms. Studies have 
proposed that the GI microbiota could be a key mediator in the diet-brain connection (Dawson et 
al., 2016) and animal models have demonstrated that diet-induced changes in the GI microbiota 
could result in behavioral changes (Li et al., 2009, Pyndt Jørgensen et al., 2014). Expanding 
these research efforts into the ASD population could provide valuable evidence for potential new 
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APPENDIX A.  
Differences in Microbiota, VFA and Nutrition Between Children with ASD and Their 
Siblings 
A.1 Introduction.  
The gastrointestinal (GI) microbiota composition is influenced by various environmental 
(i.e., diet, living environment) as well as genetic factors. Thus, including siblings as a control 
group when analyzing the microbiota in disease states is an attractive option in order to control 
for as many variables as possible that could potentially impact the GI microbiota. Previous 
studies investigating the microbiota composition in children with ASD that included a group of 
siblings as a control group showed that siblings often fall between children with ASD and 
unrelated controls in the microbiota composition (Finegold et al., 2010; Tomova et al., 2015). 
Therefore, we recruited siblings as control subjects for the current study. Initially, 15 sibling 
controls were recruited, but baseline samples were only collected from 7 of them. Due to the 
small sample size, the siblings were not included as a group in the overall analysis. Thus, the 




All samples were collected and analyzed as previously described in Chapter 4 and 5. 
Children with ASD were matched with their perspective siblings. For some children with ASD, 
more than one sibling was enrolled in the study. Thus, the sample size for this analysis is n=5 for 






The demographics for each group are shown in Table A.1. Children with ASD were 
slightly older (4.4±1.7 years) vs. than their siblings (3.5±1.9 years); however, there was no 
statistical difference between the groups. Children with ASD were slightly heavier (p=0.09) and 
taller (p=0.08) compared to their siblings, but the mean BMI did not differ between the groups. 
No significant difference between nutritional supplement use, route of birth, gestational age or 
early feeding mode. Frequent antibiotic use was reported in one child with ASD but in none of 
the siblings (p=0.003). Regarding eating behavior, children with ASD were less likely (p=0.05) 
to include 20 or more foods in their diet and were more likely to have a repetitive eating pattern 
(p=0.008) compared to their siblings. No difference was observed regarding picky eating 
behavior.  
 
GI Severity and Stool Consistency  
Gastrointestinal characteristics are shown in Table A.2. Overall the GI severity score did 
not differ between the groups. Only abdominal pain scores were higher (p=0.03) in children with 
ASD compared to their siblings. Additionally, stool consistency as measured by the Bristol stool 
chart did not differ between the groups. 
 
Microbiota Composition 
α- diversity (Chao 1 Index, Shannon, Index, Simpson Index, observed OTUs) and β-
diversity did not differ between the groups (Table A.3).  
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Abundances of individual bacterial taxa are shown in Table A.4. No differences at the 
phyla, order or family level were detected between the groups. On the genera level, children with 
ASD tended to have higher abundance of Leuconostoc (p=0.07) and Sutterella (p=0.06), but 
lower abundance of Oscillospira (p=0.06) and Coprobacillus (p=0.07).  
 
VFA Concentration 
Fecal VFA concentrations did not differ between the groups (Figure A.1).  
 
Nutrient intake  
Levels of nutrient intake derived from the 3-day food record is shown in Table A.5. 
Children with ASD had higher intakes of energy (p=0.09), total fat (p=0.01), MUFA (p=0.01) 
and PUFA (p=0.01) compared to their siblings.  
 
Servings of Food Groups 
Intakes of servings of food groups in both groups are shown in Table A.6. Siblings 
tended to have higher intakes of starchy foods (p=0.07) as well as Kid’s meals (p=0.07) 
compared with children with ASD.  
 
A.4 Discussion  
There is increasing interest to study the siblings of children with ASD to study potential 
early biomarkers (biochemical and behaviorally) of ASD in a genetically at-risk population. 
When studying the microbiota composition, including subjects living in the same household and 
having similar genetics can provide important points of control. Previous studies have shown that 
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genetics (Hallmayer et al., 2011) impacts the GI microbiota. Additionally, families tended to 
have more similar microbiota structures compared to unrelated subjects (Song et al., 2013). 
Various studies have shown that the GI microbiota composition of children with ASD is more 
similar to their siblings compared to unrelated controls (Tomova et al., 2015; Wang et al., 2011) 
This could be due to similar diet, living environment or transmission of bacteria between siblings 
(Finegold et al., 2010).  
Here, we observed that the microbiota composition was more similar between children 
with ASD and their siblings compared to unaffected controls (Chapter 4). Likewise, no 
differences were observed in concentration of VFAs. Although siblings were less likely to 
include more than 20 foods in their diet and were more likely to exhibit repetitive eating patterns, 
only minimal differences were noted regarding the food and nutrient intake. These minimal 
differences in the intake of food could be attributed to the fact that siblings are most likely 
offered similar foods at the home. Interestingly, abdominal pain scores were higher in children 
with ASD, suggesting that the GI tract might be important in ASD symptomology.  
These results illustrate that using a sibling control group can be important in controlling 
for factors such as living environment and genetics. Likewise, studying the microbiota of 
siblings can yield interesting new information on how the microbiota can potentially influence 
ASD development. Longitudinal studies including younger siblings of children with ASD would 
be interesting to elucidate whether the microbiota is dysbiotic in children that are more likely to 




A.5 Tables and Figures 
Table A. 1 Demographic characteristics of all study participants  
 
Characteristic ASD w/ 
SIB (n=5) 
SIB (n=7) p-value 











Weight (kg) 20±4.3 13.8±4.7 0.09 
Height (meters) 1.09±0.07 0.94±0.13 0.08 














































Early Feeding Mode (n (%)) 
Breast-fed only 



















































Data expressed as mean±SD or n 




Table A.2 Differences in GI Severity scores and stool consistency between children with ASD 
(ASD) and siblings  
 





























Stool Consistency (n)2 
Type 1 (separate hard lumps) 
Type 2 (sausage shaped but lumpy) 
Type 3 (sausage-shaped with cracks on 
surface) 
Type 4 (smooth and soft) 
Type 5 (soft blobs) 
Type 6 (mushy) 


















Data expressed as mean ± SD or n  
1GI severity scores were derived from the GI severity index (possible range 0-7) 





Table A.3 α-Diversity measures between children with ASD (ASD) and siblings (SIB) 
 
Diversity/Richness Measure ASD (n=5) SIB (n=7) p-value 
Shannon Index 5.6±0.3 5.7±0.5 NS 
Simpson Index 0.9±0.02 1±0.01 NS 
Observed OTUs 523±42 534±61 NS 
Chao 1 Index 584±39 571±51 NS 
Data expressed as mean ± SD;  





Table A.4 Relative abundances of bacterial taxa detected in feces of children with ASD (ASD) 
and siblings (SIB). 
 
Phyla ASD w/ SIB (n=5) SIB (n=7) p-value 
Euryarchaeota 0.02±0.03 0.02±0.05 NS 
Actinobacteria 7.15±8.2 8.48±7.1 NS 
Bacteroidetes 42.96±19.1 25.80±13.9 NS 
Cyanobacteria 0.00±0.00 0.01±0.02 NS 
Firmicutes 45.40±18 62.15±22.1 NS 
Fusobacteria 0.00±0 0.13±0.34 NS 
Proteobacteria 0.76±0.75 1.63±3.9 NS 
Tenericutes 0.00±0.00 0.61±1.6 NS 
Verrucomicrobia 3.71±7.6 0.02±2.3 NS 
 
Order ASD w/ SIB(n=5) SIB (n=7) p-value 
Bacteroidales 0.00±0.00 0.00±0.00 NS 
Streptophyta 0.003±0.006 0.01±0.02 NS 
Clostridiales 6.3±2.2 4.9±2.7 NS 
RF32 0.04±0.09 0.003±0.007 NS 
RF39 0.00±0.00 0.6±1.6 NS 
 
Family ASD w/ SIB (n=5) SIB (n=7) p-value 
Coriobacteriaceae 0.04±0.04 0.04±0.06 NS 
RF16 0.01±.03 0.01±0.03 NS 
Rikenellaceae 2±2.1 2.9±4.1 NS 
S24-7 0±0 0±0 NS 
Barnesiellaceae 0.7±1.5 0.5±1.2 NS 
Christensenellaceae 0.02±0.04 0.0006±0.005 NS 
Clostridiaceae 1.5±1.4 1.7±1.7 NS 
EtOH8 0±0 0±0 NS 
Lachnospiraceae 11.7±3.9 14±7.1 NS 
Peptostreptococcaceae 0.06±0.06 0.12±0.13 NS 
Mogibacteriaceae 0.01±0.01 0.007±0.02 NS 
Erysipelotrichaceae 0.3±0.4 1.12±1.3 NS 
Enterobacteriaceae 0.6±0.8 1.5±3.8 NS 
 
Genera ASD w/ SIB (n=5) SIB (n=7) p-value 
Archea – Euryarchaeota     
Methanobrevibacter 0.02±0.03 0.02±0.05 NS 
Actinobacteria    
Bifidobacterium 9.8±0.09 10.1±0.05 NS 
Adlercreutzia 0.01±0.01 0.02±0.03 NS 
Collinsella 2.2±3.2 1.3±1.8 NS 
Eggerthella 0.05±0.04 0.15±0.16 NS 
Slackia 0.0008±0.0007 0.001±0.002 NS 
Bacteroidetes    
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Table A.4 (cont.)    
Genera ASD w/ SIB (n=5) SIB (n=7) p-value 
Bacteroides 23.1±16.1 17.1±3.9 NS 
Parabacteroides 1.1±1.1 3.6±6.9 NS 
Prevotella 11±0.6 10.2±0.8 NS 
Alistipes 0.02±0.05 0.2±0.5 NS 
Butyricimonas 0.03±0.07 0.01±0.03 NS 
Odoribacter 0.07±0.09 0.07±.05 NS 
Paraprevotella 0.0003±0.0006 0.0005±0.0005 NS 
Prevotella 0.07±0.2 0.02±0.05 NS 
Firmicutes    
Staphylococcus 0.07±0.1 0.08±0.08 NS 
Enterococcus 0.04±0.09 0.0002±0.0003 NS 
Lactobacillus 7.1±0.6 7.1±0.9 NS 
Leuconostoc 0.0004±0.0005 0±0 0.07 
Lactococcus 0.03±0.06 0.05±0.1 NS 
Streptococcus 0.9±1.3 3.9±5.1 NS 
Turicibacter 0.09±0.12 0.06±0.03 NS 
02d06 0.01±0.009 0.01±0.02 NS 
Clostridaceae_Clostridium 1.00±1.4 0.55±0.8 NS 
SMB53 2.11±1.6 4.18±4.4 NS 
Sarcina 0.05±0.1 0.00±0.002 NS 
Eubacterium 0.007±0.008 0.2±.6 NS 
Anaerostipes 0.18±0.2 0.05±0.03 NS 
Blautia 2.22±1.5 1.70±1 NS 
Butyrivibrio 0.03±0.01 0.02±0.0007 NS 
Coprococcus 4.94±3.3 5.02±1.3 NS 
Dorea 0.83±0.5 1.43±0.9 NS 
Lachnospira 0.19±0.3 0.07±0.08 NS 
Roseburia 0.46±0.6 1.26±0.1.4 NS 
Peptococcus 0±0 0±0 NS 







Faecalibacterium 11.80±9.8 6.94±7.2 NS 
Oscillospira 0.25±0.2 0.57±0.4 0.06 
Ruminococcus 3.21±3.4 2.16±1.5 NS 
Acidaminococcus 0.04±0.09 0.02±0.06 NS 
Dialister 0.98±1.3 2.47±6.0 NS 
Megamonas 0.00±0.00 0.00±0.00 NS 
Megasphaera 0.00±0.00 0.00±0.00 NS 
Phascolarctobacterium 0.13±0.27 0.07±0.14 NS 
Succiniclasticum 0.00±0.00 0.00±0.00 NS 
Veillonella 0.14±0.26 0.06±0.05 NS 
Catenibacterium 0.00±0.00 0.00±0.00 NS 
Coprobacillus 0.00±0.00 0.01±0.009 0.07 
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Table A.4 (cont.)    
Genera ASD w/ SIB (n=5) SIB (n=7) p-value 
Holdemania 0.01±0.007 0.01±0.01 NS 
Fusobacteria    
Fusobacterium 0±0 0.13±0.3 NS 
Proteobacteria    
Sutterella 0.3±0.4 0.04±0.04 0.06 
Bilophila 0.03±0.06 0.03±0.03 NS 
Campylobacter 0.00±0.00 0.00±0.00 NS 
Haemophilus 0.74±1.5 0.03±.03 NS 
Verrucomicrobia    
Akkermansia 0.26±0.4 1.17±2.3 NS 

























Mean ± SD  



































Table A.5 Comparison of Nutrient Intake between children with ASD (ASD) and their siblings 
(SIB).  





Macronutrients:    
Energy (kcal) 1487±455 1063±338 0.09 
Total Fat (g) 64±23 39±9 0.08 
Omega-3 Fatty Acids (g) 1.1±0.4 0.7±0.2 0.07 
SFA (g) 22±11 14±4 NS 
MUFA (g) 22±7 13±3 0.01 
PUFA (g) 15±4 8.9±2.5 0.01 
Total Carbohydrate (g) 191±57 147±67 NS 
Total Sugars (g)   NS 
Added Sugars (g)  45±25 34±21 NS 
Total Grains (oz equivalents) 7.1±2.8 5.8±2.4 NS 
Whole Grains (oz equivalents) 0.8±1.3 0.8±1.2 NS 
Refined Grains (oz equivalents) 6.2±3 5±1.8 NS 
Total Protein (g) 42±17 34±8.4 NS 
Dietary Fiber    
Total Dietary Fiber (g) 11.7±5 8.0±4.7 NS 
Soluble Dietary Fiber (g) 4.3±1.2 3.1±1.6 NS 
Insoluble Dietary Fiber (g) 7.4±4.3 4.7±3.1 NS 
Pectin (g) 1.3±0.9 0.6±0.6 NS 
Vitamins     
Vitamin A (μg) 538±307 363±177 NS 
Vitamin D (μg) 2.1±1.7 3.4±3.2 NS 
Vitamin E (mg) 6.3±2.2 4.5±1.8 NS 
Vitamin K (μg) 39±21 23±12 NS 
Vitamin C (mg) 25±18 23±15 NS 
Thiamin (mg) 1.4±0.4 1.2±0.5 NS 
Riboflavin (mg) 1.6±0.7 1.4±0.8 NS 
Niacin (mg) 17±5.8 13±7.4 NS 
Pantothenic Acid (mg) 2.8±1.4 1.9±1 NS 
Vitamin B6 (mg) 1.5±0.7 1.1±0.8 NS 
Folate (μg) 310±247 330±333 NS 
Vitamin B12 (μg) 3.3±2 2.5±1.7 NS 
Minerals    
Calcium (mg) 737±282 675±29 NS 
Phosphorus (mg) 858±269 659±241 NS 
Magnesium (mg) 155±78 115±65 NS 
Iron(mg) 13 ±8.6 12.5±12.6 NS 
Zinc (mg) 6.4±5.3 6.7±5.4 NS 
Copper (mg) 0.6±0.3 0.44±0.2 NS 
Selenium (mg) 64±25 53±15 NS 
Sodium (mg) 2028±286 1711±260 NS 
Potassium (mg) 1290±259 886±535 NS 
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Table A.5 (cont.)    





Manganese (mg) 1.9±1 1.7±1.10 NS 
Data expressed as mean ± SD; nutrient intake derived from 3 day food records 
ASD, autism Spectrum disorder group; SIB, sibling group; MUFA, monounsaturated fatty acids; 
PUFA, polyunsaturated fatty acids 
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Table A.6 Differences in intake of food groups between children with ASD (ASD) and their 
siblings (SIB) 





Fruit 1.9±1.2 2.7±1.3 NS 
Vegetables 1.2±0.9 1.7±1.1 NS 
Legumes 0.3±0.2 0.2±0.1 NS 
Starchy Foods 0.2±0.1 0.4±0.3 0.07 
Starchy Vegetables 0.5±0.4 0.5±0.3 NS 
Juice  0.6±0.1 0.5±0.4 NS 
Sweetened Beverages 0.5±0.1 0.4±0.4 NS 
Grains 0.7±0.1 0.8±0.8 NS 
Refined 
Carbohydrates 
1.2±0.9 1.2±0.5 NS 
Fried Foods 0.2±0.1 0.2±0.1 NS 
Protein 1.4±0.3 1.6±0.8 NS 
Dairy 3.8±1.2 3.7±2.2 NS 
Snack  1.3±0.8 1.1±0.6 NS 
Sweets 2.9±1.8 1.8±1.2 NS 
Kid’s Meal 0.7±0.2 1.3±0.5 0.07 
Fish 0.1±0.1 0.1±0.1 NS 
Condiments 0.4±0.1 0.3±0.2 NS 





YAQ Dietary Pattern Groupings 
 
Food Group Foods included 
Fruit Grapes, Bananas, Strawberries, Blueberries, Peaches, Plums, Apricots, 
Apples, Applesauce, Pears, Oranges, Grapefruit, Watermelon, 
Pineapple, Cantaloupe, Melon 
Vegetables Green Beans, Broccoli, Cauliflower, Mixed Vegetables, Spinach, 
Collard Greens, Kale, Cooked Spinach, Bell Peppers, Zucchini, 
Summer Squash, Eggplant, Carrots, Celery, Tomatoes, Lettuce, Tossed 
Salad, Coleslaw, Cabbage, Okra 
Legumes, Nuts and 
Seeds 
Beans, Lentils, Peanuts, Other Nuts, Mixed Dried Fruit Trail Mix, 
Seeds 
Starchy Vegetables Corn, Peas, Potatoes, Yams, Sweet Potatoes 
Starchy Foods Lasagna, Baked Ziti, Ravioli, Spaghetti or Pasta with Tomato Sauce, 
Noodles or Pasta (plain), Pasta Salad, Potato Salad, 
Juice  Fruit Juice, Tomato Juice, V8 fusion 
Sweetened non-dairy 
beverages 
Diet Soda/Pop, Soda/Pop, Iced tea, Sugar Free or Low Calorie Drinks, 
Energy Drinks 
Grains Oatmeal, Whole Wheat Bread, Brown Rice 
Refined 
Carbohydrates 
White Bread Pita Bread, English Muffins, Bagels, Rolls, Muffin or 
Cornbread, Croissant, Biscuit, White Rice, Pancakes, Waffles, Corn or 
Flour Tortilla 
Fried Foods French Toast, French Fries, Tater Tots, Hash Browns 
Protein Foods Chicken, Turkey, Beef, Pork, Lamb, Meatballs, Salami, Bologna, Tuna, 
Sausage, Eggs, Bacon, Soy Dishes, Liver 
Dairy Yogurt, Butter, Margarine, Whipped Cream, Milk, Cheese, Cream 
Cheese, Milkshakes, Breakfast Drinks, Cottage and Ricotta Cheese, 
Frozen Yogurt, Ice Cream 
Snacks Pretzels, Graham Crackers, Crackers, Potato Chips, Corn Chips, 
Doritos, Snack Bars, Energy Bars, Protein Bars, Popcorn 
Sweets Fruit Snack, Cake, Cupcake, Pie, Pudding, Jello, Popsicle, Jams, 
Jellies, Syrup, Honey, Snack Cakes, Donuts, Cookies, Brownies, 
Chocolate, Other Candy Bars, Other Candy without Chocolate, 
Poptarts, Danish, Cinnamon Rolls, Pastry, Peanut Butter and Jelly 
Snacks 
Kids Meals Chicken Nuggets, Fish Sticks, Hamburger. Hot Dogs, Macaroni and 
Cheese, Pizza, Burritos, Tacos, Veggieburger, Cheeseburger, Grilled 
Cheese Sandwich 
Fish Fish, Shrimp, Lobster, Scallops 
Condiments Ketchup, Mayonnaise, Salad Dressing, Salsa 
 
